UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-K
 
  (Mark One)
 
  x            ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
 For the fiscal year ended  December 31, 2013
 
  o            TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
 For the transition period from [   ] to [   ]
 
 Commission file number  000-49877
 
ON TRACK INNOVATIONS LTD.
(Name of registrant as specified in its charter)
 
Israel
 
N/A
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
 
Z.H.R. Industrial Zone
P.O. Box 32, Rosh Pina, Israel
 
 
1200000
(Address of principal executive offices)
 
(Zip Code)
 
Registrant's telephone number  + 972-4-6868000
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Ordinary Shares, par value NIS 0.10 per share
 
Name of each exchange on which registered
NASDAQ Global Market
 
Securities registered pursuant to Section 12(g) of the Act:
 
  None.
(Title of class)
 
 
 

 
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.         
 
Yes  o    No  x
 
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.                  
 
Yes  o    No  x
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.                  
 
Yes  x    No o
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    
 
 Yes   x     No o
 
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.   x
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):
 
Large accelerated filer  o
Accelerated filer  o
Non-accelerated filer o
(do not check if a smaller reporting company)
Smaller reporting company  x   
                                                                                                     
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).            
 
Yes  o    No  x
 
State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked prices of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter:
 
$34,253,297 
 
 The number of shares of the registrant’s Ordinary Shares outstanding on March 20, 2014, was 33,140,867.
 
 
2

 
 
TABLE OF CONTENTS
 
 
5
5
18
36
36
37
37
 
38
38
39
39
53
53
53
53
54
 
55
55
67
73
76
76
 
78
78
 
In this annual report, unless otherwise specified, all dollar amounts are expressed in United States dollars.
 
As used in this annual report, the terms "we", "us", "our", “the Company”, and "OTI" mean On Track Innovations Ltd. and our subsidiaries and affiliates, unless otherwise indicated.
 
 
3

 
 
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
 
The statements contained in this Annual Report on Form 10-K, or Annual Report, that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as "believes," "intends," "plans" "expects," "may," "will," "should," or "anticipates" or the negative thereof or other variations thereon or comparable terminology, and similar expressions are intended to identify forward-looking statements.  We remind readers that forward-looking statements are merely predictions and therefore are inherently subject to uncertainties and other factors and involve known and unknown risks that could cause the actual results, performance, levels of activity, or our achievements, or industry results, to be materially different from any actual future results, performance, levels of activity, or our achievements, or industry results, expressed or implied by such forward-looking statements. Such forward-looking statements may appear in Item 1 – “Business” and Item 7 – “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” as well as elsewhere in this Annual Report and include, among other statements, statements regarding the following:  
 
 
·
the expected development and potential benefits from our existing or future products or our intellectual property;
 
 
·
increased generation of revenues from licensing, transaction fees and/or other arrangements;
 
 
·
future sources of revenue, ongoing relationships with current and future suppliers, customers, end-user customers and resellers;
 
 
·
our intention to generate additional recurring revenues and transaction fees;
 
 
·
our anticipation that revenues from our operations in Asia or elsewhere will grow in the next years;
 
 
·
future costs and expenses and adequacy of capital resources;
 
 
·
the prospects of entering into additional license, distribution, value added reseller agreements, or other forms of cooperation or business relations with other companies;
 
 
·
our intention to continue to expand our market presence via strategic partnerships around the globe;
 
 
·
the potential market demand for our existing or future products, including, without limitation, the expansion of our MediSmart product into additional countries in Eastern Africa;
 
 
·
our plans to increase our cash resources, such as by capitalizing on our patent portfolio, sales of assets or parts of our business or raising funds;
 
 
·
our plans to reduce our financial expenses, including repayment of debt instruments;
 
 
·
our expectations regarding our short-term and long-term capital requirements;
 
 
·
our intention to continue to invest in research and development both through organic growth and through purchases of other businesses;
 
 
·
our outlook for the coming months; and
 
 
·
information with respect to any other plans and strategies for our business.
 
The factors discussed herein, including those risk factors described in Item 1A. “Risk Factors”, and expressed from time to time in our press releases or filings with the Securities and Exchange Commission, or the SEC, could cause actual results and developments to be materially different from those expressed in or implied by such statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak and are made only as of the date of this filing, and except as required by law, we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
 
 
4

 
 
PART I
 
Item 1.      Business.
 
General Overview
 
We innovate, design and deliver secure cashless payment products and solutions.
 
We were incorporated under the laws of the State of Israel on February 15, 1990, under the name of De-Bug Innovations Ltd., with unlimited duration.  Our name was changed to On Track Innovations Ltd. on July 8, 1991. We are registered with the Israeli Registrar of Companies, under registration number 52-004286-2 and our Ordinary Shares are traded in the NASDAQ Global Market, or NASDAQ, under symbol OTIV.  
 
We are a pioneer and leading developer of cutting-edge secure cashless payment solutions and for over two decades, we have provided innovative technology to worldwide enterprises.
 
Our field-proven suite of cashless payment solutions is based on an extensive IP portfolio boasting 28 patent families, patents and patent applications worldwide. Since 1990, we have built an international reputation for reliability and innovation – deploying hundreds of solutions for banking, mobile network operators, vending, mass transit, petroleum and parking.
 
To support various solutions deployed in 55 countries across the globe, we operate a global network of regional offices, franchisees, distributors and partners.
 
In 2013, we made a strategic decision to focus our efforts on our core business of providing cashless payment solutions based amongst others on contactless and near-field communication, or NFC, technology and to divest businesses in the Company that are not within this business scope. According to our new strategy, in August 2013 we entered into an agreement with Supercom Ltd. for the sale of our SmartID division, including certain assets, transfer of related employees, subsidiaries directly related to the SmartID division (OTI Panama S.A. (Panama), OTI Tanzania Ltd. (Tanzania), Otignia Licensing LLP (Israel), Digoti Ltd. (Israel), and Millennium Card’s Technology Limited (Hong Kong)), and certain intellectual property directly related to the SmartID division. This sale was closed on December 26, 2013. This division was focused mainly on system integration and diminished our ability to focus on the strong competitive advantages in our core business.
 
In addition , in August 2013 we divested the operations of Parx France S.A.S., or Parx France, a distributor of our EasyPark parking solution in certain French speaking markets, which was acquired by local French private investors, while retaining exclusive distribution rights on certain French territories, subject to certain commercial terms. This divestiture demonstrates part of our new strategy to focus our business model as a business-to-business provider in partnerships with local business partners, rather than implementing the business-to-consumer approach we have taken in some of our markets.
 
Following the closing of an agreement reached in December 2013, on February 28, 2014 we also sold our wholly owned German subsidiary, Intercard System Electronics GmbH, or Intercard, that manufactures electronic assemblies and devices, including some of our NFC readers and other non-OTI related products.
 
By optimizing our operational structure, we may better leverage our core competencies in the areas of cashless payment solutions. In addition, these divestures allow us to focus on building our sales momentum, leveraging our growing industry adoption as a technology leader in the fast growing NFC and cashless payments markets, and reducing unnecessary headcount and costs. We believe that this approach will allow us to expand faster and into more new territories.
 
On March 20, 2014 we were awarded the silver medal of the 2014 PYMNTS Innovator Award in the ‘Best Comeback Story’ category of The Innovation Project™ 2014, among more than 500 companies that participate in The Innovation Project™.
 
 
5

 
 
Our Markets
 
We provide our cashless payment solutions for three major vertical markets:
 
Retail and Mass Transit Ticketing –
 
A.        Retail - The high cost of cash, cash related crime and cash impact on creating 'black economies' are major forces that drive markets to look for "Cashless Payment Solutions". Embraced by retail organizations across the globe, mobile payments, NFC and contactless technologies are helping create a cashless, paperless world.
 
As one of the pioneers of cashless payment technology, we have been working closely with companies in diverse industries and markets for over two decades. During this time, we have honed our skills at designing industry-tailored solutions that enable our banking, mobile operators, unattended solutions, and closed loop payment systems operators to achieve their goals more efficiently and more cost-effectively.
 
Our cashless payment solutions for the retail market worldwide are managed by our Company from its headquarters in Israel.
   
 
B.             Mass Transit Ticketing – The growing need for mass transit ticketing systems and services, together with the migration to contactless smart cards as the main mean for mass transit payments, have led to the development of a full unattended mass transit ticketing system by our wholly-owned Polish subsidiary ASEC S.A., or ASEC, initially for the market in Poland.
 
The system is comprised of attended and unattended Points of Sale, or POS, terminals and is fully managed by a back office solution for a full end to end turnkey service.
 
Our solutions for the mass transit ticketing market in Poland are managed by ASEC.
   
 
Vehicle Fueling – Rising fuel costs mean that customers of all types are more cost-conscious when it comes to fueling. Commercial organizations with multiple vehicles are especially sensitive to the impact of fuel expenses on their profitability.
 
Our petroleum payment solutions enable customers to precisely and effortlessly control and manage refueling operations – including automatic payments for less gas station downtime, complete remote transaction and fuel usage reporting, and tracking of odometer and/or engine operating hours.
 
Easily deployed and seamlessly integrated with existing gas station infrastructure, our EasyFuel Plus® solution is a wireless, cashless, cardless and paperless refueling tracking and payment solution, providing customers with maximum flexibility and security.
 
Our solutions for the petroleum market are managed by OTI PetroSmart (PTY) Ltd. (formerly named OTI Africa (PTY) Ltd.), or OTI PetroSmart, a wholly-owned subsidiary based in South Africa.
 
 
6

 
 
 
 
Parking – With 40% of all municipal parking sessions under 20 minutes, municipalities and city drivers need a fast, simple, and seamless on-street and parking lot payment system. Providing such a system raises municipal parking revenues, lowers enforcement overhead, and improves driver satisfaction.
 
Our EasyPark® System is a fully one-stop-shop integrated parking fee collection and parking management solution. Encompassing the full scope of parking operations from both the municipal and driver sides, EasyPark® enables cities to improve parking services, optimize operations, cut costs, increase compliance, reduce traffic congestion and pollution, and provide better service to drivers and residents.
 
Our solutions for the parking market worldwide are managed by PARX Ltd., or PARX, a subsidiary of the Company, based in Israel.
 
Our solutions for the parking market in Israel are managed by Easy Park Ltd., or Easy Park, a subsidiary of the Company, based in Israel.
 
Our Products
 
Below are the details of our offering for each of the above mentioned vertical markets.
 
Retail and Mass Transit Ticketing Market
 
 
A.
Retail
 
WAVE
 
Our innovative and proprietary  WAVE  solution adds NFC, contactless payment and security capabilities to existing iPhone® and Android® mobile devices. WAVE is completely Subscriber Identity Module, or SIM, operating system and handset-agnostic, and offers banks, loyalty card vendors, mobile network operators, or MNOs, mass transit operators, closed campus operators and other diverse vendors a cost-effective, post-market mobile payment add-on option, with quick time-to-market and cost effective implementation. With WAVE , mobile network stakeholders can rapidly rollout new services and create new revenue opportunities, all with minimal investment and implementation overhead.
 
Flexible as well as cost-effective, attaching the  WAVE  dongle to any handset requires no expertise or special tooling. WAVE’s contactless interface supports contactless payment for MasterCard, Visa and other card associations, debit and credit, e-Purse, mass transit ticketing, e-coupons, loyalty program and healthcare applications.
 
 
7

 
 
WAVE PKI
 
 
With a significant growth in the scope of daily online transactions and increasing danger of fraud, organizations are seeking tools that can seamlessly assure secured transactions and customer identification.
 
As more organizations implement Public Key Infrastructure, or PKI, solutions 1to authenticate consumers, new challenges arise. The majority of PKI endpoint devices support personal computers, but do not provide a solution for mobile devices, which have become increasingly prevalent in PKI transactions.
 
Our   WAVE   PKI is a device-agnostic add-on easily attached to the audio jacks of smartphones, tablets and PCs.
 
 
oti Payment Insert
 
 
Our   unique and field-proven   oti P ayment Insert is an innovative bridge to contactless payment – enabling the addition of NFC, contactless payment, MIFARE and NFC capabilities to most existing handset. Completely SIM, operating system, and handset-agnostic, our payment insert is a post-market accessory that can be rapidly and cost-effectively deployed with no special technical overhead.
 
oti Payment Insert supports contactless payment for MasterCard, Visa and other card associations, debit and credit, e-Purse, mass transit ticketing, e-coupons and loyalty programs. Leveraging oti Payment Insert , mobile network operators can gain first mover advantage, using existing subscriber handsets to deliver new services and create new revenue opportunities.
 
oti Readers
 
 
·
We supply NFC and contactless reader solutions to major payments point-of-sale providers. With over 23 years of experience, unique IP and know-how, technology like our matched antenna enables unparalleled quality and performance. Our solutions are Underwriters Laboratories, Inc., or UL, and Federal Communications Commission, or FCC, approved and MasterCard TQM (Terminal Quality Management) certified. Also, our reliability and performance are based on over two decades of experience with NFC and contactless solutions.
 
 
·
All of our NFC readers are certified by all leading card associations including, amongst others, Visa, MasterCard, Amex and Discover.
 
 
8

 
 
oti Saturn® 6500
 
oti Saturn® 6500 is a secured NFC and contactless reader built specifically for the unattended machine market, such as vending machines, providing quick and easy support for cashless payments.
 
oti   Saturn® 6500 offers convenient three-in-one cashless payment card options: magnetic strip, contact and contactless, in one small and stylish package. With modular design for easy installation and multiple connection options, the oti Saturn® 6500 is ideal for vending, pay-at-the-pump, and unattended payment services.
 
Available in multiple encryption configurations to ensure the highest level of security for all transaction types, the oti Saturn® 6500 is optimized to read data from a variety of sources, including NFC enabled phones, all types of credit cards, contactless key fobs and smart stickers  that comply with ISO 14443 type A, B and MIFARE.
 
 
The reader’s LCD display, LEDs and buzzer provide users with on-the-spot transaction confirmation and clear positive interactive feedback.
 
 
·
Based on our patented matched antenna technology, the oti Saturn® 6500 delivers:
 
 
§
Effective power consumption;
 
 
§
Reliable and stable communication;
 
 
§
Additional levels of security and encryption throughout the Radio Frequency, or RF, communication link.
 
oti Reader 6100
 
The oti Reader 6100 global ARM based Original Equipment Manufacturer, or OEM, reader module with integrated antenna is a compact and cost-effective contactless card reader board, designed for easy integration into mass transit validators and POS terminals.
 
Designed for seamless and simple OEM integration, the oti Reader 6100 includes a full-featured development environment, preloaded on-board payment applications (MasterCard PayPass, Visa PayWave, etc.) and smart or transparent mode options. Delivering unsurpassed price-performance, the oti Reader 6100 also supports NFC contactless payments and loyalty programs.
 
oti Saturn ® 6000
 
Our indoor countertop NFC and contactless payment reader, the oti Saturn® 6000, supports payment and loyalty programs and delivers an unsurpassed price-performance ratio. The enhanced features offered by oti Saturn® 6000 enable faster transactions and support for multiple applications and proprietary programs.
 
oti Saturn® 6000 utilizes an enhanced firmware architecture and is based on a multi-layer, multi-application approach wherein the application resides separately and securely, resulting in significant reduction of certification cost.
 
oti Saturn® 6000 is available with multiple encryption configurations to ensure the highest level of security for each transaction, and is optimized to read data from a variety of sources, including NFC enabled phones, all types of credit cards and contactless key fobs that comply with ISO 14443 type A, B and MIFARE support.​
 
 
 
9

 
 
oti Saturn® 6000 uses our patented matched antenna technology to provide:
 
 
·
Effective power consumption.
 
 
·
Reliable and stable communication.
 
 
·
Additional levels of security and encryption throughout the communication link.
 
 
·
oti Saturn® 6000 is equipped with a large display screen and is easily configured to support multiple languages. The reader features LEDs visible from both sides of the reader, offering quick transaction confirmation and provides an excellent customer experience at the point of sale.
 
 
B.
Mass Transit Ticketing
 
Our wholly owned subsidiary, ASEC, became the leading provider of contactless city transport and parking systems in Poland after ASEC's system for public transportation (metro, tramways, buses) and parking was installed in the city of Warsaw in 2004. ASEC has also become a premier provider in Poland of contactless prepaid card systems based on Global System for Mobile Communications, or GSM, while delivering such a system to be installed in press kiosks all over Poland.
 
Due to its market driven approach, its determination to explore new opportunities, and the continuous application of cutting edge technologies, ASEC has experienced a rapid growth since it was founded. The result is an impressive track record of innovative products that enable our customers to increase the efficiency of their business operations.
 
Our mass transit ticketing products offer, among others, the following benefits:
 
●   Security for information stored on a card and transferred between the card and the reader;
 
●   Reliable transfer of information to and from a card;
 
●   Durability, ease of use and multiple form factors, including credit card size solutions, key chains, tags, stickers and wristwatches;
 
●   Ease of installation and maintenance;
 
●   Ease of transition from other card technologies to our contactless microprocessor-based technology;
 
●   Support for multiple, independent applications on the same card; and
 
   Platform and device agnostic technology.

Vehicle Fueling Market
 
EasyFuel Plus®
 
Our petroleum payment solutions enable large and small customers to minutely and effortlessly control and manage refueling operations – including automatic payments for less gas station downtime, complete remote transaction and fuel usage reporting, and tracking of odometer and/or engine operating hours.
 
 
 
10

 
 
Easily deployed and seamlessly integrated with existing gas station infrastructure, our EasyFuel Plus ®  solution is a wireless, cashless, cardless and paperless refueling tracking and payment solution, providing customers with maximum flexibility and security.
 
Parking Market
 
EasyPark®
 
Our EasyPark ® set of parking solutions provides a fully integrated parking fee collection and parking management solution. Encompassing the full scope of parking operations from both the municipal and driver sides, EasyPark ® enables cities to improve parking services, optimize operations, cut costs, increase compliance, reduce traffic congestion and pollution, and provide better service to municipalities, drivers and residents.
 
EasyPark® In Vehicle Parking Meter (IVPM)
 
The core of the EasyPark® IVPM system is a durable, adaptable, contactless, multi-application smart card. It contains proprietary software and provides a simple and convenient solution, which can be used for all parking needs including on street parking, parking lots, toll roads, etc.
 
The EasyPark® system can be operated either as a stand-alone system or on top of traditional parking payment infrastructures to reduce cash handling and eliminate fraud.
 
EasyPark IVPM unique benefits:
 
 
·
A proven solution with outstanding track record
 
 
·
Simple to use
 
 
·
Cashless 
 
 
·
Driver pays only for the time used
 
 
·
Efficient and cost effective
 
 
·
Commercial model is attractive for all stakeholders
 
 
·
Based on reliable, secure and scalable technology
 
 
·
Friendly to the environment, no visual clutter 
 
 
·
No maintenance or risk of vandalism
 
 
·
A flexible and powerful back-office system.
 
EasyPark® Mobile
 
The EasyPark ® Mobile is a state of the art mobile parking payments system. The EasyPark ® Mobile can be used either as a standalone parking payment method or in conjunction with other payment methods such as the EasyPark ® PPM, Pay & Display machines and even with single space meters.
 
 
 
11

 
 
The EasyPark ® Mobile can serve for both on-street and off-street parking. Being a mobile payment method connected to the user's secured private account, EasyPark ® Mobile can be used for other types of payments such as for mass transportation using the NFC capability of the phone, payment for bike rental, and more.
 
EasyPark ® Mobile provides drivers with various input modes including interactive voice recognition systems, text messages (SMS), and a Smartphone application. EasyPark ® Mobile supports both pre-paid and post-paid options, and can be used either by registered users and non-registered occasional users.
 
In addition to payments, EasyPark ® Mobile also serves as a real-time information tool for municipalities to reach out to their residents. This is a major advantage to the city's management who wishes to have an efficient tool to inform and educate their residents.
 
The EasyPark ® System has been successfully deployed by our subsidiary PARX in markets around the globe for over a decade, delivering significant benefits to all stakeholders and consistently demonstrating cost savings and revenue growth. Offered the convenience and ease-of-use of EasyPark ® , drivers are more likely to pay parking fees, resulting in a 5-10% increase in parking collections. Additionally, EasyPark ® requires no major municipal capital investment and no maintenance – reducing total cost of ownership, and measurably impacting overall parking operation expenses.
 
Other
 
MediSmart ®
 
Our MediSmart® product is designed to securely process and manage medical information by providing doctors, hospital administrators and pharmacies with information regarding a patient’s identity, medical and medicaments history, insurance coverage and payment history.  This information can be automatically updated after each treatment or provision of remedies.  Treatment information can be automatically transferred to the corresponding medical institutions and/or the insurance provider’s computer systems.  This product reduces costs to medical providers, provides increased security for a patient’s medical history and improves the quality and speed of service to patients.  We began field tests of the product in South Africa in 2003, and the product was successfully deployed in June 2004 by CareCross Health, the leading primary healthcare provider in South Africa. Since 2007, MediSmart has been deployed in Kenya, through Smart Applications International Ltd., or SMART, and we expect to expand into more countries in Eastern Africa.
 
Industry Background
 
Contactless smart Cards and NFC are fast growing disruptive technologies that change the way consumers pay. The benefits generated to the consumers are significant and, according to leading analysts, these technologies are expected to grow rapidly in the coming years.
 
 
·
More than half of all handsets will have NFC functionality by 2015 (Pyramid Research, Jun. 2011);
 
 
·
NFC-enabled applications are expected to grow at a 35% Compound Annual Growth Rate, or CAGR, from $7.7 billion in 2011 to $34.5 billion by 2016 (Marketsandmarkets.com, Jan. 2012);
 
 
·
Mobile payments, ticketing and access control are the fastest growing NFC segments, with the mobile payment market expected to surpass $1.3 trillion in 2017 (Juniper Research, Nov. 2012); and
 
 
·
Visa’s contactless payments have quadrupled over last year, now generating about 13 million transactions per month (ZDNet, Feb. 2013).
 
 
12

 

Strategy
 
Our goal is to be the leading provider of cutting edge technology and OEM solutions based, among others, on our cashless payment solutions. Key elements of our strategy for achieving this goal include:
 
 
Enhancing our technological position .   We intend to continue to invest in research and development both through organic growth and where relevant also through acquisitions in order to enhance our technological position, develop new technologies, extend the functionality of our products and services, and offer innovative products to our customers. We will continue to leverage our twenty plus years of experience delivering cashless payment solutions to enterprises around the globe.
 
 
Expanding our global market presence .  We market our products through a global network of marketing subsidiaries in the U.S., Europe, Africa and our headquarters in Israel.  We are using these entities to strengthen our presence in existing markets, penetrate new markets, provide local customer service and technical support, and adapt our products to our local customers’ specific needs. In addition to our subsidiaries, we will continue to expand our market presence via strategic partnerships around the globe.
 
 
Increasing our focus on generating high-margin, recurring revenues .  We currently derive most of our revenues from one-time payments for our products and technologies. We intend to generate additional recurring revenues by receiving service fees for ongoing customer services and technical support and transaction fees from our customers based on the volume of transactions or monthly licensing fees from systems that contain our products. By reducing our customers’ up-front payments for our products in return for receiving on-going participation in the revenue they generate from their customers, we intend to build and maintain long-term relationships with our customers and generate a constant stream of high-margin, recurring revenues.

Customer Service and Technical Support
 
We provide our customers with training and installation support and ongoing customer service and technical support through our global network of subsidiaries, distributors and local services providers. As of December 31, 2013, we had a support team of 28 employees consisting of ten employees located in our corporate headquarters in Rosh Pina, and our office in Zur Yigal, Israel, four employees located in our subsidiary in Africa, four employees located in our subsidiary in the United States and ten employees in our subsidiary in Europe. Our customer service teams in Rosh Pina and Zur Yigal, Israel, provide central services to our network of local subsidiaries.  The subsidiaries, in turn, provide customer service and technical support through telephone and email for an ongoing fee. On-site technical support is available to customers and end-users for a fee.
 
 
13

 
 
Sales and Marketing
 
We have built a global network of subsidiaries, besides our network of distributors and other strategic business partners, through which we sell and market our products worldwide.  As of the date hereof and following the divestiture of Intercard, we have a total sales and marketing staff of 14 employees in four locations.  We market our products in the Americas through our US based subsidiary OTI America, Inc., or OTI America, which employs three people in sales and marketing.  In Africa we sell and market some of our products through our subsidiary based in South Africa, OTI PetroSmart, which employs two people in sales and marketing.  In Europe, we sell and market through ASEC, our Polish subsidiary, which employ three people in sales and marketing.  In Israel, we sell and market through our headquarters in Rosh Pina and offices in Zur Yigal, employing six people in sales and marketing. Our sales and marketing staff implements marketing programs to promote our products and services in order to enhance our global brand recognition.  Our current marketing efforts include participation in trade shows and conferences, press releases, our web site, face-to-face engagements, and advertisements in industry publications.  We also conduct technical seminars to inform customers, distributors, business partners and other industry participants of the benefits of our products and technologies.
 
Some of the independent systems integrators to which we provide our products also act as distributors for our products.  We have granted some of our systems integrators exclusive distribution rights within a particular country or region.  We generally guarantee exclusivity only if certain franchise fees are paid and/or certain sales targets are met on a case by case basis.
 
Seasonality
 
In most years, our revenues have been subject to seasonal fluctuations related to purchasing cycles of many end-users of our products during the second half of the year, which cause higher revenues in the second half of the year.  However, we cannot predict whether or not we will experience this seasonality pattern in this year or future years.
 
Manufacturing
 
We currently purchase substantially all of the principal raw materials used in the hardware and software components of our products from third-party suppliers and outsource some of the manufacturing and assembling of our products to manufacturing subcontractors.  In addition, we purchase components on a purchase order basis.  Whenever possible, our policy is to use more than one supplier and manufacturing subcontractor for each part of our production process in order to limit dependence on any one supplier or manufacturer. 
 
We maintain strict internal and external quality control processes.  We comply and maintain ISO 9001:2008 certification for our main Israeli headquarters, our subsidiaries Parx and EasyPark, and our sales subsidiary OTI America. We require that the facilities of our suppliers and manufacturing subcontractors be ISO 9001:2008 certified.  ISO 9001:2008 refers to a quality assurance model established by International Standards Organization, or ISO, for companies that design, produce, install, inspect and test products.
 
Government Regulation
 
Some of our products are subject to government regulation in the countries in which they are used.  For example, card readers that are used in the United States require certification of compliance with regulations of the FCC and those used in Europe require certification of compliance with regulations of the European Telecommunications Standards Institute regarding emission limits of radio frequency devices.  In the United States, our petroleum products are subject to compliance with regulations of UL, a public safety and testing certification organization, and in Europe to regulations of the European Union.  Our products are currently in compliance with these regulations.
 
 
14

 
 
Research and Development
 
We believe that our future success depends on, among other things, our ability to maintain our technological leadership, enhance our existing products and develop new products technologies and solutions.  Accordingly, we intend to continue devoting substantial resources to research and development. Although currently we do not receive grants from the Government of Israel in respect of our research and development activities, we have received such grants in the past, and therefore we pay royalties to the Government of Israel at a rate of 3.5% of sales of the products that the Government of Israel participated in financing through grants, up to the amounts granted, linked to the U.S. dollar with annual interest at LIBOR as of the date of the approval.  
 
The following table describes our expenditures from research and development activities during each of the past three years:
 
   
2013
   
2012
   
2011
 
Our expenditures (in Millions of US Dollars)
  $ 4.9     $ 5.7     $ 6.1  
Our net expenditures as a percentage of annual revenues
    24 %     34 %     27 %
 
Our research and development activities focus mainly on three areas:
 
·
Implementing our core technologies in microprocessors and readers;
 
·
Enhancing the functionality of our components and expanding the range of our products to serve new markets; and
 
·
Developing new innovative technologies related to the Cashless Payment Solutions market.
 
As of December 31, 2013, we employed 48 employees in our research and development activities.  Our main research and development facilities are located at our headquarters in Rosh Pina, Israel.  Additional research and development facilities are maintained by the Company’s subsidiaries such as ASEC (Poland), OTI PetroSmart (South Africa), OTI America (USA), PARX (Israel) and more. We believe that our success is based on our experienced team of senior engineers and technicians who have extensive experience in their respective fields.  Our research and development facilities are ISO 9001:2008 certified.
 
 
15

 
 
Proprietary Technologies and Intellectual Property
 
Our success and ability to compete depend in large part upon protecting our proprietary technology and intellectual property, or IP. We rely on a combination of patent, trademark, copyright and trade secret law, as well as know-how, confidentiality agreements and other contractual relationships with our employees, affiliates, agents, consultants, distributors and others. 
 
We have an extensive IP portfolio boasting 28 patent families with a number of issued patents in various jurisdictions with respect to our technologies, as well as a number of pending patent applications, trademarks and designs, encompassing product applications, software and hardware platforms, system and product architecture, product concepts and more in the fields of NFC, manufacturing techniques, contactless cards and payments, petroleum and parking solutions.
 
We cannot be certain that patents will be issued with respect to any of our pending or future patent applications.  In addition, we do not know whether any issued patents will be enforceable against alleged infringers or will be upheld if their validity is challenged. We generally enter into non-disclosure agreements with our customers, partners, employees, consultants, suppliers, subcontractors, and generally control access to the distribution of our products, documentation and other proprietary information.
 
Competition
 
Our competition is technology vendors that provide cashless payments solutions products and technologies:
 
 
·
In the Retail Market: our competition includes contactless and NFC readers, and terminal manufacturers such as ID Tech, Ingenico and Verifone. On the NFC add-on products, the competition is mainly with vendors such as DeviceFidelity , Gemalto and new technologies like Host Card Emulation, or HCE, derived by players like Google;

 
·
In the Petroleum Market: we are competing with fuel market and fleet management end to end solution vendors such as Orpak and Rozman Engineering. As this domain has high entrance barriers, there are not many players in this field; and
 
 
·
In the Parking Market: we are uniquely positioned to provide a variety of innovative technologies including enforcement systems, analytics for parking operators and drivers and asset-less parking payment solutions (not requiring for "on street" parking equipment) based on both mobile phone payments and in-vehicle parking meters. We are competing with industry players such as ParkMobile, MobileNow and Pay By Phone (Verrus) for Mobile Parking solutions.
 
Employees
 
The breakdown of the number of our employees, including employees in our subsidiaries, by department, during each of the past three years is as follows:
 
   
Number of employees as of December 31,
 
Department
 
2013
   
2012
   
2011
 
Sales and marketing
    18       32       32  
Customer service and technical support
    28       29       28  
Research and development
    48       63       68  
Manufacturing and operations
    80       81       85  
Management and administration
    60       62       66  
Total
    234(* )     267       279  
 
(*) following the divestiture of Intercard on February 28, 2014, the current number of employees decreased to 173 employees.
 
 
16

 
 
 
As of December 31, 2013, 91 of our employees were based in Israel, 101 in Europe, 35 in South Africa and 7 in the United States.  Following the divestiture of Intercard on February 28, 2014, the number of employees in Europe decreased by 61 employees. Under applicable law and by order of the Israeli Ministry of Labor and Welfare, we and our Israeli employees are subject to certain provisions of the collective bargaining agreements between the Histadrut, the General Federation of Labor in Israel and the Coordination Bureau of Economic Organizations, including the Industrialists Association.  These provisions principally concern cost of living increases, length of the working day, minimum daily wages for professional employees, contributions to pension funds, insurance for work-related accidents, procedures for dismissing employees, determination of severance pay, annual and other vacation, sick pay and other conditions of employment.  We provide our employees with benefits and working conditions above the required minimum and which we believe are competitive with benefits and working conditions provided by similar companies in our industry in Israel. Our employees are not represented by a labor union.  We have written employment agreements with substantially all of our employees.  Competition for qualified personnel in our industry is intense and it may be difficult to attract or maintain qualified personnel to our offices.  We dedicate significant resources to employee retention and have never experienced work stoppages, and we believe that our relations with our employees are good.
 
Organizational Structure
 
The chart below describes the corporate structure of our principal subsidiaries and major affiliates.
 
 
(1)           The remaining shares of Easy Park Ltd. are held by two individuals.
 
(2)           The remaining shares of PARX Ltd. are held by two individuals.
 
 
17

 
 
Easy Park Ltd.
 
Easy Park markets our EasyPark® system in Israel. Easy Park is incorporated under the laws of the State of Israel and its registered office is at Rosh Pina, Israel. We have the right to appoint all of the members of its board of directors. Currently, Mr. Ofer Tziperman (chairman), Mr. Dimitrios J. Angelis, and Mr. Charles M. Gillman serve as directors of the board.
 
PARX Ltd.
 
PARX markets our EasyPark® system worldwide. PARX is incorporated under the laws of the State of Israel and its registered office is at Rosh Pina, Israel. We have the right to appoint all of the members of its board of directors. Currently, Mr. Ofer Tziperman (chairman), Mr. Dimitrios J. Angelis, and Mr. Charles M. Gillman serve as directors of the board.
 
OTI America Inc.
 
OTI America, our wholly-owned U.S. subsidiary, is headquartered in Iselin, New Jersey and is incorporated in Delaware. OTI America provides marketing and customer support services for our products in the Americas.  We have the right to appoint all of the members of its board of directors. Currently, Mr. Ofer Tziperman (chairman), Mr. Dimitrios J. Angelis, and Mr. Charles M. Gillman serve as directors of the board.
 
OTI PetroSmart (Pty) Ltd.
 
OTI PetroSmart (formerly named OTI Africa (PTY) Ltd.), our wholly-owned South African subsidiary, is headquartered and incorporated in Cape Town, South Africa, and provides marketing, distribution and customer support services for our products in Africa. We have the right to appoint all of the members of its board of directors. Currently, Mr. Ofer Tziperman (chairman), Mr. Dimitrios J. Angelis, and Ms. Charlotte Hambly-Nuss serve as directors of the board.
 
ASEC S.A. (Spolka Akcyjna)
 
ASEC, our wholly-owned Polish subsidiary, is headquartered in Krakow, Poland. ASEC provides marketing, distribution and customer support services for some of our products in Europe, and develops and markets card readers and reader modules based on radio frequency identification technologies, including high-end programmable smart cards as well as economically priced readers.  We have the right to appoint all of the members of its advisory board of directors. Currently, Mr. Ofer Tziperman (chairman), Mr. Dimitrios J. Angelis, and Mr. Charles M. Gillman serve as directors of the board.
 
Item 1A. Risk Factors.
 
The following risk factors, among others, could in the future affect our actual results of operations and could cause our actual results to differ materially from those expressed in forward-looking statements made by us in this Annual Report or elsewhere. Before you decide to buy, hold, or sell our Ordinary Shares, you should carefully consider the risks described below, in addition to the other information contained elsewhere in this Annual Report. The following risk factors are not the only risk factors facing our Company. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business. Our business, financial condition and results of operations could be seriously harmed if any of the events underlying any of these risks or uncertainties actually occurs. In that event, the market price for our Ordinary Shares could decline, and you may lose all or part of your investment.
 
 
18

 
 
Risks Related to Our Business
 
We have a history of losses and we may continue to incur full-year losses in 2014 and in subsequent years.
 
We have incurred losses in each year since we commenced operations in 1990. We reported net losses attributable to shareholders of $6.9 million in 2011, $17.4 million in 2012, and $3 million in 2013. We may continue to incur full year losses in 2014 and afterwards, as we invest in the expansion of our global marketing network, reduce our product prices in return for future transaction fees based on the volume of transactions in systems that contain our products, invest in fixed assets that may generate revenues more slowly than expected and enhance our research and development capabilities.
 
We are under new management.
 
In December 2012, eight new directors were elected by the Company’s General Meeting of Shareholders to serve on our Board of Directors, or the Board, following resignation of the majority of the then incumbent directors. In March 2013, our new Board appointed Mr. Ofer Tziperman as new Chief Executive Officer of the Company. In April 2013, the Board replaced the then chairman of the Board and appointed Mr. Dimitrios Angelis as new chairman of our Board.  In June 2013, our Board appointed Mr. Shay Tomer to serve as new Chief Financial Officer and in August 2013, the Company appointed Mr. Shlomi Eytan as new Chief Sales and Marketing Officer. In December 2013, by recommendation of the Board, the General Meeting of Shareholders appointed Mr. Jerry L. Ivy as a new additional director to the Board. Besides the foregoing, through 2013 we made some changes in the Company’s executive management. Our members of the Board and executive management have been with us for a while, but to a degree are still in a learning process of the Company and its business, and this may affect our business in the short and mid-term.
 
We are assessing possible alternatives to maximize value for our shareholders.  This process may not result in a viable alternative, or such alternative might not be implemented successfully.
 
 Our new Board of Directors has been identifying and assessing possible alternative strategies to maximize value for our shareholders.  After the assessment period we plan to implement new strategies for growing our businesses and building shareholder value.  However, there is no certainty that we will be able to identify the strategy that will work best for us and for our shareholders, or that the strategy we choose will be actually implemented successfully, since such strategy implementation generally depends on a number of factors, many of which outside of our control.  If we fail to identify the appropriate strategy or to implement successfully the strategy we choose, this could have a material adverse effect on our business, financial condition and results of operations.
 
 
19

 
 
We may desire to exit certain product lines or businesses, or to restructure our operations, but may not be successful in doing so.
 
Our current Board of Directors has been identifying and assessing possible alternative strategies to maximize value for our shareholders.  Such process may result in a decision to divest certain product lines and businesses or restructure our current corporate structure or current operations, including, without limitation, through the contribution of assets to joint ventures or sale of some assets to third parties. However, our ability to successfully exit product lines and businesses, or to close or consolidate operations, or to sell successfully some of our assets, depends on a number of factors, many of which are outside of our control. For example, if we are seeking a buyer for a particular business line, none may be available, or we may not be successful in negotiating satisfactory terms with prospective buyers or a buyer may not meet its obligations under the applicable purchase agreement.
 
If we are unable to exit a product line or business in a properly or timely manner, or to restructure our current corporate structure or our operations in a manner we deem to be advantageous, or to enforce that a buyer meets its contractual obligations, this could have a material adverse effect on our business, financial condition and results of operations. Even if a divestment is successful, among others, we may face indemnity and other liability claims by the acquirer or other parties.
 
We depend on a small number of large customers, and the loss of one or more of them would lower our revenues.
 
Our customer base is concentrated among a limited number of large customers. Our revenues may continue to depend on a limited number of major customers. The customers we consider to be our major customers and the percentage of our revenue represented by each major customer vary from period to period. In 2011, 2012 and for 2013, our largest customer in North America provided 0%, 6% and 19% respectively, of our total revenues for such periods. In addition, another customer, related to mass transit in Poland, respectively accounted for 11%, 8% and 15% of our total revenues for 2011, 2012 and 2013, respectively.  If we were to lose any one of our major customers, or if any of our customers were to have difficulty meeting their financial obligations to us for any reason, our financial condition and results of operations would be adversely affected.
 
If the market for contactless microprocessor-based smart cards and/or NFC does not grow, sales of our products may not grow and may even decline.
 
The success of some of our products depends on commercial enterprises, governmental authorities and other potential card issuers adopting contactless microprocessor-based smart card and NFC technologies. Other card technologies, such as magnetic strips or bar codes, are widely used and could be viewed by potential customers as more cost effective alternatives to our products and/or the market for contactless microprocessor-based smart cards and/or NFC products may not grow or actually meet our current forecasts.
 
 Additionally, potential customers in developed countries, such as the United States and others, may already have installed systems that are based on technologies different from ours and therefore may be less willing to incur the capital expenditures required to install or upgrade to a contactless microprocessor-based smart card system. As a result, we cannot assure that there will be significant market opportunities for our contactless microprocessor-based smart cards and/or NFC products. New technologies for payments different than ours might also be adopted by the markets and could override the need for our contactless and NFC payment solutions.
 
 
20

 
 
If we fail to develop new products or adapt our existing products for use in new markets, our revenue growth may be impeded and we may incur significant losses.
 
 To date, we have sold products incorporating our technology within a limited number of markets. Although we are devoting significant resources to developing new products and adapting our existing products for use in new markets, such as cashless payment solutions, parking solutions, mass transit ticketing solutions and petroleum solutions, if we fail to develop new products or adapt our existing products for existing or new markets, we may not recoup the expenses incurred in our efforts to do so, our revenue growth may be impeded and we may incur significant losses.
 
We have acquired several companies or groups of companies and we intend to continue to pursue strategic acquisitions in the future.  The failure to successfully integrate acquired companies and businesses or to acquire new companies and businesses may harm our financial performance and growth.
 
During the last few years we acquired several companies or businesses in Israel and around the world.
 
In certain cases, we paid for these acquisitions through the issuance of our Ordinary Shares and in certain cases, warrants to purchase Ordinary Shares and cash consideration. These and future acquisitions could result in:
 
 
·
difficulties in integrating our operations, technologies, products and services with those of the acquired companies and businesses;
 
 
·
difficulty in integrating operations that are spread across significant geographic distances;
 
 
·
diversion of our capital and our management's attention away from other ongoing business issues;
 
 
·
potential loss of key employees and customers of companies and businesses we acquire;
 
 
·
increased liabilities as a result of liabilities of the companies and businesses we acquire; and
 
 
·
dilution of shareholdings in the event we acquire companies and businesses in exchange for our Ordinary Shares.
 
We may not successfully integrate all technologies, manufacturing facilities or distribution channels that we have or may acquire and we cannot assure that any of our recent acquisitions will be successful. In addition, if we do not acquire new companies and businesses in the future, our business may not grow as expected. If any of our recent or future acquisitions are not successful, our financial performance and business may be adversely affected.
 
 
21

 
 
Our revenue growth may be impaired if we are unable to maintain our current, and establish new, strategic relationships.
 
The markets for our products are usually highly specialized and sometimes require us to enter into strategic relationships in order to facilitate or accelerate our penetration into existing or new markets. We consider a relationship to be strategic when we integrate our technology into some of the product offerings of a business partner or manufacturer or systems integrator that has a significant position in a specified market and cooperate in marketing the resulting product. The termination of any of our strategic relationships or our failure to develop additional relationships in the future may limit our ability to expand the markets in which our products are deployed or to sell particular products.

The terms of certain of our agreements may restrict our ability to take actions that we believe to be desirable.
 
Pursuant to certain agreements we have entered into with our suppliers, sales agents and joint venture partners, we have agreed to restrict ourselves in some areas of business by providing exclusivity for different time periods, ranging from several months to several years, or sometimes providing exclusivity in specific regions. For example, in certain markets, we sell our products through sales agents which, in certain cases, have exclusive sales rights in that market or certain territories if specified sales quotas are met. The foregoing could have a material adverse effect on our business, operating results and financial condition if these partners do not perform in a satisfactory manner.
 
We face intense competition. If we are unable to compete successfully, our business prospects will be impaired.
 
We face intense competition from developers of contact and contactless microprocessor-based technologies, NFC payment solutions and products, developers of contactless payments products that use other types of technologies that are not microprocessor-based, NFC and non-smart card technologies. In some of our markets we are facing competition from new emerging technologies such as, without limitation, Bluetooth Low Energy, Host Card Emulation etc. We compete on the basis of a range of competitive factors including price, compatibility with the products of other manufacturers, and the ability to support new industry standards and introduce new reliable technologies. Many of our competitors have greater market recognition, larger customer bases, and substantially greater financial, technical, marketing, distribution, and other resources than we possess. As a result, they may be able to introduce new products, respond to customer requirements and adapt to evolving industry standards more quickly than we can.
 
From time to time, we or one or more of our present or future competitors may announce new or enhanced products or technologies that have the potential to replace or shorten the life cycles of our existing products. The announcement of new or enhanced products may cause customers to delay or alter their purchasing decisions in anticipation of such products, and new products developed by our competitors may render our products obsolete or achieve greater market acceptance than our products.
 
If we cannot compete successfully with our existing and future competitors, we could experience lower sales, price reductions, loss of revenues, reduced gross margins and reduced market share.
 
Our products may have long development cycles and we may expend significant resources in relation to a specific project without realizing any revenues.
 
The development cycle for our products varies from project to project. Typically, the projects in which we are involved are complex and require that we customize our products to our customers’ needs and specifications in return for payment of a fixed amount. We then conduct evaluation, testing, implementation and acceptance procedures of the customized products with the customer. Only after successful completion of these procedures will customers place orders for our products in commercial quantities. In addition, our sales contracts sometimes do not include minimum purchase requirements. We therefore cannot always assure that future contracts will result in commercial sales. Our average development cycle is typically between 6 and 18 months from initial contact with a potential customer until we deliver commercial quantities to the customer and recognize significant revenues. As a result, we may expend financial, management and other resources to develop customer relationships before we recognize revenues, if any.
 
 
22

 
 
Fluctuations in our quarterly financial performance may create volatility in the market price of our shares and may make it difficult to predict our future performance.
 
Our quarterly revenues and operating results have varied substantially in the past and may continue do so in the future. These fluctuations may be driven by various factors which are beyond our control, are difficult to predict and may not meet the expectations of analysts and investors. These factors include, among others, the following:
 
 
·
Our payroll expenses are relatively fixed and we would not expect to reduce our workforce due to a reduction in revenues in any particular quarter.
 
 
·
The tendency of some of our clients, due to budgetary reasons, to place orders for products toward the last quarter of their financial year.
 
As a result of these factors, our revenues and operating results in any quarter may not be indicative of our future performance, and it may be difficult to evaluate our prospects.
 
Delays or discontinuance of the supply of components may hamper our ability to produce our products on a timely basis and cause short-term adverse effects.
 
Some of the components we use in our products, including microprocessors and cards, are supplied by third party suppliers and manufacturers. Some of these suppliers are single source manufacturers. EOL (End of Life, i.e., termination of manufacturing of a certain product, provision of services or support) or allocations due to high demand, or delays or shortages could interrupt and delay the supply of our products to our customers, and may result in cancellation of orders for our products. However, we do not always have long-term supply contracts under which our suppliers are committed to supply us with components at fixed or defined prices. Suppliers sometimes may increase component prices significantly without advance warning or could discontinue the manufacturing or supply of components used in our products. In addition, third party suppliers may face other challenges in fulfilling their contractual obligations with us which are beyond our control.  For instance, our 2011 and 2012 financial results were adversely impacted by the flooding in Thailand which had direct impact on a plant of one of our then principal contractors for inlays, and this caused disruptions to our supply chain and specifically affected our ability to deliver products to certain customers.  Although we make efforts to identify and retain from time to time second source manufacturers, we may not be able always to develop alternative sources for product components, if and as may be required in the future. Even if we are able to identify alternative sources of supply, we may need to modify our products to render them compatible with other components. This may cause delays in product shipments, increase manufacturing costs and increase product prices.
 
Some of our suppliers are located in different countries, such as in Europe and Asia, and therefore we may experience logistical difficulties in our supply chain, including long lead times for receipt of products or components and shipping delays. In addition, our subcontractors may, on occasion, feel the impact of potential economic or political instability in their regions, which could affect their ability to supply us with components for our products in a timely manner.
 
 
23

 
 
If we fail to hire, train and retain qualified research and development personnel, our ability to enhance our existing products, develop new products and compete successfully may be materially and adversely affected.
 
Our success depends, in part, on our ability to hire and train qualified research and development personnel. Individuals who have expertise in research and development in our industry are scarce. Competition for such personnel in the electronics industry is intense, particularly in Israel. Consequently, hiring, training and retaining such personnel is time consuming and expensive. In addition, it may be difficult to attract qualified personnel to Rosh Pina, which is located in the northern part of Israel. If we fail to hire, train and retain employees with skills in research and development, we may not be able to enhance our existing products or develop new products.
 
If we are unable to protect or assert our intellectual property rights, our business and results of operations may be harmed.
 
Our success and ability to compete depend considerably on using our intellectual property and proprietary rights to protect our technology and products. We rely on a combination of patent, trademark, design, copyright and trade secret laws, confidentiality agreements and other contractual relationships with our employees, customers, affiliates, distributors, suppliers and others. While substantially all of our employees are subject to non-compete agreements, these agreements may be difficult to enforce as a result of Israeli law limiting the scope of employee non-competition undertakings. We further note that the Israeli Supreme Court noted (in an obiter dictum) in 2012, without making any decisive ruling, that an employee who contributes to an invention during his employment could be allowed to seek compensation for it from their employer, even if the employee’s contract of employment specifically states otherwise and the employee has transferred all intellectual property rights to the employer. The Israeli Supreme Court considered the possibility that a contract that revokes the employee’s right for royalties and compensation may not necessarily foreclose the right of the employee to claim a right for royalties. As a result, even if the Company believes that none of its employees has any rights in any of the Company’s intellectual property, or to receive royalties, it is unclear if, and to what extent, our employees may be able to claim compensation with respect to our future revenue.  As a result, we may receive less revenue from future products if such claims are successful, or incur additional royalty expenses, which in turn could impact our future profitability.
 
Our patent portfolio includes registered patents and pending patents applications worldwide encompassing, among others, product applications, system and product architecture and product concepts in the field of NFC, contactless payments, petroleum and parking solutions. Our patents are registered/pending in the United States, Europe, Asia, Australia, Israel, South Africa and other countries. We cannot be certain that patents will be issued with respect to any of our pending or future patent applications or that the scope of our existing patents, or any future patents that are issued to us, will provide us with adequate protection for our technology and products. Others may challenge our patents or patent applications as well as our registered trademarks and other intellectual property rights. We do not know whether any of them will be upheld as valid or will be enforceable against alleged infringers. Thus we do not know whether they will enable us to prevent or hinder the development of competing products or technologies. Moreover, patents provide legal protection only in the countries where they are registered and the extent of the protection granted by patents varies from country to country.
 
 
24

 
 
The measures we have taken to protect our technology and products may not be sufficient to prevent their misappropriation by third parties or their independent development by others of similar technologies or products. If our patents and other intellectual property rights do not adequately protect our technology, competitors may be able to offer products similar to our products more easily. Our competitors may also develop competing technology by designing around our patents and thereafter manufacturing and selling products that compete directly with ours, which would harm our business, financial position and results of operations.
 
In order to protect our technology and products and enforce our patents and other proprietary rights, we may need to initiate, prosecute or defend litigation and other proceedings before courts and patent and trademark offices in multiple countries. For instance, in March 2012 we filed a patent infringement lawsuit alleging that T-Mobile USA, Inc. sells NFC enabled phones that infringe a patent we own. These legal and administrative proceedings could be expensive and could occupy significant management time and resources.  In addition, since one of T-Mobile’s defenses is invalidity of the patent, there is a risk that the asserted patent will be declared invalid and we may instructed to reimburse T-Mobile for its legal expenses.
 
Security breaches and system failures could expose us to liability, harm our business or result in the loss of customers.
 
We retain sensitive data, including intellectual property, books of record and personally identifiable information, on our networks. It is critical to our business strategy that our infrastructure and other infrastructure we use to host our solutions remain secure, do not suffer system failures and are perceived by customers and partners to be secure and reliable. Despite our security measures, our infrastructure and third party infrastructure we use to host our solutions may be vulnerable to attacks by hackers or other disruptive problems. Our policy is to cap our liability to damages at the cost of the project. Yet, we cannot ensure that the actual liabilities imposed on us in case of data security issues or data loss issues would indeed be subject to such cap.  Any security breach or system failure may compromise information stored on our networks. Such an occurrence could negatively affect our reputation as a trusted provider of solutions and hosting such solutions by adversely affecting the market’s perception of the security or reliability of our products or services.
 
If we fail to adhere to regulations and security standards imposed by credit card networks, or if our products are not certified or otherwise fail to comply with such regulations and security standards (such as payment card industry standards, etc.) or if our customers fail to take proper protective measures and hold OTI liable for the consequences, our results of operations could be adversely affected.
 
Our products are designed to collect, store, and route certain personal identifiable information from our clients and/or  from end-users, as well as processing such clients’ and/or end-users payments using payment information.  In addition, we may store such information on our servers.
 
We are required by some of our customers to meet industry standards imposed by payment systems standards setting organizations such as EMVCo LLC, credit card associations such as Visa, MasterCard, Interac, Discover and other credit card associations and standard setting organizations such as the Payment Card Industry Security Standards Council, or PCI SSC, and other local organizations. Furthermore, some of our offerings are subject to the Payment Card Industry Data Security Standards, or PCI DSS, which is a set of multifaceted security standards that is designed to protect credit card and personal information as mandated by payment card industry entities. Even though we attempt to protect our company through our contracts with our customers, clients and other third-party service providers, and in certain cases assess their security controls, we have limited oversight or control over their actions and practices. We implemented an off-site backup policy that is expected to help in case of system crash caused by hackers, intruders, attackers or accidents. However, this policy cannot guarantee complete security, as not all attack possibilities are known. We also advise our customers to maintain insurance policies covering cyber-attacks on their systems, including system restore and derived liabilities in case of stolen data, and we further advise them to monitor their backup policies carefully, ensuring off-site backups.
 
 
25

 
 
New standards are continually being adopted or proposed as a result of worldwide anti-fraud initiatives, encryption of cardholder or personal information, the increasing need for system compatibility and technology developments such as wireless, optical fiber infrastructure, telecommunication, VPN, VPN infrastructure, satellite based communication and other wire line IP communication. We cannot ensure that we will be able to design our solutions to comply with future standards or regulations on a timely basis, if at all. Compliance with these standards could increase the cost of developing or producing our products, while non-compliance may harm our reputation or result in customer and client claims. New products designed to meet any new standards need to be introduced to the market and ordinarily need to be certified by the credit card associations and our customers before being purchased. The certification process is costly and time consuming and increases the amount of time and resources it takes to sell our products, as well as the product development cycle time and cost.  Selling products that are non-compliant may result in fines against us or our customers, which we may be liable to pay. After selling and/or installation of a system or a product, the customer is responsible for any operational aspect of such system or product ensuring them from unexpected crashes. We advise our clients to take backup and insurance measures for such cases. 
 
In addition, even if our products are designed to be compliant, compliance with certain security standards is determined on the basis of the network environment in which our customers and service providers install our products. Therefore, such compliance depends upon additional factors such as proper installation of the components of the environment (including our systems, compliance of software and system components provided by other vendors), implementation of compliant security processes and business practices and adherence to such processes and practices. 
 
Our business and financial condition could be adversely affected if we do not comply with new or existing industry standards and regulations, or obtain or retain necessary regulatory approval or certifications in a timely fashion, or if compliance results in increasing the cost of our products.
 
Our products may infringe on the intellectual property rights of others.
 
It is not always possible to know with certainty whether or not the manufacture and sale of our products or the licenses we are granted from third parties does or will infringe patents or other intellectual property rights owned by third parties. For example, patent applications may be pending at any time which, if granted, cover products that we developed or are developing. In certain jurisdictions, the subject matter of a patent is not published until the patent is issued. Third parties may, from time to time, claim that our products infringe on their patent or other intellectual property rights. In addition, if third parties claim that our customers are violating their intellectual property rights, our customers may seek indemnification from us (which could be costly), or may terminate their relationships with us. Our products depend also on operating systems licensed to us and we may also be subject to claims by third parties that our use of these operating systems infringes on their intellectual property rights.
 
 
26

 
 
Intellectual property rights litigation is complex and costly, and we cannot be sure of the outcome of any litigation. Even if we prevail, the cost of litigation could harm our results of operations. In addition, litigation is time consuming and could divert our management’s attention and resources away from our business. If we do not prevail in such litigation, in addition to any damages we might have to pay, we might be required to discontinue the use of certain processes, cease the manufacture, use and sale of infringing products and solutions, and expend significant resources to develop non-infringing technology or obtain licenses on unfavorable terms. In addition, some licenses are non-exclusive and, therefore, our competitors may have access to the same technology licensed to us.
 
We are susceptible to changes in international markets and difficulties with international operations could harm our business.
 
We have derived revenues from different geographical areas. Our ability to maintain our position in existing markets and/or to penetrate new, regional and local markets is dependent, in part, on the stability of regional and local economies. Our regional sales may continue to fluctuate widely and may be adversely impacted by future political or economic instability in these or other foreign countries or regions.
 
In addition, there are inherent risks in these international operations which include, among others: 
 
 
·
 
·
changes in regulatory requirements and communications standards;
 
changes in external political policies, such as embargos based on manufacturing origin;
 
 
·
political and economic instability;
 
 
·
required licenses, tariffs and other trade barriers;
 
 
·
difficulties in enforcing intellectual property rights across, or having to litigate disputes in, various jurisdictions;
 
 
·
difficulties in staffing and managing international operations;
 
 
·
potentially adverse tax consequences;
 
 
·
the burden of complying with a wide variety of complex laws and treaties in various jurisdictions; and
 
 
·
business interruptions resulting from geopolitical actions, including war and terrorism, or natural disasters including earthquakes, typhoons, floods and fires.
 
If we are unable to manage the risks associated with our focus on international sales, our business may be harmed.
 
 
27

 
 
We report in U.S. dollars while a portion of our revenues and expenses is incurred in other currencies. Therefore currency fluctuations could adversely affect our results of operations.
 
We generate a significant portion of our revenues in U.S. dollars but we incur a large portion of our expenses in other currencies. Our principal non-U.S. dollar expenses are for Israeli employees’ salaries, which are in New Israeli Shekel, or NIS, and the expenses of our international subsidiaries. Our subsidiary in France, SmartCard Engineering S.A.S, incurs expenses in Euros, our subsidiary in Poland, ASEC, incurs expenses in Polish Zloty, and our subsidiary in South Africa, OTI PetroSmart, incurs expenses in South African Rand. To the extent that we and our subsidiaries based in Israel, United States, Europe and South Africa conduct our business in different currencies, our revenues and expenses and, as a result, our assets and liabilities, are not necessarily accounted for in the same currency. We are therefore exposed to foreign currency exchange rate fluctuations. More specifically, we face the risk that our accounts receivable denominated in non-U.S. dollar currencies will be devalued if such currencies weaken quickly and significantly against the U.S. dollar. Similarly, we face the risk that our accounts payable and debt obligations denominated in non-U.S. dollar currencies will increase if such currencies strengthen quickly and significantly against the U.S. dollar. These fluctuations may negatively affect our results of operations. Our operations could also be adversely affected if we are unable to limit our exposure to currency fluctuations in the future.
 
To mitigate the risk of financial exposure to fluctuations in the exchange rate of the U.S. dollar against the NIS or other currencies, we may enter into currency hedging transactions. However, these measures may not adequately protect us from material adverse effects resulting from currency fluctuations. In addition, if we wish to maintain the U.S. dollar-denominated value of sales made in other currencies, any devaluation of the other currencies relative to the U.S. dollar would require us to increase our other currency denominated selling prices. That could cause our customers to cancel or decrease orders.
 
Our international sales and operations are subject to complex laws relating to foreign corrupt practices and bribery, among many other subjects. A violation of, or change in, these laws could adversely affect our business, financial condition or results of operations.
 
Our operations in countries outside the U.S. are subject, among others, to the Foreign Corrupt Practices Act of 1977 as amended from time to time, or FCPA, which prohibits U.S. companies or foreign companies which their shares are traded in a U.S. stock exchange, or their agents and employees from providing anything of value to a foreign public official as defined in the FCPA for the purposes of influencing any act or decision of these individuals in their official capacity to help obtain or retain business, direct business to any person or corporate entity, or obtain any unfair advantage. We have internal control policies and procedures and have implemented training and compliance programs for our employees and agents with respect to the FCPA. However, we cannot assure that our policies, procedures and programs will always protect us from reckless or criminal acts that may be committed by our employees or agents. Allegations of violations of applicable anti-corruption laws, including the FCPA, may result in internal, independent, or government investigations. Violations of the FCPA may result in severe criminal or civil sanctions, and we may be subject to other liabilities, which could have a material adverse effect on our business, consolidated results of operations and consolidated financial condition. In addition, investigations by governmental authorities as well as legal, social, economic, and political issues in countries where we operate could have a material adverse effect on our business and consolidated results of operations. We are also subject to the risks that our employees, joint venture partners or agents outside of the U.S. may fail to comply with other applicable laws. The costs of complying with these and similar laws may be significant and may require significant management time and focus. Any violation of these or similar laws, intentional or unintentional, could have a material adverse effect on our business, financial condition or results of operations.
 
 
28

 
 
We are using third parties' goods and services from time to time. Although we make efforts to ensure the service quality we cannot control the actions of such third parties, and therefore we may be subject to claims and risks.
 
We depend on third party service providers, suppliers and licensors to supply some of the services, hardware, software and operational support necessary to provide some of our services. We obtain these materials from a limited number of vendors, some of which do not have a long operating history or which may not be able to continue to supply the equipment and services we desire. Some of our hardware, software and operational support vendors, and service providers represent our sole source of supply or have, either through contract or as a result of intellectual property rights, a position of some exclusivity. If demand exceeds these vendors’ capacity or if these vendors experience operating or financial difficulties, or are otherwise unable to provide the equipment or services we need fully or in a timely manner, at our specifications and at reasonable prices, our ability to provide some services might be materially adversely affected, or the need to procure or develop alternative sources of the affected materials or services might delay our ability to serve our customers. These events could materially and adversely affect our ability to retain and attract customers, and have a material negative impact on our operations, business, financial results and financial condition. A limited number of vendors of key technologies can lead to less product innovation and higher costs. For these reasons, we generally endeavor to establish alternative vendors for materials we consider critical, but may not be able to always establish these relationships or be able to obtain required materials on favorable terms.
 
We may have to adapt our products in order to integrate them into our customers’ systems if new government regulations or industry standards are adopted or current regulations or standards are changed.
 
Some of our products and/or future products under development are or may be subject to government or international regulation in the countries in which they are used. For example, card readers used in the U.S. and in Europe require certification of compliance with regulations of the FCC and the European Telecommunications Standards Institute, respectively, regarding emission limits of radio frequency devices, some of our systems are required to meet the safety regulation standards. In addition, governmental or international certification for the systems into which our products are integrated may be required. The ISO approved industry standards regulating the transfer of data between cards and readers that we generally meet.  If there is a change in government regulations or industry standards, we may have to make significant modifications to our products and, as a result, could incur significant costs and may be unable to deploy our products in a timely manner. 
 
In addition, prior to purchasing our products, some customers may require us to receive or obtain a third party certification, or occasionally certify our products by ourselves, that our products can be integrated successfully into their systems or comply with applicable regulations. In some cases, in order for our products, or for the system into which they are integrated, to be certified, we may have to make significant product modifications.  Furthermore, receipt of third party certifications may not occur in a timely manner or at all. Failure to receive third party certifications could render us unable to deploy our products in a timely manner or at all.
 
 
29

 
 
Our products may contain defects that are only discovered after the products have been deployed or used. This could harm our reputation, result in loss of customers and revenues or subject us to product liability claims.
 
Our products are highly technical and deployed as part of large and complex projects. As a result of the nature of our products, they can only be fully tested when fully deployed. For example, the testing of our parking payment product required the distribution of sample parking payment cards to drivers, installation of electronic kiosks at which a card holder can increase the balance on his or her card, linking of kiosks to financial and parking databases, collection of data through handheld terminals, processing of data that is collected by the system, compilation of reports and clearing of parking transactions. Any defects in our products could result in:
 
 
·
harm to our reputation;
 
 
·
loss of, or delay in, revenues;
 
 
·
loss of customers and market share;
 
 
·
failure to attract new customers or achieve market acceptance for our products; and
 
 
·
unexpected expenses to remedy errors.
 
In addition, we could be exposed to potential product liability claims. While we currently maintain product liability insurance, we cannot be certain that this insurance will be sufficient to cover any successful product liability claim. Any product liability claim could result in changes to our insurance policies, including premium increases or the imposition of a large deductible or co-insurance requirements. Any product liability claim in excess of our insurance coverage would have to be paid out of our cash reserves. Furthermore, the assertion of product liability claims, regardless of the merits underlying the claim, could result in substantial costs to us, divert management’s attention away from our operations and damage our reputation.
 
We have certain operations in countries that may be adversely affected by political or economic instability.
 
We are a global company with worldwide operations. We derive certain portion of our sales and future growth from regions such as Latin America, Eastern Europe and Africa, which may be more susceptible to political or economic instability.
 
Certain portions of our operations are conducted outside the markets in which our products are sold, and accordingly we often import a substantial number of products into such markets. We may, therefore, be denied access to our customers or suppliers or denied the ability to ship products from any of our sites as a result of a closing of the borders of the countries in which we sell our products, or in which our operations are located, due to economic, legislative or political conditions.
 
Delays in the implementation stage in some of the projects we are involved with may prevent us from generating sales revenues as expected in the applicable year.
 
Delays in projects might occur as a result of factors that are beyond our control, including, without limitation, customer readiness or shortage in purchased components needed for project implementation as well as our readiness to implement the projects. If such delays occur in the future, it might affect our revenues, profitability or our share price.
 
The general economic outlook may adversely affect our business.
 
Our operations and performance depend on worldwide economic conditions and their impact on levels of business and public spending, which deteriorated significantly in many countries and regions and may remain depressed for the foreseeable future.  This may adversely affect the budgeting and purchasing behavior of our customers and our potential customers, including shifting customers purchasing patterns to lower-cost options, which could adversely affect our product sales.
 
 
30

 
 
In addition, continuing uncertainties in the financial and credit markets may adversely affect the ability of our customers, suppliers, distributors and resellers to obtain financing for significant purchases and operations and to fulfill their contractual obligations with us. As a result, we could encounter, among other adverse effects, a decrease in or cancellation of orders for our products, and an increase in additional reserves for uncollectible accounts receivable being required.
 
We derive a portion of our revenues from sales to systems integrators that are not the end-users of our products. We are dependent, to a certain extent, on the ability of these integrators to maintain their existing business and secure new business.
 
 In 2011, 2012 and 2013, 15%, 20% and 16%, respectively, of our revenues were derived from sales to systems integrators that incorporate our products into systems which they supply and install for use in a specific project. To the extent our revenues depend on the ability of systems integrators to successfully market, sell, install and provide technical support for systems in which our products are integrated or to sell our products on a stand-alone basis, our revenues may decline if the efforts of these systems integrators fail. Further, the faulty or negligent implementation and installation of our products by systems integrators may harm our reputation and dilute our brand name. We are one step removed from the end-users of our products, and therefore it may be more difficult for us to rectify damage to our reputation caused by systems integrators that have direct contact with end-users. In addition, termination of agreements with systems integrators or revocation of exclusive distribution rights within certain countries might be difficult. If we are unable to maintain our current relationships with systems integrators or develop relationships with new systems integrators, we may not be able to sell our products and our results of operations could be impaired.
 
Unless we continue to expand our direct sales, our future success will depend upon the timing and size of future purchases by systems integrators and the success of the projects and services for which they use our products.
 
We may face both reputational and SEC enforcement risks with respect to conflict minerals obligations.
 
The SEC has adopted disclosure requirements under section 102 of the Dodd-Frank Wall Street Reform and Consumer Protection Act regarding the source of certain minerals for which such conflict minerals are necessary to the functionality or production of a product manufactured, or contracted to be manufactured which are mined from the Democratic Republic of Congo, and adjoining countries, including: Sudan, Uganda, Burundi, United Republic of Tanzania, Zambia, Angola, and Central African Republic. These rules require reporting companies to file a conflict minerals report as an exhibit to a Form SD report with the SEC. The conflict minerals report is required to set out the due diligence efforts and procedures exercised on the source and chain of custody of such conflict minerals, in accordance with internationally recognized due diligence framework, and a description of the Company's products containing such conflict minerals. Although we expect that we will be able to comply with the requirements of any rules promulgated by the SEC and file our first report by May 31, 2014, as required, in preparing to do so the Company is dependent upon the implementation of new systems and processes and information supplied by certain suppliers of products that contain, or potentially contain, conflict minerals. Such preparation may be costly. To the extent that the information that it receives from its suppliers is inaccurate or inadequate or its processes in obtaining that information do not fulfill the SEC's requirements, the Company could face both reputational and SEC enforcement risks.
 
 
31

 
 
Terrorist attacks and acts of violence may have a material adverse effect on our operating results .
 
Terrorist attacks and other acts of violence or war may affect the financial markets on which our Ordinary Shares trade, the markets in which we operate, our operations and profitability and your investment. These attacks, or subsequent armed conflicts resulting from or connected to them, may directly impact our physical facilities or those of our suppliers or customers. For example, during the Second Lebanon War in 2006, numerous shells fired at Israel from Lebanese territory landed in Rosh Pina. Although such attacks did not have an adverse impact upon the Company or any of its operations, we cannot assure you that, in the future, any similar circumstances will have no such impact.  In addition, terrorist attacks may make travel and the transportation of our supplies and products more difficult and/or expensive and affect the results of our operations.
 
Risks Related to Our Ordinary Shares
 
Our share price has fluctuated in the past and may continue to fluctuate in the future.
 
The market price of our Ordinary Shares has fluctuated significantly and may continue to do so. The market price of our Ordinary Shares may be significantly affected by factors such as the announcements of new products or product enhancements by us or our competitors, technological innovations by us or our competitors or periodic variations in our results of operations. In addition, any statements or changes in estimates by analysts covering our shares or relating to the smart card industry could result in an immediate effect that may be adverse to the market price of our shares.
 
Trading in shares of companies listed on the NASDAQ Global Market in general, and trading in shares of technology companies in particular, has been subject to extreme price and volume fluctuations that have been unrelated or disproportionate to operating performance. These factors may depress the market price of our Ordinary Shares, regardless of our actual operating performance.
 
Securities litigation has also often been brought against companies following periods of volatility in the market price of its securities. In the future, we may be the target of similar litigation that could result in substantial costs and diversion of our management’s attention and resources.
 
Our share price could be adversely affected by future sales of our Ordinary Shares.
 
As of March 20, 2014, we had 33,140,867 outstanding Ordinary Shares, 1,178,699 Ordinary Shares we repurchased that are held by us as dormant shares, 371,730 warrants to purchase additional Ordinary Shares at a weighted average exercise price of $2.64 per share and 1,789,616 options to purchase additional Ordinary Shares at a weighted average exercise price of $1.65 per share.  We may, in the future, sell or issue additional Ordinary Shares. The market price of our Ordinary Shares could drop as a result of sales of substantial amounts of our Ordinary Shares in the public market or the perception that such sales may occur, including sales or perceived sales by our directors, officers or principal shareholders. These factors could also make it more difficult to raise additional funds through future offerings of our Ordinary Shares or other securities.
 
 
32

 
 
Our shareholders could experience dilution of their ownership interest by reason of our issuing more shares.
 
Under Israeli law, shareholders in public companies do not have preemptive rights. This means that our shareholders do not have the legal right to purchase shares in a new issue before they are offered to third parties. In addition, our Board of Directors may approve the issuance of shares in many instances without shareholder approval. As a result, our shareholders could experience dilution of their ownership interest by reason of our raising additional funds through the issuance of Ordinary Shares.  In addition, we may continue to acquire companies or businesses in exchange for our shares, resulting in further dilution.
 
We do not anticipate paying cash dividends in the foreseeable future.
 
We have never declared or paid cash dividends on our Ordinary Shares, and we do not anticipate paying cash dividends in the foreseeable future. The payment of any dividends by the Company is solely at the discretion of our Board of Directors and based on the conditions set forth in the Israeli Companies Law, or the Companies Law.
 
We adopted a Shareholders Rights Plan that may dilute the shares of an “Acquiring Person”.
 
On January 12, 2009, our Board of Directors approved the adoption of a Shareholders Rights Plan, as amended on January 5, 2012 and January 9, 2014, or the Plan. Pursuant to the terms of the Plan, each Ordinary Share of the Company shall give its holder one right, or Right, as detailed in the Plan. Each Right will become exercisable only after a person or a group becomes an “Acquiring Person” by obtaining beneficial ownership of, or by commencing a tender or exchange offer for, 15% or more of our Ordinary Shares (our Board of Directors may reduce this percentage, but not to less than 10%), unless our Board of Directors approves such “Acquiring Person” or redeems the Rights. Each Right, once it becomes exercisable, will generally entitle its holder, other than the “Acquiring Person”, to purchase from the Company either 0.4, half, one, two or three Ordinary Shares, as shall be determined by the Board of Directors, in consideration for the par value thereof. Therefore, the Plan may dilute the holding of shareholders who are deemed “Acquiring Persons” under the Plan. In addition, certain institutions may be discouraged from purchasing or holding our Ordinary Shares due to the Plan’s presumed anti-takeover effect.  Furthermore, the existence of the Plan may discourage bids to acquire our Company at a price that may be attractive to our shareholders.
 
We may fail to maintain effective internal control in accordance with Section 404 of the Sarbanes-Oxley Act of 2002.
 
The Sarbanes-Oxley Act of 2002 imposes certain duties on us and our executives and directors. Our efforts to comply with the requirements of the Sarbanes-Oxley Act, and in particular with Section 404, have resulted in increased general and administrative expenses and a diversion of management time and attention, and we expect these efforts to require the continued commitment of resources. If we fail to maintain the adequacy of our internal controls, we may not be able to ensure that we can conclude on an ongoing basis that we have effective internal control over financial reporting. Although our management has determined that we had effective internal control over financial reporting as of December 31, 2013, we may identify material weaknesses or significant deficiencies in our future internal control over financial reporting. In addition, as smaller reporting company, our internal control over financial reporting is not required to be audited by our independent registered public accounting firm. Failure to maintain effective internal control over financial reporting could result in investigation or sanctions by regulatory authorities, and could have a material adverse effect on our operating results, investor confidence in our reported financial information, and the market price of our Ordinary Shares.
 
 
33

 
 
We may not be able to meet NASDAQ Global Market continued listing requirements and our shares may be delisted.
 
We may not be able to meet NASDAQ Global Market continued listing requirements in the NASDAQ Listing Rules, or the NASDAQ Rules, and our Ordinary Shares may be moved to NASDAQ Capital Market or delisted.  Among other things, if the bid price of our Ordinary Shares is less than $1.00 for 30 consecutive business days or more, our shares may be moved to be traded on the NASDAQ Capital Market, or be delisted. After the bid price of a company goes below $1.00 for 30 consecutive business days, NASDAQ provides it a grace period before shares are being moved to be traded on the NASDAQ Capital Market or delisted.
 
Risks Related to Israel
 
Security, political and economic instability in the Middle East may harm our business.
 
We are incorporated under the laws of the State of Israel, and our principal offices and research and development facilities are located in Israel. Accordingly, security, political and economic conditions in the Middle East in general, and in Israel in particular, may directly affect our business.
 
Over the past several decades, a number of armed conflicts have taken place between Israel and its Arab neighbors and a state of hostility, varying in degree and intensity, has led to security and economic problems for Israel. From time to time since late 2000, there has also been a high level of violence between Israel and the Palestinians, which has strained Israel’s relationships with its Arab citizens, with Arab countries and, to some extent, with other countries around the world. In addition, Iran has threatened to attack Israel and is widely believed to be developing nuclear weapons.  In early 2011, riots and popular uprisings in various countries in the Middle East led to severe and continuing political instability in those countries. This instability may lead to deterioration of the political and trade relationships that exist between the State of Israel and these countries.  In addition, this instability may affect the global economy and marketplace. Any armed conflicts or political instability in the region, including acts of terrorism or any other hostilities involving or threatening Israel, would likely negatively affect business conditions and could make it more difficult for us to conduct our operations in Israel, which could increase our costs and adversely affect our financial results.
 
Furthermore, some countries, as well as certain companies and organizations, participate in a boycott of Israeli firms and others doing business with Israel or with Israeli companies. Restrictive laws, policies or practices directed towards Israel or Israeli businesses could have an adverse impact on the expansion of our business. In addition, we could be adversely affected by the interruption or curtailment of trade between Israel and its trading partners, a significant increase in the rate of inflation, or a significant downturn in the economic or financial condition of Israel.
 
 
34

 
 
Our operations could be disrupted as a result of the obligation of key personnel to perform Israeli military service.
 
Some of our executive officers and employees are required to perform annual military reserve duty in Israel and may be called to active duty at any time under emergency circumstances. Our operations could be disrupted by the absence for a significant period of one or more of our executive officers or other key employees due to military service. Any disruption to our operations would harm our business.
 
The Israeli government programs in which we currently participate, and the Israeli tax benefits we are currently entitled to, require us to meet several conditions, and they may be terminated or reduced in the future. This could increase our costs and/or our taxes.
 
We are entitled to certain tax benefits under Israeli government programs, largely as a result of the “Approved Enterprise” status granted to some of our capital investment programs by the Israeli Ministry of Industry and Trade. Taxable income derived from each program is tax exempt for a period of ten years beginning in the year in which the program first generates taxable income, up to 14 years from the date of approval or 12 years from the date of the beginning of production. Without such benefits our taxable income from such programs would be taxed at the regular corporate tax rate (24% in 2011, 25% in 2012 and 2013, and 26.5% as from 2014). To maintain our eligibility for these tax benefits, we must continue to meet conditions, including making specified investments in property, plant and equipment. We cannot assure that we will continue to be eligible for these tax benefits at the same rate or at all. The termination or reduction of these programs and tax benefits could increase our taxes and could have a material adverse effect on our business.
 
Because we received grants from the Israeli Office of the Chief Scientist, we are subject to ongoing restrictions relating to our business
 
We received royalty-bearing grants from the Office of the Chief Scientist of the Israeli Ministry of Industry, Trade and Labor, or the OCS, for research and development programs that meet specified criteria. We are obligated to pay royalties with respect to the grants received. In addition, the terms of the OCS grants limit our ability to manufacture products or transfer technologies outside of Israel if such products or technologies were developed using know-how developed with or based upon OCS grants. Pursuant to the Israeli Encouragement of Research and Development in the Industry Law, we and any non-Israeli who becomes a holder of 5% or more of our share capital are generally required to notify the OCS and such non-Israeli shareholder is required to undertake to observe the law governing the grant programs of the Chief Scientist, the principal restrictions of which are the transferability limits described above.
 
It may be difficult to enforce a U.S. judgment against us, our officers and directors or to assert U.S. securities law claims in Israel.
 
We are incorporated in Israel. Some of our executive officers are not residents of the United States, and a substantial portion of our assets is located outside of the United States. Therefore, it may be difficult for an investor, or any other person or entity, to enforce a U.S. court judgment based upon the civil liability provisions of the U.S. federal securities laws in an Israeli court against us or any of these persons or to affect service of process upon these persons in the United States. Additionally, it may be difficult for an investor, or any other person or entity, to enforce civil liabilities under U.S. federal securities laws in original actions instituted in Israel.
 
 
35

 
 
Provisions of Israeli law may delay, prevent or make undesirable an acquisition of all or a significant portion of our shares or assets.
 
The Companies Law regulates acquisitions of shares through tender offers, requires special approvals for transactions involving shareholders holding 5% or more of the company’s capital, and regulates other matters that may be relevant to these types of transactions. These provisions of Israeli law could have the effect of delaying or preventing a change in control and may make it more difficult for a third party to acquire us, even if doing so would be beneficial to our shareholders. These provisions may limit the price that investors may be willing to pay in the future for our Ordinary Shares. Furthermore, Israeli tax considerations may make potential transactions undesirable to us or to some of our shareholders.
 
Item 1B.  Unresolved Staff Comments.
 
Not Applicable.
 
Item 2.     Properties.
 
We lease an aggregate of 10,639 square meters of land in Rosh Pina, Israel, from the Israel Lands Authority. Of the 10,639 square meters at Rosh Pina, 2,377 square meters are leased under a 49-year lease that is set to expire on November 16, 2041, with an option to extend for an additional period of 49 years.  Our principal management, administration and marketing activities occupy a 1,188 square meter facility on the site.  The remaining 8,262 square meters of land are leased under a 49-year lease with the Israel Lands Authority, which is set to expire on September 14, 2047, with an option to extend for a further period of 49 years.  Our principal engineering, research and development facilities occupy a 4,000 square meter facility on this site.  Some of our manufacturing activities take place at this site as well. The rent for the initial 49-year term of each of these leases was prepaid in its entirety at the beginning of the lease terms as is customary in Israel for leases of property for industrial purposes from the Israel Lands Authority. Our rights under these leases, including the facilities built on the site, are pledged for the benefit of Bank Leumi Le-Israel Ltd. We lease an aggregate of approximately 300 square meters in Zur Yigal, Israel, pursuant to a lease that is set to expire on April 1, 2016.
 
OTI America leases an aggregate of 2,200 square feet of office space in Iselin, New Jersey pursuant to a lease that is set to expire on August 31, 2014.
 
OTI PetroSmart owns an aggregate of 770   square meters of office space in Century City, South Africa.
 
ASEC leases 495 square meters of office space in Krakow, Poland, pursuant to a lease terminable by giving a six months’ prior notice, 143 square meters of office space in Warsaw, Poland, pursuant to a lease that is set to expire on April 28, 2016, 60 square meters of office space in another location in Warsaw, Poland pursuant to a lease that expires on April 30, 2015, and that can be extended for another five-year period,  56 square meters of office space in Lublin, Poland pursuant to a lease that expires on October 11, 2015 and 86 square meters office space in Warsaw together with 87 square meters of warehouse space pursuant to a  lease that expires on May 2, 2016.
 
We believe that the current space we have is adequate to meet our current and near future needs.
 
 
36

 
 
 
From time to time, we become involved in various routine legal proceedings incidental to the ordinary course of our business.  We do not believe that the outcomes of these legal proceedings have had in the recent past, or will have (with respect to any pending proceedings), significant effects on our financial position or profitability.
 
On March 26, 2012, we filed a patent infringement lawsuit in the United States District Court for the Southern District of New York against T-Mobile USA, Inc. (Civil Action No. 12-cv-2224-AJN) for selling NFC enabled phones, including the Nokia Astound and HTC Amaze, that infringe our U.S. Patent No. 6,045,043. Our requested relief in this action is a declaration that T-Mobile infringes our patent, an injunction against further infringement, direct and indirect damages for the infringement, and attorneys’ fees. Our NFC technology in the phones enables contactless payments with mobile phones, loyalty programs, data mining, and other applications.  T-Mobile answered the complaint, denying that it infringes the patent, alleging that the patent is invalid, and asserting other equitable   defenses. On May 7 and 9, 2013, the Court heard arguments from both parties on proposed constructions of the asserted claim terms.  The Court issued an opinion on June 20, 2013, adopting our proposed constructions. T-Mobile subsequently filed a motion to reconsider the Court’s claim construction, which the Court denied on August 27, 2013. Fact discovery has been completed. The parties have until the end of March 2014, to file dispositive motions.
 
On September 2, 2012, we filed an insurance lawsuit in the Israeli District Court Merkaz against Harel Insurance Company Ltd. (Civil Action 2399-09-12) for damages incurred by us due to flooding in our subcontractor’s (Smartrac) manufacturing site in Thailand, in the amount of approximately $11 million. This caused disruptions to our supply chain and specifically affected our ability to deliver products to our customers. The parties have until the end of March 2014 to submit its depositions and the Court has rescheduled a preliminary hearing of the claim for July 15, 2014.
 
On October 3, 2013 , the Company received from the Commercial Court of Paris, France, or the Court , notification that a French company named SMJ PARK’IN SARL, or the Plaintiff , submitted on June 2013 a monetary claim against the Company and its French subsidiary, Parx France, or the Defendants, alleging, among others, the Defendants entered on mid 2008 into an agreement with the Plaintiff granting it the exclusive marketing rights to distribute and operate the Defendants , EasyPark Parking System (locally named PIAF) in Paris and ILE the France, and that the Defendants failed to fulfill their undertakings under such alleged agreement, by marketing their products by themselves or others causing the Plaintiff losses that it requires compensation for in its lawsuit. The total claim amount made by Plaintiff under this action is approximately 1.5 Million. The Company rejects all Plaintiff’s allegations and claims, including, the alleged agreement and the then exclusive right of the Plaintiff to distribute Company’s products, which were at the relevant time in negotiation. Following a preliminary hearing held by the Court on December 2013, the Plaintiff was required to provide additional documents and Defendants are expected to submit its detailed defense to the Court by end of April 2014. Based on the advice of counsel, management believes that the Company had no material obligation to the Plaintiff.
 
 
Not Applicable.
 
 
37

 
 
PART II
 
Item 5.    Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
 
Our Ordinary Shares are traded on the NASDAQ Global Market under the symbol “OTIV”.
 
The following table shows, for the periods indicated, the high and low closing prices of our Ordinary Shares in U.S. dollars as reported on the NASDAQ Global Market.
 
Period
 
 
NASDAQ Global Market
Per Share $
 
 
 
High
   
Low
 
2012  
First quarter
    1.70       1.07  
Second quarter
    1.78       1.34  
Third quarter
    1.69       0.96  
Fourth quarter
    1.44       1.08  
2013  
First quarter
    1.55       0.87  
Second quarter
    1.52       0.85  
Third quarter
    1.95       1.40  
Fourth quarter
    3.69       1.48  
2014  
First quarter (through March 26, 2014)
    4.16       2.78  
 
Record Holders
 
Based on a review of the information provided to us by our transfer agent, as of March 20, 2014, there were 13 holders of record of our Ordinary Shares, of which 10 record holders holding less than 1% of our Ordinary Shares had registered addresses in the United States. These numbers are not representative of the number of beneficial holders of our shares nor are they representative of where such beneficial holders reside since many of these Ordinary Shares were held of record by brokers or other nominees (including one U.S. nominee company, CEDE & Co., which held approximately 99.86% of our outstanding Ordinary Shares as of said date).
 
 
38

 
 
Dividends
 
We have never declared or paid any cash dividends on our Ordinary Shares or other securities.
 
We currently expect to retain all future earnings, if any, to finance the development of our business, and do not anticipate paying any cash dividends in the foreseeable future.  Any future determination relating to dividend policy will be made by our Board of Directors and will depend on a number of factors, including future earnings, capital requirements, financial condition and future prospects and other factors the Board of Directors may deem relevant.  In the event of a distribution of a cash dividend out of tax exempt income, we will be liable for corporate tax at a rate of up to 30% in respect of the amount distributed.
 
Though we never declared or paid a cash dividend, in November 2008 our Board of Directors authorized the repurchase of our shares in a total aggregate amount not to exceed $5 million subject to approval by court, as required under the Companies Law. In May 2009 the court approved a repurchase program in a total amount of up to $2 million and in the course of the repurchase program, 1,178,699 of our Ordinary Shares were acquired during 2010 and 2011 for an aggregate purchase price of $2 million.
 
Item 6.    Sel ected Financial Data.
 
Not Applicable.
 
Item 7.       Managemen t ’s Discussion and Analysis of Financial Condition and Results of Operations.
 
This discussion and analysis should be read in conjunction with our consolidated financial statements and notes thereto contained in “Item 8. Financial Statements and Supplementary Data” of this Annual Report.
 
Results of Operations
 
In December 2013, we completed the sale of certain assets, certain subsidiaries and IP directly related to our SmartID division, for a total purchase price of $10 million, with additional $12.5 million subject to performance-based milestones.
 
In February 2014, we sold our wholly owned German subsidiary, Intercard, for a total purchase price of EURO 700,000 (approximately $960,000). Accordingly, assets and liabilities related to the SmartID division and Intercard are presented separately in the balance sheets, as assets and liabilities held for sale and were disposed in February 2014.
 
 
39

 
 
The results from such operations and the cash flows for the reporting periods are presented in the statements of operations and in the statements of cash flow, respectively, as discontinued operations separately from continuing operations.
 
All the data in this Annual Report that is derived from our financial statements, unless otherwise specified, excludes the results of those discontinued operations.
 
Sources of Revenue
 
We have historically derived a substantial majority of our revenues from the sale of our products, including both complete systems and OEM components. In addition, we generate revenues from licensing and transaction fees, and also, less significantly, from engineering services, customer services and technical support. During the past three years, the revenues that we have derived from sales and licensing and transaction fees have been as follows (dollar amounts in thousands):
 
   
2013
   
2012
   
2011
 
Sales
  $ 15,067     $ 11,560     $ 10,844  
Licensing and transaction fees
  $ 4,801     $ 5,044     $ 12,055  
 Total revenues
  $ 19,868     $ 16,604     $ 22,899  
 
Sales increased by $3.5 million, or 30%, in 2013 compared to 2012 and increased by $716,000, or 7%, in 2012 compared to 2011. The increase in 2013 is mainly attributed to an increase in sales related to our NFC readers in the US market and Europe partially offset by a decrease in sales of parking products. The increase in 2012 is mainly attributed to an increase in sales of products to retail, mass transit ticketing and petroleum customers, partially offset by a decrease in sales of parking products.
 
Licensing and transaction fees include single and periodic payments for manufacturing or distribution rights for our products, as well as licensing our intellectual property rights to third parties.  Transaction fees are paid by customers based on the volume of transactions processed by systems that contain our products. The decrease of $243,000 in 2013, or 5%, compared to 2012 is mainly due to a decrease in license fees related to the Parking market. The decrease of $7 million, or 58%, in 2012 compared to 2011 is due to non-recurring license fees of $7 million we recognized in 2011 from a license agreement with a corporation that is located in Asia.
 
We expect to generate additional revenues from transaction fees in the future as the installation and usage of systems that contain our products become more widespread.
 
 
40

 
 
We have historically derived revenues from different geographical areas.  The following table sets forth our revenues, by dollar amount (in thousands) and as a percentage of annual revenues in different geographical areas, during the past three years:
 
   
Africa
   
Europe
   
Asia
   
Americas
   
Israel
 
2013
  $ 4,073       21 %   $ 7,060       35 %   $ 99       1 %   $ 6,856       34 %   $ 1,780       9 %
2012
  $ 4,189       26 %   $ 6,664       40 %   $ 574       3 %   $ 2,968       18 %   $ 2,209       13 %
2011
  $ 3,938       17 %   $ 6,321       28 %   $ 7,972       35 %   $ 1,160       5 %   $ 3,508       15 %
 
Our revenues from sales in Asia decreased by $475,000, or 83%, in 2013 compared to 2012 mainly due to decreased revenues from retail and petroleum products. Our revenues from sales in Asia decreased by $7.4 million, or 93%, in 2012 compared to 2011 mainly due to $7 million revenues recognized in 2011 for a license agreement with a corporation in Asia. We anticipate revenues from Asia to grow in the coming years mainly with respect to retail products. Our revenues from sales in Americas increased by $3.9 million, or 131%, in 2013 compared to 2012, and increased in 2012 by $1.8 million, or 155%, compared to 2011. The increase from sales in Americas in 2013 and in 2012 is mainly due to an increase in sales of NFC readers to the U.S. market. Our revenues from sales in Israel decreased by $429,000, or 19%, in 2013 compared to 2012, and decreased in 2012 by $1.3 million, or 37%, compared to 2011. The decrease from sales in Israel in 2013 and in 2012 is mainly due to decreased revenues from parking operations and a decrease in mass transit products. Our revenues from sales in Africa and Europe have been relatively stable. Our revenues derived from outside the U.S., which are primarily received in currencies other than the U.S. dollar, will have a varying impact upon our total revenues, as a result of fluctuations in such currencies’ exchange rates versus the U.S. dollar.
 
The following table sets forth our revenues, by dollar amount (in thousands) and as a percentage of annual revenues by segments, during the past three years:
 
   
Petroleum
   
Parking
   
Retail and Mass Transit Ticketing
   
Other
 
2013
  $ 4,532       23 %   $ 2,210       11 %   $ 11,743       59 %   $ 1,383       7 %
2012
  $ 5,205       31 %   $ 2,944       18 %   $ 7,126       43 %   $ 1,329       8 %
2011
  $ 4,748       21 %   $ 3,494       15 %   $ 13,481       59 %   $ 1,176       5 %
 
Our revenues in 2013 from Parking decreased by $734,000, or 25%, in compared to 2012 and decreased by $550,000, or 16%, in 2012 compared to 2011. The decrease in revenues from Parking in 2013 and in 2012 is mainly due to a decrease in revenues generated from the Israeli market. Revenues from Retail and Mass Transit Ticketing in 2013 increased by $4.6 million, or 65%, compared to 2012, mainly due to increased sales of NFC readers to the U.S. market. Revenues in 2012 from Retail and Mass Transit Ticketing decreased by $6.4 million, or 47%, compared to 2011, mainly due to $7 million of revenues recognized in 2011 for a license agreement with a corporation in Asia. We anticipate revenues from Retail and Mass Transit Ticketing to grow in the next years mainly from NFC readers and mass transit expansion. Revenues in 2013 from Petroleum decreased by $673,000, or 13%, compared to 2012, mainly due to decrease in sales of Petroleum products in the Americas. Revenues in 2012 from Petroleum increased by $457,000, or 10%, compared to 2011, mainly due to increase in sales in Europe.
 
 
41

 
 
Cost of Revenues and Gross Margin
 
Our cost of revenues, presented by revenue source, gross profit and gross margin percentage, for each of the past three years have been as follows (dollar amounts in thousands):
 
Cost of revenues
 
2013
   
2012
   
2011
 
Cost of sales
  $ 9,140     $ 7,298     $ 8,470  
Cost of licensing and transaction fees
    -       -     $ 714  
Total cost of revenues
  $ 9,140     $ 7,298     $ 9,184  
Gross profit
  $ 10,728     $ 9,306     $ 13,715  
Gross margin percentage
    54 %     56 %     60 %
 
Cost of sales.   Cost of revenues relating to sales consists primarily of materials, as well as salaries, fees to subcontractors and related costs of our technical staff that assemble our products.  The increase of $1.8 million, or 25%, in 2013 compared to 2012 resulted primarily from an increase in our revenues and consumption of materials from retail products. The decrease of $1.2 million, or 14%, in 2012 compared to 2011 is primarily the result of the flooding of one of our manufacturing facilities in Thailand in October 2011, which caused the Company an impairment loss of inventory, and a decrease in consumption of materials resulting from the change in the product revenues mix.
 
Cost of licensing and transaction fees.  Licensing and transaction fees revenues do not have directly attributable cost of revenues for the years ended 2012 and 2013.  The cost in 2011 is due to transaction costs in connection with a license agreement   signed with a corporation in Asia.
 
Gross margin. Gross margin decreased from 60% in 2011 to 56% in 2012 and to 54% in 2013. The decrease in 2013 in comparison to 2012 was mainly attributed to the increase of Retail revenues. The decrease in 2012 in comparison to 2011 was mainly attributed to the decrease in the licensing and transaction fees revenues. The changes in our overall gross margin are mainly attributed to a change in our revenue mix .
 
Operating expenses
 
Our operating expenses and operating loss for each of the past three years have been as follows (dollar amounts in thousands):
 
   
Year ended December 31,
 
Operating expenses
 
2013
   
2012
   
2011
 
Research and development
  $ 4,868     $ 5,678     $ 6,148  
Selling and marketing
  $ 7,914     $ 11,822     $ 8,530  
General and administrative
  $ 6,945     $ 9,022     $ 7,053  
Other operating income, net
  $ (4,081 )     -       -  
Amortization and impairment of intangible assets and goodwill
  $ 894     $ 99     $ 122  
Total operating expenses
  $ 16,540     $ 26,621     $ 21,853  
 
 
42

 
 
Research and development.   Our research and development expenses consist primarily of the salaries and related expenses of our research and development staff, as well as subcontracting expenses. All research and development costs are expensed as incurred. The decrease of $810,000, or 14%, in 2013 compared to 2012 is primarily attributed to a decrease in employment expenses due to a decrease in the number of research and development employees in certain locations and a $135,000 decrease in stock based compensation expense to employees and non-employees. The decrease of $470,000, or 8%, in 2012 compared to 2011 was primarily due to a decrease in employment expenses resulting from the revaluation of the U.S. dollars, a decrease in the number of research and development employees in certain locations and a decrease in stock based compensation expense to employees and non-employees, partially offset by an increase in severance pay provision. Our research and development expenses may increase in the future as we continue to develop new products and new applications for our existing products.
 
Selling and marketing.   Our selling and marketing expenses consist primarily of salaries and substantially all of the expenses of our sales and marketing subsidiaries and offices in the United States, South Africa and Europe, as well as expenses related to advertising, professional expenses and participation in exhibitions and tradeshows.   The decrease of $3.9 million, or 33%, in 2013 compared to 2012 is primarily due to the employment termination of the former CEO and Chairman and former president and the related provisions made in 2012 and a $67,000 decrease in stock based compensation expenses to employees and non-employees. The increase of $3.3 million, or 39%, in 2012 compared to 2011 was primarily due to a provision for termination in 2012 of the Company’s former president in the amount of $2.4 million and termination of the Company's former CEO and Chairman in the amount of $568,000, an increase in severance pay provision mainly due to an increase in salary of the Company’s former CEO and Chairman and the Company’s former President. Our selling and marketing expenses may increase in the future as we continue to expand our local sales and marketing subsidiaries, open new offices and in the event that we hire additional personnel.
 
General and administrative.   Our general and administrative expenses consist primarily of salaries and related expenses of our executive management and financial and administrative staff. These expenses also include costs of our professional advisors (such as lawyers and accountants), office expenses, insurance and vehicle expenses, which have collectively grown as a result of the growth in the scope, magnitude and complexity of our business, and provision for doubtful accounts. The decrease of $2.1 million, or 23%, in 2013 compared to 2012 was primarily due to the employment termination of the former CEO and Chairman and related to provisions made in 2012 and a decrease in legal and other professional expenses. The increase of $2.0 million, or 28%, in 2012 compared to 2011 was primarily due to a provision for termination of the Company's former CEO and Chairman in the amount of $1.7 million, an increase in severance pay provision mainly due to increased salary of the Company's former CEO and Chairman and an increase in legal and other professional expenses, partially offset by decrease in expenses due to the revaluation of the USD and decrease in office expenses. General corporate and administrative expenses may increase in the future as we continue to expand our operations.
 
 
43

 
 
Other operating income, net.   On July 10, 2013, the Company signed a settlement agreement with its former CEO and Chairman and former president with respect to their termination of employment with the Company and its subsidiaries. Based on the agreements, beside the release of existing severance payments funds, the Company paid to the former CEO and the former president an aggregate of approximately $2.5 million for the employment term and the termination thereof. The agreements further provide a mutual release from all claims between the Company and the former CEO and Chairman and the former president in connection with their employment with the Company, termination thereof, and any position they held with the Company. Consequently to the execution of the agreements mentioned above, the provisions made over their employment period were adjusted accordingly and the Company recorded other income of $4.5 million. In addition, other operating income, net, includes a $231,000 loss from disposal of our subsidiary in France, a $91,000 loss on sale of property and equipment and a $100,000 expense due to settlement on patent litigation.
 
Amortization and impairment of intangible assets and goodwill. The increase of $795,000, or 803%, in 2013 compared to 2012 resulted from an impairment of intangible assets that amounted to $328,000 and an Impairment of goodwill that amounted to $485,000, both related to parking operations partially offset by a decrease in amortization expenses due to a sale of intangible assets in France. The decrease of $23,000, or 19%, in 2012 as compared to 2011 resulted from reduction in the amortization of intangible assets, which became fully amortized during 2012. We did not incur impairment charges in 2011 and 2012.
 
Financing income (expenses), net
 
Our financing expenses, net, for each of the past three years, have been as follows (dollar amounts in thousands):
 
   
Year ended December 31,
 
   
2013
   
2012
   
2011
 
Financing income
  $ 182     $ 320     $ 609  
Financing expenses
  $ (1,095 )   $ (813 )   $ (766 )
Financing expenses, net
  $ (913 )   $ (493 )   $ (157 )
 
Financing expenses consist primarily of interest payable on bank loans, bank commissions and foreign exchange losses. Financing income consists primarily of foreign exchange gains and from interest earned on investments in short term deposits, U.S. and Israeli treasury securities and corporate bonds. The decrease in financing income of $138,000, or 43%, in 2013 compared to 2012 is due to a decrease in interest earned on investments in debt securities and short term deposits and the decrease of $289,000, or 47%, in 2012 compared to 2011 resulted from a similar decrease in such income. The increase in financing expenses in 2013 compared to 2012 of $282,000, or 35%, is mainly due to increase in expenses resulting from the changes of the U.S. dollar against the Israeli NIS and the EURO. The increase in financing expenses in 2012 compared to 2011 of $47,000, or 6%, is mainly due to increases in interest on short and long term credit.
 
 
44

 
 
Net loss from continuing operations
 
The decrease of $10.9 million, or 61%, in 2013 compared to 2012 is primarily due to an increase in the Company’s gross profit, and a decrease in the operating expenses partially offset by increase in financing expenses, net, as mentioned above. The increase of $9.5 million, or 113%, in 2012 compared to 2011 is primarily due to a decrease in the Company’s gross profit, an increase in the operating expenses mainly due to an increase in selling and marketing expenses, general and administrative expenses and an increase in financing expenses, net, as mentioned above.
 
Our net loss   from continuing operations for each of the past three years has been as follows (dollar amounts in thousands):
 
   
Year ended December 31,
 
   
2013
   
2012
   
2011
 
Net loss from continuing operations
  $ (6,928 )   $ (17,875 )   $ (8,378 )
 
Net income from discontinued operations
 
In December 2013, the Company completed the sale of certain assets, certain subsidiaries and IP directly related to its SmartID division. In February 2014, following the closing of the agreement reached in December 2013, the Company sold its wholly owned German subsidiary, Intercard.
 
The results from these operations for the reporting periods are presented in the statements of operations as discontinued operations separately from continuing operations.
 
The increase in net income from discontinued operations of $3.5 million in 2013 compared to 2012 is primarily due to a gain recorded from the divestiture of the SmartID division partially offset by an impairment expense of assets held for sale in the German subsidiary. The decrease in net income from discontinued operations of $972,000 or 76%, in 2012 compared to 2011 is primarily due to a decrease in net income relating to the SmartID division projects.
 
Our net income from discontinued operations for each of the past three years has been as follows (dollar amounts in thousands):
 
   
Year ended December 31,
 
   
2013
   
2012
   
2011
 
Net income from discontinued operations
  $ 3,777     $ 313     $ 1,285  
 
Net loss
 
The decrease in net loss of $14.4 million, or 82%, in 2013 compared to 2012 is primarily due to an increase in the Company’s gross profit, and a decrease in the operating expenses partially offset by an increase in financing expenses, net, and an increase in net income from discontinued operations as mentioned above. The increase in net loss of $10.5 million, or 148%, in 2012 compared to 2011 is primarily due to a decrease in the Company’s gross profit, an increase in the operating expenses and financing expenses, net, and a decrease in net income from discontinued operations as mentioned above.
 
 
45

 
 
Our net loss for each of the past three years has been as follows (dollar amounts in thousands):
 
   
Year ended December 31,
 
   
2013
   
2012
   
2011
 
Net loss
  $ (3,151 )   $ (17,562 )   $ (7,093 )
 
Critical Accounting Policies and Estimates
 
We prepare our consolidated financial statements in conformity with accounting principles generally accepted in the United States.  Accordingly, we are required to make certain estimates, judgments and assumptions that we believe are reasonable based upon the information available.  These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and results of operations.  To fully understand and evaluate our reported financial results, we believe it is important to understand our revenue recognition policy, our policy with respect to the impairment of goodwill, other intangible assets and long-lived assets, and our policy with respect to discontinued operations.
 
Revenue recognition.   We recognize product sale revenues upon delivery, provided there is persuasive evidence of an arrangement and that the risks and rewards of ownership have transferred to the buyer, delivery has occurred, the fee is fixed or determinable and collection is probable and no further obligation exists.  In the case of nonrecurring engineering, revenue is recognized upon completion of testing and approval of the customization of the product by the customer and provided that no further obligation exists.
 
In arrangements that contain multiple elements, the Company implements the guidelines set forth in Accounting Standards Update, or ASU, 2009-13. Such multiple element arrangements may include providing an IT solution, selling products (such as smart cards) and rendering customer services. Accordingly, the overall arrangement fee is allocated to each element (both delivered and undelivered items) based on their relative selling prices, evidenced by vendor specific objective evidence of selling price, or VSOE, or third party evidence of selling price, or TPE. In the absence of VSOE and TPE for one or more delivered or undelivered elements in a multiple-element arrangement, the Company is required to estimate the selling prices of those elements. Such estimated selling price has been determined using a cost plus margin approach. Since the cost for each element in such arrangements was estimated reliably, the estimated selling price was calculated by multiplying the costs by an average gross margin applicable to each element. Once the standalone selling price for each element was determined, the consideration allocated to each element was recognized as revenues upon meeting the required criteria as described above.
 
In revenue arrangements that include software components, the Company implements the guidelines set forth in ASU 2009-14. Accordingly, software revenue recognition is not applied for tangible products that contain both software and non-software components that function together to deliver the tangible product’s essential functionality.
 
The Company has applied the guidance described above for certain arrangements which include providing IT solutions, selling products and customer services. The total arrangement consideration is allocated proportionally to the separate deliverables in the arrangement using estimated selling price for each component. The Company recognizes revenues from sale of its IT Solution and from certain long-term contract under the percentage of completion method.  The Company measures the percentage of completion based on output or input criteria, as applicable to each contract.  For the reported years the Company used in all of its projects output measures with respect to measuring the progress of completion based on milestones (i.e., contract milestones as stated in the agreement such as the delivery, installation or shipments of various deliverables) and operational sites (i.e., progress is measured as a percentage of the sites that are already operational, out of the total sites that are required to be operational under the agreement).  Provisions for estimated losses on uncompleted contracts are made during the period in which such losses are first identified, in the amount of the estimated loss on the entire contract. Revenues and costs recognized on contracts in progress are subject to management estimates.  Actual results could differ from these estimates. Following the SmartID division divesture, revenues from such contracts are included in “net income (loss) from discontinued operations”.
 
 
46

 
 
We recognize revenues from customer services and technical support as the services are rendered ratably over the period of the related contract.
 
Licensing and transaction fees are recognized based on the volume of transactions or monthly licensing fees from systems that contain the Company’s products and usually bear no cost to the Company. In 2011, the Company engaged in a non-recurring sale of a perpetual non-exclusive license, in which it incurred certain costs to close the sale.
 
Our revenue recognition policies are consistently applied for all revenues recognized.
 
Goodwill and other intangible assets. Goodwill represents the excess of the aggregate purchase price over the fair value of the net assets acquired in a purchase businesses combination. Goodwill is reviewed for impairment at least annually, as of December every year and at other times if events or circumstances arise that indicate that impairment may have occurred.  In September 2011, the Financial Accounting Standards Board, or FASB, issued ASU 2011-08, Testing Goodwill for Impairment , which provides an entity the option to perform a qualitative assessment to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount prior to performing the two-step goodwill impairment test. If this is the case, the two-step goodwill impairment test is required. If it is more-likely-than-not that the fair value of a reporting is greater than its carrying amount, the two-step goodwill impairment test is not required. The Company adopted this guidance in 2012. If the two-step goodwill impairment test is required, first, the fair value of the reporting unit is compared with its carrying value (including goodwill). If the fair value of the reporting unit is less than its carrying value, an indication of goodwill impairment exists for the reporting unit and the enterprise must perform step two of the impairment test (measurement).  Under step two, an impairment loss is recognized for any excess of the carrying amount of the reporting unit’s goodwill over the implied fair value of that goodwill. The implied fair value of goodwill is determined by allocating the fair value of the reporting unit in a manner similar to a purchase price allocation. The residual fair value after this allocation is the implied fair value of the reporting unit goodwill. If the fair value of the reporting unit exceeds its carrying value, step two does not need to be performed.
 
In 2013, following the change as to segment reporting in 2013, the Company allocated goodwill of $485,000 to the parking segment. Upon analyzing the fair value of the parking segment, the Company concluded that the goodwill had been impaired and therefore wrote-off such goodwill balance. Impairment for goodwill amounted to $485,000 for the year ended December 31, 2013. No impairment losses were recorded in 2011 and 2012.
 
Purchased intangible assets are carried at cost, less accumulated amortization. Amortization is computed over the estimated useful lives of the respective assets. Impairment of intangible assets amounted to $328 for the year ended December 31, 2013. No impairment losses were recorded in 2011 and 2012.
 
 
47

 
 
Discontinued operations.
 
Upon divesture of a business, we classify such business as a discontinued operation, if the divested business meets the following criteria:
 
 
1. 
The business qualifies as a component of an entity, as it comprises operations and cash flows that can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the Company.
 
 
2. 
Both of the following conditions are met or expected to be met within one year:
 
 
i. 
The operations and cash flows of the business have been or will be eliminated from the ongoing operations of the entity in the disposal transaction; and
 
 
ii. 
The Company will not have any significant continuing involvement in the operations of the component after the disposal transaction. The eligibility to receive contingent consideration from future sales of the divested business does not necessarily indicate that there is continuing involvement in the operations of the business.
 
For disposals other than by sale such as abandonment, the results of operations of a business would not be recorded as a discontinued operation until the period in which the business is actually abandoned.
 
We have concluded that at December 31, 2013, the divesture of the SmartID division and the divesture of Intercard qualify as discontinued operations and therefore have been presented as such. The sale of Parx France does not qualify as a discontinued operation as the Company has significant involvement after the disposal transaction.
 
Assets and liabilities of discontinued operations that have not yet been actually sold are presented on the balance sheet in one line item. Assets and liabilities of such discontinued operations are not offset and are presented as such only for the current year balance sheet.
 
The results of businesses that have qualified at December 31, 2013 as discontinued operations have been presented as such for all reporting periods. Results of discontinued operations include all revenues and expenses directly derived from such businesses; general corporate overhead is not allocated to discontinued operations.
 
Any loss or gain that arose from the divesture of a business that qualifies as discontinued operations has been included within the results of the discontinued operations.
 
We also present cash flows from discontinued operations separately from cash flows of continuing operations.
 
Contingent consideration.
 
Our sale arrangements consist of contingent consideration based on the divested businesses future sales or profits. We record the contingent consideration portion of the arrangement when the consideration is determined to be realizable.
 
 
48

 
 
Liquidity and Capital Resources. Returns of Loans
 
Our principal sources of liquidity since our inception have been sales of equity securities, borrowings from banks, cash from the exercise of options and warrants and proceeds from divestiture of part of our businesses. We had cash and cash equivalents of $15 million as of December 31, 2013 and $9.3 million as of December 31, 2012.  In addition, we had short-term investments of $2.6 million as of December 31, 2013 representing bank deposits (of which an amount of $2.4 million has been pledged as a security in respect of guarantees granted to third parties, loans and credit lines received from a bank), and $8.7 million as of December 31, 2012 (of which an amount of $5.7 million had then been pledged as a security in respect of guarantees granted to third parties, loans and credit lines received from a bank).  We believe that we have sufficient capital resources to fund our operations in the next 12 months.   We adhere to an investment policy which is intended to enable the Company to avoid being classified as a “passive foreign investment company” under United States law, or PFIC.  That said, we cannot provide complete assurance that PFIC status will be avoided in the future.  In addition, our investment policy requires investment in high-quality investment-grade securities. As of December 31, 2013, the balance of our long-term loans was $4.2 million. Such loans are denominated in U.S. dollars, NIS, South African Rand and Polish Zloty and are repayable from 2017 to 2023. As of December 31, 2013 these loans bear interest at rates ranging from 3.6%-8.5% (mainly 5%) per annum.
 
Agreements that were made with banks, in order to secure bank services and obtain bank credit and loans, include financial covenants and restrictive covenants. Under the covenants definitions, we are obligated to meet at least one of the following: (i) annual revenues of $15 million; (ii) operating profit; (iii) cash balances of $6 million; and (iv) equity at a level of 30% of the total assets.  As of December 31, 2013, we are in compliance with all of its covenants.
 
The Company's and certain subsidiaries' manufacturing facilities and certain equipment have been pledged as security in respect of a loan received from a bank. The Company's short term deposits in the amount of $2.4 million have been pledged as security in respect of guarantees granted to third parties, loans and credit lines received from a bank. Such deposits cannot be pledged to others or withdrawn without the consent of the bank.
 
As of December 31, 2013, we granted guarantees to third parties including performance guarantees and guarantees to secure customer advances in the sum of $1.5 million.
 
The expiration dates of the guarantees range from February 2014 to May 2016.
 
Over the past few years we had negative cash flow from operations.  In 2013 and 2012 we had a negative cash flow from continuing operations of $10.6 million and $6.4 million, respectively.  We may continue to suffer from negative cash flow from operations. We are looking for ways to increase our cash resources, such as capitalizing on our patent portfolio, sales of assets or parts of our business or raising funds. In addition, we are looking for ways to reduce our financial expenses, including repayment of debt instruments.
 
Operating activities related to continuing operations  
 
For the year ended December 31, 2013, net cash used in continuing operating activity was $10.6 million primarily due to a $6.9 million net loss from operating activities, a $3.5 million decrease in other current liabilities mainly due the termination of senior employees, a $3.2 million decrease in accrued severance pay, a $765,000 increase in trade receivables, a $181,000 decrease in trade payables, a $166,000 increase in accrued interest and a $11,000 increase in inventory, partially offset by a $1.3 million decrease in other receivables and prepaid expenses, $1.1 million of depreciation, $894,000 of amortization and impairment of intangible assets and goodwill, a $307,000 expense due to stock based compensation issued to employees and others, a $231,000 loss from disposal of a subsidiary, a $112,000 increase in deferred tax ,net and a $91,000 loss on sale of property and equipment.
 
For the year ended December 31, 2012, net cash used in continuing operating activity was $6.4 million primarily due to a $17.9 million net loss from operating activities, a $2.4 million increase in other receivables and prepaid expenses, a $295,000 gain on sale of property and equipment, a $232,000 in accrued interest and linkage differences and a $12,000 decrease in deferred tax, net, partially offset by a $4.8 million increase in other current liabilities mainly due to provisions for termination of senior employees, a $4.1 million decrease in trade receivables, a $1.6 million increase in trade payables, a $1.1 million increase in accrued severance pay, net,  $1.1 million of depreciation, $734,000 expense due to stock based compensation issued to employees and others, a $831,000 decrease in inventory and $99,000 of amortization of intangible assets.
 
For the year ended December 31, 2011, net cash used in continuing operating activity was $9 million primarily due to an $8.4 million net loss from operating activities, a $5 million increase in trade receivables, net, mainly due to consideration under a license agreement that was paid in the first half of 2012, a $1.7 million decrease in other current liabilities, $370,000 in accrued interest and linkage differences on long term loans a $369,000 increase in other receivables and prepaid expenses, a $68,000 linkage difference on receivable from sale of operation and a $19,000 decrease in deferred tax, net, partially offset by a $2.4 million increase in trade payables, $1.8 million of stock based compensation issued to employees and others, $1.1 million of depreciation, a $859,000 decrease in inventory, a $648,000 increase in accrued severance pay, $122,000 of amortization of intangible assets and a $24,000 loss on sale of property and equipment.
 
 
49

 
 
Operating activities related to discontinued operations
 
For the year ended December 31, 2013, net cash used in discontinued operation activities was $1.4 million. For the year ended December 31, 2012, net cash provided by discontinued operating activities was $1.8 million.  For the year ended December 31, 2011, net cash used in discontinued operating activities was $2.5 million. All such cash flows relate to the SmartID division and the German subsidiary Intercard. In 2012 and 2011, such cash flows related also to our sale of assets to Smartrac group in the asset sale agreement of 2009 .
 
Investing and financing activities related to continuing operations
 
For the year ended December 31, 2013, net cash provided by continuing investing activities was $7.0 million, mainly due to $6.5 million in proceeds from the maturity and sale of short term investments, $3.4 million proceeds from restricted deposits for employee benefits and $168,000 of proceeds from the sale of property and equipment, partially offset by $2.8 million purchases of property and equipment and a $325,000 investment in short term investments. For the year ended December 31, 2012, net cash provided by continuing investing activities was $2.6 million, mainly due to $17.7 million in proceeds from the maturity and sale of short term investments and $299,000 of proceeds from sale of property and equipment, partially offset by a $10.4 million investment in short term investments, a $3.9 million investment in restricted deposits for employee benefits, $1 million purchases of property and equipment and a $100,000 acquisition of a business operation. For the year ended December 31, 2011, net cash used in continuing investing activities was $8.3 million, mainly due to a $14.7 million investment in short term investments, $674,000 purchases of property and equipment and a $400,000 acquisition of a business operation, partially offset by $7.4 million in proceeds from the maturity and sale of short term investments and $93,000 proceeds from the sale of property and equipment.
 
For the year ended December 31, 2013, net cash provided by continuing financing activities was $1.8 million mainly due to $3.2 million in proceeds from long term bank loans mainly to support the expansion of the mass transit ticketing project in Poland and $968,000 in proceeds from the exercise of options and warrants, partially offset by a $1.3 million repayment of long-term bank loans and a $1.1 million decrease in short-term bank credit. For the year ended December 31, 2012, net cash provided by continuing financing activities was $31,000 mainly due to a $1.8 million increase in short-term bank credit, net, $390,000 in proceeds from long term bank loans and $12,000 in proceeds from the exercise of options and warrants, partially offset by a $2.2 million repayment of long-term bank loans. For the year ended December 31, 2011, net cash provided by continuing financing activities was $16 million mainly due to $16.6 million in proceeds from issuance of Ordinary Shares, net of issuance expenses, $2.8 million in proceeds from long term bank loans, and $208,000 in proceeds from the exercise of options and warrants partially offset by a $1.6 million decrease in short-term bank credit, net $1.3 million repayment of long-term bank loans and $864,000 of payments to acquire treasury shares.
 
 
50

 
 
Investing and financing activities related to discontinued operations
 
For the year ended December 31, 2013 net cash provided by discontinued investing activities was $9.9 million due to payments received related to the sale of certain assets, subsidiaries and IP relating to its SmartID division. For the year ended December 31, 2012, cash used in discontinued investing activities was $72,000. For the year ended December 31, 2011, net cash provided by discontinued investing activities was $1.9 million due to payments received related to the sale of assets to Smartrac group in the assets sale agreement of 2009 .  
 
For the year ended December 31, 2013, 2012 and 2011 net cash used in discontinued financing activities was $985,000, $1.4 million and $812,000, respectively, mainly due to repayments of short and long terms loans related to the SmartID division.
 
Market Risks
 
Market risks relating to our operations result primarily from changes in interest rates and currency fluctuations.  In order to limit our exposure, we may enter, from time to time, into various non-speculative derivative transactions. Our objective is to reduce exposure and fluctuations in earnings and cash flows associated with changes in interest rates and foreign currency rates.  We do not use financial instruments for trading purposes.
 
Interest Rate Risks
 
We are exposed to market risks resulting from changes in interest rates, primarily in connection with our loan obligations to banks. We do not currently use derivative financial instruments to limit exposure to interest rate risk. As of December 31, 2013, we had long-term loan obligations of $4.2 million, the vast majority of which is subject to variable interest rates.  Of this amount, $1.8 million was denominated in Polish Zloty, $1.1 million was denominated in South African Rand, $848,000 was denominated in NIS and $538,000 was denominated in U.S. dollars. These loans will be repaid during the next ten years. The carrying values of the loans are equivalent to or approximate their fair market value as they bear interest at approximate market rates.
 
Impact of Inflation and Currency Fluctuations
 
Our functional and reporting currency is the U.S. dollar. We generate a significant portion of our revenues and we incur some of our expenses in other currencies. As a result, we are exposed to the risk that the rate of inflation in countries in which we are active other than the United States will exceed the rate of devaluation of such countries’ currencies in relation to the dollar or that the timing of any such devaluation will lag behind inflation in such countries. To date, we have been affected by changes in the rate of inflation or the exchange rates of other countries’ currencies compared to the dollar, and we cannot assure you that we will not be adversely affected in the future.
 
The annual rate of inflation in Israel was 1.8% in 2013, 1.6% in 2012 and 2.2% in 2011. The NIS revaluated against the U.S. Dollar by approximately 7.0% in 2013, 2.3% in 2012 and devaluated against the U.S. Dollar by approximately 7.7% in 2011.
 
The functional currency of SmartCard Engineering is the Euro, of ASEC is the Polish Zloty and of OTI PetroSmart   is the South-African Rand. Significantly all of these subsidiaries’ revenues are earned, and significantly all of their expenses are incurred, in their functional currencies. To the extent that there are fluctuations between the Euro, the Polish Zloty and/or the South-African Rand against the U.S. dollar, the translation adjustment will be included in our consolidated statements of changes in equity as other comprehensive income or loss and will not impact the consolidated statements of operations. We cannot assure you that we will not be adversely affected in the future.
 
 
51

 
 
Corporation Tax Rate
 
Under Israeli law, the corporation tax rates applicable from the 2011 tax year are as follows: in the 2011 tax year – 24%; and from the 2012 tax year – the corporation tax rate will be 25%. On August 5, 2013 the Israeli parliament, or the Knesset, passed the Law for Changes in National Priorities (Legislative Amendments for Achieving Budget Objectives in the Years 2013 and 2014) – 2013, by which, inter alia, the corporate tax rate would be raised by 1.5% to a rate of 26.5% from 2014. As of December 31, 2013, our net operating loss carry-forwards for Israeli tax purposes amounted to approximately $144.6 million. Under Israeli law, net operating losses can be carried forward indefinitely and offset against certain future taxable income. Since we have incurred tax losses through December 31, 2013, we have not yet utilized the tax benefits for which we are eligible under the “Approved Enterprise” status. $4.5 million of our investment programs in buildings, equipment and production facilities have been granted “Approved Enterprise” status and we are, therefore, eligible for a tax exemption under the Law for the Encouragement of Capital Investments, 1959. Subject to compliance with applicable requirements, the portion of our income derived from the “Approved Enterprise” programs is tax-exempt for a period of ten years commencing in the first year in which it generates taxable income; but not later than (1) 14 years from the date of approval; or (2) 12 years from the date of beginning of production. If we do not comply with these requirements, the tax benefits may be cancelled and we may be required to refund the amount of benefits received, in whole or in part, with the addition of linkage differences to the Israeli consumer price index and interest. As of the date of this Annual Report, we believe that we are in compliance with these conditions.
 
Government of Israel Support Programs
 
Until 2005, we participated in programs offered by the Office of the OCS that support research and development activities. Under the terms of these programs, a royalty of 3.5% of the sales of products must be paid to the OCS, beginning with the commencement of sales of products developed with grant funds and ending when the dollar value of the grant is repaid. In 2006, we decided to cease our participation with the OCS.
 
Royalties payable with respect to grants received under programs approved after January 1, 1999, however, will be subject to interest on the dollar-linked value of the total grants received at an annual rate of LIBOR applicable to dollar deposits. As of December 31, 2013, we have received a total of $3.8 million from the OCS net of royalties paid to it (or accrued for). The terms of Israeli government participation also require that the manufacturing of products developed with government grants be performed in Israel, unless the OCS has granted special approval. If the OCS consents to the manufacture of the products outside Israel, we may be required to pay increased royalties, ranging from 120% to 300% of the amount of the OCS grant, depending on the percentage of foreign manufacture. These restrictions continue to apply even after we have paid the full amount of royalties payable with respect of the grants. Based upon the aggregate grants received to date, we expect that we will continue to pay royalties to the OCS to the extent of our sales of our products and related services for the foreseeable future.  Separate OCS consent is required to transfer to third parties technologies developed through projects in which the government participates. These restrictions do not apply to exports from Israel of products developed with these technologies.
 
 
52

 
 
 
Not Applicable.
 
 
Our financial statements are stated in thousands of United States dollars (US$) and are prepared in accordance with U.S. GAAP.
 
The following audited consolidated financial statements are filed as part of this Annual Report on Form 10-K:
 
Report of Independent Registered Public Accounting Firm, dated March 31, 2014.
 
Consolidated Balance Sheets.
 
Consolidated Statements of Operations.
 
Consolidated Statements of Comprehensive Loss. 
 
Consolidated Statements of Changes in Equity.
 
Consolidated Statements of Cash Flows.
 
Notes to the Consolidated Financial Statements.
 
 
Not Applicable.
 
 
Disclosure Controls and Procedures
 
Our management, including our Chief Executive Officer, or CEO, and Chief Financial Officer, or CFO, are responsible for establishing and maintaining our disclosure controls and procedures (within the meaning of Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended, or Exchange Act). These controls and procedures are designed to ensure that information required to be disclosed in the reports that we file under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and that such information was made known to our management, including our CEO and CFO, by others within the Company, as appropriate to allow timely decisions regarding required disclosure. We evaluated these disclosure controls and procedures under the supervision of our CEO and CFO as of December 31, 2013. Based upon that evaluation, our management, including our CEO and CFO, concluded that our disclosure controls and procedures are effective as of such date.
 
 
53

 
 
Management’s Annual Report on Internal Control over Financial Reporting
 
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) of the Exchange Act.  Our internal control over financial reporting policies and procedures are designed under the supervision of the CEO and CFO to provide reasonable assurance regarding the reliability of the financial reporting and preparation of the financial statements for the external reporting purposes in accordance with U.S. GAAP. Under the supervision and with the participation of our management, including our CEO and CFO, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control—Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
 
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
 
Based on our evaluation under the framework in Internal Control—Integrated Framework (1992) , our management concluded that our internal control over financial reporting was effective as of December 31, 2013.
 
This Annual Report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Management’s report regarding internal control over financial reporting was not subject to attestation by our registered public accounting firm pursuant to rules of the SEC that permit us to provide only management's report in this Annual Report.
 
Changes in Internal Control over Financial Reporting
 
There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended December 31, 2013,  that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
 
 
Not Applicable.
 
 
54

 
 
 
 
Our Directors and executive officers, as of the date hereof, together with their ages and business backgrounds are as follows:
 
Name
 
Age
 
Position(s) Held
Dimitrios J. Angelis
 
44
 
Chairman of the Board of Directors;
Chief Executive Officer of OTI America
Eileen Segall (1) (3) (4)
 
35
 
Director
Charles M. Gillman (2)(4)
 
43
 
Director
Dilip Singh (2)
 
65
 
Director
Richard K. Coleman Jr. (2)
 
57
 
Director
Mark Stolper (2) (3) (4)
 
42
 
Director
John A. Knapp Jr. (2) (3)
 
62
 
Director
Jerry L. Ivy Jr.
 
51
 
Director
Ofer Tziperman
 
52
 
Chief Executive Officer
Shay Tomer
 
35
 
Chief Financial Officer
Shlomi Eytan
 
39
 
Chief Sales and Marketing Officer
 
(1) External Director
 
(2) Independent Director
 
(3) Member of Compensation Committee
 
(4) Member of Audit Committee
 
Directors:
 
Dimitrios J. Angelis was appointed as a director of the Company on December 30, 2012 to hold office until the first general meeting of the shareholders of the Company to be held following the termination of a 36 month-period that commenced as of December 30, 2012. On April 26, 2013, Mr. Angelis was appointed by the Company’s Board as the Chairman of the Board of Directors instead of former Chairman Mr. Oded Bashan. On December 6, 2013, in addition to his position as Chairman of the Company’s Board, Mr. Angelis was appointed at the general shareholders meeting according to the Companies Law as the Chief Executive Officer of OTI America. Since 2012 until immediately prior to his appointment as Chief Executive Officer of OTI America, Mr. Angelis was the General Counsel of Wockhardt Inc., a biologics and pharmaceutical company (generics). From 2008 to 2012, Mr. Angelis was a senior counsel in Dr. Reddy’s Laboratories, Ltd., a publicly traded pharmaceutical company, and during 2008 he was the Chief Legal Officer and Corporate Secretary of Osteotech, Inc., a publicly traded medical device company with responsibility for managing the patent portfolio (approximately 42 patents). Prior to that, Mr. Angelis worked in the pharmaceutical industry in various corporate, strategic and legal roles. In addition, he worked for McKinsey & Company, Merrill Lynch, and the Japanese government. He began his legal career as a transactional associate with law firm Mayer Brown. Mr. Angelis holds a B.A. in Philosophy and English from Boston College, an M.A. in Behavioral Science from California State University and Juris Doctor from New York University School of Law.
 
 
55

 
 
The Company believes Mr. Angelis’s experience – over a decade as an accomplished attorney, negotiator, and general counsel to public as well as private companies – brings a wealth of strategic, legal and business acumen to the Board, and his qualifications make him suitable to serve as a director and Chairman of the Company.
 
Eileen Segall was appointed as an External Director under the Companies Law on December 30, 2012 to hold office for a three-year term that commenced on December 30, 2012 and thereafter was appointed as Chair of the Company’s Audit and Compensation Committees. Ms. Segall is the Founder and General Partner of Tildenrow Partners, LP, a private investment partnership, and the sole managing member of Tildenrow Advisors, LLC, New York, an investment advisory firm (2006 to present). Ms. Segall is a value investor with fourteen years of professional experience analyzing companies from a financial and corporate strategic perspective.  Previously, from 2003 to 2006, Ms. Segall was an assistant Portfolio Manager and Director of Research at Nicusa Capital Partners, LP.  Prior to portfolio management, from 2000 to 2002, Ms. Segall covered publicly traded equities in the telecommunications equipment industry as an equity Research Associate at Robertson Stephens, Inc. investment bank. Ms. Segall holds a B.S. in Materials Science and Engineering from the Massachusetts Institute of Technology (M.I.T.).
 
The Company believes Ms. Segall’s professional experience analyzing companies from a financial and corporate strategic perspective, as well as her knowledge and familiarity with corporate finance and accounting, make her suitable to serve as an external director of the Company.
 
Charles M. Gillman was appointed as a director on December 30, 2012 to hold office until the first general meeting of the shareholders of the Company to be held following the termination of a 36-month period commencing as of December 30, 2012. In June 2001, Mr. Gillman was employed by Nadel and Gussman, LLC, or NG, to serve as portfolio manager of certain investment portfolios of NG and its related family interests. NG is a management company located in Tulsa, Oklahoma that employs personnel for business entities related to family members of Herbert Gussman. In June 2002, Mr. Gillman founded Value Fund Advisors, LLC, or VFA, to serve as investment advisor to certain NG family related assets. VFA discontinued its role as investment advisor to these assets in December 2008. In December 2008, Mr. Gillman entered into an employment agreement with NG to provide portfolio management services to NG, including serving as Portfolio Manager of certain NG and family assets. Mr. Gillman began his career as a strategic management consultant for McKinsey & Company, New York, where he worked to develop strategic plans for business units of companies located both inside the United States and abroad. Thereafter and prior to joining NG, Mr. Gillman held a number of positions in the investment industry and developed an expertise in the analysis of companies going through changes in their capital allocation strategy. In addition, Mr. Gillman currently serves on the boards of directors of Digirad Corporation.   He also serves on the Board of the Penn Club of New York, the private charitable gaming company Littlefield Corp, and the private medication management company CompuMed, Inc. Mr. Gillman previously served as a director of InfuSystem Holdings, Inc., MRV Communciations, Inc., and Aetrium, Inc. Mr. Gillman holds a B.S., summa cum laude , from the Wharton School of the University of Pennsylvania.
 
The Company believes that Mr. Gilman’s years of experience analyzing companies and familiarity with corporate finance, as well as his experience serving as a director of diverse companies, make him suitable to serve as a director of the Company.
 
Dilip Singh was appointed as a director on December 30, 2012 to hold office until the first general meeting of the shareholders of the Company to be held following the termination of a 36-month period that commenced as of December 30, 2012. Mr. Singh has served as the General Partner of Value Generation Capital Fund LP since December 2013 and has also served as a director of Concurrent Computer Corporation, Inc., a provider of high-performance, real-time computer systems and software solutions, since July 2012. From April 2012 to April 2013, Mr. Singh served as the interim Chief Executive Officer, President and as a director of InfuSystem Holdings Inc., a provider of ambulatory infusion pumps and associated clinical services.  Prior to joining InfuSystem, Mr. Singh served as the Chief Executive Officer of MRV Communications, Inc., a provider of optical communications network infrastructure equipment and network management products, as well as network integration and managed services, from July 2010 to December 2011 and as a director from October 2010 to December 2011.  From December 2008 to May 2009, Mr. Singh served as the Chief Executive Officer of Telia-Sonera Spice Nepal, a large Asian mobile operator.  From October 2004 to November 2008, Mr. Singh served as the Chief Executive Officer and President of Telenity, Inc., a convergence applications, service delivery platform and value added services software company.   Mr. Singh earned a Master’s of Science in Physics from the University of Jodhpur and a Masters of Technology in Electronics & Communications Electrical Engineering from the Indian Institute of Technology.  Mr. Singh has over 40 years of operational executive management and board experience with global Fortune 500 telecom carriers and network equipment providers, healthcare services company, entrepreneurial experience with start-ups and early stage software and solution companies and a venture capital firm.
 
 
56

 
 
The Company believes Mr. Singh’s vast operational executive management and board experience with global companies make him suitable to serve as a director of the Company. 
 
Richard K. Coleman, Jr.   was appointed as a director on December 30, 2012 to hold office until the first general meeting of the shareholders of the Company to be held following the termination of a 36-month period that commenced as of December 30, 2012. Mr. Coleman brings to the board almost 40 years of executive leadership and operations experience in the high-tech sector. Mr. Coleman is the founder and President of Rocky Mountain Venture Services.  Since 1998, his company has helped technology companies plan and launch new business ventures and restructuring initiatives.  As a private investor and advisor, Mr. Coleman helps companies develop and execute strategic changes, often serving as an interim executive and/or board member.  Mr. Coleman is currently the President and Chief Executive Officer of Crossroads Systems, Inc., a global provider of data archive solutions, a position he has held since November 2013.  He has also served on the Board of Directors of Crossroads since April 2013. Previously, he served as the interim President and Chief Executive Officer Crossroads from May 2013 until November 2013.  Mr. Coleman has served on the Board of Directors of NTS, Inc., a broadband services and telecommunications company, since December 2012, where he serves as Chairman of the Strategy Advisory Committee and as a member of the Special Committee.  Mr. Coleman has also been a director of Aetrium Incorporated, a manufacturer of a variety of electromechanical equipment used in the handling and testing of semiconductor devices, since January 2013 and is currently a member of its Audit and Compensation Committees as well as Chairman of the Nominating and Corporate Governance Committee. Previously, Mr. Coleman served in a variety of senior operational roles including Chief Executive Officer of Vroom Technologies Inc. (1999-2000), a Customer Relationship Management software company, Chief Operating Officer of MetroNet Communications (1997-1998), a Canadian telecom start-up, and President of US West Long Distance (1995-2000).  Mr. Coleman also previously held significant officer level positions with Frontier Communications and Centex Telemanagement.  From 1983 to 1992, Mr. Coleman held multiple positions with Sprint Corporation, culminating in his appointment to lead the company’s Technology Management Division.  Mr. Coleman began his career as an Air Force Telecommunications Officer managing Department of Defense R&D projects. He has served as an Adjunct Professor for Regis University’s Graduate Management program and is a guest lecturer for Denver University, focusing on leadership and ethics.  Mr. Coleman holds a B.S. Degree from the United States Air Force Academy, an M.B.A. from Golden Gate University, and is a graduate of the United States Air Force Communications Systems Officer School.  
 
 
57

 
 
The Company believes that Mr. Coleman’s long years of executive leadership and operations experience in the high-tech sector, as well as his experience serving as a director in diverse companies, make him suitable to serve as a director of the Company.
 
Mark Stolper was appointed as a director on December 30, 2012 to hold office until the first general meeting of the shareholders of the Company to be held following the termination of a 36-month period that commenced as of December 30, 2012. Since 2004, Mr. Stolper has served as the Executive Vice President and Chief Financial Officer of RadNet, Inc., the largest owner and operator of freestanding medical diagnostic imaging centers in the United States.  At RadNet, Mr. Stolper is responsible for all accounting, finance, reimbursement operations, investor relations, treasury and related financial functions.  Prior to joining RadNet, Mr. Stolper had diverse experiences in investment banking, private equity, venture capital investing and operations.  Mr. Stolper began his career as a member of the corporate finance group at Dillon, Read and Co., Inc., executing mergers and acquisitions, public and private financings and private equity investments with Saratoga Partners LLP, an affiliated principal investment group of Dillon Read.  After Dillon Read, Mr. Stolper joined Archon Capital Partners, which made private equity investments in media and entertainment companies.  Mr. Stolper also worked for Eastman Kodak, where he was responsible for business development for Kodak's Entertainment Imaging subsidiary ($1.5 billion in sales).  Mr. Stolper was also co-founder of Broadstream Capital Partners, a Los Angeles-based investment banking firm focused on advising middle market companies engaged in financing and merger and acquisition transactions.  Mr. Stolper graduated magna cum laude with a liberal arts degree from the University of Pennsylvania and a finance degree from the Wharton School.  Mr. Stolper also has a postgraduate Award in Accounting from UCLA. 
 
The Company believes Mr. Stolper’s professional and corporate experience, as well as his knowledge and familiarity with corporate finance and accounting as an experienced Chief Financial Officer in a Nasdaq traded company, make him suitable to serve as a director of the Company.
 
John A. Knapp Jr. was appointed as a director on December 30, 2012 to hold office until the first general meeting of the shareholders of the Company to be held following the termination of a 36-month period that commenced as of December 30, 2012. Mr. Knapp has been the President and principal shareholder of Andover Group, Inc. since 1978.  Andover’s two main business lines are real estate development and investment management.  In October 2005, Mr. Knapp became Chief Executive Officer of ICO, Inc. and served in that capacity, as well as a director, until April 2010, when ICO was acquired by A. Schulman, Inc. for a significant premium.  During Mr. Knapp's tenure as Chief Executive Officer of ICO, the firm grew annual revenues from $250 million to over $400 million and the stock price rose from approximately $2.50 per share to over $8 per share. Mr. Knapp, through Andover Group, Inc., was a partner in San Juan Partners, LLC, which in 1998 acquired Burlington Resources Coal Seam Royalty Trust for $100 million, the assets of which were subsequently sold at a significant premium.  Mr. Knapp is a CFA and serves as a partner of CCM Opportunistic Partners, an investment fund that invests with emerging managers.  Mr. Knapp has served as a trustee of Annunciation Orthodox School in Houston, and is currently a trustee of the Armand Bayou Nature Center.  Mr. Knapp is an honors graduate of Williams College.
 
The Company believes that Mr. Knapp’s corporate and business strategy experience make him suitable to serve as a director of the Company.
 
Jerry L. Ivy Jr. was appointed as a director on December 6, 2013 to hold office until the first general meeting of the shareholders of the Company to be held following the termination of a 36 months period commencing as of December 6, 2013. Mr. Ivy brings 30 years of experience as a business owner, private investor, and entrepreneur.  Mr. Ivy has been active in diverse industries ranging from the manufacture and nationwide distribution of such personal items as cosmetics and beauty products to such commercial items as restaurant equipment and chemicals. Mr. Ivy has also actively traded commercial, agricultural, and residential real estate throughout the western United States over the past three decades. Mr. Ivy has made significant investments in the software and technology industry, and is currently the single largest individual shareholder of the Company’s stock.  Mr. Ivy has taken similarly large stakes in other small cap companies.
 
 
58

 
 
The Company believes Mr. Ivy’s executive management, investing and entrepreneur experience, as well as his knowledge and familiarity with corporate finance, make him suitable to serve as a director of the Company.
 
Executive Officers:
 
Ofer Tziperman is serving as the Company’s Chief Executive Officer and as the Chief Executive Officer of PARX and Easy Park since March 7, 2013. Mr. Tziperman brings over 20 years of managerial experience in the international high-tech industry. Mr. Tziperman originally joined the Company in 1995, where for nearly five years as VP Marketing and Sales he played a major role in turning the Company into an international organization with subsidiaries and distributors around the world. Mr. Tziperman was heavily involved in the Company's initial public offering in 1999 in Germany. Mr. Tziperman left the Company in 2000 to co-found LocatioNet Systems Ltd., where he served as its Chief Executive Officer and President.  In this capacity he led LocatioNet Systems to become one of the pioneering technology providers in the Location-based Services market. During this period, Mr. Tziperman gained practical experience in monetizing the LocatioNet patents. Mr. Tziperman is a former attorney and practiced commercial and business law.  In 2001, the World Economic Forum honored Mr. Tziperman as a 'Technology Pioneer'. In 2011, Mr. Tziperman re-joined the Company to lead its global parking business as the President of PARX until October 1, 2013. Mr. Tziperman is a co-inventor of four new patent applications in the field of car parking. Mr. Tziperman holds an LLB degree from the Faculty of Law at Tel Aviv University, and is a graduate of the Israeli Navy's Naval Officers Academy.
 
Shay Tomer is serving as the Company’s Chief Financial Officer since June 1, 2013. Mr. Tomer is a Certified Public Accountant in Israel. Mr. Tomer joined the Company in 2007, first as a controller at its headquarters in Israel and since 2008 as deputy Chief Financial Officer. Among his responsibilities are the consolidation of global quarterly and annual reports, budget planning for each subsidiary, implementation of Sarbanes-Oxley compliance and managing the Company’s cash flow.  Prior to joining the Company, Mr. Tomer was from 2004 to 2007 in Ernst & Young’s audit department and was a lecturer and instructor in accounting at the Open University of Israel. Mr. Tomer holds a B.A. in Accounting and Economics from the University of Haifa.
 
Shlomi Eytan is serving as the Company’s Chief Sales and Marketing Officer since August 1, 2013. Mr. Eytan has more than 15 years of experience managing global sales and marketing organizations in high tech companies. Prior to joining the Company and between the years of 2004-2013, Mr. Eytan acted in several key roles working for NICE Systems, a publically-traded multi-million dollar software company. In his last position at NICE, Mr. Eytan was a vice president of sales, focused on the Middle East and Africa, as well as Eastern Europe markets, and was instrumental in exceeding sales goals for these regions while shifting the focus from sales of infrastructure to advanced solution selling. Mr. Eytan holds an MBA, with an emphasis in information systems, and a Bachelor of Business Administration in Management Information Systems, both from the College of Management School in Israel.
 
Board Practices
 
Election of Directors; Appointment of Officers
 
Our current Board consists of eight directors, of which one is an External Director under Israeli law (following former external director Mr. Jeffrey E. Eberwein’s resignation on March 21, 2014). A majority of these directors must be non-executive directors, who are directors that are neither office holders nor our employees. Our non-External Directors are appointed, removed or replaced by a majority vote of our shareholders present in person or by proxy at a general meeting of our shareholders according to the Companies Law.
 
Once elected at a shareholders’ meeting, our directors, except for our External Directors, hold office until the first general meeting of shareholders held at least thirty six months after their election.  Incumbent directors may be reelected at that meeting. A director may be elected for consecutive terms, unless prohibited by law.
 
 
59

 
 
Under the Companies Law, neither the Chief Executive Officer of a public company nor a family member thereof or any person directly or indirectly subordinate to the Chief Executive Officer, may serve as a Chairman of the Board of Directors, and vice versa, unless authorized by a general meeting of the shareholders and then only for a period of time that does not exceed three years.
 
Our Board elected Mr. Angelis to serve as its chairman and, following his election, the Board determined that in light of his experience for over a decade as an accomplished attorney, negotiator, and general counsel to public as well as private companies, the Company and its shareholders can further benefit from Mr. Angelis' capabilities and expertise as a full-time officer of the Company who will personally oversee the monetization of the company’s intellectual property, and offered him the position of the Chief Executive Officer of OTI America, the Company's US subsidiary. The Company’s Board believes that as an accomplished attorney and corporate executive, Mr. Angelis as a full-time officer will be able to work closely with our consulting and legal teams to execute on the company’s long-term IP assertions and monetization plan. In accordance to the Companies Law, on December 6, 2013 the general shareholders meeting approved Mr. Angelis’ appointment as Chief Executive Officer of OTI America who reports to the Company’s Board, in addition to his role as Chairman of the Board of Directors.
 
Our Board appoints our Chief Executive Officer and his terms of employment are approved by the general shareholders meeting according to the provisions of the Companies Law.  Each of our executive officers serves at the discretion of the Board, subject to the terms of any employment agreement, and holds office until his or her successor is elected or until his or her earlier resignation or removal.
 
On March 7, 2013, our Board appointed Mr. Ofer Tziperman to serve as our Chief Executive Officer. None of our independent directors serves as the lead independent director. We believe that this leadership structure is appropriate to our Company given the current size and operations of the Company. Our Board’s role in risk oversight includes risk analysis and assessment in connection with each financial and business review, update and decision-making proposal and deliberations. The Board's role in our risk oversight is consistent with our leadership structure, with our Chief Executive Officer, whose performance is assessed by the Board, and other members of senior management having responsibility for assessing and managing our risk exposure, and the Board providing oversight in connection with those efforts.
 
External Directors
 
Under the Companies Law, companies incorporated under the laws of the State of Israel with shares listed on an exchange, including The NASDAQ Global Market, must appoint at least two External Directors. On March 21, 2014, External Director Mr. Jeffrey E. Eberwein resigned from the Board of Directors and the Company remained with one External Director. However, the Company is taking the necessary steps to convene a General Meeting of Shareholders to elect an additional External Director within a 90 days period provided by the Companies Law to elect an external director under such circumstances.
 
The Companies Law provides that a person may not be appointed as an External Director if the person is a relative of the controlling shareholder of the company or if the person (or any of the person's relatives, partners, employers or anyone to whom the person is directly or indirectly subjected to or any entity under the person's control) has or had during the two years preceding the date of appointment any affiliation with the company, its controlling shareholder, any of the controlling shareholder's relatives, any other entity under the control of the company or the company's controlling shareholder, and, where there is no controlling shareholder and no shareholder holding 25% or more of the voting power of the company, any affiliation to the chairman of the board of directors of the company, the company's chief executive officer, any beneficial owner of 5% or more of the issued shares or the voting power of the company or the most senior executive officer of the company in the finance field.
 
 
60

 
 
The term affiliation includes:
 
•              an employment relationship;
 
•              a business or professional relationship maintained on a regular basis;
 
•              control; and
 
 
service as an office holder, excluding service as a director in a private company prior to the first offering of its shares to the public, if such director was appointed as a director of the private company in order to serve as an External Director following the public offering.
 
"Office holder" is defined in the Companies Law as a chief executive officer, chief business manager, deputy general manager, vice general manager, any person who holds such position in the company, even if such person holds a different title, any director and other manager or officer who reports directly to the chief executive officer.
 
No person can serve as an External Director if his or her position or other business interests create, or may create, a conflict of interest with his or her responsibilities as an External Director or may otherwise interfere with his or her ability to serve as an External Director.
 
No person can serve as an External Director if the person (or any of the person's relatives, partners, employers, anyone to whom the person is directly or indirectly subjected to or any entity under the person's control) has business or professional relations with anyone the affiliation with whom is prohibited by the Companies Law, even if those affiliations are not of an ongoing nature, excluding negligible affiliations.
 
Our External Directors are required to possess professional qualifications as set out in regulations promulgated under the Companies Law. In addition, our Board is required to determine how many of our non-External Directors should be required to have financial and accounting expertise. In determining such number, the Board must consider, among other things, the type and size of the company and the scope and complexity of its operations.
 
Under the Companies Law, each of our External Directors must also serve on our Audit Committee and Compensation Committee. Following director Mr. Eberwein’s resignation, Ms. Segall is currently the only external director member of our Audit Committee and Compensation Committee. As noted above, the Company is taking the necessary steps to convene a General Meeting of Shareholders for the election of an additional External Director and upon his election the elected external director is expected to become a member of the Audit Committee and Compensation Committee. Ms. Segall serves as Chairman of our Audit and Compensation Committees.
 
Under the Companies Law, until the lapse of two years from termination of office (and with respect to a relative of an External Director who is not the External Director's spouse or child, one year from termination of office), we, our controlling shareholders and any corporation in their control, may not grant a person who served as an External Director of the company, or to its spouse or child, any benefit, directly or indirectly, and may not engage a person who served as an External Director of the company, or its spouse or child, as an office holder of the company or an entity under the control of the company's controlling shareholder and cannot employ or receive services from that person, either directly or indirectly, including through a corporation controlled by that person.
 
 
61

 
 
None of the External Directors has any relationship with us besides serving on our Board.
 
If, at the time an External Director is appointed, all current members of the Board, who are not controlling shareholders or family members thereof, are of the same gender, then that External Director must be of the other gender.  Regulations promulgated under the Companies Law provide that the requirement of Israeli residency does not apply to the External Directors of companies whose shares are listed for trading outside of Israel.
 
External Directors are elected by a majority vote at a shareholders’ meeting at which either the majority of shares voted at the meeting, including at least a majority of the shares held by non-controlling shareholders disinterested with respect to the interests of controlling shareholders voted at the meeting, vote in favor of the election of the External Director, or the total number of shares held by non-controlling shareholders disinterested with respect to the interests of controlling shareholders voted against the election of the External Director does not exceed two percent of the aggregate voting rights in the company.
 
The initial term of an External Director is three years commencing from the date of his or her election and under regulations that apply to Israeli companies whose shares that have been offered to the public outside of Israel or traded on a stock exchange outside of Israel, may be extended for consecutive additional three year periods (unlike other public companies, in which only two additional three year periods are allowed).  External Directors may only be removed by the same percentage of shareholders as is required for their election, or by a court, and then only if the External Directors cease to meet the statutory qualifications for their appointment or if they violate their duty of loyalty to the company.  If an External Directorship becomes vacant, our Board is required under the Companies Law to call a shareholders’ meeting promptly to appoint a new External Director. Each committee of our Board must include at least one External Director and the Audit Committee and Compensation Committee must include all of the External Directors.  An External Director is entitled to compensation as provided in regulations adopted under the Companies Law and is otherwise prohibited from receiving any other compensation, directly or indirectly, in connection with services provided as an External Director.
 
Alternate Directors
 
Under our current articles of association as amended and restated on December 6, 2013, each of our directors may appoint, with the agreement of the Board and subject to the provisions of the Companies Law, by written notice to us, any person to serve as an alternate director.  Under the Companies Law, neither a current serving director, nor a currently-serving alternate director or any person not eligible under the Companies Law to be appointed as a director, may be appointed as an alternate director.  An alternate director has all the rights and duties of the director appointing him, unless the appointment of the alternate provides otherwise, and the right to remuneration.  The alternate director may not act at any meeting at which the appointing director is present.  Unless the time period or scope of the appointment is limited by the appointing director, the appointment is effective for all purposes, but expires upon the expiration of the appointing director’s term.  Currently, none of our directors has appointed any alternate directors.
 
Directors’ Service Contracts
 
Other than directors that serve as officers of the Company or any of its subsidiaries, none of our directors have any services contracts either with us, or with any of our subsidiaries, which provide for benefits upon termination of employment or service.
 
 
62

 
 
Board Committees
 
Our Board has established an Audit Committee and a Compensation Committee.
 
Audit Committee
 
Under the Companies Law, the board of directors of a public company must appoint an Audit Committee. The Audit Committee must be comprised of at least three directors, including all of the External Directors, one of whom must serve as chairman of the committee. The Audit Committee may not include the chairman of the board, any director employed by or otherwise providing services on a regular basis to the Company, to a controlling shareholder or to any entity controlled by a controlling shareholder, any director whose main livelihood is dependent on a controlling shareholder, nor a controlling shareholder or a relative thereof.
 
In addition, the Audit Committee of our Board must include at least three independent directors within the meaning of Rule 5605(a)(2) to the NASDAQ Rules. Our External Director, Eileen Segall, and our directors, Mark Stolper and Charles M. Guillman, all of whom are “unaffiliated directors” under the Companies Law, qualify as independent directors under NASDAQ Rules and as Audit Committee independent directors under the NASDAQ Rules.  Eileen Segall is the Audit Committee’s Chairman.  In addition, our directors Dilip Singh, Richard Kenneth Coleman, and John Knapp are qualified as independent directors under the NASDAQ Rules. Our Board has determined that Mark Stolper is an “Audit Committee Financial Expert” within the meaning of SEC rules and has the requisite experience under NASDAQ Rules.
 
Under the Companies Law, the Audit Committee of a publicly traded company must consist of a majority of unaffiliated directors. An "unaffiliated director" is defined as either an External Director or as a director, classified as an “unaffiliated director” by the Company, who meets the following criteria: (i) he or she meets the qualifications for being appointed as an External Director, except for (i) the requirement that the director be an Israeli resident (which in any event does not apply to companies such as ours whose securities have been offered outside of Israel or are listed outside of Israel), (ii) the requirement for accounting and financial expertise or professional qualifications, and the Audit Committee of the company confirmed such qualifications and (iii) with respect to companies such as ours whose securities have been listed on the NASDAQ Global Market, where the director qualifies as an “independent director” under the NASDAQ Rules, the requirements relating to affiliation other than to controlling shareholder, any of the controlling shareholder's relatives or any other entity under the control of the company's controlling shareholder (which is not the company itself or an entity under the company’s control) ; and (ii) he or she has not served as a director of the Company for a period exceeding nine consecutive years. For this purpose, a break of less than two years in the service shall not be deemed to interrupt the continuation of the service.
 
Our Board adopted an Audit Committee charter that sets forth the responsibilities of the Audit Committee consistent with the rules of the SEC and the Listing Rules of the NASDAQ Stock Market, as well as the requirements for such committee under the Companies Law, as described below. The Audit Committee charter is posted on our website at http://investors.otiglobal.com/phoenix.zhtml?c=144733&p=irol-govHighlights . The information contained in, or accessible through, our website does not constitute part of this Annual Report.
 
Our Audit Committee provides assistance to our Board in fulfilling its legal and fiduciary obligations in matters involving our accounting, auditing, financial reporting, internal control and legal compliance functions by pre-approving the services performed by our independent accountants and reviewing their reports regarding our accounting practices and systems of internal control over financial reporting. Our Audit Committee also oversees the audit efforts of our independent accountants and takes those actions that it deems necessary to satisfy itself that the accountants are independent of management. During the fiscal year ended December 31, 2013, we had seven meetings of our Audit Committee.
 
 
63

 
 
Under the Companies Law and the NASDAQ Rules, our Audit Committee is responsible for (i) determining whether there are deficiencies in the business management practices of our company, including in consultation with our internal auditor or the independent auditor, and making recommendations to the Board to improve such practices, (ii) determining whether to approve certain related party transactions (including transactions in which an office holder has a personal interest) and whether such transaction should be deemed as material or extraordinary, (iii) where the Board approves the working plan of the internal auditor, to examine such working plan before its submission to the Board and propose amendments thereto, (iv) examining our internal controls and internal auditor's performance, including whether the internal auditor has sufficient resources and tools to dispose of its responsibilities, (v) examining the scope of our auditor's work and compensation and submitting a recommendation with respect thereto to our Board or shareholders, depending on which of them is considering the appointment of our auditor, and (vi) establishing procedures for the handling of employees' complaints as to the management of our business and the protection to be provided to such employees. In compliance with regulations promulgated under the Companies Law, our Audit Committee also approves our financial statements, thereby fulfilling the requirement that a board committee provide such approval. Our Audit Committee may not approve an action or a related party transaction, or take any other action required under the Israeli Companies Law, unless at the time of approval a majority of the committee's members are present, which majority consists of unaffiliated directors including at least one External Director, and it further complies with the committee composition set forth above.
 
Internal Auditor
 
Under the Companies Law, the Board must appoint an internal auditor that is recommended by the Audit Committee. The role of the internal auditor is to examine, among other things, whether the company’s actions comply with the law and orderly business procedure.  Under the Companies Law, the internal auditor may not be an office holder or an interested party, as defined below, or a relative of an office holder or an interested party, or the company’s independent accountant or the independent accountant’s representative.  The Companies Law defines an “interested party” as a holder of 5% or more of the issued shares or voting rights of a company, a person or entity who has the right to designate at least one director or the general manager of the company, and a person who serves as a director or general manager. On March 5, 2012, our Audit Committee recommended the appointment of Mr. Gali Gana, from the offices of Rosenblum Holzman & Co., as our internal auditor for the year 2012, and our Board approved the appointment on that date. On February 25, 2013, our Audit Committee recommended the reappointment of Mr. Gana, CPA, as our internal auditor for the year 2013, and our Board approved the appointment and the execution of a suggested annual internal auditors plan for the year 2013 on March 7, 2013. On December 30, 2013, our Board approved the execution of a suggested annual internal auditors plan for the year 2014.
 
Compensation Committee
 
Under an amendment to the Companies Law, effective December 12, 2012, and pursuant to the NASDAQ Rules, the board of directors of a public company must appoint a Compensation Committee. The Compensation Committee must be comprised of at least three directors, including all of the External Directors, which shall be a majority of the members of the Compensation Committee and one of whom must serve as chairman of the committee. The rest of the members of the Compensation Committee shall be directors who do not receive direct or indirect compensation for their role as directors (other than compensation paid or given in accordance with the regulations of the Companies Law applicable to the compensation of External Directors, or amounts paid pursuant to indemnification and/or exculpation contracts or commitments and insurance coverage).
 
The Compensation Committee may not include the chairman of the board, any director employed by or otherwise providing services on a regular basis to the Company, to a controlling shareholder or to any entity controlled by a controlling shareholder, any director whose main livelihood is dependent on a controlling shareholder, nor a controlling shareholder or a relative thereof.
 
 
64

 
 
Our Board of Directors adopted a charter for our Compensation Committee. The Compensation Committee charter is posted on our website at http://investors.otiglobal.com/phoenix.zhtml?c=144733&p=irol-govHighlights . The information contained in, or accessible through, our website does not constitute part of this Annual Report.
 
Under the Companies Law and the NASDAQ Rules, our Compensation Committee is responsible for (i) proposing an office holder compensation policy to the board of directors, (ii) propose necessary revisions to the compensation policy and examine its implementation, (iii) determining whether to approve transactions with respect to compensation of office holders, and (iv) determining, in accordance with our office holder compensation policy, whether to exempt an engagement with an unaffiliated nominee for the position of chief executive officer from requiring shareholders’ approval.
 
During 2013, our Compensation Committee had nine meetings. The current members of our Compensation Committee are Eileen Segall, Mark Stolper and John Knapp.  Ms. Eileen Segall is the Compensation Committee’s Chairman.
 
Pursuant to a recent amendment to the Companies Law, all public Israeli companies, including companies whose shares are only publicly-traded outside of Israel, such as the Company, are required to adopt a written compensation policy for their executives, which addresses certain items prescribed by the Companies Law. The adoption, amendment, and restatement of the policy is to be recommended by the Compensation Committee and approved by the Board and shareholders, except that the approval of the shareholders may be waived in certain circumstances prescribed by the Companies Law.
 
In accordance with the new Israeli law requirements, our Compensation Committee reviewed and adopted a written compensation policy for our executive officers, which addresses the items prescribed by the Companies Law. Our Board subsequently approved the policy and recommended that it be adopted by the shareholders. On December 6, 2013, the General Meeting of Shareholders of the Company approved the Executive Compensation Policy. The Compensation Committee engage the services of external compensation consultants on a case by case basis, and have engaged the services of such consultant with respect to the preparation of the Executive Compensation Policy. We believe all compensation consultants we have engaged are independent for the purposes of NASDAQ Rules.
 
Under the Companies Law, compensation of executive officers (including exculpation, indemnification and insurance) is determined and approved by our compensation committee and our Board of Directors, and in certain circumstances by our shareholders, either in consistency with our office holder compensation policy or, in special circumstances in deviation therefrom, taking into account certain considerations stated in the Companies Law. On December 6, 2013 the general shareholders meeting of the Company approved the Company the issuance of Indemnification Agreements to the directors and officers of the Company in the form prescribed in the invitation for the general meeting. 
 
Shareholder approval is required in the event (i) approval by our Board of Directors and our compensation committee is not consistent with our office holders compensation policy, or (ii) compensation required to be approved is that of our chief executive officer even if not a director or an executive officer who is also the controlling shareholder of our company (including an affiliate thereof). Such shareholder approval shall require a majority vote of the shares present and voting at a shareholders meeting, provided either (i) such majority includes a majority of the shares held by non-controlling shareholders who do not otherwise have a personal interest in the compensation arrangement that are voted at the meeting, excluding for such purpose any abstentions disinterested majority, or (ii) the total shares held by non-controlling and disinterested shareholders voted against the arrangement does not exceed two percent (2%) of the voting rights in our company. 
 
 
65

 
 
Additionally, approval of the compensation of an executive officer, who is also a director, requires a simple majority vote of the shares present and voting at a shareholders meeting, if consistent with our office holders compensation policy. Our compensation committee and Board of Directors may, in special circumstances, approve the compensation of an executive officer (other than a director, a chief executive officer or a controlling shareholder) or approve the compensation policy despite shareholders’ objection, based on specified arguments and taking shareholders’ objection into account. Our compensation committee may further exempt an engagement with a nominee for the position of chief executive officer, who meets the non-affiliation requirements set forth for an external director, from requiring shareholders’ approval, if such engagement is consistent with our office holders compensation policy and our compensation committee determines based on specified arguments that presentation of such engagement to shareholders’ approval is likely to prevent such engagement. To the extent that any such transaction with a controlling shareholder is for a period extending beyond three years, approval is required once every three years. 
 
A director or executive officer may not be present when the board of directors of a company discusses or votes upon the terms of his or her compensation, unless the chairman of the board of directors (as applicable) determines that he or she should be present to present the transaction that is subject to approval. 
 
Under Rule 5605(d)(1) to the NASDAQ Rules, compensation of the chief executive officer must be determined, or recommended to the Board of Directors for determination, either by: (i) a majority of the independent directors, or (ii) a compensation committee comprised solely of independent directors. The Chief Executive Officer may not be present during voting or deliberations. Under Rule 5605(d)(2) to the NASDAQ Rules compensation of all executive officers, except the chief executive officer, must be determined, or recommended to the Board for determination, either by (i) a majority of the independent directors, or (ii) a compensation committee comprised solely of independent directors.
 
Nominating Committee; Director Candidates.
 
We do not have a Nominating Committee or any committees of a similar nature, nor any charter governing the nomination process. Our Board does not believe that such committees are needed for a company our size. However, our independent directors will consider stockholder suggestions for additions to our Board.
 
Code of Ethics
 
We have adopted a Code of Business Conduct and Ethics that applies to our directors, executive and financial officers and all of our employees.  The Code of Business Conduct and Ethics is publicly available on our website at www.otiglobal.com and we will provide, at no charge, persons with a written copy upon written request made to us.  If we make any substantive amendments to the Code of Business Conduct and Ethics or grant any waivers, including any implicit waiver, from a provision of this code to our Chief Executive Officer, Chief Financial Officer or corporate controller, we will disclose the nature of such amendment or waiver on our website within four business days.   The information contained in, or accessible through, our website does not constitute part of this Annual Report.
 
Section 16(a) Beneficial Ownership Reporting Compliance
 
As of January 1, 2014, Section 16(a) of the Exchange Act requires our executive officers and directors, and persons who own more than 10% of our ordinary shares, to file reports regarding ownership of, and transactions in, our securities with the SEC and to provide us with copies of those filings. However, during the fiscal year 2013 our directors, officers and persons who own more than 10% of our ordinary shares were not required to comply with the reporting requirements of Section 16(a) because the Company was exempt from these requirements by virtue of being a “foreign private issuer”.
 
 
66

 
 
Item 11.    Executive Compensation.
 
This section provides information regarding compensation earned by the six executive officers whose compensation is disclosed in the compensation tables for the years ended December 31, 2013 and 2012. We refer to these executive officers as Named Executive Officers, or NEOs. We do not currently have any other executive officers.
 
Summary Compensation Table
 
Name
and Principal Position
 
Year
   
Salary
($) (1)
   
Stock-based Awards
($) (2)
   
All
Other Compensation
($) (3)
   
Bonus
   
Total
($)
 
Dimitrios J. Angelis
 
Chairman of the Board of Directors (3)
Chief Executive Officer of OTI America (4)
   
2013
 
 
2012
     
29,003
 
 
-
     
222,340
 
 
-
     
-
 
 
-
     
-
 
 
-
     
251,343
 
 
-
 
                                                 
Ofer Tziperman
 
Chief Executive Officer (5)
   
2013
 
2012
     
297,790
 
174,968
     
554,530
 
13,302
     
86,475
 
54,924
     
169,262
 
66,339
     
1,108,057
 
309,533
 
                                                 
Shay Tomer
 
Chief Financial Officer (6)
   
2013
 
2012
     
120,011
 
83,145
     
28,799
 
-
     
47,068
 
37,914
     
26,575
 
30,425
     
222,453
 
151,484
 
                                                 
Shlomi Eytan
 
Chief Sales and Marketing Officer (7)
   
2013
 
2012
     
62,288
 
  -
     
28,799
 
  -
     
20,222
 
-
     
-
 
-
     
111,309
 
-
 
                                                 
Ohad Bashan
 
Former President (8)
   
2013
 
2012
     
274,643
 
408,965
     
-
 
  -
     
1,134,176
 
34,880
     
-
 
51,625
     
1,408,819
 
495,470
 
                                                 
Tanir Horn-Wekselman
 
Former Chief Financial Officer(9)
   
2013
 
2012
     
78,306
 
106,308
     
-
 
73,891
     
161,405
 
45,324
     
-
 
-
     
239,711
 
225,523
 
 
 
67

 
 
(1)  
Salary payments which were in NIS were translated into US$ according to annually average exchange rate.
 
(2)  
The fair value recognized for the stock-based awards was determined as of the grant date in accordance with FASB ASC Topic 718 (see Note 11C. to our consolidated financial statements included elsewhere in this Annual Report).
 
(3)  
This cost reflects social benefits (as required under applicable Israeli Law), car expenses and termination payments.
 
(4)  
Mr. Dimitrios J. Angelis is serving as Chairman of the Board of Directors since April 26, 2013, and as Chief Executive Officer of OTI America since December 6, 2013.
 
(5)  
Mr. Ofer Tziperman is serving as Company's Chief Executive Officer and as the Chief Executive Officer of PARX and Easy Park since March 7, 2013. Prior to that, he served as Company's VP Marketing and Sales for nearly five years since 1995, and in 2011, re-joined the Company to lead its global parking business as the President of PARX until October 1, 2013. The 2013 “All Other Compensation” of Mr. Tziperman, as shown in the table above, is comprised of $23,253 of car expenses and $63,222 of social benefits. The “Bonus” of Mr. Tziperman for 2013, as shown in the table above, is comprised of $79,570 for serving as President of PARX, and $89,692 for serving as Company's Chief Executive Officer. The “Bonus” of Mr. Tziperman for 2012, as shown in the table above, relates to Mr. Tziperman’s serving as President of PARX.
 
(6)  
Mr. Shay Tomer is serving as Company's Chief Financial Officer since June 1, 2013. Prior to that, he served as Company's controller since 2007 and as Company's Deputy Chief Financial Officer since 2008. The 2013 “All Other Compensation” of Mr. Tomer, as shown in the table above, is comprised of $21,592 of car expenses and $25,476 of social benefits.
 
(7)  
Mr. Shlomi Eytan is serving as Company's Chief Sales and Marketing Officer since August 1, 2013. The 2013 “All Other Compensation” of Mr. Eytan, as shown in the table above, is comprised of $9,000 of car expenses and $11,222 of social benefits.
 
(8)  
Mr. Ohad Bashan served as Company's President until June 23, 2013. The 2013 “All Other Compensation” of Mr. Bashan, as shown in the table above, is comprised of $12,457 of car expenses and $1,121,719 of social benefits and termination payment.
 
(9)  
Ms. Tanir Horn-Wekselman served as Company's Chief Financial Officer until May 31, 2013. The 2013 “All Other Compensation” of Ms. Horn-Wekselman, as shown in the table above, is comprised of $18,687 of car expenses and $142,718 of social benefits and termination payment.
 
All of the Named Executive Officers and our directors mentioned in are entitled to acceleration of the vesting of any unvested stock options and restricted stock in the event of a change of control of the Company.
 
Pension, Retirement or Similar Benefit Plans
 
Except as required by applicable law (relating to severance payments to Israeli employees), Mr. Dimitrios Angelis, Mr. Ofer Tziperman and Mr. Shay Tomer shall be entitled to receive a one-time payment upon termination of their employment for commitment to confidentiality and non-competition, as detailed in the description of their agreements below.
 
 
68

 
 
Employment Agreements
 
We maintain written employment and related agreements with all of our office holders. These agreements provide for monthly salaries and contributions by us to executive insurance and vocational studies funds. The employment agreements of certain office holders provide that we may give the employee an annual bonus in accordance with annual targets determined by our Chief Executive Officer in consultation with our Compensation Committee by January 31 of each calendar year in respect of the following year. In determining the amount of the bonus, the Compensation Committee and the Board must relate it to our revenues or profits, as applicable to the employee. If justifiable in light of our quarterly financial results, we may make advances on bonus payments pursuant to a resolution of our Board. All of our office holders’ employment and related agreements contain provisions regarding noncompetition, confidentiality of information and assignment of inventions. The enforceability of covenants not to compete in Israel is unclear.
 
In accordance with recent requirements and limitations set forth in the Companies Law the Company adopted an Executive Officers Compensation Policy, or the Policy , which was formulated by the Compensation Committee, approved by the Board and recommended to the shareholders, which approved the adoption of the Policy at our annual general meeting held on December 6, 2013.
 
The Policy sets rules and guidelines with respect to the compensation strategy of Company’s executive officers designed to retain and attract highly qualified executives by providing competitive compensation, within the Company's ability to fund compensation based on its financial resources, while creating appropriate incentives considering, inter alia , risk management factors arising from the business of the Company, executives compensation benchmarks used in the industry, the size of the Company (including without limitation, its sales volume and number of employees), the nature of its business and its then current cash flow situation, in order to promote Company’s long-term goals, work plan, policies and the interests of the shareholders of the Company.
 
The Policy is designed to allow the Company to create a full compensation package for each of its executives based on common principles. With respect to variable compensation components, the Policy is designed to allow the Company to consider each executive's contribution in achieving the Company's short-term and long-term strategic goals and in maximizing its profits from long-term perspective and in accordance with the executive's position
 
We have the following written agreements and other arrangements concerning compensation with our Named Executive Officers:
 
(1)  
Agreement with Dimitrios J. Angelis . The employment agreement of Mr. Angelis with the Company, dated December 22, 2013, provides that Mr. Angelis will act as the Chief Executive Officer of OTI America, in consideration of an annual gross salary of $300,000. The employment agreement is for an initial term of 3 years, commencing December 6, 2013, and may be terminated at any time and without notice. This initial term shall be automatically extended for successive periods of one year each, unless either party submits a 180-day notice prior to the expiration of the initial period. If the Company terminates Mr. Angelis' employment other than for cause or total disability or if Mr. Angelis terminates his employment for good reason (as such terms are defined in Mr. Angelis’ employment agreement), the Company shall pay Mr. Angelis his unpaid salary earned through the termination date and a separation payment in an amount equal to 12 months’ annual base salary in effect at the time of termination. Under his employment agreement, Mr. Angelis was granted 150,000 stock options of the Company.
 
(2) 
Agreement with Ofer Tziperman . The employment agreement of Mr. Tziperman with the Company, dated December 22, 2013, provides that Mr. Tziperman will act as the Chief Executive Officer of the Company and the Chief Executive Officer of the Company’s subsidiaries, PARX and EasyPark, in consideration of a monthly gross salary of NIS 90,000. The employment agreement is for an initial three-year term commencing on March 7, 2013 and ending on March 6, 2016. This initial term shall be automatically extended for two successive periods of three years each. Nevertheless, other than in the case of termination of the agreement for cause, the term of the agreement may be terminated by either party upon at least six months' prior written notice. In the event of termination (by either party), Mr. Tziperman shall be entitled to severance pay equal to the statutory rate of one month’s current salary multiplied by the number of years of employment, unless the termination occurs as a result of circumstances depriving him of the right to severance pay at law. Additionally, in consideration for his commitment to confidentiality and non-competition, Mr. Tziperman shall be entitled to receive a one-time payment equal to twelve months of the then applicable salary, where 50% of this amount shall be paid upon the termination of his employment and the remaining 50% shall be held in escrow and released 12 months after the termination of his employment, provided Mr. Tziperman has complied with his confidentiality and non-competition commitments. Under his employment agreement, Mr. Tziperman was granted 266,666 stock options of the Company.
 
 
69

 
 
(3)  
Agreement with Shay Tomer . The initial employment agreement of Mr. Tomer with the Company, dated April 24, 2007, provides that Mr. Tomer shall act as the Company's Comptroller in the Company's finance department. As of June 1, 2013, Mr. Tomer has been promoted and appointed as the Company's Chief Financial Officer and accordingly a new employment agreement dated August 6, 2013 has been executed by Mr. Tomer for his current position as the Company’s Chief Financial Officer. The latest employment agreement is for an unspecified term and either party may terminate the employment agreement upon 6 months advance notice. In the event of termination (by either party), Mr. Tomer is entitled to receive severance pay equal to the statutory rate of one month’s current salary multiplied by the number of years of employment, unless the termination occurs as a result of circumstances depriving him of the right to severance pay at law or as a result of a breach of trust or a material breach of his undertakings. Additionally, in consideration for his commitment to confidentiality and non-competition, Mr. Tomer shall be entitled to receive a one-time payment equal to 6 months of the then applicable salary, where 50% of this amount shall be paid upon the termination of his employment and the remaining 50% shall be held in escrow and released 12 months after the termination of his employment, provided that Mr. Tomer has complied with his confidentiality and non-competition commitments. Under the employment agreement Mr. Tomer was granted 40,000 stock options of the Company in addition to stock options granted previously to Mr. Tomer for his prior services as a comptroller in the finance department.
 
(4)  
Agreement with Shlomi Eytan . The employment agreement of Mr. Eytan with the Company, dated June 2, 2013, provides that Mr. Eytan will act as the Company's Chief Sales and Marketing Officer. The employment agreement is for an unspecified term and either party may terminate the employment agreement upon a 3 month advance notice. In the event of termination (by either party), Mr. Eytan is entitled to receive all contributions made by the Company for severance payments in his executive insurance policy and any interest and/or profit accumulated thereto equal to 8.33% of his monthly based salary paid during his employment, in accordance with section 14 of the Israeli Severance Pay Law 1963, unless the termination occurs as a result of circumstances depriving him of the right to severance pay at law or as a result of a breach of trust or a material breach of his undertakings. Under the employment agreement, Mr. Eytan was granted 40,000 stock options of the Company.
 
Outstanding Equity Awards At Fiscal Year-End
 
           The following table shows stock option awards outstanding on the last day of the fiscal year ended December 31, 2013 for each of our Named Executive Officers.
 

Number of Securities Underlying Unexercised
 
   
Option Awards
   
Stock Awards
 
Name
 
Number of securities underlying unexercised options (#) exercisable
   
Number of securities underlying unexercised options (#) unexercisable
   
Option exercise price($)
   
Option expiration date
   
Number of shares that have not vested (#)
   
Market value of shares that have not vested ($)
 
Dimitrios Angelis (1)
    -       150,000     $ 3.23    
12/06/2018
      -       -  
Ofer Tziperman (2)(3)
    -      
166,666
 
100,000
   
$
 
$
0.90
 
3.18
   
12/06/2018
 
12/30/2018
      -       -  
Shay Tomer (4)(5)
    -      
40,000
 
  5,000
   
$
 
$
1.46
 
2.37
   
07/20/2018
 
03/24/2016
      -       -  
Shlomi Eytan (4)
    -       40,000     $ 1.46    
07/20/2018
      -       -  
Ohad Bashan
    -       -       -       -       -       -  
Tanir Horn- Wekselman
    -       -       -       -       -       -  
 
(1)  
On December 6, 2013, 150,000 options were granted to Dimitrios Angelis under the 2001 Stock Option Plan. The options vest in three equal annual installments, commencing December 6, 2014.
 
(2)  
On December 6, 2013, 166,666 options were granted to Ofer Tziperman under the 2001 Stock Option Plan. The options vest in three equal annual installments, commencing March 7, 2014.
 
(3)  
On December 30, 2013, 100,000 options were granted to Ofer Tziperman under the 2001 Stock Option Plan. The options vest in three equal annual installments, commencing December 30, 2014.
 
(4)  
On July 20, 2013, 40,000 options were granted to each of Shay Tomer and Shlomi Eytan under the 2001 Stock Option Plan. The options vest in three equal annual installments, commencing July 20, 2014.
 
(5)  
On March 24, 2011, 15,000 options were granted to Shay Tomer under the 2001 Stock Option Plan, out of which 10,000 options were exercised. The options vest in three equal annual installments, commencing March 24, 2012.
 
 
70

 

Director Compensation for 2013
 
The following table provides information regarding compensation earned by, awarded or paid to each person for serving as a director who is not an executive officer during the fiscal year ended December 31, 2013:
 
Name (1)
 
Fees Earned or Paid in Cash ($) (2)
   
Total ($)
 
Eileen Segall
    39,670       39,670  
Jeffrey E. Eberwein (3)
    31,452       31,452  
Charles M. Gillman
    29,003       29,003  
Dilip Singh
    28,386       28,386  
Richard K. Coleman Jr.
    29,003       29,003  
Mark Stolper
    32,166       32,166  
John A. Knapp Jr.
    33,402       33,402  
Jerry L. Ivy Jr.
    3,611       3,611  
 
(1)  
The table above does not include Dimitrios J. Angelis, Company's Chairman, who is included in the description of compensation of Named Executive Officers above.
 
(2)  
This column represents the sums that our non-executive directors received according to the Israeli regulations as an annual fee as well as for attendance to Board and Board Committees meetings.
 
(3)  
Former external director Mr. Eberwein resigned from the Board of Directors on March 21, 2014, and the table above represents the compensation paid to Mr. Eberwein in 2013.
 
 
71

 
 
We reimburse our directors for expenses incurred in connection with attending board meetings and provide the following compensation for directors: annual compensation of $18,516; meeting participation fees of $1,082 per in-person meeting; meeting participation by telephone of $648 per meeting; and $542 per written resolution.
 
Our executive directors do not receive separate compensation for their service on the Board or any committee of the Board.  During 2013, our non-executive directors were reimbursed for their expenses for each board meeting attended and in addition received compensation for their service on the board. The aggregate amount paid by us to our non-executive directors during 2013 was $226,693.
 
With the exception of our Chairman and CEO of OTI America, none of our currently serving directors has received any equity compensation.
 
See the section entitled “Security Ownership of Certain Beneficial Owners and Management” below for information on beneficial ownership of our shares by our directors and executive officers.  We have no outstanding loans to any of our directors or executive officers.
 
Under the Companies Law, each of our External Directors is entitled to compensation as provided in regulations adopted under the Companies Law and is otherwise prohibited from receiving any other compensation, directly or indirectly, in connection with services provided as an External Director.
 
 
 
72

 
 
Item 12.    Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters.
 
The following table sets forth certain information, to the best knowledge and belief of the Company, as of March 20, 2014   (unless provided herein otherwise), with respect to holdings of our ordinary shares by (1) each person known by us to be the beneficial owner of more than 5% of the total number of shares of our ordinary shares outstanding as of such date; (2) each of our directors; (3) each of our Named Executive Officers; and (4) all of our directors and our executive officers as a group.
 
All information with respect to the ownership of any of the below shareholders has been furnished by such shareholder and, unless otherwise indicated below, we believe that persons named in the table have sole voting and sole investment power with respect to all of the shares shown as owned, subject to community property laws, where applicable. The shares owned by the directors and executive officers include the shares owned by their family members to which such directors and executive officers disclaim beneficial ownership, as provided for below.
 
As of March 20, 2014, we had 33,140,867 Ordinary Shares outstanding.
 
 
73

 
 
Name of beneficial owner
 
Position
 
Number of Shares Beneficially Owned (*)
   
% of Class of Shares
   
Dimitrios J. Angelis   (1)
 
Director and Officer
    616,378       1.9 %  
Jerry L. Ivy, Jr. (2)
 
Director
    3,063,916       9.3 %  
Charles M. Gillman (3)
 
Director
    516,300       1.6 %  
Jeffrey E. Eberwein (4)
 
Director
    377,200       1.1 %  
Dilip Singh (5)
 
Director
    300,000       **    
John A. Knapp Jr.(6)
 
Director
    100,700       **    
Eileen Segall
 
Director
    -       -    
Richard K. Coleman Jr.
 
Director
    -       -    
Mark Stolper
 
Director
    -       -    
Ofer Tziperman (7)
 
Officer
    55,555      
* *
   
Shay Tomer (8)
 
Officer
    5,000       **    
Shlomi Eytan
 
Officer
    -       -    
                       
All executive officers and directors as a group (12 persons)
        5,035,049      
15.2
%  
5% Shareholders
                     
C. Silk & Sons, Inc. (9)
 
Shareholder
    2,636,537      
8.0
%  
Jack Silver (10)
 
Shareholder
    1,868,550      
5.6
%  
 
(*)
 
 
(**)
(1)
 
 
If a shareholder has the right to acquire shares by exercising options currently exercisable or exercisable within 60 days of the date of this table, these shares are deemed outstanding for the purpose of computing the percentage owned by the specific shareholder (that is, they are included in both the numerator and the denominator), but they are disregarded for the purpose of computing the percentage owned by any other shareholder.
Less than 1%
Includes 35,500 Ordinary Shares held by Mr. Angelis, and 580,878 Ordinary Shares as to which Mr. Angelis has voting rights in his capacity as Chairman of the Board of Directors, pursuant to irrevocable proxies previously granted to the Chairman of the Board of Directors of the Company. Does not include options held by Mr. Angelis to purchase 150,000 Ordinary Shares, which are not currently exercisable or exercisable within 60 days of the date of this table.
 
(2)
Includes 2,641,116 Ordinary Shares held by Mr. Ivy and 422,800 Ordinary Shares held in an account with Marlene A. Ivy as joint tenants with rights of survivorship.
 
(3)
Includes 498,300 Ordinary Shares purchased pursuant to a Rule 10b5-1 trading plan entered into by Boston Avenue Capital LLC and Williams Trading LLC on June 6, 2013 (implemented at a time when Mr. Gillman was a portfolio manager for Boston Avenue Capital, LLC, to whom Mr. Gillman makes, from time to time, non-binding investment recommendations.
 
(4)
Includes 297,200 Ordinary Shares purchased by Mr. Eberwein pursuant to a Rule 10b5-1 trading plan entered into by Mr. Eberwein and Williams Trading LLC on June 6, 2013 and 80,000 held by Mr. Eberwein’s wife. Mr. Eberwein’s 10b5-1 trading plan was subsequently terminated. The shares were transferred on September 30, 2013 to Lone Star Value Investors, LP, an affiliate of Mr. Eberwein, in an exempt transaction. Mr. Eberwein resigned from the Board of Directors on March 21, 2014, and the table above represents Mr. Eberwein beneficial holdings as of December 31, 2013.
 
(5)
Includes 300,000 Ordinary Shares held by Value Generation Capital Fund, LP. The general partner of Value Generation Capital Fund, LP is Value Generation Capital, LLC. Mr. Singh is the managing member of Value Generation Capital, LLC, and may be deemed to have voting and dispositive power with respect to the shares held by Value Generation Capital Fund, LP.
 
(6)
Includes 100,700 Ordinary Shares purchased by Mr. Knapp pursuant to a Rule 10b5-1 trading plan entered into between Mr. Knapp and UBS Financial Services on June 14, 2013.
 
(7)
Consists of options held by Mr. Tziperman to purchase 55,555 Ordinary Shares currently exercisable or exercisable within 60 days of the date of this table .
 
(8)
Consists of options held by Mr. Tomer to purchase 5,000 Ordinary Shares currently exercisable or exercisable within 60 days of the date of this table.
 
(9)
Information is based solely on Amendment No. 1 of Schedule 13G/A filed with the SEC on February 14, 2014. C. Silk & Sons, Inc. beneficially owns 2,636,537 ordinary shares, and has the sole voting and dispositive power with respect thereof.
 
(10)
Information is based solely on Amendment No. 3 of Schedule 13G/A filed with the SEC on February 12, 2014. Mr. Silver beneficially owns 1,868,550 ordinary shares, and has the sole voting and dispositive power with respect thereof.
 
 
The table above does not contain information regarding Mr. Ohad Bashan, former President, and Ms. Tanir Horn-Wekselman, former Chief Financial Officer, who, to the best of Company’s knowledge do not have options of the Company, and the Company does not  have the information with respect to their holdings (if any).
 
 
 
74

 
 
The following table summarizes certain information regarding our equity compensation plan as of December 31, 2013:
 
Plan Category
 
Number of securities to be issued upon exercise of outstanding options
   
Weighted-average exercise price of outstanding options
   
Number of securities remaining available for future issuance under equity compensation plans
 
Equity compensation plan approved by security holders
    -       -       -  
Equity compensation plan not approved by security holders
    1,789,616     $ 1.65       2,308,655  
Total
    1,789,616     $ 1.65       2,308,655  
 
2001 Share Option Plan
 
         We established our 2001 Share Option Plan, or the 2001 Plan, in February 2001 (as amended and restated on November 30, 2011), and have amended it several times.  The 2001 Plan provides for the grant of options to our employees, directors and consultants, and those of our subsidiaries and affiliates. 
 
         Under the 2001 Plan, as of March 20, 2014, 13,547,900 options had been exercised and 1,633,061 options are outstanding including 795,894 exercisable.  Of the options that are outstanding, as of March 20, 2014, 501,666 options are held by our directors and officers, and have a weighted average exercise price of $2.15.
 
 
75

 
 
Item 13.    Certain Relationships and Related Transactions , and Director Independence.
 
Our policy is to enter into transactions with related parties on terms that are on the whole no less favorable to us than those that would be available from unaffiliated parties at arm’s length.  Based on our experience in the business sectors in which we operate and the terms of our transactions with unaffiliated third parties, we believe that all of the transactions described below met this policy standard at the time they occurred.
 
Agreement with HolyTech Ltd.
 
In January 1996, we entered into an agreement with HolyTech Ltd., a company that to our knowledge is owned by Mrs. Varda Bashan, Mrs. Ora Gilboa and certain other of our former executive officers, which formalized an arrangement that had existed since 1992. Mrs. Bashan is the spouse of Mr. Oded Bashan, former CEO and Chairman of the Board of Directors, and Ora Gilboa is the spouse of Mr. Ronnie Gilboa, a former director. In recent years, HolyTech provided us with management services through Mrs. Bashan. The aggregate consideration paid by us for the services that HolyTech provided to us was $80,000 in 2012 and $7,700 in 2013. The agreement with HolyTech was terminated on February 3, 2013.
 
Agreements with Directors and Officers
 
We have entered into employment agreements with all of our officers as mentioned above. In addition, we have granted options to purchase our Ordinary Shares to our officers, as mentioned elsewhere is this Annual Report.
 
Other than described above, none of our independent directors has any relationship with the Company besides serving as directors.
 
Our Board has determined that Eileen Segall, Mark Stolper and Charles M. Guillman qualify as independent directors under NASDAQ Rules and as Audit Committee independent directors under the NASDAQ Rules.
 
Item 14.    Principal Accounting Fees and Services.                                                                                     
 
Independent Registered Public Accounting Firm
 
The Company has engaged Somekh Chaikin, a member of KPMG International, or Somekh Chaikin, as its principal independent registered public accounting firm for the fiscal year ended December 31, 2013.
 
Policy on Pre-Approval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm
 
Our Audit Committee is generally responsible for the oversight of our independent auditors’ work. The Audit Committee’s policy is to pre-approve all audit and non-audit services provided by Somekh Chaikin. These services may include audit services, audit-related services, tax services and other services, as further described below. The Audit Committee sets forth the basis for its pre-approval in detail, listing the particular services or categories of services which are pre-approved, and setting forth a specific budget for such services. Additional services may be pre-approved by the Audit Committee on an individual basis. Once services have been pre-approved, Somekh Chaikin and our management then report to the Audit Committee on a periodic basis regarding the extent of services actually provided in accordance with the applicable pre-approval, and regarding the fees for the services performed.
 
Our Audit Committee pre-approved all audit and non-audit services provided to us and to our subsidiaries during the periods listed below. The Audit Committee approves discrete projects on a case-by-case basis that may have a material effect on our operations and also considers whether proposed services are compatible with the independence of the independent auditors.
 
 
76

 
 
Pursuant to our pre-approval policy, the Audit Committee pre-approves and delegates to our Chairman of the Board the authority to approve the retention of ad-hoc audit and non-audit services from our independent auditors, beyond the scope approved by the Audit Committee as part of the annual audit plan.
 
Pursuant to said policy, our Chairman of the Board, upon the recommendation of our management, can approve an audit or non-audit service, for a specific and limited scope, the fees for which do not exceed $5,000, provided that such additional services by the independent auditors shall not impair their independency. The Chairman shall notify the Audit Committee of any such additional services approved and the delegation of authority to the Chairman shall not derogate from the Audit Committee’s responsibilities.
 
Principal Accountant Fees and Services
 
The following fees were billed by Somekh Chaikin for professional services rendered thereby for the years ended December 31:
 
   
2013
   
2012
 
Audit fees (1)
  $ 241,609     $ 290,904  
Audit related fee (2)
  $ 47,750     $ 24,930  
Tax fees (3)
  $ 16,003     $ 19,300  
All Other Fees
    -       -  
Total
  $ 305,362     $ 335,134  
 
(1)  
The audit fees for the years ended December 31, 2013 and 2012, are the aggregate fees billed or billable (for the year) for the professional services rendered for the audits of our 2013 and 2012 annual consolidated financial statements, review of consolidated quarterly financial statements of 2013 and 2012, and services that are normally provided in connection with statutory audits of us and our subsidiaries, consents and assistance with review of documents filed with the SEC.
 
(2)  
The audit-related fees for the year ended December 31, 2013 included services in respect of the carve-out financial report for the SmartID division. For the year ended December 31, 2012, audit related fees included services for examination of a possible transition to IFRS GAAP reporting .
 
(3)  
Tax fees are the aggregate fees billed (in the year) for professional services rendered for tax compliance and tax advice other than in connection with the audit.
 
 
77

 
 
PART IV
 
Item 15.  Exhibits and Financial Statement Schedules.
 
3.1
Amended and Restated Articles of Incorporation (incorporated by reference to the Company’s report on Form 6-K (Report No. 3) filed with the SEC on October 31, 2013 and Company’s report on Form 6-K filed with the SEC on December 9, 2013.
 
4.1
Shareholders Rights Agreement, dated as of January 12, 2009, as amended and restated on January 11, 2012 and January 9, 2014, between the Company and Continental Stock Transfer & Trust Company (incorporated by reference to the Company’s Periodic Report on Form 8-K filed with the SEC on January 9, 2014).
 
10.1
Original Section 102 Share Option Plan of the Registrant (incorporated by reference to the amendment to the Company’s Registration Statement on Form F-1, filed with the SEC on September 11, 2002).
 
10.2
Stock Compensation Program and Stock Award Agreement of OTI America, Inc. (incorporated by reference to the Company’s Registration Statement on Form F-1, filed with the SEC on June 14, 2002).
 
10.3
2008 Employee Stock Purchase Plan of the Registrant (incorporated by reference to the Company’s Registration Statement on Form S-8, filed with the SEC on March 6, 2008).
 
10.4
2001 Share Option Plan of the Registrant (incorporated by reference to the Company’s Registration Statement on Form S-8, filed with the SEC on March 25, 2011).
 
10.5
Application to Approve a Trustee for an Option Plan pursuant to Section 102 of the Income Tax Ordinance; and Deed of Trust (incorporated by reference to the amendment to the Company’s Registration Statement on Form F-1, filed with the SEC on September 11, 2002).
 
10.6
Long Term Lease Agreement, dated as of March 6, 2002 by and between the Israel Lands Authority and the Company (incorporated by reference to the Company’s Registration Statement on Form F-1, filed with the SEC on June 14, 2002).
 
10.7
Form of Letter of Exemption and Indemnification between the Company and its directors and officers (incorporated by reference to the Company’s report on Form 6-K, as Schedule B to such report, filed with the SEC on June 25, 2008).
 
10.8
Supply Agreement, dated December 22, 2009, by and between Smartrac N.V. and the Company (incorporated by reference to the Company’s Annual Report on Form 20-F/A (Amendment No. 2), filed with the SEC on March 16, 2012).
 
10.9*
Asset purchase agreement, dated August 14, 2013, by and between the Company and SuperCom Ltd.
 
10.10*
Employment agreement with Shay Tomer, dated August 6, 2013, by and between the Company and Shay Tomer.
 
10.11*
Employment agreement with Shlomi Eytan, dated June 2, 2013, by and between the Company and Shlomi Eytan.
 
10.12*
Employment agreement with Ofer Tziperman, dated December 22, 2013, by and between the Company and Ofer Tziperman.
 
10.13*
Employment agreement with Dimitrios Angelis, dated December 22, 2013, by and among the Company, OTI America, Inc. and Dimitrios Angelis.
 
21.1*
List of Subsidiaries of the Company.
 
23.1*
Consent of Independent Registered Public Accounting Firm.
 
 
78

 
 
31.1*
Certification pursuant to Rule 13a-14(a)/15d-14(a) of Ofer Tziperman.
 
31.2*
Certification pursuant to Rule 13a-14(a)/15d-14(a) of Shay Tomer.
 
32.1**
Certification pursuant to 18 U.S.C. Section 1350 of Ofer Tziperman.
 
32.2**
Certification pursuant to 18 U.S.C. Section 1350 of Shay Tomer.
 
101 *
The following materials from our Annual Report on Form 10-K for the year ended December 31, 2013 formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Statements of Comprehensive Loss (iv) the Consolidated Statements of Changes in Equity, (v) the Consolidated Statements of Cash Flows, and (vi) the Notes to the Consolidated Financial Statements, tagged as blocks of text and in detail.
 
* Filed herewith.
 
** Furnished herewith.
 
∞ English translation of original Hebrew document.
 
 
79

 
 
SIGNATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
On Track Innovations Ltd.
 
By: /s/ Ofer Tziperman
 
Ofer Tziperman, Chief Executive Officer
 
(Principal Executive Officer)
 
Dated: March 31, 2014
 
By: /s/ Shay Tomer
 
Shay Tomer, Chief Financial Officer
 
(Principal Financial and Accounting Officer)
 
Dated: March 31, 2014
 
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
 
By:   /s/ Dimitrios J. Angelis
 
Dimitrios J. Angelis, Chairman of the Board of Directors and Chief Executive Officer of OTI America, Inc.
 
Dated: March 31, 2014
 
By:   /s/ Richard K. Coleman Jr.
 
Richard K. Coleman Jr., Director
 
Dated: March 30, 2014
 
 
80

 
 
By:   /s/ Charles M. Gillman
 
Charles M. Gillman, Director
 
Dated: March 31, 2014
 
By: /s/ Jerry L. Ivy Jr.
 
Jerry L. Ivy Jr., Director
 
Dated: March 31, 2014
 
By:   /s/ John A. Knapp Jr.
 
John A. Knapp Jr., Director
 
Dated: March 30, 2014
 
By:   /s/ Eileen Segall
 
Eileen Segall, Director
 
Dated: March 29, 2014
 
By:   /s/ Dilip Singh
 
Dilip Singh, Director
 
Dated: March 30, 2014
 
By:   /s/ Mark Stolper
 
Mark Stolper, Director
 
Dated: March 31, 2014
 
 
81

 
 
 
On Track Innovations Ltd.
and its Subsidiaries
 
Consolidated Financial Statements
As of December 31, 2013
 
 
 

 
 
On Track Innovations Ltd.
and its Subsidiaries

Consolidated Financial Statements as of December 31, 2013

 
Contents
 
 
 
 

 
 
Report of Independent Registered Public Accounting Firm

The Board of Directors and Shareholders
On Track Innovations Ltd.

We have audited the accompanying consolidated balance sheets of On Track Innovations Ltd. ("the Company") and its subsidiaries as of December 31, 2013 and 2012 and the related consolidated statements of operations, comprehensive loss, changes in equity and cash flows for each of the years in the three-year period ended December 31, 2013. These consolidated financial statements are the responsibility of the Company’s management.  Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).  Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.  An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements.  An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.  We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company and its subsidiaries as of December 31, 2013 and 2012 and the results of their operations and their cash flows for each of the years in the three-year period ended December 31, 2013, in conformity with U.S. generally accepted accounting principles.
 
/s/ Somekh Chaikin
Somekh Chaikin
Certified Public Accountants (Isr.)
A Member Firm of KPMG International

Tel Aviv, Israel
March 31, 2014
 
 
F - 2

 
 
On Track Innovations Ltd.
and its Subsidiaries

Consolidated Balance Sheets

US dollar in thousands except share and per share data
 
   
December 31
 
   
2013
   
2012
 
Assets
           
             
Current assets
           
Cash and cash equivalents
  $ 14,962     $ 9,304  
Short-term investments
    2,601       8,712  
Trade receivables (net of allowance for doubtful
               
  accounts of $610 and  $431 as of December 31, 2013
               
  and December 31, 2012, respectively)
    5,134       7,516  
Other receivables and prepaid expenses
    4,632       5,349  
Short term restricted deposit for employees benefit
    -       2,922  
Inventories
    3,477       7,049  
Assets from discontinued operations - held for sale
    3,919       -  
                 
Total current assets
    34,725       40,852  
                 
Long term restricted deposit for employees benefit
    623       1,099  
                 
Severance pay deposits
    738       836  
                 
Property, plant and equipment, net
    9,837       13,074  
                 
Deferred tax asset
    173       -  
                 
Intangible assets, net
    -       656  
                 
Goodwill
    -       485  
                 
Total Assets
  $ 46,096     $ 57,002  
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
F - 3

 
 
On Track Innovations Ltd.
and its Subsidiaries

Consolidated Balance Sheets

US dollar in thousands except share and per share data
 
   
December 31
 
   
2013
   
2012
 
Liabilities and  Equity
           
             
Current Liabilities
           
Short-term bank credit and current maturities
           
  of long-term bank loans
  $ 3,842     $ 7,368  
Trade payables
    9,255       10,696  
Accrued severance pay
    -       3,539  
Other current liabilities
    6,299       10,971  
Liabilities from discontinued operations - held for sale
    2,956       -  
Total current liabilities
    22,352       32,574  
                 
Long-Term Liabilities
               
Long-term loans, net of current maturities
    3,342       2,224  
Accrued severance pay
    1,706       2,032  
Deferred tax liability
    292       53  
Total long-term liabilities
    5,340       4,309  
                 
Total Liabilities
    27,692       36,883  
                 
Commitments and Contingencies
               
                 
Equity
               
Shareholders' Equity
               
Ordinary shares of NIS 0.1 par value: Authorized –
               
50,000,000 shares as of December 31, 2013 and
               
December 31, 2012; issued: 34,199,511  and 32,938,011
               
shares as of December 31, 2013 and December 31, 2012,
               
respectively; outstanding: 33,020,812  and 31,759,312 shares
               
as of December 31, 2013 and December 31, 2012, respectively
    854       820  
Additional paid-in capital
    212,246       210,853  
Treasury shares at cost - 1,178,699 shares as of December 31,
               
2013 and December 31, 2012.
    (2,000 )     (2,000 )
Accumulated other comprehensive income
    28       36  
Accumulated deficit
    (192,179 )     (189,131 )
Total Shareholder’s equity
    18,949       20,578  
Non-controlling interest
    (545 )     (459 )
                 
Total Equity
    18,404       20,119  
                 
Total Liabilities and Equity
  $ 46,096     $ 57,002  

The accompanying notes are an integral part of these consolidated financial statements.
 
 
F - 4

 
 
On Track Innovations Ltd.
and its Subsidiaries
Consolidated Statements of Operations

US dollar in thousands except share and per share data
 
   
Year ended December 31
 
   
2013
      2012*       2011*  
Revenues
                     
Sales
  $ 15,067     $ 11,560     $ 10,844  
Licensing and transaction fees
    4,801       5,044       12,055  
                         
Total revenues
    19,868       16,604       22,899  
                         
Cost of revenues
                       
Cost of sales
    9,140       7,298       8,470  
Cost of licensing and transaction fees
    -       -       714  
Total cost of revenues
    9,140       7,298       9,184  
                         
Gross profit
    10,728       9,306       13,715  
Operating expenses
                       
Research and development
    4,868       5,678       6,148  
Selling and marketing
    7,914       11,822       8,530  
General and administrative
    6,945       9,022       7,053  
Other operating income, net
    (4,081 )     -       -  
Amortization of intangible assets
    81       99       122  
Impairment of goodwill and intangible assets
    813       -       -  
                         
Total operating expenses
    16,540       26,621       21,853  
                         
Operating loss from continuing operations
    (5,812 )     (17,315 )     (8,138 )
Financial expenses, net
    (913 )     (493 )     (157 )
                         
Loss from continuing operations before taxes on income
    (6,725 )     (17,808 )     (8,295 )
 
                       
Income tax
    (203 )     (67 )     (83 )
                         
Net loss from continuing operations
    (6,928 )     (17,875 )     (8,378 )
Net income from discontinued operations
    3,777       313       1,285  
                         
Net loss
    (3,151 )     (17,562 )     (7,093 )
                         
Net loss attributable to noncontrolling interest
    103       168       168  
Net loss attributable to shareholders
  $ (3,048 )   $ (17,394 )   $ (6,925 )
                   
Basic and diluted net profit (loss) attributable to
                 
 shareholders per ordinary share
                 
From continuing operations
  $ (0.21 )   $ (0.56 )   $ (0.27 )
From discontinued operations
  $ 0.12     $ 0.02     $ 0.05  
    $ (0.09 )   $ (0.54 )   $ (0.22 )
Weighted average number of ordinary shares used in computing basic and diluted net profit (loss) per ordinary share
    32,673,123       32,168,373       31,524,315  

*Reclassified to conform with the current year presentation, see note 1B.
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
F - 5

 
 
 
On Track Innovations Ltd.
and its Subsidiaries

Consolidated Statements of Comprehensive Loss

 
US dollar in thousands
   
Year ended December 31
 
   
2013
   
2012
   
2011
 
Total comprehensive loss:
                 
Net loss
  $ (3,151 )   $ (17,562 )   $ (7,093 )
Foreign currency translation adjustments
    44       171       (438
Net unrealized gain (loss) on available-for-sale securities
    34       43       (32
Reclassification adjustment for loss on
                       
 available-for-sale securities
    (69 )     (99 )     (253 )
                         
Total comprehensive loss
  $ (3,142 )   $ (17,447 )   $ (7,816 )
Comprehensive loss attributable to the non-controlling interest
    86       172       163  
Total comprehensive loss attributable to shareholders
  $ (3,056 )   $ (17,275 )   $ (7,653 )
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
F - 6

 
 
 
On Track Innovations Ltd.
and its Subsidiaries

Consolidated Statements of Changes in Equity
 
US dollar in thousands, except share and per share data

                           
Accumulated
                   
               
Additional
         
other
          Non-    
 
 
   
Number of
   
Share
   
paid-in
   
Treasury
   
comprehensive
   
Accumulated
   
controlling
      Total  
   
Shares issued
   
capital
   
capital
   
Shares
   
Income (loss)
   
deficit
   
interest
   
equity
 
                                                                 
Balance as of January 1, 2011
    25,384,010     $ 610     $ 190,933     $ (1,136   $ 645     $ (164,812 )   $ (124   $ 26,116  
                                                                 
Changes during the year ended
                                                               
 December 31, 2011:
                                                               
Stock-based compensation related to
 options and shares issued
                                                               
 to employees and others
    -       -       1,933       -       -       -       -       1,933  
Exercise of options
    799,230       22       186       -       -       -       -       208  
Shares issued in connection with the purchase   of  business operation
    130,521       4       358       -       -       -       -       362  
Adjustment to contingent consideration in connection with the purchase of business  operation
    -       -       (116 )     -       -       -       -       (116 )
Issuance of shares, net of issuance expenses  of $268
    6,000,000       172       16,447       -       -       -       -       16,619  
Payments to acquire treasury shares
    -       -       -       (864 )     -       -       -       (864 )
Foreign currency translation adjustments
    -       -       -       -       (443 )     -       5       (438 )
Change in net unrealized gain on available- for-sale securities
    -       -       -       -       (285     -       -       (285
Net loss
    -       -       -       -       -       (6,925 )     (168 )     (7,093 )
                                                                 
Balance as of December  31, 2011
    32,313,761     $ 808     $ 209,741     $ (2,000   $ (83   $ (171,737 )   $ (287   $ 36,442  
 
Changes during the year ended
 December 31, 2012:
 
Stock-based compensation related to options  issued to employees and others
    -       -       951       -       -       -       -       951  
Exercise of options
    624,250       12       -       -       -       -       -       12  
Warrants issued in connection with the purchase of  business operation
    -       -       147       -       -       -       -       147  
Adjustment to contingent consideration in  connection with the purchase of business operation
    -       -       14       -       -       -       -       14  
Foreign currency translation adjustments
    -       -       -       -       175       -       (4 )     171  
Change in net unrealized gain on available- for-sale securities
    -       -       -       -       (56     -       -       (56
Net loss
    -       -       -       -       -       (17,394 )     (168 )     (17,562 )
                                                                 
Balance as of December  31, 2012
    32,938,011     $ 820     $ 210,853     $ (2,000   $ 36     $ (189,131 )   $ (459   $ 20,119  
 
Changes during the year ended
 December 31, 2013:
 
Stock-based compensation related to options
                 
   issued to employees and others
    -       -       364       -       -       -       -       364  
Exercise of options
    1,261,500       34       1,029       -       -       -       -       1,063  
Foreign currency translation adjustments
    -       -       -       -       27       -       17       44  
Change in net unrealized gain on available-  for-sale securities
    -       -       -       -       (35 )     -       -       (35 )
Net loss
    -       -       -       -       -       (3,048 )     (103 )     (3,151 )
                                                                 
Balance as of December 31, 2013
    34,199,511     $ 854     $ 212,246     $ (2,000 )   $ 28     $ (192,179 )   $ (545 )   $ 18,404  
 
The accompanying notes are an integral part of these consolidated financial statements.

 
F - 7

 


 
On Track Innovations Ltd.
and its Subsidiaries
Consolidated Statements of Cash Flows
 
US dollar in thousands
 
   
Year ended December 31
 
   
2013
      2012*       2011*  
Cash flows from continuing operating activities
                     
Net loss from continuing operations
  $ (6,928 )   $ (17,875 )   $ (8,378 )
Adjustments required to reconcile net loss to
                       
net cash used in continuing operating activities:
                       
Stock-based compensation related to options and shares issued
                       
  to employees and others
    307       734       1,787  
Loss (gain) on sale of property and equipment
    91       (295 )     24  
                         
Amortization of intangible assets
    81       99       122  
Impairment of goodwill and intangible assets
    813       -       -  
Loss from sale of a subsidiary (Supplement D)
    231       -       -  
Depreciation
    1,135       1,099       1,124  
                         
Changes in operating assets and liabilities:
                       
Accrued severance pay, net
    (3,165 )     1,132       648  
Accrued interest and linkage differences
    (166 )     (232 )     (370 )
Deferred tax, net
    112       (12 )     (19 )
Linkage differences on receivable from sale of operation
    -       -       (68 )
Decrease (increase) in trade receivables
    (765 )     4,089       (4,960 )
Decrease (increase) in other receivables and prepaid expenses
    1,332       (2,432 )     (369 )
Decrease (increase)  in inventories
    (11     831       859  
Increase (decrease) in trade payables
    (181 )     1,598       2,365  
Increase (decrease) in other current liabilities
    (3,472 )     4,849       (1,720 )
Net cash used in continuing operating activities
    (10,586 )     (6,415 )     (8,955 )
                         
Cash flows from continuing investing activities
                       
                         
Acquisition of  business operation (Supplement C)
    -       (100 )     (400
Purchase of property and equipment
    (2,784 )     (971 )     (674 )
Purchase of short term investments
    (325 )     (10,403 )     (14,697 )
Investment in restricted deposit for employees benefit
    -       (3,891 )     -  
Proceeds from restricted deposit for employees benefit
    3,390       -       -  
Proceeds from maturity or sale of short term investments
    6,549       17,712       7,420  
Proceeds from sale of property and equipment
    168       299       93  
Net cash provided by (used in) continuing investing activities
    6,998       2,646       (8,258 )
                         
Cash flows from continuing financing activities
                       
Increase (decrease) in short-term bank credit, net
    (1,073 )     1,822       (1,576 )
Proceeds from long-term bank loans
    3,184       390       2,814  
Repayment of long-term bank loans
    (1,316 )     (2,193 )     (1,268 )
Proceeds from issuance of shares, net of issuance expenses
    -       -       16,619  
Payments to acquire treasury shares
    -       -       (864 )
Proceeds from exercise of options
    968       12       208  
Net cash provided by continuing financing activities
    1,763       31       15,933  
                         
Cash flows from discontinued operations
                       
Net cash (used in) provided by discontinued operating activities
    (1,391 )     1,768       (2,465 )
Net cash provided by (used in) discontinued investing activities
    9,858       (72 )     1,887  
Net cash used in discontinued financing activities
    (985 )     (1,427 )     (812 )
Total net cash provided by (used in) discontinued activities
    7,482       269       (1,390 )
                         
Effect of exchange rate changes on cash and cash equivalents
    1       256       (222
                         
Increase (decrease) in cash and cash equivalents
    5,658       (3,213 )     (2,892
Cash and cash equivalents at the beginning of the year
    9,304       12,517       15,409  
                         
Cash and cash equivalents at the end of the year
  $ 14,962     $ 9,304     $ 12,517  
 
*Reclassified to conform with current year presentation, see note 1B.
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
F - 8

 
On Track Innovations Ltd.
and its Subsidiaries

Consolidated Statements of Cash Flows (cont’d)

 
US dollar in thousands
 
   
Year ended December 31
 
   
2013
   
2012
   
2011
 
Supplementary cash flows information:
                 
                   
A.            Cash paid during the period for:
                 
Interest paid
  $ 286     $ 329     $ 324  
Income taxes paid
  $ 194     $ -     $ -  
                         
B.            Non-cash investing and financing transactions:
                       
Receivables for issuance of equity, collected immediately after balance sheet date
  $ 95     $ -     $ -  
Other liabilities
  $ -     $ (14   $ 116  
                         
C.            Acquisition of business operations, see note 1C:
                       
Assets acquired and liabilities assumed of the
                       
 business at date of acquisition:
                       
                         
Working capital surplus
  $ -     $ 9     $ (89 )
Property and equipment
    -       -       (15 )
Goodwill
    -       -       (485 )
Customer relationships
    -       -       (102 )
Brand
    -       -       (28 )
Technology
    -       (256 )     (43 )
    $ -     $ (247 )   $ (762 )
                         
Issuance of shares and warrants  in consideration for the acquisition
    -       147       362  
    $ -     $ (100 )     $ (400 )
D.            Sale of consolidated subsidiary, see note 1B(2):
                       
                         
Assets and liabilities of the previously consolidated
                       
subsidiary at the time it ceased being consolidated:
                       
Working capital surplus
  $ (4 )   $ -     $ -  
Property and equipment
    41       -       -  
Intangible assets
    248       -       -  
Deferred tax liability
    (46 )     -       -  
Minority interest
    (5 )     -       -  
Other comprehensive loss
    (3     -       -  
Proceeds from sale of subsidiary
    -       -       -  
Loss on sale of a subsidiary
  $ 231     $ -     $ -  
 
The accompanying notes are an integral part of these consolidated financial statements.
 
 
F - 9

 
 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 1 - General

A.
Introduction

On Track Innovations Ltd. (the “Company”) was founded in 1990, in Israel. The Company and its subsidiaries (together “the Group”) are principally engaged in the field of design and development of cashless payment solutions. The Company’s shares are listed for trading on NASDAQ.
 
Until the end of 2012 the Company considered itself to be in a single reporting segment and operating unit structure. In 2013 following the change in the Company’s Board of directors composition, the Company now operates in three operating segments (see Note 16).

As to the Company’s major customers, see Note 17.

Certain definitions

$ - United States Dollars     
NIS - New Israeli Shekel

B.
Divestiture of operations:

 
1.
In December 2013, the Company completed the sale of certain assets, subsidiaries and intellectual property (IP) relating to its Smart ID division, for a total purchase price of $10 million in cash and an additional $12.5 million subject to performance-based milestones (“the SmartID Division Divesture”). Accordingly the results and the cash flows of this operation for all reporting periods are presented in the statements of operations and in the statements of cash flows, respectively, as discontinued operations separately from continuing operations. The Company recorded a gain from this divesture, net of transaction costs, in the amount of $8,944.
 
During 2013 the Company reached an initial agreement, which eventually closed in February 2014, to sell its wholly owned German subsidiary, Intercard System Electronics GmbH (hereinafter – “Intercard”), for total purchase price of EURO 700 (approx. $960) and an additional immaterial contingent consideration based on future sales (“the German Subsidiary Divesture”). Accordingly, assets and liabilities related to the German subsidiary are presented separately in the balance sheets, as assets and liabilities held for sale, which was consummated in February 2014. As of December 31, 2013, the Company recognizes a loss from impairment assets in the amount of  $2,970 that reflects the difference between the book value of Intercard’s assets, net of liabilities, and the consideration (see also note 14). The Company recorded the impairment charge of $2,970 in its statement of operations for the year ended December 31, 2013, among “net income from discontinued operations”. The results and the cash flows of this operation for the reporting periods are presented in the statements of operations and in the statements of cash flows, respectively, as discontinued operations separately from continuing operations.
 
All prior periods' information has been reclassified to conform with the current year presentation.

As to contingent considerations see note 2V.

 
2.
In August 2013 the Company, through its subsidiary, Parx Ltd. entered into a share purchase agreement with a third party for the sale of 100% of the shares of a subsidiary, Parx France, for consideration of 25% of Parx France’s future profits on an EBITDA basis . The Company has recorded a loss in the amount of $231, presented in the statement of operations among “other operating income, net”.

Parx France will retain its exclusive distribution rights to France, Belgium, Luxembourg, Switzerland, and several domestic and overseas French Territories, subject to certain commercial terms. The Company will retain its intellectual property related to the EasyPark system, and will provide to Parx France the full suite of its parking products, including the EasyPark in vehicle meter device and EasyPark Mobile service.
 
As to contingent considerations see note 2V.
 
 
F - 10

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 1 - General (cont'd)

C.
Acquisition of subsidiaries and business operations

 
1.
In April 2012, the Company completed, through its subsidiary Parx Ltd, the purchase of 100% of the share capital of CPI Communication Ltd. (“CPI”), an Israeli-based company that provides private parking solutions across Israel (hereinafter- "the CPI Transaction"). CPI was purchased in order to expand the Company’s product offering, for a purchase price of $247, comprised of $100 in cash and $147 by issuance of 90,361 warrants to purchase the Company's ordinary shares.

The 90,361 warrants were issued with a par value exercise price and become exercisable in five equal installments over a period of five years.
 
The acquisition was accounted for as a business combination, using the purchase method of accounting and the Company allocated the purchase price according to the fair value of the tangible and intangible assets acquired and liabilities assumed. Transaction costs were expensed.
 
As part of the purchase price allocation, the Company recognized a technology intangible asset, at an estimated fair value of $256. The intangible asset is amortized on a straight line basis, over its estimated useful life, which was determined to be eight years.
 
During the end of 2013 the Company’s management decided to abandon the operations of CPI. This change required an impairment analysis to be performed. As for the impairment of the technology intangible asset, see note 6B.i.
 
 
2.
On January 4, 2011 Parx Ltd., the Company’s subsidiary, entered into an assets acquisition agreement with Ganis Systems Ltd. (“Ganis”) for the acquisition of assets and intellectual property (IP). In consideration for this acquisition, the Company paid Ganis $400 in cash and issued to it 130,521 ordinary shares of the Company. The ordinary shares will be subject to lock-up, where 26,760 ordinary shares will be free from lock up seven months after the closing date and additional amounts of 34,587 ordinary shares will be released from lock-up 12, 18 and 24 months after the closing date. If the aggregate value of the shares when released from their lock-up is below a certain amount, the Company was to compensate Ganis. As of December 31, 2012 the Company recorded a liability in the amount of $116 for this matter. The amount was fully paid in February 2013. In addition, under an earn-out agreement, Ganis may be entitled to certain earn-out payments of up to an additional $450 over the next three years, based on reaching certain success criteria determined by the companies. No such earn-out payments were made as of December 31, 2013. Under the terms of the agreement, the chairman of board of the Company (or the board) will be granted an irrevocable proxy to vote the shares that are issued as part of the transaction.
 
The acquisition was accounted for as a business combination, using the purchase method of accounting and the Company allocated the purchase price according to the fair value of the tangible and intangible assets acquired and liabilities assumed. Transaction costs were expensed.
 
In connection with the acquisition, the Company recognized three intangible assets: (1) customer relationships, estimated fair value of $102, with an estimated useful life of 11 years, (2) technology, estimated fair value of $43 with an estimated useful life of 14 years, and (3) brand, estimated fair value of $28, with an estimated useful life of 12 years. Amortization was computed on a straight line basis over the estimated useful lives of the respective assets. The Company also recognized goodwill in the estimated amount of $485. Amortization of the goodwill is a recognized expense for tax purposes.
 
During 2013, due to the Company’s change in its operating segments reporting, the goodwill mandatory annual impairment testing and the current period operating and cash flow losses combined with negative projections regarding Ganis operations, the Company assessed the recoverability of the customer relationships, the brand and the technology acquired. The Company has also performed an assessment under the annual goodwill testing. As for the impairment of these intangible assets and goodwill see note 6A and 6B.i., respectively.
 
 
F - 11

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 2 – Significant Accounting Policies

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).

The significant accounting policies followed in the preparation of the financial statements, applied on a consistent basis, are as follows:

A.
Financial statements in U.S. dollars

Substantially all of the Company’s and certain of its subsidiaries’ revenues are in U.S. dollars. A significant portion of purchases of materials and components and most marketing costs are denominated in U.S. dollars. Therefore, both the functional and reporting currencies of the Company and certain of its subsidiaries are the U.S. dollar.

Transactions and balances denominated in U.S. dollars are presented at their original amounts.
 
For entities with a U.S. dollar functional currency, transactions and balances in other currencies are remeasured into U.S. dollars in accordance with the principles set forth in ASC Topic 830, Foreign Currency Matters, i.e. at the date the transaction is recognized, each asset, liability, or instance of revenue, expense, gain, or loss arising from the transaction is measured and recorded in the functional currency by use of the exchange rate in effect at that date. When translation using the exchange rates at the dates that the numerous revenues, expenses, gains, and losses are recognized is impractical, an appropriately weighted average exchange rate for the period is used to translate those elements. At each balance sheet date, recorded balances of monetary assets and liabilities that are denominated in a currency other than the functional currency are adjusted to reflect the current exchange rate. Exchange gains and losses from the remeasurement of such items denominated in non U.S. dollar currencies are reflected in the consolidated statements of operations, in ‘financial expenses, net’, as appropriate.

The functional currencies of the remaining subsidiaries are their local currencies. The financial statements of those companies are translated into U.S. dollars using the exchange rate at the balance sheet date for assets and liabilities, and weighted average exchange rates for revenues and expenses (which approximates the translation of each transaction). Translation adjustments resulting from the process of the aforesaid translation are included as a separate component of equity (accumulated other comprehensive gain or loss).

B.
Principles of consolidation

The consolidated financial statements include the financial statements of the Company, its wholly-owned subsidiaries and its majority owned subsidiaries. Intercompany transactions and balances have been eliminated in consolidation.

C.
Estimates and assumptions

The preparation of the consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the year. Such estimates include the valuation of useful lives of long-lived assets, revenue recognition, valuation of accounts receivable and allowance for doubtful accounts, valuation of inventories and investments, legal contingencies, the assumptions used in the calculation of share based compensation, income taxes and other contingencies. Estimates and assumptions are periodically reviewed by management and the effects of any material revisions are reflected in the period that they are determined to be necessary. Actual results, however, may vary from these estimates.
 
 
F - 12

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 2 - Significant Accounting Policies (cont'd)
 
D.
Cash equivalents

Cash equivalents are short-term highly liquid investments and debt instruments that are readily convertible to cash with original maturities of three months or less from the date of purchase.

E.
Short-term investments

The Company accounts for investments in U.S and Israeli treasury securities and in corporate bonds in accordance with ASC Topic 320, Investments – Debt and Equity Securities .
 
Management determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such determinations at each balance sheet date. At December 31, 2012 the Company's investments were classified as available-for-sale and are stated at market value. As of December 31, 2013, the Group does not hold any debt securities.
 
Unrealized gains and losses, are reported as a separate component of equity (accumulated other comprehensive gain or loss) until realized. Interest income is recognized when earned and included in the consolidated statement of operations in financial income. Realized gains and losses, as well as premium or discount amortization, are included in financial income or expenses.

F.
Trade receivables

Trade receivables are recorded at the invoiced amount and do not bear interest. Collection of trade receivables are included in net cash provided by operating activities in the consolidated statements of cash flows. The consolidated financial statements include an allowance for loss from receivables for which collection is in doubt.  In determining the adequacy of the allowance consideration is given to each trade receivable historical experience, aging of the receivable, adjusted to take into account current market conditions and information available about specific debtors, including their financial condition, the amount of receivables in dispute, current payment patterns, the volume of their operations, and evaluation of the security received from them or their guarantors.

G.
Inventories

Inventories are stated at the lower of cost or market value. Cost is determined by calculating raw materials, work in process and finished products on a "moving average" basis. Inventory write-offs are provided to cover risks arising from slow moving items or technological obsolescence. Such write-offs, which were not material for the reported years, have been included in cost of revenues.

The Company applies ASC Topic 330, Inventory which clarifies the accounting for abnormal amounts of idle facility expense, freight, handling costs, and wasted material (spoilage) requiring that those items be recognized as current-period charges. In addition, the above topic requires that allocation of fixed production overhead costs be based on the normal capacity of the production facilities.

H.
Property, plant and equipment, net

Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets as follows:
 
   
Years
Leasehold land (over the terms of the lease, see note 7A(1))
49
Buildings
25
Computers, software and manufacturing equipment
3-5
Office furniture and equipment
5-16
 
  (mainly - 10)
   
 
 
F - 13

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 2 - Significant Accounting Policies (cont'd)

I.
Impairment of long-lived assets

Long-lived assets, such as property, plant, and equipment, and purchased intangible assets subject to amortization, are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset to be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by an asset to the carrying value of the asset. If the carrying value of the long-lived asset is not recoverable on an undiscounted cash flow basis, impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary.
 
In 2013 the Company recorded an impairment of intangible assets in the amount of $328 (see Note 6B).
 
No impairment losses were recorded in 2011 and 2012.

J.
Goodwill and purchased intangible assets

Goodwill represents the excess of the aggregate purchase price over the fair value of the net assets acquired in a purchase businesses combination. Goodwill is reviewed for impairment at least annually, as of December every year .

In September 2011, the Financial Accounting Standards Board (“FASB”) issued ASU 2011-08, Testing Goodwill for Impairment , which provides an entity the option to perform a qualitative assessment to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount prior to performing the two-step goodwill impairment test. If this is the case, the two-step goodwill impairment test is required. If it is more-likely-than-not that the fair value of a reporting unit is greater than its carrying amount, the two-step goodwill impairment test is not required. The Company adopted this guidance in 2012.
 
If the two-step goodwill impairment test is required, first, the fair value of the reporting unit is compared with its carrying value (including goodwill). If the fair value of the reporting unit is less than its carrying value, an indication of goodwill impairment exists for the reporting unit and the enterprise must perform step two of the impairment test (measurement).

Under step two, an impairment loss is recognized for any excess of the carrying amount of the reporting unit’s goodwill over the implied fair value of that goodwill. The implied fair value of goodwill is determined by allocating the fair value of the reporting unit in a manner similar to a purchase price allocation. The residual fair value after this allocation is the implied fair value of the reporting unit goodwill. If the fair value of the reporting unit exceeds its carrying value, step two does not need to be performed.
 
Testing for impairment is to be done at least annually and at other times if events or circumstances arise that indicate that impairment may have occurred. The Company has set its annual impairment testing date at December 31.
 
In 2013 the Company recorded an impairment of goodwill in the amount of $485, see note 6A.

The Company has concluded there has been no impairment of goodwill as a result of its testing in 2011 and 2012.
 
Purchased intangible assets are carried at cost, less accumulated amortization. Amortization is computed over the estimated useful lives of the respective assets.

 
F - 14

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 2 - Significant Accounting Policies (cont'd)

K.
Revenue recognition

The Group generates revenues from product sales, licensing and transaction fees. Revenues are also generated from non-recurring engineering, customer services and technical support.

Revenues from product sales and non-recurring engineering are recognized when delivery has occurred provided there is persuasive evidence of an agreement, the fee is fixed or determinable, collection of the related receivable is probable and no further obligations exist. In the case of non-recurring engineering, revenue is recognized upon completion of testing and approval of the customization of the product by the customer, provided that no further obligation exists. Revenues are recognized net of value added tax.

License and transaction fees are recognized as earned based on actual usage. Usage is determined by receiving confirmation from the users.
 
Revenues relating to customer services and technical support are recognized as the services are rendered ratably over the term of the related contract.

In arrangements that contain multiple elements, the Company implements the guidelines set forth in ASU 2009-13. Such multiple element arrangements may include providing an IT solution, selling products (such as smart cards) and rendering customer services. Accordingly, the overall arrangement fee is allocated to each element (both delivered and undelivered items) based on their relative selling prices, evidenced by vendor specific objective evidence of selling price ("VSOE") or third party evidence of selling price ("TPE"). In the absence of VSOE and TPE for one or more delivered or undelivered elements in a multiple-element arrangement, the Company is required to estimate the selling prices of those elements. Such estimated selling price has been determined using a cost plus margin approach. Since the cost for each element in such arrangements is reliably estimable, the estimated selling price was calculated by multiplying the costs by an average gross margin applicable to each element. Once the standalone selling price for each element was determined, the consideration allocated to each element was recognized as revenues upon meeting the required criteria as described above.

In revenue arrangements that include software components, the Company implements the guidelines set forth in ASU 2009-14. Accordingly, software revenue recognition is not applied for tangible products that contain both software and non-software components that function together to deliver the tangible product’s essential functionality.

The Company has applied the guidance described above for certain arrangements which include providing IT Solution, selling products and customer services. The total arrangement consideration is allocated proportionally to the separate deliverables in the arrangement using the estimated selling price for each component. The Company recognizes revenues from sale of its IT Solution and from certain long-term contract in accordance with ASC Topic 605-35, " Construction-Type and Production-Type Contracts " (“ASC 605-35”).

Pursuant to ASC 605-35, revenues from these contracts are recognized under the percentage of completion method.  The Company measures the percentage of completion based on output or input criteria, as applicable to each contract. For the reported years, the Company used in all of its projects output measures with respect to measuring the progress of completion. These measures are based on completion of milestones (i.e., contract milestones as stated in the agreement such as the delivery, installation or shipments of various deliverables) and the amount of operational sites (i.e., progress is measured as a percentage of the sites that are already operational, out of the total sites that are required to be operational under the agreement).
 
Following the SmartID Division Divesture, revenues from such contracts are included in “net income (loss) from discontinued operations”.
 
 
F - 15

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 2 - Significant Accounting Policies (cont'd)
 
K.
Revenue recognition (cont'd)

Provisions for estimated losses on uncompleted contracts are made during the period in which such losses are first identified, in the amount of the estimated loss on the entire contract. As of December 31, 2013, no such estimated losses were identified.

Revenues and costs recognized pursuant to ASC 605-35 on contracts in progress are subject to management estimates.  Actual results could differ from these estimates.

Licensing and transaction fees are recognized based on the volume of transactions or monthly licensing fees from systems that contain the Company’s products and usually bear no cost to the Company.

The cost to the Company of warranting that the product will perform according to certain specifications and that the Company will repair or replace the product if it ceases to work properly, is insignificant and is treated according to accounting guidance for contingencies.

L.
Research and development costs

Research and development costs, which consist mainly of labor costs, materials and subcontractors, are charged to operations as incurred.

M.
Stock-based compensation

Employees

The Company measures and recognizes compensation expense for all share-based payment awards made to employees and directors based on estimated grant date fair values. The estimated fair value of awards is charged to income on a straight-line basis over the requisite service period, which is generally the vesting period.

ASC Topic 718, Compensation – Stock Compensation , requires estimating the fair value of share based payments awards on the date of the grant using an option pricing model. The Company uses the Black-Scholes option pricing model.
 
The Company elected to recognize compensation cost for awards with only service conditions that have a graded vesting schedule using the straight-line method.

Non-Employees

The Company uses an option valuation model to measure the fair value of these options at the grant date and at each subsequent reported period until the exercise date is reached. During 2013 no options were granted. During 2012 all options were granted with a par value exercise price and during 2011 most of the options were granted with a par value exercise price. Due to the par value nominal amount of NIS 0.1, the fair value of these options was estimated to be almost equal to the Company’s market share price at the grant date.

N.
Basic and diluted net loss per share

Basic and diluted net loss per ordinary share is computed based on the weighted average number of ordinary shares outstanding during each year. Shares issuable for little or no cash consideration, are considered outstanding ordinary shares and included in the computation of basic net loss per ordinary share as of the date that all necessary conditions have been satisfied.

Outstanding stock options and warrants in the amounts of 2,066,730, 2,230,730 and 2,499,475 for December 31, 2013, 2012 and 2011, respectively, have been excluded from the calculation of the diluted net loss per ordinary share because all such securities have an anti-dilutive effect for all periods presented.
 
 
F - 16

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 2 - Significant Accounting Policies (cont'd)

O.
Fair value of financial instruments

The Company's financial instruments consist mainly of cash and cash equivalents, short-term interest bearing investments, accounts receivable, restricted deposits for employee benefits, accounts payable and short-term and long-term loans.

Fair value for the measurement of financial assets and liabilities is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The Company utilizes a valuation hierarchy for disclosure of the inputs for fair value measurement. This hierarchy prioritizes the inputs into three broad levels as follows:
 
 
·
Level 1 Inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.
 
 
·
Level 2 Inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.
 
 
·
Level 3 Inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date.
 
By distinguishing between inputs that are observable in the market place, and therefore more objective, and those that are unobservable and therefore more subjective, the hierarchy is designed to indicate the relative reliability of the fair value measurements. A financial asset or liability's classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.

The Company, in estimating fair value for financial instruments, used the following methods and assumptions:

The carrying amounts of cash and cash equivalents, trade receivables, short-term bank credit and trade payables are equivalent to, or approximate their fair value due to the short-term maturity of these instruments.

The fair value of the investment securities is based on quoted market prices and thus is based on  level 1 inputs.

The fair value of the liability in respect of the contingent consideration included in business combinations (see note 1B(2)) is based on discounted future expected sales and thus is based on level 3 inputs. The liability was determined to be insignificant.

The carrying amounts of variable interest rate long-term loans are equivalent or approximate to their fair value as they bear interest at approximate market rates. At December 31, 2013, fair value of bank loans with fixed interest rates did not differ materially from the carrying amount.

 
F - 17

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data

Note 2 - Significant Accounting Policies (cont'd)

P.
Income tax

The Company accounts for taxes on income in accordance with ASC Topic 740, Income Taxes . Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statement of operations in the period that includes the enactment date. The Company provides a valuation allowance to reduce deferred tax assets to the amount that is more likely than not to be realized.

The Company applies the guidelines of ASC Subtopic 740-10 regarding uncertainty in income taxes (previously known as “FIN 48”), which clarify the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements (“ASC 740-10”). ASC 740-10 prescribes a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. ASC 740-10 also provides guidance on derecognition of tax positions, classification on the balance sheet, interest and penalties, accounting in interim periods, disclosure, and transition. ASC 740-10 requires significant judgment in determining what constitutes an individual tax position as well as assessing the outcome of each tax position.

The Company accounts for interest and penalties related to unrecognized tax benefits as a component of income tax expense.

Q.
Non-controlling Interest

The Company implements ASC Topic 810- Consolidation , which requires net loss attributable to non-controlling interests to be classified in the consolidated statements of operations as part of consolidated net earnings ( $103, $168 and $168,  for the years ended December 31, 2013, 2012 and 2011, respectively) and to include the accumulated amount of non-controlling interests in the consolidated balance sheets as part of equity ($545 and $459 at December 31, 2013 and December 31, 2012, respectively). If a change in ownership of a consolidated subsidiary results in loss of control and deconsolidation, any retained ownership interests are remeasured with the gain or loss reported in net earnings.
 
R.
Severance pay

The Company’s liability for severance pay for some of its Israeli employees is calculated pursuant to Israeli severance pay law based on the most recent salary of the employee multiplied by the number of years of employment, as of the balance sheet date. Those employees are entitled to one month’s salary for each year of employment or a portion thereof. Certain senior executives were entitled to receive additional severance pay. During 2013 the employment of most of such senior executives was terminated and related severance pay liability was settled.
 
The Company records the liability as if it were payable at each balance sheet date on an undiscounted basis. The liability is classified based on the expected date of settlement, and therefore is usually classified as a long-term liability, unless the termination of the employees is expected during the upcoming year.

 
F - 18

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 2 - Significant Accounting Policies (cont'd)

R.
Severance pay (cont'd)

The Company’s liability for those Israeli employees is partially provided for by monthly deposits for insurance policies and the remainder by an accrual. The value of these policies is recorded as an asset in the Company’s balance sheet.

The deposited funds include profits and losses accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to Israeli Severance Pay Law or labor agreements. The value of the deposited funds is based on the cash redemption value of these policies. In addition, during 2012 the Company deposited certain amounts with a trustee, to compensate for any severance pay liability that is not covered by other funds. These deposits are restricted and may be withdrawn only for payment of severance pay liabilities. The severance pay funds and the restricted deposits for employee benefits are classified based on the classification of the corresponding liability.
 
In respect of other Israeli employees, the Company obtained approval from the Israeli Ministry of Labor and Welfare, pursuant to the terms of Section 14 of the Israeli Severance Pay Law, 1963, according to which the current deposits in the pension fund and/or with the insurance company exempt the Company from any additional obligation to these employees for whom the said depository payments are made. These deposits are accounted as defined contribution payments.

Severance pay expenses for the years ended December 31, 2013, 2012 and 2011 amounted to approximately $609, $1,630 and $1,189, respectively. Defined contribution plan expenses were $415, $412 and $445 in the years ended December 31, 2013, 2012 and 2011, respectively.
 
S.
Advertising expenses

Advertising expenses are charged to the statements of operations as incurred. Advertising expenses for the years ended December 31, 2013, 2012 and 2011 amounted to approximately 1,503$, $1,550 and $1,487, respectively.
 
T.
Concentrations of credit risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash equivalents, bank deposits, U.S and Israeli treasury securities, corporate bonds and trade receivables.

Cash equivalents are invested mainly in U.S. dollars with major banks in Israel and Europe. Management believes that the financial institutions that hold the Group’s investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments.

Most of the Company’s trade receivables are derived from sales to large and financially secure organizations. In determining the adequacy of the allowance, management bases its opinion, inter alia, on the estimated risks, current market conditions, in reliance on available information with respect to the debtor's financial position.  As for major customers, see Note 17.

The activity in the allowance for doubtful accounts for the years ended December 31, 2013, 2012 and 2011 is as follows:
 
   
2013
   
2012
   
2011
 
Allowance for doubtful accounts at beginning of year
  $ 431     $ 233     $ 2,832  
Additions charged to allowance for doubtful accounts
    220       319       90  
Write-downs charged against the allowance
    (41 )     (127 )     (2,688
Currency translation differences
    -       6       (1 )
                         
Allowance for doubtful accounts at end of year
  $ 610     $ 431     $ 233  
 
 
F - 19

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 2 - Significant Accounting Policies (cont'd)

U.
Commitments and contingencies

Liabilities for loss contingencies arising from claims, assessments, litigations, fines and penalties and other sources are recognized when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.

V.
Business divestures

As described in Note 1B, the Company has sold certain operations during 2013. Upon reaching a definitive agreement with an acquirer, the Company recognizes the consideration received from the divesture, less all assets and liabilities sold, as a gain or loss.

Discontinued operations

Upon divesture of a business, the Company classifies such business as a discontinued operation, if the divested business meets the following criteria:
 
 
(i)
The business qualifies as a component of an entity, as it comprises operations and cash flows that can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the Company.
 
 
(ii) 
Both of the following conditions are met or expected to be met within one year:
 
 
1)
The operations and cash flows of the business have been or will be eliminated from the ongoing operations of the entity in the disposal transaction;
 
 
2)
The Company will not have any significant continuing involvement in the operations of the component after the disposal transaction. The eligibility to receive contingent consideration from future sales of the divested business does not necessarily indicate that there is continuing involvement in the operations of the business.

For disposals other than by sale such as abandonment, the results of operations of a business would not be recorded as a discontinued operation until the period in which the business is actually abandoned.

The Company has concluded that at December 31, 2013, the SmartID Division Divesture and the German Subsidiary Divesture qualify as discontinued operations and therefore have been presented as such. The sale of PARX France (see note 1B(2)) does not qualify as a discontinued operation as the Company has significant involvement after the disposal transaction.

Assets and liabilities of discontinued operations that have not yet been actually sold are presented on the balance sheet in one line item. Assets and liabilities of such discontinued operations are not offset and are presented as such only for the current year balance sheet.

The results of businesses that have qualified at December 31, 2013 as discontinued operations have been presented as such for all reporting periods. Results of discontinued operations include all revenues and expenses directly derived from such businesses; general corporate overhead is not allocated to discontinued operations.

Any loss or gain that arose from the divesture of a business that qualifies as discontinued operations has been included within the results of the discontinued operations.

The Company also presents cash flows from discontinued operations separately from cash flows of continuing operations.

Contingent consideration

The Company’s sale arrangements consist of contingent consideration based on the divested businesses future sales or profits. The Company records the contingent consideration portion of the arrangement when the consideration is determined to be realizable.
 
 
F - 20

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 2 - Significant Accounting Policies (cont'd)
 
W.
Recent accounting pronouncements

In February 2013, the FASB issued ASU No. 2013-02, Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income.  ASU 2013-02 requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component.  In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated comprehensive income by the respective line items of net income but only if the amount reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period.  For other amounts that are not required under U.S. GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under U.S. GAAP that provide additional detail about those amounts.  ASU 2013-02 does not change the requirements for reporting net income or other comprehensive income in financial statements.  The new standard is effective for reporting periods beginning after December 15, 2013.  The Company will implement the provisions of ASU 2013-02 as of January 1, 2014. The implementation is not expected to have a material effect on the Company consolidated financial statements.
 
In July 2013, the FASB issued ASU 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.  ASU 2013-11 requires an unrecognized tax benefit, or a portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward.  ASU 2013-11 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2014.  The new standard is to be applied prospectively but retrospective application is permitted.  The Company will implement the provisions of ASU 2013-11 as of January 1, 2015, and the implementation is not expected to have a material effect on the Company consolidated financial statements.
 
 
F - 21

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 3 – Short term investments:

A.
Consist of:

   
December 31
 
   
2013
   
2012
 
Investment securities
  $ -     $ 1,013  
Short-term bank deposits *
    2,601       7,699  
                 
    $ 2,601     $ 8,712  

*See Note 10C as to restrictions on certain deposits.

B.
Investment securities

 
As of December 31, 2013 no investment securities were held by the Company.
 
 
The carrying amount, gross unrealized holding gains and losses, and fair value of available-for-sale debt securities by major security type and class of security at December 31, 2012 were as follows:
 
         
Gross
   
Gross
       
         
unrealized
   
unrealized
       
   
Aggregate
   
holding
   
holding
   
Aggregate
 
   
cost basis
   
gains
   
(losses)
   
fair value
 
At December 31, 2012:
                       
     Israeli treasury
    669       22       (9 )     682  
Corporate bonds
    308       23       (- )     331  
      977       45       (9 )     1,013  
 
The Company concluded that the securities in unrealized loss position held at December 31, 2012 were not considered other-than-temporarily impaired, since it believed it is more-likely-than-not that it would not be required to sell the investment before recovery of its amortized cost basis. The Company had not identified securities for which it did not expect to receive future cash flows sufficient to recover the entire amortized cost basis of the security.
 
During 2013 , the Company received proceeds of $1,123 upon sale of investment securities, net of realized gains of $17 recorded in finance income.
 
During 2012 , the Company received proceeds of $6,518 upon sale of investment securities, net of realized gains of $134 recorded in finance income.
 
 
F - 22

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 4 - Other Receivables and Prepaid Expenses

   
December 31
 
   
2013
   
2012
 
Government institutions
    309     $ 1,054  
Prepaid expenses
    818       563  
Short term severance pay deposits
    -       574  
Receivables under contractual obligations to be  transferred to others *
    1,288       2,377  
Receivables related to the Smart ID Division Divestiture
    1,572       -  
Other receivables
    645       781  
                 
    $ 4,632     $ 5,349  

*
The Company’s subsidiary in Poland is required to collect certain fees that are to be transferred to local authorities.

Note 5 - Inventories

   
December 31
 
   
2013
   
2012
 
Raw materials
  $ 775     $ 2,994  
Work in progress
    665       1,777  
Finished products
    2,037       2,278  
                 
    $ 3,477     $ 7,049  
 
Note 6 - Goodwill and Intangible Assets, Net
 
A.
Goodwill

   
December 31
 
   
2013
   
2012
 
Balance as of January 1
  $ 485     $ 485  
Impairment of Goodwill
    (485 )     -  
                 
Balance as of December 31
  $ -     $ 485  

Following the change in the Company’s operational structure as well as the change to its segment reporting and the reporting units in 2013 (see note 16), the goodwill resulted from Ganis acquisition has been fully allocated to the Ganis reporting unit. As a result, the Company determined the fair value of Ganis and concluded that goodwill had been impaired and therefore wrote-off the full amount of the goodwill. Impairment for goodwill amounted to $485 for the year ended December 31, 2013.

 
F - 23

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 6 - Goodwill and Intangible Assets, Net (cont’d)

B.
Intangible assets, net

   
 
December 31
 
   
2013
   
2012
 
Cost
           
Technology
  $ 1,188     $ 1,938  
Brand
    607       607  
Know-how
    452       452  
Customer contracts and relationships
    4,065       6,243  
                 
Total cost
    6,312       9,240  
                 
Accumulated amortization and impairments
               
Technology
  $ 1,188       1,710  
Brand
    607       586  
Know-how
    452       452  
Customer contracts and relationships
    4,065       5,836  
Total Accumulated amortization
    6,312       8,584  
                 
    $ -     $ 656  
 
 
i.
Impairment of intangible assets, which have been recorded following the acquisitions of Ganis and CPI, has been recorded in the amount of $328 for the year ended December 31, 2013.
 
 
ii.
Amortization expense amounted to $81, $99 and $122 for the years ended December 31, 2013, 2012 and 2011 respectively.
 
 
iii.
Intangible assets in the amount of $248 were sold during 2013 as part of the sale of PARX France, see note 1B(2).
 
Amortization expenses of intangible assets are recorded in the statement of operations as incurred .

 
F - 24

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 7 - Property, Plant and Equipment, Net

A.
Consist of:
 
   
December 31
 
   
2013
   
2012
 
Cost
           
Land
  $ -     $ 461  
Leasehold land (1)
    272       272  
Buildings on leasehold land (1)
    4,339       4,356  
Buildings
    1,160       5,309  
Computers, software and manufacturing equipment
    15,311       14,444  
Office furniture and equipment
    817       1,958  
Motor vehicles
    393       570  
                 
Total cost
    22,292       27,370  
                 
Total accumulated depreciation
    12,455       14,296  
                 
Net book value
  $ 9,837     $ 13,074  

 
(1)
The leasehold land consists of two plots owned by the Israel Lands Administration.  Rights to leasehold land on the first plot extend over the original period of 49 years ending in the year 2041 with an option to extend for an additional 49 years, and on the second plot for a period of 49 years, which will end in the year 2047 with an option to extend for a further 49 years.  The amount includes payments on account of land development and payments of the capitalization of leasing payments.  The rent for the initial 49-year term of each of these leases was prepaid in its entirety at the beginning of the lease terms as is customary in Israel for leases of property for industrial purposes from the Israel Lands Authority.
 
B.
As to liens - See Note 10C.

C.
Depreciation expenses amounted to $1,135, $1,099 and $1,124 for the years ended December 31, 2013, 2012 and 2011, respectively.
 
Note 8 - Other Current Liabilities

   
December 31
   
December 31
 
   
2013
   
2012
 
Employees and related expenses                                                      
  $ 2,116     $ 1,590  
Provision for termination of employees(*)
    -       4,852  
Accrued expenses
    1,541       2,305  
Customer advances
    877       1,693  
Government institutions related to the Smart ID Division Divesture
    1,572       -  
Other current liabilities
    193       531  
                 
    $ 6,299     $ 10,971  

(*) see note 10A(3).
 
 
F - 25

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 9 - Bank Loans

A.
Composition of long-term loans:
 
   
December 31
   
December 31
 
   
2013
   
2012
 
Long-term loans
  $ 4,216     $ 4,389  
Less - current maturities
    874       2,165  
                 
    $ 3,342     $ 2,224  
 
As of December 31, 2013, the bank loans are denominated in the following currencies: U.S. dollars ($538; matures in the years 2014 - 2019), New Israeli Shekel ($848; matures in the years 2014-2019) South African Rand ($1,051; matures in the years 2014 - 2023) and Polish Zloty ($1,779; matures in 2014-2017). As of December 31, 2013 these loans bear interest at rates ranging from 3.6%-8.5% (mainly 5%) per annum.
 
B.
Repayment dates of long-term loans subsequent to December 31, 2013:
 
2014
  $ 874  
2015
    957  
2016
    855  
2017
    513  
2018
    323  
Thereafter
    694  
         
    $ 4,216  
 
C.
Composition of short-term loans, bank credit and current maturities of long-term loans:

   
December 31
   
December 31
 
   
2013
   
2012
   
2013
   
2012
 
   
%
   
%
             
   
Interest rate
             
In NIS
    6.49       5.09     $ 993     $ 2,081  
In USD
    4.72       4.13       1,010       2,014  
In Euro
    -       5.50       -       1,108  
In Polish Zloty
    3.59       -       965       -  
                      2,968       5,203  
Current maturities of long-term loans
                    874       2,165  
                                 
                    $ 3,842     $ 7,368  
 
The weighted average interest rate of the short-term bank credit for the years ended December 31, 2013 and 2012 were 4.94% and 4.80%, respectively.
 
D.
Liens for short-term and long-term borrowings - see Note 10C.
 
E.
As of December 31, 2013, the Group has authorized and used credit lines of approximately $3,268 and $2,968, respectively.
 
F.
Agreements that were made with banks, in order to secure bank services and obtain bank credit and loans, include financial covenants and restrictive covenants. Under the covenants definitions, the Company is obligated to meet at least one of the following: (i) annual revenues of $15 million; (ii) operating profit; (iii) cash balances of $6 million; and equity at a level of 30% of the total assets.  As of the balance sheet date the Company is in compliance with all of its covenants.
 
 
F - 26

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 10 - Commitments and Contingencies
 
A.
Commitments and Contingencies:

 
1.
The Company and its Israeli subsidiary, EasyPark, have entered into several research and development agreements, pursuant to which the Company and EasyPark received grants from the Government of Israel, and are therefore obligated to pay royalties to the Government of Israel at a rate of 3.5% of its sales up to the amounts granted (linked to the U.S. dollar with annual interest at LIBOR as of the date of approval, for programs approved from January 1, 1999 and thereafter).  The total amount of grants received until December 31, 2013, net of royalties paid, was approximately $3,790 (including accrued interest). No grants from the Government of Israel were received during the three-year period ended December 31, 2013.
 
Royalties paid or accrued amounted to $325, $375 and $512 for the years ended December 31, 2013, 2012 and 2011, respectively, and were charged to cost of revenues.

 
2.
The Company entered into a long term supply agreement with SMARTRAC under which SMARTRAC became the Company’s exclusive supplier for wire-embedded and dual  Interface inlays, according to its needs, and its supplier for other products at defined terms and prices.

 
3.
On March 16, 2012, the Company’s shareholders approved the extension of the Company’s employment agreement with Mr. Oded Bashan, the Company’s former Chairman and Chief Executive Officer, until December 31, 2015. Mr. Oded Bashan's agreement shall be automatically extended or terminated by either party upon a six months' notice, where if either party terminates the employment prior to December 31, 2015, the Company shall be obligated to continue paying Mr. Oded Bashan contract benefits for the full term of the agreement. On December 23, 2012 Mr. Oded Bashan notified the Company of his impending resignation. Mr. Oded Bashan is no longer providing essential services to the Company. Consequently, the Company recorded in its 2012 statement of operations a provision based on the employment agreement in the amount of $2,272.

The employment agreement with Mr. Ohad Bashan, the Company’s former President,  was amended by the Company’s  board of directors on May 24, 2012 and was extended until December 31, 2016. Mr. Ohad Bashan's agreement shall be automatically extended or terminated by either party upon a six months' notice, where if either party terminates the employment prior to December 31, 2016, the Company shall be obligated to continue paying Mr. Ohad Bashan contract benefits for the full term of the agreement. On December 23, 2012 Mr. O ha d Bashan notified the Company of his impending resignation. Mr. O ha d Bashan is no longer providing services to the Company. Consequently, the Company recorded in its 2012 statement of operations a provision based on the employment agreement in the amount of $2,447.

The above amounts were in addition to $2,854 net severance pay provisions the Company had recorded over the employment years through December 31, 2012.

 
F - 27

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 10 - Commitments and Contingencies (cont’d)

A.
Commitments and Contingencies: (cont’d)

On July 12, 2013 the Company signed settlement agreement with Messrs. Oded Bashan and Ohad Bashan with respect to their termination of employment with the Company and its subsidiaries. Based on the agreements, besides the release of existing severance payments funds, the Company paid to Messrs. Oded Bashan and Ohad Bashan approximately $2,500 for the employment term and the termination thereof. These amounts were paid out of funds that were deposited in an escrow account already recorded as short term restricted deposit for employees’ benefits in the Company's financial statements for the year 2012. The agreements further provide a mutual release from all claims between the Company and Messrs. Oded Bashan and Ohad Bashan in connection with their employment with the Company, termination thereof, and any position they held with the Company. Consequently to the execution of the agreements mentioned above, the Company recorded income of $4,503 in its statement of operations, among “other operating income, net”.

B.
Leases

The Group operates from leased facilities in the United States, Israel, Poland and South Africa, leased for periods expiring in years 2014 through 2018.
 
Minimum future rentals of premises under non-cancelable operating lease agreements at rates in effect as of December 31, 2013 are as follows:

2014
  $ 279  
2015
    220  
2016
    191  
2017
    175  
2018
    175  
         
    $ 1,040  

Rent expenses amounted to $425, $455 and $491 for the years ended December 31, 2013, 2012 and 2011, respectively.

C.
Liens

The Company and certain subsidiaries have recorded floating charges on all of its tangible assets in favor of banks.

The Company's and certain subsidiaries' manufacturing facilities and certain equipment have been pledged as security in respect of a loan received from a bank.

The Company's short term deposits in the amount of $2,381 have been pledged as security in respect of guarantees granted to third parties, loans and credit lines received from a bank . Such deposits cannot be pledged to others or withdrawn without the consent of the bank.

D.
Guarantees

As of December 31, 2013, the Company granted guarantees to third parties including performance guarantees and guarantees to secure customer advances in the sum of $1,497.
The expiration dates of the guarantees range from February 2014 to May 2016.

 
F - 28

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data

Note 10 - Commitments and Contingencies (cont’d)

E.
Legal claims

On January 27, 2013, a former employee of the Company (in this paragraph, the "Plaintiff"), filed a law suit against the Company in the District Labor Court in Tel Aviv (the “Court”) in the amount of NIS 1,400 (approximately $375). The plaintiff alleges that the Company breached the employment agreement with him, and that the Company owes him commission payment for certain sales. On March 2, 2014, subsequent balance sheet date, the parties filed a settlement agreement to the Court according to which the parties release each other from their respective claims and counter claims, which was approved by the Court on March 4, 2014.
 
On October 3, 2013 the Company received from the Commercial Court of Paris, France (in this paragraph, the “Court”) notification that a French company named SMJ PARK’IN SARL (in this paragraph the “Plaintiff”) submitted on June 2013 a monetary claim against the Company and its French subsidiary, Parx France (in this paragraph the “Defendants”), alleging, among others, the Defendants entered on mid 2008 into an agreement with the Plaintiff granting it the exclusive marketing rights to distribute and operate the Defendants PIAF Parking System in Paris and ILE the France, and that the Defendants fail to fulfill its undertakings under such alleged agreement, by marketing its products by themselves or others causing the Plaintiff losses that it requires compensation for in its lawsuit. The total claim amount made by Plaintiff under this action is approximately 1.5 Million (approximately $2 million). The Company rejects all Plaintiffs allegations and claims, including, the alleged agreement and the then exclusive right of the Plaintiff to distribute Company’s products, which were only in the relevant time on negotiation. Following a preliminary hearing held by the Court on December 2013, the Defendants are expected to submit its detailed defense to the Court by end of April 2014. Based on the advice of counsel, management believes that the Company had no   material obligation to the Plaintiff. Accordingly, no provision has been made in the Company’s financial statements for the claim.
 
Note 11 - Equity

A.
Share capital

 
1.
On January 12, 2009, the Company’s Board of Directors approved the adoption of a Shareholders Rights Plan, as amended on January 11, 2012 and on January 9,   2014. Pursuant to the terms of the Plan, each Ordinary Share of the Company shall give its holder one Right, as detailed thereto. Each such Right will become exercisable only after a person or a “Group” become an “Acquiring Person”, by obtaining beneficial ownership of, or by commencing a tender or exchange offer for, 15% or more of the Company’s Ordinary Shares (the Board of Directors may reduce this percentage, but to not less than 10%), unless our Board of Directors approves such “Acquiring Person” or redeems the rights. Each Right, once it becomes exercisable, will generally entitle its holder, other than the “Acquiring Person”, to purchase from the Company either 0.4, half (1/2), one, two or three Ordinary Shares, as shall be determined by the Board of Directors,  at par value.
 
 
2.
On February 8, 2011 the Company closed a firm commitment underwritten public offering of 6,000,000 ordinary shares, including shares issued pursuant to the underwriters over-allotment option, at a public offering price of $3.00 per share. The proceeds to the Company, net of issuance costs, were approximately $16,619.

 
3.
As to shares issued as part of business combinations, see Note 1B.

 
F - 29

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 11 - Equity (cont’d)

B.
Options to non-employees

The Company issued options to non-employees as follows:

 
1.
In 2012, the Company issued 130,500 par value options and shares to non-employees with respect to services rendered.  The aggregate fair value of the options was $181, based on the share market price as of day of grant.
 
 
2.
In 2011, the Company issued 622,000 par value options and shares to non-employees with respect to services rendered.  The aggregate fair value of the options was $1,167, based on the share market price as of day of grant.

The fair value of each option granted to non employees during 2011 for which the exercise price was greater than par value (see note 2M), was estimated on the date of grant, using the Black-Scholes model using the following assumptions:

 
1.
Dividend yield of zero percent.
 
 
2.
Risk-free interest rate of 1.01%.
 
 
3.
Estimated expected lives of 2.5-5 years.
 
 
4.
Expected average volatility of 77% which represent a weighted average standard deviation rate for the price of the Company's Ordinary Shares in the NASDAQ Global Market.

C.
Stock option plans

 
In February 2001, the Company’s Board of Directors approved an additional option plan, under which up to 75,000 share options are to be granted to the Company’s employees, directors and consultants and those of the Company’s subsidiaries and affiliates.

During the years 2002 to 2010, the Company's Board of Directors approved an increase of 12,125,000 shares options to be reserved under the Company’s share option plan.

On November 30, 2011, the Company's Board of Directors approved a further increase of 1,000,000 options to be reserved under the Company’s share option plan.

On October 22, 2013, the Company's Board of Directors approved a further increase of 2,500,000 options to be reserved under the Company’s share option plan.

The vesting period for the options ranges from immediate vesting to ratable vesting over a four- year period.  The exercise price of options under the plan is at varying prices. Those options expire up to five years after the date of the grant. Any options which are forfeited or cancelled before expiration become available for future grants.

During 2011 and 2012 some of the options were granted with a par value exercise price. Due to the par value nominal amount of NIS 0.1, the fair value of these options was estimated to be equal to the Company’s share’s market price at the grant date.

The fair value of each option granted to employees during 2013, 2012 and 2011, for which the exercise price was greater than par value, was estimated on the date of grant, using the Black-Scholes model and the following assumptions:
 
 
1.
Dividend yield of zero percent for all periods.
 
 
2.
Risk-free interest rate of 0.57%-1.02%, 0.76% and 1.01% for, 2013, 2012 and 2011, respectively, based on U.S. Treasury yield curve in effect at the time of grant.
 
 
3.
Estimated expected lives of 2.5-5 years for all periods.
 
 
4.
Expected average volatility of 59%-70%, 73% and 77% for 2013, 2012 and 2011, respectively, which represent a weighted average standard deviation rate for the price of the Company's Ordinary Shares in the NASDAQ Global Market.
 
 
F - 30

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 11 - Equity (cont’d)

C.
Stock option plans (cont’d)

The Company’s options activity (including options to non-employees) and options outstanding and options exercisable as of December 31, 2011, 2012 and 2013 are summarized in the following table:
 
   
Number of
   
Weighted
 
   
options
   
average exercise
 
   
outstanding
   
price per share
 
Outstanding – January 1, 2011
    2,527,030       1.16  
Options granted
    1,663,000       1.04  
Options cancelled or forfeited
    (235,643 )     1.55  
Options exercised
    (799,230 )     0.26  
Outstanding – December 31, 2011
    3,155,157       1.22  
Options granted
    650,500       0.72  
Options cancelled or forfeited
    (768,291 )     1.94  
Options exercised
    (624,250 )     0.03  
Outstanding – December 31, 2012
    2,413,116       1.16  
                 
Options granted
    831,000       1.76  
Options cancelled or forfeited
    (193,000 )     1.34  
Options exercised
    (1,261,500 )     0.84  
Outstanding – December 31, 2013
    1,789,616       1.65  
                 
Exercisable as of:
               
December 31, 2011
    1,749,990     $ 0.84  
December 31, 2012
    1,690,616     $ 1.03  
December 31, 2013
    800,616     $ 1.53  
 
The weighted average fair value of options granted during 2013 is $1.26 per option.
 
The aggregate intrinsic value of outstanding options at December 31, 2013 is approximately $2,774. The aggregate intrinsic value of exercisable options at December 31, 2013 is approximately $1,391.

The following table summarizes information about options outstanding and exercisable (including options to non-employees) as of December 31, 2013:
 
   
Options outstanding
   
Options Exercisable
 
   
Number
   
Weighted
         
Number
   
Weighted
       
   
outstanding
   
average
   
Weighted
   
Outstanding
   
average
   
Weighted
 
   
as of
   
remaining
   
Average
   
As of
   
remaining
   
Average
 
Range of
 
December 31,
   
contractual
   
Exercise
   
December 31,
   
contractual
   
Exercise
 
exercise price
 
2013
   
life (years)
   
Price
   
2013
   
life (years)
   
Price
 
$ 0.03
    94,116       2.05     $ 0.03       94,116       2.05     $ 0.03  
0.90
    313,000       4.58       0.90       147,000       4.19       0.90  
1.08-1.42
    275,000       2.65       1.13       124,500       2.27       1.12  
1.46
    245,000       4.55       1.46       -       -       -  
1.67-2.08
    216,000       2.85       1.69       133,500       2.76       1.67  
2.24-2.58
    396,500       4.67       2.42       301,500       1.51       2.42  
3.18-3.23
    250,000       4.96       3.21       -       -       -  
      1,789,616       3.35               800,616       2.39          
 
 
F - 31

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 11 - Equity (cont'd)

C.
Stock option plans (cont’d)

The total grant date intrinsic value of options exercised during the years ended December 31, 2013, 2012 and 2011, was approximately $1,357, $1,568 and $2,014, respectively. The total exercise date intrinsic value of options exercised during the years ended December 31, 2013, 2012 and 2011, was approximately $1,199, $798 and $1,700, respectively.

As of December 31, 2013, there was approximately $1,207 of total unrecognized compensation cost related to non-vested share based compensation arrangements. That cost is expected to be recognized over a weighted-average period of 2 years. The total fair value of shares vested during the year ended December 31, 2013 was approximately $455.
 
During 2013, 2012 and 2011, the Company recorded share-based compensation expenses in the amount of $364, $951 and $1,933, respectively, in accordance with ASC 718.
 
D.
Warrants

 
1.
During 2012 the Company issued 90,361 warrants with a par value exercise price and shell vest in five equal installments over a vesting period of five years, as part of acquisition of business operations as described in note 1C(1).
 
 
2.
The number of warrants issued by the Company during the year ended December 31, 2011, as part of its offering of shares described in note 11A(2), were 260,869, with a per share exercise price of $3.75.
 
The following table summarizes information about warrants outstanding and exercisable as of December 31, 2013:

   
Warrants outstanding
   
Warrants Exercisable
 
   
Number
   
Weighted
         
Number
   
Weighted
       
   
outstanding
   
average
   
Weighted
   
Outstanding
   
average
   
Weighted
 
   
as of
   
remaining
   
Average
   
As of
   
remaining
   
Average
 
Range of
 
December 31,
   
contractual
   
Exercise
   
December 31,
   
contractual
   
Exercise
 
exercise price
 
2013
   
life (years)
   
Price
   
2013
   
life (years)
   
Price
 
$ 0.03
    110,861       3.1     $ 0.03       38,572       2.77     $ 0.03  
$3.75
    260,869       2.1       3.75       260,869       2.1       3.75  
      371,730       2.4               299,441       2.19          

E.
Repurchase program

The Company had adopted a repurchase program in a total amount of up to $2,000. In the course of the repurchase program which was completed during 2011, 1,178,699 of our Ordinary Shares were acquired for an aggregate purchase price of $2,000. During 2011 the Company acquired an amount of 616,224 of its ordinary shares, for an aggregate purchase price of $864.

 
F - 32

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 12 – Other operating income, net

Consists of :

   
Year ended December 31
 
   
2013
 
Loss from sale of a subsidiary (see note 1B.2.)
    231  
Termination of employment agreements (see note 10A.3.)
    (4,503 )
Loss on sale of property and equipment
    91  
Other
    100  
Other operating income, net
    (4,081 )
 
Note 13 - Income Taxes
 
A.
The Company and its Israeli subsidiaries

 
1.
Measurement of taxable income under the Income Tax (Inflationary Adjustments) Law, 1985
 
The Company and one of its Israeli subsidiaries are foreign invested companies, and have elected, commencing January 1, 2007, to maintain their books and records in U.S dollars for tax purposes, as permitted under the tax regulations.
 
 
2.
Tax benefits under the Law for the Encouragement of Capital Investments, 1959
 
The Company maintains three investment programs in buildings, equipment and production facilities, which have been granted the status of “Approved Enterprise” under the Law for the Encouragement of Capital Investments, 1959. The Company elected to adopt the “Alternative Benefits Program” status. This status entitles the Company (due to its location in Israel) to an exemption from taxes on income derived therefrom for a period of 10 years starting in the year in which the Company first generates taxable income, but not later than 14 years from the date of approval (the last of which was received in February 2000) or 12 years from commencement of operations. The tax-exempt profits that are earned by the Company’s “Approved Enterprises” can be distributed to shareholders, without additional tax liability on the Company only upon its complete liquidation.

If these retained tax-exempt profits are distributed in a manner other than in the complete liquidation of the Company, they would be taxed at the regular corporate tax rate applicable to such profits as if the Company had not elected the alternative system of benefits (depending on the level of foreign investment in the Company) currently between 10% to 25% for an “Approved Enterprise”. As the Company has not yet reported any taxable income, the benefit period has not yet commenced as of December 31, 2013.

Income from sources other than the “Approved Enterprise” during the benefit period will be subject to tax at the regular corporate tax rate (see 4 below).
 
The entitlement to the above mentioned benefits is conditional upon the Company's fulfilling the conditions stipulated by the above mentioned law, regulations published there under and the certificates of approval for the specific investments in the Approved Enterprises. In the event of failure to comply with these conditions, the benefits may be canceled and the Company may be required to refund the amount of the benefits, in whole or in part, with the addition of linkage differences to the consumer price index and interest. Management believes that the Company is in compliance with the above-mentioned conditions as of December 31, 2013.
 
 
F - 33

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 13 - Income Taxes (cont’d)

A.
The Company and its Israeli subsidiaries (cont’d)
 
 
2.
Tax benefits under the Law for the Encouragement of Capital Investments, 1959 (cont’d)
 
Amendment to the Law for the Encouragement of Capital Investments – 1959

On December 29, 2010 an amendment to the Law for the Encouragement of Capital Investments – 1959 was approved (hereinafter – “the Amendment to the Law”). The Amendment to the Law was published in the Official Gazette on January 6, 2011. The Amendment to the Law is effective from January 1, 2011 and its provisions will apply to preferred income derived or accrued in 2011 and thereafter by a preferred company, per the definition of these terms in the Amendment to the Law. Companies can choose to not be included in the scope of the Amendment to the Law and to stay in the scope of the law before its amendment until the end of the benefits period. The 2012 tax year is the last year companies can choose as the year of election, providing that the minimum qualifying investment began in 2010.

The Amendment provides that only companies in Development Area A will be entitled to the grants track and that they will be entitled to receive benefits under this track and under the tax benefits track at the same time. In addition, the existing tax benefit tracks were eliminated (the tax exempt track, the “Ireland track” and the “Strategic” track) and two new tax tracks were introduced in their place, a preferred enterprise and a special preferred enterprise, which mainly provide a uniform and reduced tax rate for all the company’s income entitled to benefits, such as: for a preferred enterprise – in the 2012-2013 tax years – a tax rate of 10% for Development Area A and of 15% for the rest of the country, in the 2013-2014 tax years – a tax rate of 7% for Development Area A and of 12.5% for the rest of the country, and as from the 2015 tax year – 6% for Development Area A and 12% for the rest of the country. On August 5, 2013 the Knesset passed the Law for Changes in National Priorities (Legislative Amendments for Achieving Budget Objectives in the Years 2013 and 2014) – 2013, which cancelled the planned tax reduction so that as from the 2014 tax year the tax rate on preferred income will be 9% for Development Area A and 16% for the rest of the country. Furthermore, an enterprise that meets the definition of a special preferred enterprise is entitled to benefits for a period of 10 consecutive years and a reduced tax rate of 5% if it is located in Development Area A or of 8% if it is located in a different area.

The Amendment to the Law also provides that no tax will apply to a dividend distributed out of preferred income to a shareholder that is a company, for both the distributing company and the shareholder. A tax rate of 15% shall continue to apply to a dividend distributed out of preferred income to an individual shareholder or foreign resident, subject to double taxation prevention treaties, similar to the provisions of the existing law. The Law for Changes in National Priorities (Legislative Amendments for Achieving Budget Objectives in the Years 2013 and 2014) – 2013 raised to 20% the tax rate on a dividend distributed to an individual and foreign resident out of preferred income as from January 1, 2014. Furthermore, the Amendment to the Law provides relief (hereinafter – “the relief”) with respect to tax paid on a dividend received by an Israeli company from profits of an approved/alternative/beneficiary enterprise that accrued in the benefits period according to the version of the law before its amendment, if the company distributing the dividend notifies the tax authorities by June 30, 2015 that it is applying the provisions of the Amendment to the Law and the dividend is distributed after the date of the notice.
 
 
F - 34

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 13 - Income Taxes (cont’d)

A.
The Company and its Israeli subsidiaries (cont’d)

 
3.
The Law for the Encouragement of Industry (taxes), 1969

The Company believes that it qualifies as an “Industrial Company” under the Law for the Encouragement of Industry. The principal tax benefits for the Company are the deductibility of costs in connection with public offerings and amortization of certain intangibles.

 
4.
Tax rates

Presented hereunder are the tax rates relevant to the Company in the years 2011-2013:
2013 – 25%
2012 – 25%
2011 – 24%

On August 5, 2013 the Knesset passed the Law for Changes in National Priorities (Legislative Amendments for Achieving Budget Objectives in the Years 2013 and 2014) – 2013, by which, inter alia, the corporate tax rate would be raised by 1.5% to a rate of 26.5% as from 2014.

The deferred tax balances as at December 31, 2013 were calculated according to the new tax rates specified in the Law for Changes in National Priorities, at the tax rate expected to apply on the date of reversal. The effect of the change on the financial statements as at December 31, 2013 is reflected in an increase in the deferred tax asset in the amount of $ 2,394 against a similar change in the Company's valuation allowance.

Current taxes for the reported periods are calculated according to the tax rates presented above.

B.
Non-Israeli subsidiaries are taxed based on the income tax laws in their country of residence.

C.
Deferred income taxes:

   
December 31
   
December 31
 
   
2013
   
2012
 
Deferred tax assets:
           
Net operating loss carryforwards
  $ 40,181     $ 36,841  
Goodwill
    -       1,762  
Other
    2,683       3,399  
                 
Total gross deferred tax assets
    42,864       42,002  
Less – valuation allowance
    (42,691 )     (42,002 )
                 
Net deferred tax assets
  $ 173     $ -  
                 
Deferred tax liability -
               
                 
Other
    (292 )     (- )
 Intangible assets
    (- )     (53 )
                 
Net deferred tax liability
  $ (292 )   $ (53 )
 
 
F - 35

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 13 - Income Taxes (cont’d)

The net change in the total valuation allowance for each of the years ended December 31, 2013, 2012 and 2011, are comprised as follows:
 
   
Year ended December 31
 
   
2013
   
2012
   
2011
 
                         
Balance at beginning of year
    42,002       37,643       27,311  
                         
Additions during the year from
Continued operation
    1,654       4,155       1,445  
Changes due to amendments to tax laws
                       
    and applicable future tax rates, see note 13A(4)
    2,394       -       8,858  
Smart ID Division Divesture and sale of subsidiary,
see note 1B(1) and 1B(2)
    (3,402 )     181       75  
Other changes
    43       23       (46 )
Balance at end of year
    42,691       42,002       37,643  

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets depends on the generation of future taxable income during the periods in which those temporary differences are deductible. Based on the level of historical taxable losses, management believes that it is more likely than not that the Company will not realize the benefits of these deductible differences.

D.
As of December 31, 2013, the net operating loss carryforwards for tax purposes relating to Israeli companies amounted to approximately $144,638. Tax loss carryforwards in Israel may be carried forward indefinitely to offset against future taxable operational income. Under the Income Tax (Inflationary Adjustments) Law, 1985, and based on the Company’s election (see note13A), tax loss carryforwards are linked to the USD.  Tax loss carryforwards relating to non-Israeli companies aggregate approximately $5,093, which will expire as follows: 2025 - $841, 2026 - $3,206 and 2027- $533. The remaining balance of $513 can be utilized with no expiration date.

E.
The Company has not recognized a deferred tax liability for the undistributed earnings of its foreign subsidiaries that arose in 2013 and prior years, because the Company considers these earnings to be indefinitely reinvested. A deferred tax liability will be recognized when the Company can no longer demonstrate that it plans to indefinitely reinvest these undistributed earnings. As of December 31, 2013, the undistributed earnings of these foreign subsidiaries were approximately $5,098. It is impracticable to determine the additional taxes payable when these earnings are remitted.

 
F - 36

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 13 - Income Taxes (cont’d)

F.
No current or net deferred taxes were recorded in Israel. Non-Israeli income tax expenses included in the consolidated statements of operations are as follows:

   
Year ended December 31
 
   
2013
   
2012
   
2011
 
Current
  $ (265 )   $ (2 )   $ (4 )
Deferred
    62       (65 )     (79
                         
Income tax expenses
  $ (203   $ (67   $ (83

Income tax expenses for the years ended December 31, 2013, 2012 and 2011, differed from the amounts computed by applying the Israeli statutory tax rates of 25%, 25% and 24% to loss from continuing operations before taxes on income, as a result of the following:

   
Year ended December 31
 
   
2013
   
2012
   
2011
 
Computed “expected” income tax benefit
  $ 1,681     $ 4,366     $ 1,929  
Decrease in income tax benefit
                       
 resulting from:
                       
Change in valuation allowance, net
    (1,654 )     (4,155 )     (1,445 )
Stock-based compensation related to options
                       
 issued to employees
    (91 )     (188 )     (235 )
Non-deductible expenses
    (43 )     (35 )     (65 )
Other (mainly foreign jurisdiction tax effect)
    (96 )     (55 )     (267
                         
Total income tax expenses
  $ (203 )   $ (67   $ (83

G.
Income (loss) from continuing operations before taxes on income consists of the following:

   
Year ended December 31
 
   
2013
   
2012
   
2011
 
Israel
  $ (8,842 )   $ (16,983 )   $ (7,533 )
Non-Israel
    2,117       (825 )     (762 )
                         
    $ (6,725 )   $ (17,808 )   $ (8,295 )

H.
Accounting for uncertainty in income taxes

As of December 31, 2013, 2012 and 2011, the Company did not have any unrecognized tax benefits. In addition, the Company does not expect that the amount of unrecognized tax benefits will change significantly within the next twelve months.

For the years ended December 31, 2013, 2012 and 2011, no interest and penalties related to unrecognized tax benefits have been accrued.

The Company and its major subsidiaries file income tax returns in Israel, Poland and Germany. With few exceptions, the income tax returns of the Company and its major subsidiaries are open to examination by the Israeli and the respective foreign tax authorities for the tax years beginning in 2008.

 
F - 37

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 14 – Discontinued operations
 
As described in Note 1B1, the Company divested its interest in the SmartID division and its interest in the German subsidiary, and presented these activities as discontinued operations. Total gain from the SmartID Division Divesture, net of transaction costs   and offset by the impairment charge of the German Subsidiary’s assets (see Note 1B(1)) totaled $5,974, which is presented below as ‘other income, net’.
 
Set forth below are the results of the discontinued operations:

   
Year ended December 31
 
   
2013
   
2012
   
2011
 
Revenues
  $ 16,034     $ 23,360     $ 28,356  
Expenses
    (18,231 )     (23,047 )     (27,071 )
Other income, net
    5,974       -       -  
                         
Net income from discontinued operations
  $ 3,777     $ 313     $ 1,285  
 

The following table summarizes information about assets and liabilities from discontinued operations held for sale as of December 31, 2013:

   
December 31
 
   
2013
 
Assets held for sale from discontinued operations:
       
Trade receivable, net
    223  
Other receivables and prepaid expenses
    144  
Inventories
    2,082  
Property, plant and equipment, net of impairment
   
1,470
 
Total assets held for sale from discontinued operations
    3,919  
         
Liabilities held for sale from discontinued operations:
       
Short term credit and current maturities of long term loans
    1,354  
Trade payables
    495  
Other current liabilities
    177  
Long-term loans, net of  current maturities
    930  
Total  liabilities held for sale from discontinued operations
    2,956  
 
Note 15 - Related Party Balances and Transactions

Transactions
 
   
Year ended December 31
 
   
2013
   
2012
   
2011
 
                   
Costs and expenses*
  $ 13     $ 80     $ 101  
 
* Cost and expenses relate to services provided to the Company by related parties.

Balances
 
As of December 31, 2013 and 2012 the Company has no related party balances.
 
 
F - 38

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 16 - Operating segments

Through 2012, the Company had commingled sales channel payroll expense, inventories, merchandise procurement and distribution networks. As a result of these operations and in view of how the Company's chief operating decision maker (CODM) reviewed operating results for the purposes of allocating resources and assessing performance, the Company operated as a single segment. Beginning 2013, following the change of the board of directors and the review of all of the Company’s operations in order to improve profitability, the new CODM has changed the way it reviews operating results for the purposes of allocating resources and assessing performance, and currently reports three segments which are the Group's strategic business units: Retail and Mass transit, Petroleum and Parking.
 
All prior periods' information has been reclassified to conform with the current year presentation

The following summary describes the operations in each of the Group’s operating segments:
 
Petroleum - includes manufacturing and selling of fuel payment and management solutions. The Company's solution   is a wireless, cashless, cardless and paperless refueling tracking and payment solution, providing customers with maximum flexibility and security.

Retail and Mass transit - includes selling and marketing variety of products for cashless payment solutions for the retail market and mass transit ticketing.

·
Parking - includes selling of products and managing cashless parking solutions. The Company's parking solution is a fully integrated parking fee collection and parking management solution.

In addition to its three reportable segments, certain products for the medical industry and other secure smart card solutions are classified under "Other".
 
The strategic business unit's allocation of resources and evaluation of performance are managed separately. The CODM does not examine assets or liabilities for those segments and therefore they are not presented.

Information regarding the results of each reportable segment is included below based on the internal management reports that are reviewed by the CODM.

   
Year ended December 31, 2013
 
   
Petroleum
   
Retail and Transit
   
Parking
   
Other
   
Consolidated
 
                               
Revenues
    4,532       11,743       2,210       1,383       19,868  
                                         
Reportable segment gross profit *
    2,694       6,469       1,366       808       11,337  
                                         
Reconciliation of reportable segment
                                       
gross  profit to profit for the period
                                       
                                         
Depreciation and amortization
                                    (577 )
Stock based compensation
                                    (32 )
                                         
Gross profit for the year
                                    10,728  
 
   
Year ended December 31, 2012
 
   
Petroleum
   
Retail and Transit
   
Parking
   
Other
   
Consolidated
 
                               
Revenues
    5,205       7,126       2,944       1,329       16,604  
                                         
Reportable segment gross profit *
    2,704       4,837       1,661       710       9,912  
                                         
Reconciliation of reportable segment
                                       
gross  profit to profit for the period
                                       
                                         
Depreciation
                                    (557 )
Stock based compensation
                                    (49 )
                                         
Gross profit for the period
                                    9,306  
 
 
F - 39

 
On Track Innovations Ltd.
and Subsidiaries
Notes to the Consolidated Financial Statements


In thousands, except share and per share data
 
Note 16 - Operating segments (cont’d)

   
Year ended December 31, 2011
 
   
Petroleum
   
Retail and Transit
   
Parking
   
Other
   
Consolidated
 
                               
Revenues
    4,748       13,481       3,494       1,176       22,899  
                                         
Reportable segment gross profit *
    2,171       10,069       1,542       628       14,410  
                                         
Reconciliation of reportable segment
                                       
gross  profit to profit for the period
                                       
                                         
Depreciation
                                    (671 )
Stock based compensation
                                    (24 )
                                         
Gross profit for the period
                                    13,715  
 
* Gross profit as reviewed by the CODM, represents gross profit, adjusted to exclude depreciation and stock based compensation.
 
Note 17 - Geographic Information and Major Customers

The data is presented in accordance with ASC Topic 280, " Disclosures About Segments of an Enterprise and Related Information ".
 
   
Year ended December 31
 
   
2013
   
* 2012
   
*2011
 
Revenues by geographical areas from external customers
                 
 
                 
Americas
  $ 6,856     $ 2,968     $ 1,160  
Asia
    99       574       7,972  
Africa
    4,073       4,189       3,938  
Europe
    7,060       6,664       6,321  
Total export
    18,088       14,395       19,391  
Domestic (Israel)
    1,780       2,209       3,508  
                         
    $ 19,868     $ 16,604     $ 22,899  
 
*Reclassified to conform with current year presentation, see note 1B
 
   
December 31
   
December 31
 
   
2013
   
2012
 
Long lived assets by geographical areas
           
Domestic (Israel)
  $ 3,027     $ 4,531  
Germany
    -       4,371  
Poland
    5,485       3,407  
South Africa
    1,206       1,460  
France
    -       347  
America
    119       99  
                 
    $ 9,837     $ 14,215  

Major Customers
 
   
Year ended December 31
 
   
2013
   
2012
   
2011
 
   
%
   
%
   
%
 
Major Customers by percentage from total revenues
                 
Customer A
    19 %     6 %     -  
Customer B
    15 %     8 %     11 %
Customer C
    -       -       32 %
 
F - 40


 

 

 

 

 


Exhibit 10.9
ASSET PURCHASE AGREEMENT

BY AND AMONG

On Track Innovations Ltd.

AND

SuperCom Ltd.

Dated as of August 14, 2013
 
 
 

 

EXHIBITS AND SCHEDULES


EXHIBITS :
 
Exhibit A
Bank Guarantee
Exhibit B
Non Disclosure Agreement
Exhibit C
Seller Promissory Note
Exhibit D
Buyer Promissory Note
   
   
SCHEDULES :
 
   
Schedule 2.1.2
Tangible Property
Schedule 2.3.1
Specific Excluded Asset
Schedule 1.1.69
Products
Schedule 7.1.4
List of Major Issues
Schedule 5
Seller Disclosure Schedule

 
 

 
 
THIS ASSET PURCHASE AGREEMENT (this “ Agreement ”), dated as of August 14, 2013 (the "Signing Date" ), is made by and among On Track Innovations Ltd ., a company organized and existing under the laws of the State of Israel with offices located at Z.H.R. Industrial Zone, Rosh Pina 12000, Israel (" Seller "), and SuperCom Ltd ., a  company organized and existing under the laws of the State of Israel with offices located at Nolton House, 14 Shenkar Street, Hertzliya Pituach 46725, Israel (" Buyer "). Each of Buyer and Seller may also be referred to herein as a " Party " and collectively as the " Parties ".
 
WHEREAS   each of the Parties has determined that it is in its respective best interests, for the Seller to sell to the Buyer, and for the Buyer to buy from the Seller the Purchased Assets and to assume the Assumed Liabilities (as such terms are defined herein), all on the terms and subject to the conditions contained in this Agreement (the “ Acquisition ”); and
 
WHEREAS , the parties hereto desire to set the terms and conditions for the Acquisition and to make certain representations, covenants and warranties with respect thereto;
 
NOW, THEREFORE , Seller and Buyer hereby agree, as follows:

1.
DEFINITIONS & INTERPRETATION.
 
1.1.       Definitions . Wherever used in this Agreement, the following capitalized terms shall have the meanings attached to them:
 
1.1.1.                 "Accounts Receivable" means all trade accounts receivable and other rights to payment from customers of the Business and the full benefit of all security for such accounts or rights to payment, including all trade accounts receivable representing amounts receivable in respect of Products sold or Services rendered to customers of the Business.
 
1.1.2.                " Acquired Assets " shall have the meaning set out in Section 2.1.
 
1.1.3.                " Action " or "Proceedings" means any lawsuit, action, arbitration proceeding, Claim, complaint, criminal prosecution, investigation, demand letter, governmental or other administrative proceeding, before or by any Court or Governmental Authority.
 
1.1.4.                 "Advance Balances" shall have the meaning ascribed to it in Section 5.8.6 below.
 
1.1.5.                “ Affiliate ” means, with respect to any Party hereof, any Person controlled by, controlling or under common control with such party, and any shareholder, director or officer of such party; "control" for the purpose hereof shall mean the effective ability to control the operations of such entity or the possession, directly or indirectly, of 50% or more of the voting power or the right to appoint 50% or more of the members of the board of directors or equivalent body of such entity; the term "Affiliate" shall also include all Affiliates of such persons or entities.
 
1.1.6.                “ Aggregate Earn-Out Amount ” means the aggregate of all amounts of the Purchase Price payable by way of the Earn-Out Mechanism;
 
 
2

 
 
1.1.7.                " Approval " or "Permit" means any license, permit, consent, approval, authorization, registration, filing, qualification or certification issued by any Governmental Authority or under any applicable Law.
 
1.1.8.                " Assigned Claims " shall have the meaning set out in Section 2.1.
 
1.1.9.                " Assigned Contracts " shall have the meaning set out in Section 2.1.5.
 
1.1.10.              " Assumed Liability " shall have the meaning set out in Section 2.4.
 
1.1.11.              “ Bank Guarantee ” means an irrevocable bank guarantee issued by an Israeli bank in the amount of US$5,000,000 (Five Million United States Dollars) substantially in the form of the bank guarantee attached hereto as Exhibit A .
 
1.1.12.              “ Base Purchase Price ” shall have the meaning set forth in Section 3.1,
 
1.1.13.               "Books and Records" means all books of account, records, and other Documents, to the extent relating to the Business, the Acquired Assets or the Assumed Liabilities.
 
1.1.14.              " Buffalo Project " shall mean the Potential Project referred to in the Potential Projects List as the “Buffalo Project”.
 
1.1.15.              " Business " means the Seller’s existing Smart ID business that relates specifically to the development, license, sale, distribution, maintenance or support of governmental identification technologies and projects, including national identification cards and/or tags, traditional and electronic passports, drivers licenses, voters, elections, visas, border control, census and population registries, but expressly excluding the Seller’s other existing lines of business including, without limitation, (i) Seller’s businesses related to its existing medical, payment, parking and petroleum solutions as well as (ii) any other solutions currently under development or which may in the future be developed or undertaken by the Seller, together with all related assets and technologies, provided such solutions, related assets and technologies are not in direct competition with Seller’s existing Smart ID business.
 
1.1.16.              “ Business Day ” means any day other than a Friday, a Saturday, a public holiday or the ev e of a public holiday in the State of Israel, or any other day on which banks are closed for foreign currency transactions in the State of Israel [or in the US].
 
1.1.17.              " Business Data and Records " shall have the meaning set out in Section 2.1.4.
 
1.1.18.              “ Buyer Promissory Note ” means an unconditional promissory note for the amount of US$ 2,500,000 (Two Million Five Hundred Thousand United States Dollars) issued by Buyer in favor of Seller and payable on Seller’s first demand, in the form attached hereto as Exhibit B .
 
1.1.19.               "Carve-out Financial Statements" means the audited carved-out financial statements of the Business, prepared pursuant to GAAP for the twelve month period ending on December 31, 2012, containing: (a) comparative balance sheet data for December 31, 2011, and (b) comparative profit and loss and cash-flow data for the period ending December 31, 2011.
 
 
3

 
 
1.1.20.              " Claim " means any claim, demand, cause of action, chose in action, right of recovery, right of set off, or right of recoupment.
 
1.1.21.              " Closing " shall have the meaning set out in Section 4.1.
 
1.1.22.              “ Closing Certificate” means a Closing Certificate in a form to be agreed by the Parties prior to Closing.
 
1.1.23.              " Closing Date " shall have the meaning set out in Section 4.1.
 
1.1.24.              " Closing Balance Sheet " reviewed, not audited, balance sheet of the Business (including for each of the Seller Subsidiaries) as of the Signing Date.
 
1.1.25.               "Conditions Precedent ” means the conditions precedent detailed in Section 8.
 
1.1.26.              " Contract " means any written or oral contract, agreement, arrangement, bid, understanding, license, commitment or other instrument, and all amendments, modifications and supplements thereto, whether express or implied.
 
1.1.27.              “ Court ” means any court or arbitration tribunal of any jurisdiction, or any state, province or other subdivision thereof, including, without limitation, the State of Israel.
 
1.1.28.               "Documents" means all files, documents, instruments, papers, books, reports, tapes, microfilms, photographs, letters, budgets, forecasts, ledgers, journals, title policies, customer lists, regulatory filings, operating data and plans, technical documentation (production files, design specifications, functional requirements, operating instructions, logic manuals, flow charts, etc), user documentation (installation guides, user manuals, training materials, release notes, working papers, etc.), marketing documentation (catalogs, sales brochures, sales literature, promotional materials, flyers, pamphlets, web pages, etc.), and other similar materials, in each case whether or not in electronic form.
 
1.1.29.               "Disclosure Schedule Delivery Date" shall have the meaning ascribed to it in Section 7.1.1;
 
1.1.30.              “ Drop Dead Date ” shall have the meaning set forth in Section 11.1.1.
 
1.1.31.              “ Due Diligence Review ” shall have the meaning set forth in Section 7.1.
 
1.1.32.              “Earn-Out Mechanism ” shall mean the earn-out payment mechanism detailed in Section 3.2;
 
1.1.33.              “ Escrow Agent” means as shall be defined in the Escrow Agreement.
 
 
4

 
 
1.1.34.              " Escrow Agreement " means an escrow agreement to be entered into by and between the Parties   and Escrow Agent, in   a form to be agreed by the Parties prior to Closing, in connection with the holding and release of  the Escrow Amount.
 
1.1.35.               "Escrow Amount" shall have the meaning set out in Section 10.4.6.
 
1.1.36.              “ Excluded Assets ” shall have the meaning set out in Section 2.3.
 
1.1.37.              " Excluded Liabilities " shall have the meaning set out in Section 2.5.
 
1.1.38.               "GAAP" means generally accepted accounting principles and procedures in the United States of America.
 
1.1.39.              “ General Assignment, Assumption and Bill of Sale ” means the General Assignment, Assumption and Bill of Sale in a form to be agreed by the Parties prior to Closing.
 
1.1.40.              " Governmental Authority " means any governmental agency, authority, department, commission, board, bureau, Court or instrumentality of any jurisdiction, including, without limitation, the State of Israel, and any subdivision or agency thereof, and any such authority having governmental or quasi-governmental powers, including any administrative agency or commission.
 
1.1.41.              "Guarantee" of or by any Person means any obligation, contingent or otherwise, of such Person guaranteeing any Indebtedness of any other Person in any manner, and including (i) any obligation of such Person (a) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or to purchase (or to advance or supply funds for the purchase of) any security for the payment of such Indebtedness; or (b) to purchase property, securities or services for the purpose of assuring the owner of such Indebtedness of the payment of such Indebtedness; or (ii) any autonomous bank guarantees, bonds, letters of credit and other similar instruments.
 
1.1.42.               "Hazardous Substance" means any substance (including radiation), which might damage or pollute the environment (including surface water, ground water, sea water, air and land) or be a hazard to human beings.
 
1.1.43.               "Indebtedness" of any Person means any obligations of such Person (a) to repay borrowed money; or (b) evidenced by notes, bonds, debentures, loan agreements, capital leases or similar financial instruments;
 
1.1.44.              “ Intellectual Property ” means all forms of intangible proprietary rights recognized under any applicable laws, whether or not patentable, including without limitation: (i) patents, patent applications, patent disclosures, inventions, patent rights, including but not limited to any and all continuations, divisions, reissues, re-examinations or extensions of the above; (ii) trademarks, trade secrets, service marks, trade names, logos and slogans (and all translations, adaptations, derivations and combinations of the foregoing), rights in brands, and Internet domain names; (iii) copyrights and copyrightable works; (iv) computer software, computer programs, file layouts, and (v) registrations, applications and renewals for any of the foregoing (vii) Know-how (viii) rights in business methods, concepts, confidential information, firmware, composition of matter or materials, certification marks, collective marks, customer lists, databases, designs (whether registered or unregistered), including designs of electronic circuits and computer-aided or other representations of the foregoing, ideas, improvements, industrial designs, innovations, manufacturing information, materials, original works of authorship, plans, processes, proprietary technology, reputation, research results, research records, specifications, systems, techniques, and any rights analogous to the foregoing as well as any other proprietary rights relating to any of the foregoing (including without limitation moral rights or similar rights and remedies against infringements thereof and rights of protection of an interest therein under the laws of all jurisdictions) – all of the foregoing whether or not registered or capable of registration, and whether subsisting in any specific country or countries or any other part of the world.
 
 
5

 
 
1.1.45.                "Interim Period" means the period between the Signing Date and the Closing Date.
 
1.1.46.               "Inventories" means all inventories, wherever located , including all finished goods , work in process, raw materials, spare parts, packaging materials and all other materials and supplies that are   used or consumed   by the Seller Group as of the Signing Date in the production of those finished goods that are directly related to the Business.
 
1.1.47.               "Know-How" means any and all scientific, technical and/or commercial information, knowledge, or data, of any kind whatsoever.
 
1.1.48.               “knowledge” (including any derivation thereof, such as “know” or “knowing”) means, with respect to   the Seller, the knowledge of any officer of Seller with authority to create and enforce Seller policies.
 
1.1.49.              “ Law " means any law, statute, code, written policy, licensing requirements, ordinances, rules and regulations of any Governmental Authority.
 
1.1.50.              " Liabilities " means any debt, obligation, duty or liability of any nature (including any unknown, undisclosed, unmatured, unaccrued, unasserted, contingent, indirect, conditional, implied, vicarious, derivative, joint, several or secondary liability), regardless of whether such debt, obligation, duty or liability would be required to be disclosed on a balance sheet prepared in accordance with any generally accepted accounting principles, and regardless of whether such debt, obligation, duty or liability is immediately due and payable.
 
1.1.51.              " Licensed Intellectual Property " means any Intellectual Property that shall remain owned by Seller and licensed to Buyer pursuant to the OTI IP License Agreement.
 
1.1.52.              “ Lien ” means any charge, pledge, condition to title, encumbrance, attachment, security interest, mortgage, right of way, easement, servitude, right to acquire, right of first option, right of first refusal or similar restriction.
 
1.1.53.              " Lion Project " shall mean the Potential Project referred to in the Potential Projects List as the “Lion Project”.
 
 
6

 
 
1.1.54.              “ Losses ” means losses, damages, Liabilities, Actions, sanctions, deficiencies, assessments, judgments, costs, interest, penalties, fines and expenses, (including, without limitation, reasonable attorneys’ fees).
 
1.1.55.              “ Magna License Agreement ” means the Magna License Agreement in a form to be agreed by the Parties prior to Closing.
 
1.1.56.              “ Major Issue ” shall have the meaning set forth in Section 7.1.4.
 
1.1.57.              " Material Adverse Effect " means, (A) with respect to Seller, a material adverse effect on (i) the ability of the Seller to perform its obligations under this Agreement; or (ii) the validity or enforceability of this Agreement; (B) with respect to the Acquired Assets (i) a material adverse effect on the Acquired Assets, their condition or value (other than changes or circumstances affecting general market conditions or which are generally applicable to the industry in which Seller engages); (ii) the ability of Seller to assign, sell, convey or transfer, or to procure the assignment, sale, transfer or conveyance of, the Acquired Assets free and clear of any Lien except for Permitted Liens; or (iii) the ability of Seller or any other Person to use the Acquired Assets substantially in the same manner they were used immediately prior to the occurrence of an event having such material adverse effect; (C) with respect to the Assumed Liabilities, a material adverse effect on the Assumed Liabilities and any material change in the value, scope or amount of, or the terms and conditions pertaining to such Assumed Liabilities (other than changes or circumstances affecting general market conditions or which are generally applicable to the industry in which Seller engages); and (D) with respect to the Business, a material adverse effect on the Business or its condition (other than changes or circumstances affecting general market conditions or which are generally applicable to the industry in which Seller engages).
 
1.1.58.              “ Net Proceeds ” in respect of a Secondary Offering (as referred to in Section 3.1 below), means the gross proceeds derived to the Buyer from such Secondary Offering, less those costs and expenses thereof detailed in the prospectus relating to such Secondary Offering.
 
1.1.59.              “ Non Disclosure Agreement ” means the Non Disclosure Agreement in the form attached hereto as Exhibit C .
 
1.1.60.              “ Operating Guarantees ” means all (i) Guarantees issued or made available by the Seller Group in support of the Seller Group’s undertakings to third parties, including, without limitation, its customers and suppliers, pursuant to Assigned Contracts, and (ii) deposits made by the Seller Group with any third party in support of the Seller's the Seller’s undertakings to third parties, including, without limitation, its customers and suppliers, pursuant to Assigned Contracts.
 
1.1.61.              “ Order ” means any judgment, order, writ, injunction, ruling, verdict, decision or decree of, or any settlement under the jurisdiction of any Court or Governmental Authority.
 
1.1.62.              “ Organizational Documents ” means, with respect to any incorporated legal entity, the memorandum of association, articles of association, certificate of incorporation, by-laws, certificate(s) of designation, partnership agreement or other constitutional documents of any type, including all restatements thereof and amendments thereto.
 
 
7

 
 
1.1.63.              “ OTI IP License Agreement ” means the License Agreement in a form to be agreed by the Parties prior to the Closing.
 
1.1.64.              “ Permitted Liens ” means (i) statutory Liens for Taxes which are not yet due and payable or are due but not delinquent or are being contested in good faith by appropriate proceedings, (ii) Liens imposed under applicable Law, including statutory Liens in favor of carriers, warehousemen, mechanics, workmen, repairmen and materialmen to secure claims for labor, materials or supplies, and (iii) with respect to any Assigned Contract, any Liens arising under the terms of such Contract, provided such Liens are not resulting from a breach, default or violation by the Seller Group of any Contract or Law occurring prior to the Signing Date.
 
1.1.65.              " Person " means an individual, corporation, partnership, association, trust, unincorporated organization, limited liability company or other legal entity.
 
1.1.66.              “ Potential Project ” means each of the potential projects listed on the Potential Projects List.
 
1.1.67.              “ Potential Projects List ” means a list of potential projects of the Business that shall be provided to Buyer by Seller on the Signing Date.
 
1.1.68.              " Potential Transferred Employees " shall mean all of those employees of Seller who are directly involved in the Business and spend the majority time of their working time in the Business, a list of whom shall be provided to Buyer upon the Signing Date and who, upon the terms and subject to the conditions of this Agreement, shall be approached by Buyer to become Transferred Employees.
 
1.1.69.                "Product(s)" means the products that are developed, manufactured or marketed by the Seller Group as part of the Business, as listed in Schedule 1.1.69, to be prepared and attached to this Agreement by Seller on or around the Disclosure Schedule Delivery Date;
 
1.1.70.              “ Promissory Notes ” means the Buyer Promissory Note and the Seller Promissory Note.
 
1.1.71.              “ Purchase Price ” shall mean the amounts payable by Buyer under Section 3.
 
1.1.72.              " Release " means a waiver and release to be executed by each Transferred Employee in favor of each of Buyer and Seller in a form to be agreed by the Parties prior to Closing.
 
1.1.73.               "Seller Contracts" means any Contract (a) under which the Seller Group has or may acquire any rights or benefits; or (b) by which the Seller Group is or may become bound, in each case, directly related to the Business.
 
1.1.74.              “ Seller Disclosure Schedule ” or the " Disclosure Schedule " shall have the meaning set out in Section 5.
 
 
8

 
 
1.1.75.              “ Seller Promissory Note ” means an unconditional promissory note for the amount of US$ 2,500,000 (Two Million Five Hundred Thousand United States Dollars) issued by Seller in favor of Buyer and payable on Buyer’s first demand, in the form attached hereto as Exhibit D .
 
1.1.76.              " Seller Group " means the Seller, together with the Seller Subsidiaries.
 
1.1.77.              “ Seller Subsidiaries ” means: (i) OTI Panama S.A.; (ii) OTI Tanzania Ltd.; (iii) Digoti Ltd., a company registered in Israel, and (iv) Otignia LLP, a limited liability partnership registered in Israel.
 
1.1.78.               "Services" means Services provided by the Seller Group with respect to the Products, including integration and systems support.
 
1.1.79.              “ Signing Date ” as defined in the preamble to this Agreement.
 
1.1.80.              “ Supply Agreement” means the Supply and Services Agreement in a form to be agreed by the Parties prior to Closing.
 
1.1.81.              " Tangible Property " shall have the meaning set out in Section 2.1.2.
 
1.1.82.               “ Taxes ” means any state, local, foreign and other taxes, assessments, or other governmental charges, including, without limitation, income, estimated income, business, occupation, franchise, property, sales, use, employment or withholding taxes, including interest, penalties and additions in connection therewith.
 
1.1.83.              " Transaction Documents " means the documents, instruments and certificates contemplated by this Agreement or to be executed in connection with the execution of this Agreement and the consummation of the transactions contemplated hereby.
 
1.1.84.              “ Transferred Employees ” means those Potential Transferred Employees who will execute a Release, accept Buyer's offer of employment to be employed by Buyer as of the Closing Date.
 
1.1.85.               “Transferred Intellectual Property” means that Intellectual Property of the Seller that shall be listed in Item 5.9 of the Seller Disclosure Schedule.
 
1.2.       Interpretation .  The schedules and exhibits attached hereto are an integral part of this Agreement.  All schedules and exhibits attached to this Agreement are incorporated herein by this reference and all references herein or therein to this “ Agreement ” shall mean this Agreement together with all such schedules and exhibits.  Except as may be otherwise specifically indicated,  when a reference is made in this Agreement to Sections, Schedules, or Exhibits, such reference shall be to a Section, schedule or exhibit to this Agreement unless otherwise indicated.  The words “include,” “includes” and “including” when used herein shall be deemed in each case to be followed by the words “without limitation.”  The word “herein” and similar references mean, except where a specific Section or Article reference is expressly indicated, the entire Agreement rather than any specific Section.  The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.  As used herein, all pronouns shall include the masculine, feminine, neuter, singular and plural thereof whenever the context and facts require such construction.
 
 
9

 
 
2.
PURCHASE AND SALE OF ASSETS.
 
2.1.       Purchase and Sale of Acquired Assets . Upon the terms and subject to the conditions set forth in this Agreement, at the Closing, Seller shall sell, transfer, assign and deliver to Buyer, and the Buyer shall purchase and accept from the Seller, all right, title and interest in and to all of the Acquired Assets, free and clear of all Liens except for Permitted Liens.

As used in this Agreement, the term “ Acquired Assets ” means all of the following business, assets, properties, contractual and other rights, and goodwill, wherever situated and of every kind and nature, real or personal, whether tangible and intangible, owned, used or held for use by Seller in relation to the Business, whether or not reflected on the Books and Records of the Seller Group, as at the Closing Date, but excluding, however, the Excluded Assets:
 
2.1.1.                The Transferred Intellectual Property;
 
2.1.2.                 All tools and equipment, machinery, and other tangible property owned by Seller Group to the extent directly related to the Business, as shall be listed in Schedule 2.1.2 to be to be prepared and attached to this Agreement by Seller on or around the Disclosure Schedule Delivery Date, in being agreed that such Schedule 2.1.2 shall exclude those tangible assets directly of the Business that the Parties mutually agree to exclude, as may be updated to reflect any changes between the date hereof and the Closing Date (together, the " Tangible Property "), including related documentation, instructions and manuals;
 
2.1.3.                All Inventories owned by the Seller Group to the extent related to the Business, as may be updated to reflect any changes between the date hereof and the Closing Date;
 
2.1.4.                All Documents to the extent related to the Business, including Documents relating to (i) the Products, the Services, or the Transferred Intellectual Property, and (ii) (subject to applicable Laws), personnel files for Transferred Employees (together, “ Business Data and Records ”)   provided that Seller may retain copies of the foregoing Business Data and Records (a) if and to the extent required by Law or (b) if and to the extent related to Excluded Assets or Excluded Liabilities, or (c) as may be related to Liabilities that Seller may incur in connection with the Acquired Assets or the Assumed Liabilities provided such Business Data and Records referenced in this subsection (c) will be used solely for the purpose of allowing Seller to defend against such Liabilities and will be kept in escrow by Seller's General Counsel in accordance with a letter of confirmation to be provided by such General Counsel in form and substance reasonably satisfactory to Buyer's counsel, until the latest Survival Date or until such Business Data and Records are required in connection with such defense. ;
 
 
10

 
 
2.1.5.                All rights, other than Accounts Receivable of Seller, whether fixed, contingent or otherwise of Seller, under all past and present Seller Contracts, including under those Seller Contracts with lessors of Tangible Property, service providers, agents, promoters and distributors relating to Products and Services, proposals and tender bids and further including, without limitation, those to be listed in Part 5.8.1 of the Seller Disclosure Schedule, all to the extent related to the conduct of the Business from and after the Signing Date (together, the “ Assigned Contracts ”);
 
2.1.6.                All Approvals issued to and used by Seller and all pending applications therefor or renewals thereof, to the extent related to the Business, in each case to the extent transferable to the Buyer, including those to be listed in Part 5.3 of the Disclosure Schedule;
 
2.1.7.                All Accounts Receivable of Seller, to the extent related to the conduct of the Business from and after the Signing Date;
 
2.1.8.                All Claims of Seller Group, to the extent related to the conduct of the Business in respect of the period from and after the Signing Date, whether known or unknown (the " Assigned Claims ");
 
2.1.9.                All of the shares of each of the Seller Subsidiaries held by the Seller;
 
2.1.10.              All goodwill related to the Business, including without limitation, the goodwill related to the Transferred Intellectual Property;
 
2.1.11.              All deposits made by any third party (including without limitation the Seller Group's customers and suppliers) to the Seller Group and that are held by the Seller Group, in support of such third party's undertakings to Seller pursuant to Assigned Contracts;
 
2.1.12.              All other assets directly related to the Business and reflected in the Closing Balance Sheet (subject to updates resulting from the ordinary course of the Business following the date of the Closing Balance Sheet and until the Closing Date).
 
2.2.      Notwithstanding the foregoing, the transfer of the Acquired   Assets pursuant to this Agreement shall not include the assumption of any Liability related to the Business, unless the Buyer expressly assumes such Assumed Liability pursuant to Section 2.4 hereof.
 
2.3.       Excluded Assets .  Notwithstanding any provision of Section 2.1 above, the following assets of the Seller shall be excluded from the Acquired Assets, and all rights in, such assets shall remain exclusively with the Seller (collectively, the “ Excluded Assets ”):
 
2.3.1.                 All of the business, assets, properties, goodwill and rights of Seller of every kind and nature, tangible and intangible, including for the sake of clarity under Seller Contracts or Approvals that are not related to the Business;
 
2.3.2.                All Accounts Receivable of Seller or the Seller Group to the extent related to the conduct of the Business prior to the Signing Date;
 
 
11

 
 
2.3.3.                All cash, cash balances, deposits, short term investments and cash equivalents of Seller as of the Signing Date;
 
2.3.4.                All Tax returns filed and associated Tax records and rights to refunds or claims to overpayments attributed to Tax payments made, in each case, to the extent relating to the conduct of the Business in respect of the period prior to the Signing Date;
 
2.3.5.                The benefits of all third party property and casualty insurance policies, whether or not related to the Business;
 
2.3.6.                All rights and interests of Seller in, to and in respect of the Excluded Liabilities;
 
2.3.7.                All rights and interests of Seller in, to and in respect of any legal entity owned by Seller other than the Seller Subsidiaries;
 
2.3.8.                All ownership, leasehold or other interest of Seller in any real property, or in any improvements, fixtures and other appurtenances thereto;
 
2.3.9.                All rights, title and interest of Seller in, to and under this Agreement and any of the Transaction Documents.
 
2.4.       Assumption of Liabilities .  Upon the terms and subject to the conditions set forth in this Agreement, as of the Signing Date (but subject to the consummation of the Closing), Buyer shall assume, and from and after the Closing, Buyer shall pay, discharge when due, and perform, all of the following Liabilities of Seller Group, other than the Excluded Liabilities (collectively, the “ Assumed Liabilities ”):
 
2.4.1.                All trade accounts payable and accrued expenses incurred by Seller Group, including all trade accounts payable representing amounts payable to suppliers of the Business, to the extent directly related to the conduct of the Business from and after the Signing Date;
 
2.4.2.                All Liabilities with respect to the Transferred Employees, including, without limitation, (i) all past obligations of the Seller toward the Transferred Employees; (ii) all ongoing obligations toward the Transferred Employees following their transfer to the Buyer; and (iii) all Claims of the Transferred Employees arising from their employment with the Seller, as of the Signing Date;
 
2.4.3.                All Liabilities, other than trade accounts payable and accrued expenses of the Seller Group, whether fixed, contingent or otherwise of Seller Group, under all Assigned Contracts, accruing from and after the Signing Date;
 
2.4.4.                All Liabilities attributable to the Acquired Assets with the exception of the Excluded Liabilities; and
 
2.4.5.                All other Liabilities related to the conduct of the Business and reflected in the Closing Balance Sheet (subject to updates resulting from the ordinary course of the Business following the date of the Closing Balance Sheet and until the Closing Date).
 
 
12

 
 
2.5.       Excluded Liabilities .  Notwithstanding any provision of this Agreement to the contrary, Buyer shall not be deemed to assume, nor shall it assume or be obligated to pay, discharge or perform, the following Liabilities (collectively, the “ Excluded Liabilities ”), all of which shall remain the sole responsibility of Seller, and shall be retained, paid, performed and discharged by Seller:
 
2.5.1.                All trade accounts payable and accrued expenses incurred by Seller Group, including all trade accounts payable representing amounts payable to suppliers of the Business, to the extent directly related to the conduct of the Business up to the Signing Date;
 
2.5.2.                All Liabilities of Seller arising under any Seller Contract other than the Assigned Contracts;
 
2.5.3.                All Liabilities of Seller for Claims made in respect of a breach of, or a default by, the Seller Group accruing under (i) Assigned Contracts or (ii) Permits to the extent related to the Business, in each case with respect to the period prior to the Signing Date;
 
2.5.4.                All Liabilities arising out of, under or in connection with any Indebtedness of the Seller Group;
 
2.5.5.                All Liabilities of Seller in respect of the Excluded Assets;
 
2.5.6.                All Liabilities of Seller resulting from any act or omission of Seller occurring from and after the Signing Date;
 
2.5.7.                All Liabilities for (a) Taxes of the Seller Group, or its shareholders or their beneficial shareholders; (b) Taxes that relates to the conduct of the Business for taxable periods (or portions thereof) ending on or before the Signing Date; and (c) payments under any Tax allocation, sharing or similar agreement (whether oral or written);
 
2.5.8.                All Liabilities in respect of any pending or threatened Action arising out of, relating to or otherwise in respect of: (a) the operation of the Business to the extent such Action relates to such operation on or prior to the Signing Date, or (b) any Excluded Asset;
 
2.5.9.                Any third-party-beneficiary claim or any other type of claim of direct or indirect holders of interests in the Business or the Acquired Assets to any portion of the Purchase Price;
 
2.5.10.              All Liabilities with respect to the Potential Transferred Employees, including, without limitation, all obligations of the Seller toward the Potential Transferred Employees and all Claims of the Potential Transferred Employees arising from their employment with the Seller until the Signing Date;
 
2.5.11.              All Liabilities relating to amounts required to be paid by the Seller to its shareholders or beneficial shareholders;
 
 
13

 
 
2.5.12.              Product warranties detailed in Assigned Contracts as at the Signing Date that were provided by Seller in respect of products manufactured by Seller and supplied under such Assigned Contracts;
 
2.5.13.              All of the Seller's Liabilities under this Agreement including with respect to costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby, as well as any Liabilities incurred by Seller in facilitating the transfer of the Acquired Assets at the Closing, unless specifically defined otherwise within this Agreement (it being agreed that nothing in this provision shall impose on the Seller any Liabilities not otherwise imposed by this Agreement).
 
2.6.       Conveyances.   The sale, conveyance, transfer, assignment and delivery to the Buyer of the Acquired Assets on the Closing, as herein provided, shall be effected by the Assignment and Bill of Sale and by such other bills of sale, endorsements, assignments and other instruments of transfer and conveyance as may be necessary to vest in the Buyer, as relevant, the respective rights, title and interests in and to the Acquired Assets, free and clear of all Liens except for Permitted Liens.
 
2.7.       Assumption of Contracts.   The Buyer shall at the Closing execute General Assignment, Assumption and Bill of Sale and will, at any time or from time to time after the Closing, upon reasonable request by the Seller, perform or cause to be performed such acts, and execute, acknowledge and deliver or cause to be executed, acknowledged and delivered such other documents, as may be reasonably required or requested for the assumption by the Buyer of the Assigned Contracts or for the discharge or the performance by the Buyer of any of the other Assumed Liabilities.
 
2.8.       Further Conveyances and Assumptions; Consent of Third Parties .   From time to time following the Closing, each of the Parties shall, and shall cause their respective Affiliates to, execute, acknowledge and deliver all such further conveyances, notices, assumptions, releases, and such other instruments, and shall take such further actions, as may be necessary or appropriate to assure fully to the other Party and its respective successors or assigns, the performance in full of the intents and purposes of Sections 2.6 and 2.7 and to otherwise make effective the Acquisition.
 
2.9.       Non-Assignable Contracts .
 
2.9.1.                Nothing in this Agreement nor the consummation of the Acquisition shall be construed as an attempt or agreement to assign any Assigned Contract or Approval, which by its terms or by Law is non-assignable without the consent of a third party including any Governmental Authority, or is cancellable by a third party or any Governmental Authority in the event of an assignment, or that the assignment thereof may otherwise affect the rights of the Buyer thereunder (“ Non-assignable Assets ”), unless and until such consent shall have been obtained.
 
 
14

 
 
2.9.2.                The Seller shall use reasonable commercial efforts to obtain the consent of any relevant third party or Governmental Authority to the assignment of any Seller Contracts or any other asset included in the Acquired Assets, to the extent such consent is needed.  To the extent permitted by applicable Law, in the event that consents to the assignment thereof cannot or may not be obtained, such Non-assignable Assets shall be held, as of and from the Closing Date, by the Seller (or, in the event of a Non-assignable Asset from another member of the Seller Group, by such member of the Seller Group) in trust for the Buyer, and the covenants and obligations thereunder shall be performed by the Buyer in the Seller’s name and all benefits and obligations existing thereunder shall be for the Buyer’s account. The Seller shall take or cause to be taken, at the Buyer’s expense, such actions in its name or otherwise as the Buyer may reasonably request so as to provide the Buyer with the benefits of the Non-assignable Assets and to effect collection of money or other consideration that becomes due and payable under the Non-assignable Assets, and the Seller shall deposit all money or other consideration received by it in respect of all Non-assignable Assets in a special separate escrow account and shall promptly pay over such monies to the Buyer. As of and from the Closing Date, the Seller shall authorize the Buyer, either by delivering to the Buyer at the Closing Date, an irrevocable power of attorney, to the extent permitted by Law and the terms of the Non-assignable Assets, by entering into subcontracting, sublicensing or subleasing arrangements, or in any other manner as shall be reasonably requested by Buyer, at the Buyer’s expense, to perform all the obligations and receive all the benefits of Seller under the Non-assignable Assets and appoints Buyer, solely for this purpose, as its attorney-in-fact to act in its name on its behalf.  Notwithstanding anything to the contrary stated herein, Seller’s undertakings under this Section 2.9.2 as it relates to the Lion Project, shall be subject to Buyer procuring a guarantee from the third party guarantor and in a form acceptable to Seller, which guarantor undertakes to guarantee all of the obligations of Buyer under the Lion Project and to indemnify Seller in respect of all Liabilities arising under the Lion Project beyond the amount of any performance bond issued by Seller under the Lion Project.
 
3.
PURCHASE PRICE
 
3.1.       Purchase Price . In consideration of the Acquisition the Buyer shall pay to the Seller the Purchase Price, as follows:
 
3.1.1.                In the event Buyer raises Net Proceeds of at least US$20,000,000 (Twenty Million United States Dollars) through a secondary public offering of any Buyer securities prior to the Closing (a “ Secondary Offering ”), at the Closing, Buyer shall pay to the Seller in immediately available funds, the amount of US$17,500,000 (Seventeen Million Five Hundred Thousand United States Dollars) (the “ Base Purchase Price ”); or
 
3.1.2.                In the event Buyer closes prior to the Closing Date a Secondary Offering with Net Proceeds of less than US$20,000,000 (Twenty Million United States Dollars) through a Secondary Offering, at the Closing: (A) Buyer shall pay to the Seller in immediately available funds: (i) US$10,000,000 (Ten Million United States Dollars); plus (ii) the amount of Net Proceeds arising from such Secondary Offering less US$12,000,000 (Twelve Million United States Dollars); and (B) the balance of the Base Purchase Price shall be paid in accordance with and subject to the Earn-Out Mechanism detailed in Section 3.2 below.
 
 
15

 
 
3.1.3.                In the event Buyer fails to close a Secondary Offering prior to the Closing Date: (A) at the Closing: (i) Buyer shall pay to the Seller in immediately available funds US$5,000,000 (Five Million United States Dollars); and (ii) Buyer shall deliver to Seller the Bank Guarantee; and (B) the balance of the Base Purchase Price shall be paid in accordance with and subject to the Earn-Out Mechanism detailed in Section 3.2 below, provided however that:
 
(X)      In the event Buyer closes a Secondary Offering following the Closing, then within 15 days of the closing of such Secondary Offering buyer shall pay to Seller in immediately available funds:
 
(i)        if such Secondary Offering results in Net Proceeds to Buyer of at least US$20,000,000 (Twenty Million United States Dollars), the balance of the Base Purchase Price outstanding at such time;
 
(ii)       if such Secondary Offering results in Net Proceeds to Buyer of less than US$20,000,000 (Twenty Million United States Dollars) but more than US$7,000,000 (Seven Million United States Dollars), (a) the amount of US$5,000,000 (Five Million United States Dollars), provided the Seller has not by such time drawn on the Bank Guarantee; plus (b) the amount of Net Proceeds arising from such Secondary Offering less US$12,000,000 (Twelve Million United States Dollars), provided that the aggregate amounts paid under this Section 3.1.3(X) shall in no event exceed the Base Purchase Price; or
 
(iii)      if such Secondary Offering results in Net Proceeds to Buyer of up to US$7,000,000 (Seven Million United States Dollars), then paragraph (Z) below alone shall apply.
 
(Y)      Payment by the Buyer of the amounts referenced in Section 3.1.3(X) above, shall be made against the return of the Bank Guarantee to the Buyer, to the extent it has not previously been drawn upon.
 
(Z)      The balance of the Base Purchase Price that remains outstanding following payment of any amount pursuant to paragraph (X) above shall be paid in accordance with the Earn-Out Mechanism.
 
3.1.4.                In the event that Buyer is awarded the Buffalo Project, then upon the later of: (a) the Closing Date; or (b) 15 days following Buyer’s receipt of the full amount of the advance payment payable under the Buffalo Project, Buyer shall pay to Seller in full and in immediately available funds all amounts of the Purchase Price outstanding at such date.  Buyer shall notify Seller as soon as practicable following its award of the Buffalo Project, to the extent so awarded.
 
3.1.5.                In the event that Buyer sells all or substantially all of the assets or contractual rights of the Business or the Division (defined below) to a third party other than an Affiliate of Buyer, then within 15 days of the consummation of such transaction Buyer shall pay to the Seller in full and in immediately available funds all amounts of the Purchase Price outstanding at such date.
 
3.1.6.                To the extent that Buyer closes a Secondary Offering as contemplated above and then subsequently closes a further Secondary Offering, then within 15 days of the closing of such subsequent Secondary Offering, Buyer shall pay to Seller in immediately available funds the lower of: (i) the balance of the Purchase Price outstanding at such time; and (ii) 40% of the Net Proceeds to Buyer of such subsequent Secondary Offering.
 
 
16

 
 
3.1.7.                If at any time during the period commencing as of the Signing Date and ending on the third anniversary of the Closing Date, the Buyer and/or any of its Affiliates are awarded or otherwise receive orders under any Potential Projects other than the Buffalo Project (“ Bookings ”), then: (i) Buyer shall provide written confirmation to Seller of its engagement in respect of the relevant Potential Project, as soon as practicable following such engagement; (ii) the gross amount of all potential revenues under all Bookings during each of the three 12-month periods following the Closing Date (a “ Year ”) shall be divided into units of US$20,000,000 each (“ Award Unit ”); (iii) with respect to each full Award Unit in each Year, Buyer shall pay to Seller as additional consideration for the Acquisition the amount of US$1,666,667 (the “ Additional Consideration ”), which shall be payable in accordance with the Earn-Out Mechanism detailed in Section 3.2 below, provided that the aggregate amount of all Additional Consideration shall be no more than US$5,000,000.
 
3.2.      Any amount of the Purchase Price payable by way of the Earn-Out Mechanism, shall be paid as follows: within 90 days of the end of each calendar quarter following the Closing Date, Buyer shall pay to Seller an amount equal to 7% of the gross revenues derived from that business division of the Buyer and any of its Affiliates into which the Business shall be incorporated (excluding those revenues derived from the Buffalo Project, provided Buyer has paid the full amount owing under Section 3.1.4 above), currently known as the Buyer’s ∑ID division (the “ Division ”) and recognized by Buyer during such calendar quarter.  Such payment shall be accompanied by a certificate issued by the Buyer’s CEO or CFO, detailing the gross revenues derived by the Division and recognized by Buyer during the relevant calendar quarter.  Within 10 days of the publication of the Buyer’s annual audited financial statements (the “ Buyer’s Annual Reports ”), the Buyer shall deliver to the Seller a certificate issued by the Buyer’s auditors confirming the amount payable to Seller pursuant to this Earn-Out Mechanism during the year to which the Buyer’s Annual Reports relate (the “ Buyer’s Auditor Certificate ”).  The amount payable hereunder in respect of the last calendar quarter of each year shall be paid within 10 days of the publication of the Buyer’s Annual Reports and shall be adjusted to reflect any difference between the amounts actually paid to Seller during the previous calendar quarters and the amount that should have been paid pursuant to the Buyer’s Auditor Certificate.  Payments under this Earn-Out Mechanism shall be made over a seven year period commencing as of the Closing Date, provided that such period shall be extended by an additional year for each Award Unit recognized under Section 3.1.7 above (the “ Earn-Out Period ”). Notwithstanding anything to the contrary herein, provided that Buyer is in full compliance with its obligations under this Agreement, any amount of the Purchase Price payable pursuant to this Earn-Out Mechanism that has not become payable by Buyer to Seller out of the gross revenues derived by the Division up to the end of the Earn-Out Period, shall cease to be owing by Buyer, and Seller shall be deemed to have waived its entitlement to any such amount, as of such date.
 
3.3.      With respect to any amount payable under the Earn-Out Mechanism that Buyer fails to pay to Seller in accordance with Section 3.2 for two consecutive calendar quarters, such amount shall be deemed to be doubled and shall continue to double at the end of each additional six (6) month period therafter that such amount remains unpaid until the aggregate amount owing hereunder is paid in full by the Buyer.  Notwithstanding anything to the contrary in the immediately preceding sentence, in no event will the amount payable hereunder exceed the Aggregate Earn-Out Amount.
 
 
17

 
 
3.4.       Purchase Price Allocation . The Parties agree that the allocation of the Purchase Price of the Acquired Assets shall be detailed in an Exhibit to this agreement to be attached at the Closing.
 
3.5.      Value Added Taxes . The Purchase Price does not include any value added taxes applicable to the Acquisition. Value added taxes applicable in Israel in accordance with the requirements of the Israeli Value Added Tax Law, 5735-1975 (respectively, “VAT” and the "VAT Law" ) shall be added by Buyer to the Purchase Price. At the Closing Buyer shall pay to the Seller the VAT applicable to the amount that is equal to the higher of (i) cash amounts actually paid at the Closing on account of the Purchase Price pursuant to Section 3.1 above; or (ii) US$10,000,000 (Ten Million US Dollars) against issuance by the Company of a duly issued invoice therefor. The Seller and the Buyer agree  to cooperate in the submission of a joint request to the Israeli Value Added Tax authorities under Section 20 of the VAT Law  (the “VAT Approval” ).  In the event that VAT Approval is not received within 45 days of the Signing Date then the Parties shall negotiate and agree in good faith the manner in which the VAT will be paid with respect to that amount of the Purchase Price payable at the Closing. All VAT applicable to additional payments made on account of the Purchase Price following the Closing Date, shall be added to such payments and paid by Buyer to Seller against receipt of a duly issued invoice therefor.
 
The Seller and the Buyer  shall cooperate in minimizing all Value Added Taxes relating to the Acquisition, in accordance with all applicable Law.
 
3.6.       Withholding Taxes .  Buyer shall deduct and withhold from the Purchase Price any Taxes required to be withheld at source under Israeli Law or any other applicable Law , and shall provide Seller a certificate evidencing such withholder, unless Seller shall provide Buyer an appropriate certificate of exemption with regard to withholding at source of taxes that Buyer would otherwise be required to withhold under Israeli Law or any other applicable Law.
 
4.
CLOSING
 
4.1.       Closing .  The closing of the transactions contemplated by this Agreement (the “ Closing ”) will take place at 11:00 a.m. (Israel Time) on the third (3 rd ) Business Day following the satisfaction (or waiver, where permitted) of all Conditions Precedent, but no later than sixty (60) days following the Disclosure Schedule Delivery Date, unless another time or date is agreed to in writing by the parties (the “ Closing Date ”). The Closing shall be held at Seller’s offices in Rosh Pina, unless another place is agreed to in writing by the parties.
 
 
18

 
 
4.2.       Transactions at Closing . At the Closing, all of the actions set forth in this Section 4.2 below shall occur and shall be deemed to occur simultaneously, such that no action shall be deemed to have been completed or any document delivered until all such actions have been completed and all such documents have been delivered:
 
4.2.1.                In addition to any other documents expressly required to be delivered under other provisions of this Agreement, Seller shall deliver or cause to be delivered to Buyer the following deliverables, each of which may be waived by Buyer at Buyer's discretion:
 
(a)               a Closing Certificate, executed by the Chief Executive Officer and Chief Financial Officer of Seller, certifying that: (i) the execution, delivery and performance of this Agreement, the Transaction Documents to which Seller is a party, and the transactions contemplated hereby and thereby, and the acts of the officers of Seller in carrying out the terms and provisions hereof and thereof, have been authorized and approved by all corporate action required to be taken on the part of Seller; (ii) except as otherwise expressly set forth in such Closing Certificate, (which exceptions may not reflect  a Major Issue), each of the representations and warranties of Seller in this Agreement, are true and correct in all material respects as of the Closing Date, and (iii) certifying that the Conditions Precedent set forth in Sections 8.1 and 8.3, have been satisfied or otherwise waived by Seller; and
 
(b)               all Approvals and other consents by any Person, the lack of which would constitute a Major Issue.
 
(c)               a duly issued invoice portion of the Purchase Price payable at the Closing pursuant to Section 3 above.
 
(d)               the Closing Balance Sheet;
 
(e)               deeds, bills of sales, endorsements, assignments, registrations and other instruments of transfer and conveyance, certificates of title, documents  and other instruments of transfer and conveyance, duly executed by the Seller Group, including assignments of all Transferred Intellectual Property and separate assignments of all registered marks, internet domain names, patents and copyrights, duly executed by Seller Group;
 
(f)                the Buyer’s Promissory Note; and
 
(g)               such other documents, instruments and certificates as may be required, in the reasonable opinion of Seller's Representative, to effect and consummate the Acquisition, which documents, instruments and certificates shall be attached to this Agreement.
 
4.2.2.                Buyer shall deliver or cause to be delivered to Seller:
 
(a)               a Closing Certificate, executed by the Chief Executive Officer and Chief Financial Officer of Buyer, certifying that: (i) the execution, delivery and performance of this Agreement, the Transaction Documents to which Buyer is a party, and the transactions contemplated hereby and thereby, and the acts of the officers of Buyer in carrying out the terms and provisions hereof and thereof, have been authorized and approved by all corporate action required to be taken on the part of Buyer; (ii) except as otherwise expressly set forth in such Closing Certificate, each of the representations and warranties of the Buyer in this Agreement, as amended or updated, are true and correct in all material respects as at the Closing Date, and (iii) certifying that the Conditions Precedent set forth in Sections 8.1 and 8.2, have been satisfied in all material respects or otherwise waived by Buyer; and
 
 
19

 
 
(b)               to the extent necessary, the Supporting Bank Guarantee in an amount determined in accordance with Section 7.11.2 below;
 
(c)               deeds, bills of sales, endorsements, assignments, registrations and other instruments of transfer and conveyance, certificates of title, documents  and other instruments of transfer and conveyance, duly executed by the Seller Group, including assignments of all Transferred Intellectual Property and separate assignments of all registered marks, internet domain names, patents and copyrights, duly executed by Buyer;
 
(d)               the Seller’s Promissory Note;
 
(e)               the Bank Guarantee, to the extent required pursuant to Section 3.1 above; and
 
(f)                such other documents, instruments and certificates as may be required, in the reasonable opinion of Seller's Representative, to effect and consummate the Acquisition, which documents, instruments and certificates shall be attached to this Agreement.
 
4.2.3.                The Parties shall duly execute, deliver and exchange, to the extent agreed by the Parties prior to the Closing, each of  the General Assignment, Assumption and Bill of Sale, the OTI IP License Agreement, the Magna License Agreement and the Supply Agreement.  In addition the Parties shall duly execute, deliver and exchange the Escrow Agreement, to the extent an Escrow Amount is required to be deposited with the Escrow Agent at the Closing under this Agreement and provided that the form of the Escrow Agreement is agreed by the Parties prior to the Closing.
 
4.2.4.                Buyer shall pay to Seller, in immediately available funds transferred by wire transfer to Seller’s bank account designated by Seller to Buyer, in writing, at least five (5) Business Days prior to the Closing Date, the cash amounts payable at Closing in accordance with Section 3 above, as adjusted for the Adjustment Amount, in accordance with Section 7.2.1 less : (i) the amount of the Advance Balances; and (ii) the Escrow Amount, to the extent the Escrow Amount is required to be deposited under this Agreement and the Escrow Agreement is executed at the Closing, in which case the Escrow Amount shall be so deposited by the Buyer with the Escrow Agent at the Closing.
 
4.3.      Termination of Prior Agreement . Subject to and effective immediately upon the Closing, all service and supply agreements between Seller and Buyer shall terminate in its entirety and be of no further force or effect, including, without limitation the Service and Supply Agreement between the Parties dated as of December 31, 2006.
 
REPRESENTATIONS AND WARRANTIES OF THE SELLER.

Except as disclosed by Seller in the disclosure schedule that Seller shall provide to Buyer by the Disclosure Schedule Delivery Date pursuant to Section 7.1.1 below(the “ Seller Disclosure Schedule ”), Seller hereby represents and warrants to Buyer that the statements contained in this Section 5 are true, complete and accurate as of the date of this Agreement and, in all material respects, as of the Closing Date, subject to the contents of the Seller’s Closing Certificate.
 
 
20

 
 
5.1.       Organization and Qualification of Seller and the Seller Subsidiaries .  Seller is a corporation duly organized and validly existing under the Laws of the State of Israel. Each of the Seller Subsidiaries is a corporation duly organized and validly existing under the Laws of its place of incorporation as further detailed in Part 5.1 of the Disclosure Schedule.  Seller and each of the Seller Subsidiaries has all requisite power and authority to own, lease and operate its properties and to carry on its business as it is now being conducted and as contemplated to be conducted. The Seller Group has at all times carried on the Business in accordance with its Organizational Documents and in in all material respects under all applicable Laws. Seller Group is not in a material violation or default with respect to any Law or Permit which could have a Material Adverse Effect upon the Acquisition, the Business, the Acquired Assets or the Assumed Liabilities.
 
The Seller Group is duly qualified to conduct the Business and is in good standing in each jurisdiction in which it currently conducts the Business.
 
5.2.       Authorization; Binding Obligation .
 
5.2.1.                Subject to the fulfillment of all of the Conditions Precedent contained in Section 8.1, the Seller Group has all necessary power and authority to execute and deliver this Agreement, and each Transaction Document required to be executed and delivered by it pursuant to this Agreement, and to perform its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby.  The execution and delivery by Seller of this Agreement and each Transaction Document required to be executed and delivered by it pursuant to this Agreement, the performance of its obligations hereunder and thereunder, and the consummation by Seller of the transactions contemplated hereby and thereby, have been duly and validly authorized by all required corporate action on the part of Seller, and no other corporate proceedings on the part of Seller are necessary to authorize this Agreement or any such Transaction Document or on the part of Seller Group to consummate the transactions contemplated herein and therein.  This Agreement has been, and each of the Transaction Documents required to be executed and delivered by it pursuant to this Agreement, when executed and delivered by Seller, will be, duly and validly executed and delivered by Seller, and this Agreement constitutes, and each such Transaction Document, when executed and delivered, will constitute, a legal, valid and binding obligation of Seller enforceable against Seller in accordance with their terms.  There is no outstanding Order binding on the Seller Group, and Seller Group is not a party to or bound by any agreement, restricting the transfer or sale of any of the Acquired Assets or the free and unhindered use of the Acquired Assets by the Buyer after the Closing.
 
5.3.       Consents and Approvals for Transaction .  The execution and delivery by Seller of this Agreement, and each Transaction Document required to be executed and delivered by it pursuant to this Agreement, do not, and the performance of the foregoing shall not, require Seller to obtain any Approval of any Person or Governmental Authority, or make any filing with or notification to, any Governmental Authority, except as set forth in Part 5.3 of the Seller Disclosure Schedule.
 
5.4.       No Violation .  Except as set forth in Part 5.4 of the Seller Disclosure Schedule, the execution and delivery by Seller of this Agreement, and each Transaction Document required to be executed and delivered by it pursuant to this Agreement, do not, and the performance and consummation of this Agreement, and each Transaction Document required to be executed and delivered by the Seller Group  pursuant to this Agreement, will not: (a) conflict with or violate the Organizational Documents of the Seller Group, (b) to Seller's knowledge, conflict with or violate any Law applicable to Seller Group or by which its properties are bound or affected, (c) to Seller's knowledge, result in any breach or violation of, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, any Contract of the Seller Group or by which Seller Group  is bound; which conflict, violation, breach or default is likely to affect the transactions contemplated hereby or Seller's ability to fulfill its obligations under this Agreement or any Transaction Document required to be executed and delivered by Seller pursuant to this Agreement; (d) result in any violation of, or conflict with, or constitute a default under any term of, or result in the creation or enforcement of any Lien upon any of the Acquired Assets (except for Permitted Liens); or (e) result in a Material Adverse Effect.
 
 
21

 
 
5.5.       Business Approvals . Except as set forth in Part 5.5 of the Seller Disclosure Schedule: (i) the Seller Group, has all Approvals that are materially required for the conduct the Business, (ii) each such Approval is valid and in full force and effect, and (iii)  Seller Group has materially complied with all such Approvals, and (iv) to Seller's knowledge, there is no event that has occurred or circumstances that exist, that may constitute or result in a violation of, or in the revocation, withdrawal or suspension or modification of, any of such Approvals. There is no Action pending or to Seller's knowledge, threatened that could result in the termination, revocation, limitation, suspension, restriction or impairment of any Approval that is required for the conduct the Business, or the imposition of any fine, penalty or other sanctions for violation of any legal or regulatory requirements relating to any such Approval.
 
5.6.      Absence of Certain Events .  Except as set forth in Part 5.6 of the Seller Disclosure Schedule, since December 31, 2012, Seller Group has conducted the Business in the ordinary and usual course and has used commercially reasonable efforts to preserve intact its business organization and properties, to keep available the services of the present officers, employees, consultants and independent contractors of Seller Group, and to preserve the present relationships of Seller Group with suppliers, customers, and other Persons with which Seller Group has business relations. Without derogating from the generality of the preceding sentence, except as set forth in Part 5.6 of the Seller Disclosure Schedule, since December 31, 2012:
 
5.6.1.                Seller has not authorized or consummated any merger, consolidation, sale or other disposition of all or substantially all of the Acquired Assets,
 
5.6.2.                there has not been any other event or circumstance which has had or could reasonably be expected to have, a Material Adverse Effect on the Business, the Acquired Assets or the Assumed Liabilities;
 
5.6.3.                there has not been any damage to or destruction or loss of any asset or property comprising part of the Business, of an aggregate amount of more than US$500,000 (Five Hundred Thousand Dollars), whether or not covered by insurance, materially and adversely affecting the Business, the Acquired Assets or the Assumed Liabilities.
 
5.6.4.                there has not been any agreements or undertaking by the Seller Group to do any of the foregoing.
 
 
22

 
 
5.7.       Title to Acquired Assets .
 
5.7.1.                Except for a minority shareholding by a third party in Otignia LLP and a minority shareholding by an Affiliate of Seller in OTI Tanzania Ltd., the Seller Group is the sole and exclusive legal and equitable or beneficial owner of, and has good, free and clear, and marketable title to or is the rightful licensee with right of assignment transfer or sublicense of, all of the Acquired Assets, free and clear of all Liens, except for Permitted Liens, subject to the Approval of counterparties to the Assigned Contracts whose consent is required for the assignment by the Seller to the Buyer of such Assigned Contracts.  Seller has the necessary and sufficient  authority and capacity to sell, transfer, assign, convey and deliver the Acquired Assets that will be transferred to the Buyer by it free and clear of all Liens (except for Permitted Liens), subject to the aforesaid consents of counterparties to Assigned Contracts.
 
5.7.2.                The Acquired Assets, together with the Licensed Intellectual Property:  (a) constitute all assets used in or held for use in the Business and are sufficient for the conduct of the Business as presently conducted; and (b) include all of the operating assets relating solely to the Business.
 
5.8.      Assigned Contracts .
 
5.8.1.                The Seller Disclosure Schedule lists all of the Assigned Contracts. Each Assigned Contract is a legal, valid and binding obligation of the parties thereto and in full force and effect. The Seller Group is in compliance therewith, in all material respects. To the Seller’s knowledge, none of the other parties thereto is in default thereunder, nor has any Assigned Contract been cancelled by the other party; and the Seller is not in receipt of any claim of default by the Seller under any Assigned Contracts.
 
5.8.2.                The Seller Group has, or will have up to the Disclosure Schedule Delivery Date, furnished to the Buyer true, correct, and complete copies (or where oral, written descriptions containing all material terms) of the Assigned Contracts and will list them on Part 5.8 of the Seller Disclosure Schedule.

5.8.3.                Except as set forth in Seller's Disclosure Schedule, no party to an Assigned Contract has made a claim to the effect that the Seller Group has failed to perform an obligation thereunder, nor has any such party notified the Seller Group of an intention to make such claim or materially modify or terminate or, if applicable, not renew any such Assigned Contracts.

5.8.4.                Except as set forth in Seller's Disclosure Schedule and except as may be set out within the terms of the Assigned Contracts, there are no material renegotiations of, attempts to materially renegotiate or outstanding rights to renegotiate any material amounts paid or payable to the Seller or the Seller Subsidiaries under current or completed Assigned Contracts with any Person having the contractual or statutory right to demand or require such renegotiation and no such Person has made written demand for such renegotiation.

5.8.5.                Other than the Assigned Contracts, there are no material agreements, contracts or arrangements in effect relating to the Acquired Assets or the Business.
 
 
23

 

5.8.6.                Other than as set forth in Part 5.8.6 of the Seller Disclosure Schedule, the Seller Group has not received any advance payment on account of the consideration or compensation due and payable to the Seller Group pursuant to any Assigned Contracts. Part 5.8.6 of the Seller Disclosure Schedule lists, with respect to each item the description of the applicable Assigned Contract, the amount of advance payment received by the Seller Group in connection therewith, the terms for repayment to the relevant customer of such advance payment and the outstanding balance due and owing by the Seller Group on account of such advance payment (the "Advance Balances" ).
 
5.9.      Intellectual Property.
 
5.9.1.                The Transferred Intellectual Property is described in Part 5.9.1 of the Disclosure Schedule, including a full and accurate list of all registrations and applications for registration of Intellectual Property and renfewals thereof, the applicable jurisdiction, registration number (or application number) and date issued (or date filed). The Seller Group is the true, lawful, and sole and exclusive owner of the Transferred Intellectual Property and has valid and marketable title in and to all of the Transferred Intellectual Property, free and clear of any Liens. To Seller’s knowledge, the Transferred Intellectual Property does not infringe any enforceable patent or other Intellectual Property of any other Person. The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby will not breach, violate or conflict with any instrument or agreement governing any of the Transferred Intellectual Property. There are no overdue registration, maintenance, renewal or any other fees in connection with each item of the Transferred Intellectual Property, and all material documents and certificates required to be filed under the Law where such Transferred Intellectual Property is registered, have been filed with the relevant authorities.
 
5.9.2.                All of the software underlying the Transferred Intellectual Property is owned or duly licensed by the Seller Group (and if licensed, then freely transferable to the Buyer without any liabilities or obligations to the licensor).
 
5.9.3.                Except as set forth in the Seller Disclosure Schedule: (a) the Seller Group has not licensed-in any Transferred Intellectual Property from any third party for use by the Seller Group in connection with the Acquired Assets or the Business (excluding off the shelf software which was not incorporated into the Products); (b) Seller Group has not used modified, distributed, or embedded into or otherwise combined with its products any open source software; and (c) the Seller has not deposited any Transferred Intellectual Property in escrow for the benefit of any third party.
 
5.9.4.                Except as set forth in the Seller Disclosure Schedule and except for licenses granted in the ordinary course to customers of the Business under Assigned Contracts, the Seller Group has not granted any license of any Transferred Intellectual Property to any third party.
 
5.9.5.                Except for payment of fees with respect to off-the-shelf licenses or off-the-shelf software, and except as set out in the terms of any Assigned Contract, the Seller Group owns, or has the right to use, all of the Transferred Intellectual Property required for the operation of the Acquired Assets and the Business as currently conducted, without payment of a royalty to any third party.
 
 
24

 
 
5.9.6.                There is no pending or, to Seller's knowledge, threatened Claim against the Seller Group or litigation contesting the validity, ownership or right to use, sell, license or dispose of any of the Transferred Intellectual Property.  None of the Seller Group has received any notice from any third party alleging their infringement, misappropriation or misuse of the Intellectual Property rights of any third party. Except as set out in the the Seller Disclosure Schedule, none of the Products have been developed upon the basis of any Intellectual Property of any third party, including on the basis of specifications of any customers, and none of the customers of the Business have any rights whatsoever to any Transferred Intellectual Property.
 
5.9.7.                No former or present employees, consultants, officers, directors of the Seller Group owns, directly or indirectly, or has any other right or interest in, in whole or in part, any of the Transferred Intellectual Property. Each developer, inventor or other contributor to the Transferred Intellectual Property and each current and former employee of, or consultant to the Seller, has signed a proprietary information and inventions assignment agreement protecting Seller's rights in the Transferred Intellectual Property. With the exception of Transferred Employees who may have previously been in the employ of Buyer, the Seller Group does not make or use nor has it made any use of, any invention or other creation of any of the Transferred Employees or any employee or consultant of the Seller Group, made by such person prior to such person's employment or engagement by the Seller Group.
 
5.9.8.                The consummation of the Acquisition will not result in the loss or impairment of the Buyer’s right to own or use any item of the Transferred Intellectual Property.
 
5.10.     Employees .
 
5.10.1.              The Seller Disclosure Schedule lists all of the Potential Transferred Employees and shows all benefits payable or which the Seller Group are bound to provide (whether now or in the future) thereto, including without limitation the names, the commencement  date of their employment, current compensation levels (including salaries, bonuses, incentives, commissions, and deferred compensation), share options, pensions (including those required by all applicable Laws), retirement benefits, company cars, profit sharing, any interests in any incentive compensation plan, accrued severance pay, contributions to pension scheme unused accrued vacation, and job titles of all the Potential Transferring Employees as they are as at the Signing Date.
 
5.10.2.              Except to the extent stated otherwise in the Seller Disclosure Schedule, all past and present employees, consultants, service providers, officers, and directors of the Seller that are or were engaged in the Business are parties to a written agreement, under which each such person or entity (i) is obligated to disclose and transfer to the Seller, all inventions, developments and discoveries which, during the period of employment with or performance of services for the Seller he or she makes or conceives of either solely or jointly with others, that directly relate to the Business, and (ii) is obligated to maintain the confidentiality of proprietary information of the Seller.
 
 
25

 
 
5.10.3.              The Seller has delivered not later than by the Disclosure Schedule Delivery Date to the Buyer true and complete copies of all existing written agreements with the Transferred Employees.
 
5.10.4.              To the Seller's knowledge, Seller has complied in all material respects with all contractual requirements and the requirements of any applicable Law relating to the Potential Transferred Employees and has made all deductions and payments to the Income Tax Authorities and the National Insurance Institute required to be made by Law or under their respective employment agreements, the Seller's policies and practices and applicable Laws, collective bargaining agreements, extension orders and other legislation, to the extent applicable, including without limitation with regard to salaries, social benefits, insurances, pensions, expenses, health schemes, bonuses, vacations, sick leave and hours of work.
 
5.10.5.              Except to the extent stated otherwise in the Seller Disclosure Schedule, Seller did not receive notice from any Potential Transferred Employee of his or her current intention to terminate their employment with Seller, nor does Seller have a present intention to terminate any of the foregoing.
 
5.10.6.              Seller is not a member of any Employers' Union and there is no current union organizing activity among any of the Potential Transferred Employees or any union representative petition pending or threatened. Seller is not a party to any pending or, to the Seller’s knowledge, threatened, labor dispute, including any strike, work stoppage, or work slowdown with any Potential Transferred Employee. There are no claims pending, or to the Seller’s knowledge, threatened to be brought, in any governmental forum by any Potential Transferred Employee for compensation, pending severance benefits, vacation time or pay, pension benefits, claims for employment discrimination, harassment, unfair labor practices, grievances, wrongful discharge, or otherwise.
 
5.10.7.              All sums and deductions required to be made by the Seller, with respect to the Transferred Employees on account of employee health and welfare insurance, severance pay, managers’ insurance, study funds, vacation pay and similar payments, whether due under the terms of any agreement or by Law owing up to the Signing Date, will have been paid in full by the Closing Date.
 
5.10.8.              Except as set forth in Part 5.10.8 of the Disclosure Schedule, there are no agreements between the Seller and any of the Potential Transferred Employees which, subject to any termination procedure prescribed by Law, cannot be terminated by the Seller with up to 30-days’ notice.
 
5.11.     Accounts Receivable .
 
The Seller Disclosure Schedule sets out a true and complete list of all Accounts Receivable as of the Signing Date.
 
5.12.     Taxes .
 
5.12.1.              All Taxes for which the Seller Group is liable with respect to the Business and the Acquired Assets up to the Signing Date (including with respect to their transfer and sale to the Buyer hereunder and including, without limitation, any income, social security, unemployment insurance, worker’s compensation premiums, withholding, sales, use, excise, franchise and other Taxes, any deposits required to be made with respect thereto, and all penalties and interest charges thereon, have been or will be paid by the Seller  Group within the period required for such payment by applicable Law. The Seller Group has duly filed (or will file within the period required for such filing under applicable Law) all returns and reports of Taxes required to be filed prior to such date with respect to the Business and Acquired Assets, and all such returns and reports are (or will be) true and correct in all material respects. There are no Liens for Taxes on any of the Acquired Assets, the Business and the Assigned Contracts.
 
 
26

 

5.12.2.              There is no dispute with any Tax authority in in any jurisdiction in which the Seller Subsidiaries are registered. The Seller is not aware of any circumstances in connection with the Acquisition which will give rise to any dispute with any relevant Tax authority in relation to the Business or the Acquired Assets, which may be imposed on the Buyer.

5.12.3.              All Taxes that the Seller Group is or was required by Law to withhold, deduct or collect in the conduct of the Business have been duly withheld, deducted and collected and, to the extent required, have been paid to the proper Governmental Authority.

5.12.4.              There is no tax sharing agreement, tax allocation agreement, tax indemnity obligation or similar written or unwritten agreement, arrangement, understanding or practice with respect to Taxes (including any advance pricing agreement, closing agreement or other arrangement relating to Taxes) that will require any payment by the Buyer.

5.12.5.              The Seller Group has not made, prepared or filed any elections, designations or similar filings relating to Taxes or entered into any agreement or other arrangement in respect of Taxes or tax returns that has effect for any period ending after the Signing Date, in connection with the Business or the Acquired Assets.

5.12.6.              The Seller Group did not sign an agreement with any Tax authority or received any ruling or decision from any Tax authority in connection with the Acquired Assets, the Business or the Acquisition.
 
5.13.     Assumptions or Guaranties of Indebtedness of Other Persons. Seller has not assumed, guaranteed, endorsed or otherwise become directly or contingently liable for (including, without limitation, liability by way of agreement, contingent or otherwise, to purchase, to provide funds for payment, to supply funds to or otherwise to invest in the debtor or otherwise to assure the creditor against loss) any Indebtedness of any other Person which are or could become a Lien against or otherwise have an adverse effect on any of the Acquired Assets or their use by Buyer.
 
5.14.     Compliance with Laws .  To Seller's knowledge, except as set forth in Seller Disclosure Schedule, Seller has not violated any Law applicable to the Business or any of the Acquired Assets in any material respects.
 
 
27

 

The Seller Group did not receive notice or other communication (whether oral or written) from any Governmental Authority regarding (i) any actual, alleged, possible or potential violation of, or failure to comply with, any Law or Governmental Authorization held or not held by the Seller Group in relation to the Business or the Acquired Assets; or (ii) any actual, alleged, possible or potential obligation on the part of the Seller Group to undertake, or to bear all or any portion of the cost of, any remedial action of any nature, or any actual, proposed, possible or potential revocation, withdrawal, suspension, cancellation, termination of or modification to any Governmental Authorization.
 
5.15.     Legal Proceedings .
 
5.15.1.              Except as set forth in Seller Disclosure Schedule, there is no Action, including oppositions to Intellectual Property registration, pending or, to the knowledge of Seller, threatened by or against the Seller Group, or any of their officers, directors or employees (in such capacity) relating to, or which could reasonably be expected to affect, the Business, the Acquired Assets, the Assumed Liabilities, or the transactions contemplated by this Agreement and by any Transaction Document required to be executed hereunder.

5.15.2.              The Seller Group is not subject to any Order or investigation by Governmental Authority that has a Material Adverse Effect on the Business, the Acquired Assets, or the Assumed Liabilities.
 
5.16.     Interested Party Transactions .
 
Except as set forth in the Seller Disclosure Schedule, no  related Person, officer, director or shareholder (direct or indirect) of the Seller Group, or any family member thereof, is a party to any Assigned Contact or has or has had, directly or indirectly, (a) an interest in any Person which: (i) furnishes or sells services or products which are furnished or sold, or are proposed to be furnished or sold by the Seller Group as part of the Business, or (ii) purchases from or sells or furnishes to the Seller Group any goods or services as part of the Business, or (b) as of the Closing Date a beneficial interest in the Business, any Assigned Contract or the Acquired Assets.
 
5.17.     No Bankruptcy Event & Insolvency .
 
No insolvency proceeding of any kind or Order or application has been made or resolution passed, during the two years immediately preceding the Signing Date, for the winding up of the Seller Group or for the appointment of a liquidator to the Seller Group or for an administration order in respect of the Seller or the Seller Subsidiaries. No receiver, trustee or administrator has been appointed of the whole or part of the Seller Group's business or assets during the two years immediately preceding the Signing Date nor has the Seller Group applied or consented for such appointment. No voluntary arrangement has been proposed in respect of the Seller Group during the two years immediately preceding the Signing Date,. No compromise or arrangement with creditors has been proposed, agreed to or sanctioned in respect of the Seller Group during the two years immediately preceding the Signing Date. The Seller Group is not insolvent or unable to pay its debts, has not stopped paying its debts as they fall due or has admitted its inability to pay its debts. There is no unsatisfied Order outstanding against the Seller Group in relation to the Business.  The Seller Group has not, during the two years immediately preceding the Signing Date, suffered any equivalent or analogous proceedings or Orders to any of those described in this Section 5.17 under the law of any jurisdiction in which it carries on the Business or has an asset that is part of the Acquired Assets.
 
 
28

 
 
5.18.     No Brokers .  Seller has not employed or engaged, either directly or indirectly, or incurred or will incur any Liability to, any broker, finder, investment banker or other agent in connection with the transactions contemplated by this Agreement.
 
5.19.     Carve-Out Financial Statements
 
5.19.1.              The Carve-Out Financial Statements will be substantially in accordance with the Books and Records of the Seller Group as they relate directly and solely to the Business and will be complete and correct in all material respects as of December 31, 2012. The Carve-Out Financial Statements will present a true, complete and fair view of the state of affairs, financial position, assets and Liabilities of the Seller Group as they relate directly and solely to the Business as of December 31, 2012, in all material respects.

5.19.2.              As of as of December 31, 2012, there were no material Liabilities, claims, or obligations of any nature directly and solely related to the Business, whether accrued, absolute, contingent, anticipated, or otherwise, whether due or to become due, that will not be shown or provided for in the Carve-out Financial Statements. Except to the extent noted otherwise in the Carve-out Financial Statements, the Liabilities of the Seller Group as they relate directly and solely to the Business and as detailed in the Carve-Out Financial Statements, were incurred in the ordinary course of business.
 
5.19.3.              The Closing Balance Sheet will be substantially in accordance with the Books and Records of the Seller Group as they relate directly and solely to the Business and will be complete and correct in all material respects as of the Signing Date. The Closing Balance Sheet will present a true, complete and fair view of the state of affairs, financial position, assets and Liabilities of the Seller Group as they relate directly and solely to the Business as of the Signing Date, in all material respects.

5.19.4.               As of the Signing Date, there were no material Liabilities, claims, or obligations of any nature directly and solely related to the Business, whether accrued, absolute, contingent, anticipated, or otherwise, whether due or to become due, that will not be shown or provided for in the Closing Balance Sheet. Except to the extent noted otherwise in the Closing Balance Sheet, the Liabilities of the Seller Group as they relate directly and solely to the Business and as detailed in the Closing Balance Sheet, were incurred in the ordinary course of business.
 
 
29

 
 
5.20.     Business Books and Records
 
The Business Books and Records of Seller Group as they relate directly and solely to the Business, all of which will be made available to Buyer by the Disclosure Schedule Delivery Date, will be complete and correct in all material respects and represent actual, bona fide and arm's length transactions relating to the Business, and have been maintained in accordance with sound business practices of the Business.
 
5.21.     Assigned Real Property

5.21.1.              The Seller will make available to the Buyer, by the Disclosure Schedule Delivery Date, a correct and complete copy of the property lease agreement, together with all amendments, modifications or supplements thereto, relating to the real property leased by OTI Panama S.A. (the “ Real Property ”).

5.21.2.              OTI Panama S.A. has valid and enforceable leasehold interests over the Real Property. The Real Property lease is in full force and effect, and OTI Panama S.A. has not received or given any notice of any default or event that with notice or lapse of time, or both, would constitute a default or breach by OTI Panama S.A. under the Real Property lease and, to the Seller’s knowledge, no other party is in breach or default thereof, and no party to the Real Property lease has exercised any termination rights with respect thereto.

5.21.3.              The Real Property is the only real property leased by the Seller’s Subsidiaries.
 
5.22.     Tangible Property
 
The Seller Group has sole, good and marketable title to all of the items of Tangible Property as reflected in the Carve-Out Financial Statements (except as sold or disposed of subsequent to the date thereof in the ordinary course of business), free and clear of any and all Liens except for Permitted Liens. All such items of Tangible Property which, individually or in the aggregate, are material to the operation of the Business are in good operating condition and in a good state of maintenance and repair (ordinary wear and tear excepted) and are suitable for the purposes used.
 
5.23.     Inventories
 
5.24.    Part 5.24 of the Disclosure Schedule sets forth a complete list of all Inventories of the Seller Group related directly and solely to the Business as of Signing Date, including details of the cost and quantity and production completion percentage (in the production process of the Seller Group) of each item of all such Inventories as of the Signing Date.
 
5.25.    All items included in the Inventories of the Seller Group related to the Business consist of a quality and quantity usable and, with respect to finished goods, saleable, in the ordinary course of business of the Seller Group except for obsolete items and items of below-standard quality, all of which have been written off or written down to net realizable value in the Carve-Out Financial Statements or on the Books and Records of the Seller Group as of the Signing Date, as the case may be.
 
 
30

 
 
5.26.     Incentives and Benefits
 
The Seller Group has not received any grants, incentives and subsidies from,, and has no outstanding applications (pending, outstanding, or otherwise) therefor to, any Governmental Authorities (including without limitation, foreign governmental or administrative agencies), granted to the Seller Group, in relation solely to the Acquired Assets and the Business.
 
5.27.     Health, Safety and Environment
 
5.27.1.              The Acquired Assets have not been the subject of any environment, health and safety (" EH&S ") audit or any evaluation, assessment, study or test, nor has Seller received any notification from any Governmental Authority of any violation of any EH&S-related Law in connection with the Acquired Assets or the Business.
 
5.27.2.              Neither the Seller Group nor anyone acting on their behalf has stored, treated, discharged, transported or disposed of any Hazardous Substance other than in a safe manner in accordance with applicable law.
 
5.28.     Disclosure .
 
Neither this Agreement (including the exhibits and schedules hereto) nor any other Transaction Document required to be executed by Seller hereunder, contains or will contain any untrue statement of a material fact or omits or will omit to state a material fact necessary in order to make the statements contained herein or therein not misleading in light of the circumstances under which they were made or necessary to provide a prospective buyer of the Business, the Acquired Assets or the Assumed Liabilities with all information material thereto.
 
6.
REPRESENTATIONS AND WARRANTIES OF BUYER.

Buyer hereby represents and warrants to Seller that the statements contained in this Section 6 are complete and accurate as of the date of this Agreement.
 
6.1.       Organization and Qualification of Buyer .  Buyer is a corporation duly organized and validly existing under the Laws of the State of Israel. Buyer has all requisite power and authority to own, lease and operate its properties and to carry on its business as it is now being conducted.
 
6.2.       Authorization; Binding Obligation . Subject to the fulfillment of all of the Conditions Precedent contained in Section 8.1, Buyer has all necessary power and authority to execute and deliver this Agreement, and each Transaction Document required to be executed and delivered by it pursuant to this Agreement, and to perform its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby.  The execution and delivery by Buyer of this Agreement and each Transaction Document required to be executed and delivered by it pursuant to this Agreement, the performance of its obligations hereunder and thereunder, and the consummation by Buyer of the transactions contemplated hereby and thereby, have been duly and validly authorized by all required corporate action on the part of Buyer, and no other corporate proceedings on the part of Buyer are necessary to authorize this Agreement or any such Transaction Document or to consummate the transactions so contemplated herein and therein.  This Agreement has been, and each of the Transaction Documents required to be executed and delivered by Buyer pursuant to this Agreement, when executed and delivered, will be, duly and validly executed and delivered by Buyer, and this Agreement constitutes, and each such Transaction Document, when executed and delivered, will constitute, a legal, valid and binding obligation of Buyer, enforceable against it in accordance with its terms.
 
 
31

 
 
6.3.       Consents and Approvals .  The execution and delivery by Buyer of this Agreement, and of each Transaction Document required to be executed and delivered by it pursuant to this Agreement, do not, and the performance of the foregoing shall not, require Buyer to obtain the Approval of any Person or Governmental Authority, or make any filing with or notification to, any Governmental Authority.
 
6.4.       No Violation .  To the knowledge Buyer, and subject to receipt of all Approvals and Governmental Authorizations to be delivered by Seller to Buyer pursuant to this Agreement, the execution and delivery by Buyer of this Agreement and of each Transaction Document required to be executed and delivered by it pursuant to this Agreement, do not, and the performance of this Agreement, and each Transaction Document required to be executed and delivered by it pursuant to this Agreement, will not, (a) conflict with or violate the Organizational Documents of Buyer, (b) conflict with or violate any Law applicable to Buyer, or by which its properties are bound or affected, or (c) result in any breach or violation of, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, any Contract to which Buyer is a party or by which it is bound; which conflict, violation, breach or default is likely to affect the transactions contemplated hereby or Buyer's ability to fulfill its obligations under this Agreement or any Transaction Document required to be executed and delivered by it pursuant to this Agreement.
 
6.5.       Litigation .  There is no Action pending, or to the knowledge of Buyer, currently threatened against Buyer, that questions the validity of this Agreement or any of the Transaction Documents required to be executed by Buyer pursuant to this Agreement, or the right of Buyer to enter into this Agreement or any of the Transaction Documents required to be executed by Buyer pursuant to this Agreement, or to consummate the transactions contemplated hereby or thereby.
 
6.6.       Financing and Capital Resources . At the Closing, Buyer shall have adequate cash on its balance sheet or borrowing capacity facilities to pay that amount of Purchase Price payable at the Closing under Section 3.1 above, together with all fees and expenses of Buyer associated with the transactions contemplated hereby, and to make any other payments necessary to consummate the Acquisition in accordance with the terms of this Agreement.
 
6.7.       No Brokers . Buyer has not employed or engaged, either directly or indirectly, or incurred or will incur any Liability to, any broker, finder, investment banker or other agent in connection with the transactions contemplated by this Agreement.
 
6.8.       Disclosure of Information; No Further Representations . Except for the representations and warranties expressly set forth in Section 5, Seller has not made any further representations or warranties with respect to any subject matter of this Agreement, and the Acquired Assets shall be sold, transferred and assigned to, and the Assumed Liabilities shall be assumed by, Buyer, without any further representation, warranty or guarantee whether express, implied or statutory on the part of Seller or any representatives thereof.
 
 
32

 

7.
COVENANTS.
 
7.1.       Access to Information; Due Diligence .
 
7.1.1.                The Parties agree and acknowledge that Buyer shall first receive a copy of the Seller Disclosure Schedule not later than 30 days following the Signing Date (the date in which a full copy of Seller Disclosure Schedule is actually delivered to Buyer shall be referred to herein as the "Disclosure Schedule Delivery Date" ).  By no later than the Disclosure Schedule Delivery Date Seller shall provide Buyer access to or deliver to Buyer copies of, substantially all the Books and Records of the Business.
 
7.1.2.                Subject to applicable Law, any applicable Order and the execution of the Non-Disclosure Agreement (which Buyer and Seller shall execute simultaneously with its execution of this Agreement) Seller shall afford certain representatives, officers and employees of Buyer, as well as its legal advisors and accountants, throughout the Interim Period, to make such investigation of the Business, including examination of the Business Books and Records as the Buyer reasonably requests and to make extracts and copies of the foregoing for the sole purpose of Buyer conducting a due diligence review of the Business, the Acquired Assets and the Assumed Liabilities (the “ Due Diligence Review ”). Buyer's Due Diligence Review shall be conducted during normal working hours and with Seller's reasonable cooperation, provided that Buyer's access to Seller's officers and employees and customers of the Business shall be limited as instructed by Seller's CEO and any meetings with same shall be coordinated in advance with Seller's CEO.
 
7.1.3.                No investigation by the Buyer prior to or after the Signing Date shall diminish or obviate any of the representations, warranties, or covenants of Seller contained in this Agreement or any other Transaction Documents, as may be updated by the Seller’s Closing Certificate.
 
7.1.4.                 If at any time prior to the Closing Date Buyer reveals the existence of any of the issues listed in Schedule 7.1.4 (each, a “ Major Issue ”), it shall promptly notify Seller thereof, providing full details including copies of all relevant documentation supporting the existence of the Major Issue (a " Major Issue Notice ").
 
 
33

 
 
7.2.       Conduct of Business by Seller Group during the Interim Period .
 
7.2.1.                Subject to the consummation of the Closing, the rights, benefits, risks and Liabilities associated with the Business, including those attached to the Acquired Assets and Assumed Liabilities, shall be deemed to be those of the Buyer, effective as of the Signing Date.  At the Closing, Seller shall deliver to Buyer a report (the “ Adjustment Report ”), certified by Seller’s CFO, relating solely to Business during the Interim Period, which Adjustment Report shall reflect:
 
(i)                     the profit & loss results relating to the Business during the Interim Period;
 
plus
 
(ii)                    the value on the Books and Records of the Seller of the Business-related inventory as at the Signing Date less the value of the Business-related inventory as at the Closing Date.
 
The Purchase Price shall be adjusted by the result reflected in the Interim Report (the “ Adjustment Amount ”).  To the extent the Adjustment Amount is negative, Buyer shall add such negative amount to the cash portion of the Purchase Price payable to Seller at the Closing. If the Adjustment Amount is positive, Buyer shall reduce the cash portion of the Purchase Price payable to Seller at the Closing by such positive amount.
 
7.2.2.                Seller covenants and agrees that, during the Interim Period, the Seller Group shall conduct the Business in the ordinary course consistent with past practice, in all material respects and shall use commercially reasonable efforts to preserve intact, the present relationships of Seller Group with suppliers, customers, and other Persons with which Seller Group have business relations related to the Business.
 
7.2.3.                Without derogating from the generality of the preceding Section 7.2.1, during the Interim Period, except as required by this Agreement or to the extent not resulting in a Material Adverse Effect, the Seller Group shall:
 
7.2.3.1.                     use commercially reasonable efforts to preserve the Acquired Assets intact and to maintain the Acquired Assets in a state of repair and condition that complies with applicable Law and is consistent with the requirements and normal conduct of the Business, subject to normal wear and tear and, at all times in the ordinary course consistent with past practice, in all material respects;
 
7.2.3.2.                     maintain existing insurance coverage which each of the Seller and the Seller Subsidiaries maintains as of the date hereof;
 
7.2.3.3.                     use commercially reasonable efforts to perform its obligations under the Assigned Contracts and Permits, in the ordinary course consistent with past practice, in all material respects;
 
7.2.3.4.                     use commercially reasonable efforts to comply with all requirements of the Law, in the ordinary course consistent with past practice, in all material respects;
 
7.2.3.5.                     use commercially reasonable efforts to perform all actions necessary to maintain existing rights in the Transferred Intellectual Property, in the ordinary course consistent with past practice, in all material respects;
 
7.2.3.6.                     report periodically to the Buyer concerning the status of the Business, operations and finances;
 
 
34

 
 
7.2.3.7.                     keep in full force and effect, without amendment, all material rights relating to the Business; and
 
7.2.3.8.                     reasonably cooperate with Buyer and assist Buyer in identifying the Governmental Authorizations required by Buyer to operate the Business from and after the Closing Date.
 
7.2.4.               Without derogating from the generality of the preceding Section 7.2.1, during the Interim Period, except as required by this Agreement or to the extent not resulting in a Material Adverse Effect, the Seller Group shall not, without Buyer’s prior written consent:
 
7.2.4.1.                     authorize or consummate any merger, consolidation, sale or other disposition of any or all of the Acquired Assets, except in the ordinary and usual course of business, or issue or sell any shares, stock, options or other securities in any of the Seller Subsidiaries;
 
7.2.4.2.                     enter into any Contracts which would reasonably be expected to result in a Material Adverse Affect on the Acquired Assets or the Business;
 
7.2.4.3.                     change its practices with respect to billing customers of the Business, extending credit to customers of the Business, collecting Accounts Receivable relating to the Business, paying Accounts Payable relating to the Business or otherwise discharging its Liabilities relating to the Business;
 
7.2.4.4.                     enter into any financing arrangement or incur, increase or Guarantee any Indebtedness, all pertaining solely to the Business, except accounts payable in the ordinary course of business;
 
7.2.4.5.                     waive any right, forgive any debt or release any claim relating to the Business, except in the ordinary course of business;
 
7.2.4.6.                     enter into any transaction (including purchase orders) in excess of US$ 5,000 (Five Thousand United States Dollars);
 
7.2.4.7.                     enter into or be a party to any new transaction with any related party, pertaining to the Business:
 
7.2.4.8.                     take or omit to take any action that is reasonably likely to cause any of the representations and warranties of the Seller under this Agreement not to be true and correct in all material respects as of the Closing without change, or that is likely to affect the Closing;
 
7.2.4.9.                     acquire any additional assets or dispose of or agree to dispose of (or grant any option or interest in respect of) any Acquired Assets, except in the ordinary course of business; or
 
7.2.4.10.                    enter into, materially amend or terminate any Contracts pertaining to the Business (including the Assigned Contracts).
 
 
35

 
 
7.3.       No Control . Notwithstanding anything to the contrary herein, prior to the Closing Date, Seller shall exercise, consistent with and subject to the terms and conditions of this Agreement, complete control and supervision over its operations.
 
7.4.       No Default . Neither Party shall take any action that would reasonably be expected to result in the representations and warranties provided by such Party in Sections 5 and 6, respectively, becoming untrue or inaccurate in any material respect or that could materially impair the ability of the Parties to consummate the transactions contemplated hereby in accordance with the terms hereof.
 
7.5.       Cooperation; Approvals, Filings and Consents .
 
7.5.1.                Upon the terms and subject to the conditions set forth in this Agreement, each Party shall use commercially reasonable efforts to take, or cause to be taken, all actions, and do, or cause to be done, and to assist and cooperate with the other Party in doing, all things necessary, proper or advisable to consummate the transactions contemplated hereby and to satisfy or cause to be satisfied all of the Conditions Precedent that are set forth in Section 8, as applicable to each of them.  Each Party, at the reasonable request of the other Party, shall execute and deliver such other instruments and do and perform such other acts and things as may be necessary or desirable for effecting completely the consummation of this Agreement and the transactions contemplated hereby.
 
7.5.2.                Each Party shall, as promptly as practicable, use commercially reasonable  efforts to obtain all necessary Approvals (or waivers from a legal requirement to obtain Approvals) from Governmental Authorities and make all other necessary registrations and filings under applicable Law required to be obtained or made by it in connection with the authorization, execution and delivery of this Agreement and the Transaction Documents required to be executed by such Party hereunder or thereunder and the consummation of the transactions contemplated hereby and thereby.  The Parties shall, and shall cause their respective Affiliates to, act in good faith and reasonably cooperate with the each other in connection therewith and in connection with resolving any investigation or other inquiry with respect thereto. To the extent not prohibited by Law, each Party to this Agreement shall use commercially reasonable efforts to furnish to each other all information required for any application or other filing to be made pursuant to any Law in connection with the transactions contemplated by this Agreement. Each Party shall give the other party reasonable prior notice of any communication with, and any proposed understanding, undertaking, or agreement with, any Governmental Authority regarding any such Approval.
 
7.5.3.                Upon the terms and subject to the conditions set forth in this Agreement, each of the Parties agrees to use commercially reasonable efforts to take, or cause to be taken, all actions and to do, or cause to be done, and to assist and cooperate with the other parties in doing, all things necessary, proper or advisable to consummate and to make effective, in the most expeditious manner practicable, the Acquisition, including: (a) the obtaining of all necessary Approvals (or waivers from the requirement to obtain Approvals) from any Governmental Authorization and other third parties; (b) the defending of any lawsuits or other legal proceedings, whether judicial or administrative, challenging the transactions contemplated under this Agreement and the other Transaction Documents or the consummation thereof; and (c) the execution and delivery of any additional instruments necessary to consummate the Acquisition and to fully carry out the purposes of, this Agreement.
 
 
36

 
 
7.5.4.                It is hereby further agreed that the Seller and the Seller Subsidiaries, as the case may be, will bear any and all costs, expenses, penalties or fines (whether or not consensual) or other liabilities regarding the taking of the action referred to in Sections 7.5.1 - 7.5.3 (inclusive).
 
7.5.5.                Notwithstanding anything in this Agreement to the contrary, nothing contained in this Agreement (including under this Section 7.5 or under Section 8.1(a)) shall require any Party to take or agree to take any action with respect to, or agree to any prohibition or limitation on, or other requirement which would prohibit, impair or otherwise materially adversely affect the ownership or operations of all or any portion of the business or properties of such Party or any of its shareholders (including, without limitation, the Business).
 
7.6.       Public Announcements .  All announcements to third parties pertaining to this Agreement or the transactions contemplated hereby will be subject to review and approval of both parties before public disclosure. The Parties agree to keep confidential the terms of this Agreement and any Transaction Document required to be executed hereby until they mutually agree upon the language and timing of a press release or until such time as one of the parties determines, based upon the advice of counsel, that a public announcement is required by Law, in which case the parties shall in good faith attempt to agree on any public announcements or publicity statements with respect thereto.
 
7.7.       Disclosure to Seller Employees, Customers and Suppliers . The Seller and the Buyer will consult with each other concerning the means by which Seller's employees, customers, suppliers and others having dealings with the Seller Group in relation to the Business will be informed of the Acquisition, and the Buyer will have the right to participate in any such communication, other than Seller’s communication of the Acquisition to its employees.
 
7.8.      No Solicitation of Other Proposals .  From the date hereof until the earlier of the Closing Date or the termination of this Agreement in accordance with its terms, the Seller Group shall not, nor shall they permit any of their officers, directors, employees, representatives or agents (collectively, the “ Seller Representatives ”), directly or indirectly, to (i) solicit, encourage, facilitate, or initiate any inquiries or communications offer that constitutes or may constitute an Acquisition Proposal, (ii) participate or engage in any inquiries, discussions or negotiations with any Person concerning any Acquisition Proposal; or (iii) enter into or execute any agreement relating to an Acquisition Proposal.  For purposes of this Agreement, the term “ Acquisition Proposal ” shall mean any proposal or offer from any Person (other than Buyer or any of its Affiliates) relating to any merger, consolidation or other business combination involving the sale or other disposition of all or any significant portion of the Business or the Acquired Assets.
 
7.9.       Notice of Certain Events; Updates to Disclosure Schedules.
 
7.9.1.                Until the earlier of the Closing Date or the termination of this Agreement in accordance with its terms, each Party shall promptly notify the other Party, in writing, of: (i) any event, condition, fact or circumstance, of which it becomes aware, that would cause or constitute a material inaccuracy in or a material breach of any representation or warranty made by such Party in this Agreement; (ii) any material breach of any covenant or obligation hereunder of such Party ; and (iii) with respect to the Seller Group only, any and all material adverse events and developments concerning the Business, the Acquired Assets or the Assumed Liabilities.
 
 
37

 
 
7.9.2.                Until the earlier of the -Closing Date or the termination of this Agreement in accordance with its terms, each Party shall give the other prompt written notice of (i) any notice or other communication from any Person alleging that the consent of such Person is or may be required in connection with the consummation of the transactions contemplated by this Agreement, (ii) any notice or other communication from any Governmental Authority in connection with the transactions contemplated by this Agreement, (iii) any Action or threatened Action relating to or involving or otherwise affecting the transactions contemplated by this Agreement, and (iv) the occurrence of a breach or default or event that, with notice or lapse of time or both, could become a breach or default under this Agreement.
 
7.10.     Employment Matters .
 
7.10.1.              During the Interim Period: (i) Buyer shall offer employment to all Potential Transferred Employees, contingent upon the Closing, under terms of employment at least as beneficial to the Potential Transferred Employees as their existing terms with the Seller; and (ii) Seller shall permit Buyer to approach, interview and negotiate with each of the Potential Transferring Employees (but only with such Potential Transferred Employees), in respect of their potential employment by Buyer pursuant to (i) above.
 
7.10.2.              The Seller shall not take any actions that are intended to or are likely to dissuade any Potential Transferred Employee from accepting employment by Buyer.
 
7.10.3.              Without derogating from the provisions of Section 12 below, other than as expressly permitted pursuant to Section 7.10.1 above, Buyer shall not approach or discuss with any of the Potential Transferring Employees or any other employee, officer, consultant or representative of the Seller (other than those directly and actively involved in negotiating this Agreement) any of the terms of this Agreement and shall not directly or indirectly, solicit or encourage any such person to cease to work with the Seller, or solicit or encourage for purposes of directly or indirectly hiring any such person
 
7.10.4.              Seller undertakes that as of the Closing Date and for a period of at least 5 years thereafter, it will not, directly or indirectly, employ or engage as consultant, or solicit the employment or engagement as consultant of, any Potential Transferred Employee.
 
7.10.5.              At the Closing:
 
7.10.5.1.                 The Seller shall terminate the employment of all of the Potential Transferred Employees who did not become Transferred Employees effective on or around the Closing Date, except to the extent Buyer consents otherwise.
 
7.10.5.2.                 In respect of each Potential Transferred Employee who accepts employment by the Buyer and agrees to execute a Release, Buyer shall enter into an employment agreement with each such Transferred Employee under terms of employment at least as beneficial to the Transferred Employees as their existing terms with the Seller and which includes an undertaking to maintain continuity of their rights as employees despite their transfer to the employ of Buyer.
 
 
38

 
 
7.10.6.              In addition, and without derogating from Seller's liabilities hereunder, the Seller shall transfer to each Transferred Employee the pension fund/manager's insurance policy and education fund of such Transferred Employee. As soon as practicable after the Signing Date, the Seller shall submit to the Assessor Office of the Israeli Income Tax, the forms required for the continuity of employment of the Transferred Employees and for transferring their pension funds pursuant to the Income Tax Circular 6/2011. The Buyer shall assist the Seller in such submission and shall execute and deliver all documents as reasonably required in connection therewith.
 
7.10.7.              The Seller shall be responsible for settling all amounts owing to the Transferred Employees up to the Closing Date. Without derogation from the generality of the foregoing, the Seller shall be liable for and shall pay all wages, bonuses, commissions, vacation pay, vacation accrual, recuperation pay, travel pay, pay for other compensated absences and other remuneration (including mandatory or discretionary benefits) earned or accrued by the Transferred Employees according to any applicable Law and/or agreement up to the close of business on the Closing Date, including any related payroll deductions (such as employee benefit plan contributions and employment taxes but excluding those payment expressly stated in Schedule 7.10.5.1 hereof) with respect thereto, regardless of whether such amounts have been accrued on the books of Seller at close of business on the Closing Date.
 
7.10.8.              The Buyer shall be solely liable for and shall pay all wages, bonuses, commissions, vacation pay, vacation accrual, recuperation pay, travel pay, pay for other compensated absences and other remuneration (including mandatory or discretionary benefits) owing to the Transferred Employees according to any applicable Law and/or agreement effective as of the close of business on the Closing Date, including any related payroll deductions (such as employee benefit plan contributions and employment taxes with respect thereto
 
7.10.9.              Seller hereby waives any claim it may have against Buyer (but does not waive any such claim Seller may have against any Transferred Employee, except to the extent such Transferred Employee is engaged by Buyer in the Business) arising solely from the employment of each such Transferred Employee by Buyer hereunder, in respect of the non-compete/non solicitation undertaking pursuant to such Transferred Employee’s current employment agreement with Seller, any applicable Laws or pursuant to any other instrument or Contract. Such waiver is expressly made also for the benefit of the Transferred Employees.
 
7.11.     Supporting Bank Guarantee
 
7.11.1.              Buyer shall up to the Closing Date: (i) use best efforts to replace all Operating Guarantees issued by or on behalf of Seller under the Assigned Contracts (“ Seller Operating Guarantees ”) with substantially identical Operating Guarantees issued by or on behalf of Buyer; and (ii) provide all such assistance to Seller to enable Seller to release and terminate all such Seller Operating Guarantees (without breaching the relevant Assigned Contracts), as at the Closing Date.
 
 
39

 
 
7.11.2.              To the extent that any such Seller Operating Guarantees are not so replaced by the Closing Date (the “ Remaining Seller Operating Guarantees ”) Buyer shall deliver to the Seller, at the Closing, the Supporting Bank Guarantee in an amount equal to the aggregate of the underlying value of all of the Remaining Seller Operating Guarantees and shall thereafter continue to use best efforts to replace, release and terminate all Remaining Seller Operating Guarantees in accordance with Section 7.11.1 above.
 
7.11.3.              The Supporting Bank Guarantee shall remain in full force and effect until all Remaining Seller Operating Guarantees are released and terminated and Seller shall be entitled to immediately draw on the Supporting Bank Guarantee in the event that any third party makes a claim on a Remaining Seller Operating Guarantee and to the extent of such claim.
 
7.12.     Tax Matters .
 
7.12.1.              To the extent relevant to the Acquired Assets or the transactions contemplated hereby, each Party shall: (i) provide the other with such assistance as may  reasonably be required in connection with the preparation of any filings, reports or returns to the Israel Tax Authority (“ Tax Returns ”) and the conduct of any audit or other examination by the Israel Tax Authority  or in connection with judicial or administrative  proceedings relating to any Liability for Taxes; and (ii) retain for the period of time required at Law and provide the other with all records or other information that may be relevant to the preparation of any Tax Returns, or the conduct of any audit or examination, or other proceeding relating to Taxes.
 
7.12.2.               Each Party shall bear its own Taxes in connection with the transactions contemplated hereby.
 
7.13.     Litigation Cooperation .
 
7.13.1.              Until the earlier of the Closing Date or the termination of this Agreement in accordance with its terms, the Seller shall promptly notify Buyer of any Claims or Actions which after the date hereof are commenced against the Seller, or any officer, director, employee, consultant, agent or shareholder, in their capacities as such, and which relates to the Business or the Acquired Assets.
 
7.13.2.              Buyer acknowledges and agrees that Seller shall be entitled to control any and all Actions up to the Closing Date, subject to consultation with Buyer.
 
7.14.     Change of Seller Subsidiaries Trading Names .  Promptly following the Closing, Buyer shall take, or cause to be taken, all actions, do, or cause to be done, all things and execute, deliver or file, or cause to be executed, delivered or filed all documents and statements,  necessary, proper or advisable to ensure that no later than the 60 th day following the Closing, all Seller Subsidiaries and all Seller Foreign Branches shall cease to trade or otherwise be identified by any name containing the words: "OTI" or "On Track Innovations".
 
 
40

 
 
8.
CONDITIONS PRECEDENT TO CLOSING.
 
8.1.       Conditions to Obligations of Each Party .  The respective obligations of each Party to consummate the transactions contemplated by this Agreement shall be subject to the satisfaction of the following conditions:
 
8.1.1.                 Governmental Approvals . All Approvals of, or declarations or filings, with any Governmental Authority, the lack of which shall constitute a violation of applicable Law, shall have been obtained or made at or prior to the Closing Date. Such Approvals, declarations or filings shall be detailed in a list to be prepared by the Parties' counsels until the Disclosure Schedule Delivery Date.
 
8.1.2.                 No Injunctions or Restraints; Illegality .  No temporary restraining order, preliminary or permanent injunction, or other Order (whether temporary, preliminary or permanent) issued by any Court, or other legal restraint or prohibition shall be in effect at or prior to the Closing Date, which prevents the consummation of the transactions contemplated hereby on the terms contemplated herein.
 
8.2.       Additional Conditions of Buyer .  The obligation of Buyer to consummate the transactions contemplated by this Agreement shall be subject to the satisfaction of the following additional conditions, unless waived in writing by Buyer:
 
8.2.1.                 Closing Documents . All of the documents to be delivered by the Seller pursuant to Section 4.2.1 above shall have been executed and delivered to the Buyer at or prior to the Closing Date, which includes the delivery of the Disclosure Schedule and all other schedules which are required to be annexed hereto as of the Closing, the lack of which would constitute a Major Issue.
 
8.2.2.                 Required Approvals and Consents . Seller shall have obtained all Approvals and other consents by any Person, the lack of which would constitute a Major Issue.
 
8.2.3.                 Due Diligence Review . Buyer’s Due Diligence Review (including its review of the Seller Disclosure Schedule) shall not have revealed any Major Issue that was not substantially remedied by Seller until the Closing.
 
8.2.4.                 Agreements and Covenants . Seller shall have performed, procured or complied with in all material respects each obligation, agreement and covenant to be performed or complied with by it or by Seller Group under this Agreement at or prior to the Closing Date.
 
8.3.       Additional Conditions of Seller . The obligation of Seller to consummate the transactions contemplated by this Agreement shall be subject to the satisfaction of the following additional conditions, unless waived in writing by Seller:
 
8.3.1.                 Closing Documents . All of the documents to be delivered by the Buyer pursuant to Section 4.2.2 above shall have been executed and delivered to the Seller at or prior to the Closing Date, which includes the delivery of all schedules which are required to be annexed hereto as of the Closing.
 
 
41

 
 
8.3.2.                 Agreements and Covenants . Buyer shall have performed or complied with in all material respects each obligation, agreement and covenant to be performed or complied with by it under this Agreement at or prior to the Closing Date.
 
9.
BREAK-UP.
 
9.1.      Simultaneously with the execution of this Agreement: (i)  Buyer shall execute the Buyer Promissory Note and shall deliver same to Seller; and (ii) Seller shall execute the Seller Promissory Note and shall deliver same to the Buyer.
 
9.2.      If, notwithstanding the fulfillment or waiver in accordance with Section 8 of the Conditions Precedent, either Party (a “ Refusing Party ”) refuses or otherwise fails to consummate the transactions set out herein at the Closing for any reason then, without limiting any other right or remedy available to the other Party (the “ Closing Party ”) under this Agreement or at Law, the Refusing Party shall pay the Closing Party, as liquidated damages, a break-up fee in the amount of US$ 2,500,000 (Two Million Five Hundred Thousand United States Dollars) (the “ Break-Up Fee ”).
 
9.3.      In the event the Closing is not consummated solely as a result of the failure of any Condition Precedent to be fulfilled (and absent the waiver of its requirement in accordance with Section 8), then, upon the Drop Dead Date each Party shall deliver to the other Party such other Party’s Promissory Note, without liability to the other Party.
 
9.4.      In the event the Refusing Party refuses to consummate the Closing notwithstanding the fulfillment of all of the Conditions Precedent (or waiver by the Closing Party of any unfulfilled Condition Precedent, in the event such Condition Precedent may be waived by the Closing Party in accordance with Section 8), then from the date all such Conditions Precedents precedent are so fulfilled or waived, the Break-Up Fee will become immediately payable by the Refusing Party to the Closing Party and the  Closing Party shall be entitled to draw on the Refusing Party’s Promissory Note immediately and in full.
 
9.5.      In the event the Closing fails to consummate for any reason other than as a result of Seller being the Refusing Party, then:
 
9.5.1.                as of the Signing Date Buyer shall not, and shall procure that its Affiliates do not, directly or indirectly compete with the Seller Group in respect of any of the Potential Projects (other than the Potential Projects in Zambia and Sri-Lanka), including by submitting competing bids in respect of such Potential Projects or offer or providing competing products or services to the customers of such Potential Projects, whether as principal or for another's account, solely or jointly with others, or through any form of ownership in another entity or otherwise (other than by holding less than 5% of the equity or voting power of any publicly traded company); and
 
9.5.2.                in the event Buyer is awarded the Buffalo Project, then 50% of all gross profits (EBIT) earned by Buyer and its Affiliates and deriving from the Buffalo Project shall be paid to Seller on a quarterly basis, without any set-off or withholding of any kind (the “ Seller Project Share ”).  The Seller   Project Share owing in respect of each calendar quarter shall be paid to Seller within 90 days following the end of such calendar quarter and shall be accompanied by a certificate issued by the Buyer’s CEO or CFO, detailing the gross profits derived from the Buffalo Project during the relevant calendar quarter.  Within 10 days of the publication of the Buyer’s Annual Reports, the Buyer shall deliver to the Seller a Buyer’s Auditor Certificate confirming the Seller   Project Share payable to Seller during the calendar year to which the Buyer’s Annual Reports relate.  The amount payable hereunder in respect of the last calendar quarter of each year shall be paid within 10 days of the publication of the Buyer’s Annual Reports and shall be adjusted to reflect any difference between the amounts actually paid to Seller during the previous calendar quarters and the amount that should have been paid pursuant to the Buyer’s Auditor Certificate.  Payments of the Seller   Project Share shall be made over the life of the Buffalo Project.
 
 
42

 
 
9.6.      In the event the Closing fails to consummate as a result of the Seller being the Refusing Party, then, in the event Seller is awarded the Buffalo Project, then 50% of all gross profits (EBIT) earned by the Seller and its Affiliates and deriving from the Buffalo Project shall be paid to Buyer on a quarterly basis, without any set-off or withholding of any kind (the “ Buyer Project Share ”).  The Buyer Project Share owing in respect of each calendar quarter shall be paid to Buyer within 90 days following the end of such calendar quarter and shall be accompanied by a certificate issued by the Seller’s CEO or CFO, detailing the gross profits derived from the Buffalo Project during the relevant calendar quarter.  Within 10 days of the publication of the Seller’s annual audited financial statements (the “ Seller’s Annual Reports ”), the Seller shall deliver to the Buyer a certificate issued by the Seller’s auditors confirming the Buyer Project Share payable to Buyer during the year to which the Seller Annual Reports relate (the “ Seller’s Auditor Certificate ”).  The amount payable hereunder in respect of the last calendar quarter of each year shall be paid within 10 days of the publication of the Seller’s Annual Reports and shall be adjusted to reflect any difference between the amounts actually paid to Buyer during the previous calendar quarters and the amount that should have been paid pursuant to the Seller’s Auditor Certificate.  Payments of the Buyer Project Share shall be made over the life of the Buffalo Project.
 
10.
SURVIVAL; INDEMNIFICATION.
 
10.1.     Survival of Representations and Warranties . All representations and warranties contained in Sections 5 and 6 shall survive the Closing for a period of 24 months following the Closing Date.  For convenience of reference, the date upon which any representation or warranty shall terminate is referred to herein as the “ Survival Date ”.
 
10.2.     Indemnification by Seller .  From and after the Closing , Seller shall indemnify, defend and hold harmless Buyer, and each of its officers, directors, employees, advisors, agents, parents, subsidiaries, affiliates, successors and assigns (the “ Buyer Indemnified Persons ”) from and against any and all Losses arising out of,  attributable to, occasioned by or resulting from:
 
10.2.1.              any breach or violation of the Seller’s representations, warranties, covenants and undertakings made or given in this Agreement;
 
 
43

 
 
10.2.2.              any Claims or Actions resulting from or relating to any Excluded Liabilities (including, without limitation, the conduct and operation of the Business and the ownership of the Acquired Assets prior to the Signing Date).
 
10.3.    Indemnification by Buyer .  From and after the Closing, Buyer shall indemnify, protect, defend and hold harmless Seller, and each of its officers, directors, employees, advisors, agents, parents, subsidiaries, affiliates, successors and assigns (the “ Seller Indemnified Persons ”) from and against any and all Losses arising out of, attributable to, occasioned by or resulting from:
 
10.3.1.              any breach or violation of the Buyer’s representations, warranties, covenants and undertakings made or given in this Agreement;
 
10.3.2.              any Claims or Actions resulting from or relating to any Acquired Assets or Assumed Liabilities from and after the Signing Date; or
 
10.3.3.              in connection with or resulting directly or indirectly from any action carried out by the Seller on the Buyer's behalf or otherwise pursuant to Section 2.9.2.
 
10.4.     Limitations on Indemnification .
 
10.4.1.              To the extent that any circumstance giving rise to indemnification under this Section 10 is reasonably capable of being remedied by the Indemnifying Person (as defined below), the Indemnified Person (as defined below) shall afford the Indemnifying Person such opportunity as is reasonable to remedy such circumstance.
 
10.4.2.              No indemnification shall be payable to any Buyer Indemnified Person under Section 10.2.1 or to any Seller Indemnified Person under Section 10.3.1, until the aggregate amount of all Losses incurred by all Buyer Indemnified Persons or all Seller Indemnified Persons, as the case may be, exceeds US$300,000 (Three Hundred Thousand United States Dollars), whereupon Buyer Indemnified Persons or Seller Indemnified Persons, as the case may be, shall be entitled to receive the full amount of all Losses ( i.e. , including the first US$300,000 (Three Hundred Thousand United States Dollars) of such Losses);
 
10.4.3.              The maximum aggregate liability of Seller pursuant to Section 10.2.1 and of Buyer pursuant to 10.3.1 shall be the equal to $5,250,000 (Five Million Two Hundred Fifty Thousand United States Dollars) (the “ Maximum Indemnification Amount ”), except for claims arising from fraud or willful misrepresentation, to which the Maximum Indemnification Amount shall not apply;
 
10.4.4.              Anything herein to the contrary notwithstanding, Buyer shall not be entitled to recover any indirect, consequential, special, exemplary, punitive or similar damages, except to the extent that such damages are awarded to a third party in a Third Party Claim (as defined below);
 
10.4.5.              No claims for indemnification against any Indemnifying Person (as such term is defined below) under this Section 10, may be made following the expiration of the Survival Date, with the exception only of claims based on fraud or willful misrepresentation, which shall survive for the period of their statutory limitation.
 
 
44

 
 
10.4.6.              As security for the indemnity provided by Seller for in Section  10.2.1 above only, at the Closing, the Buyer shall deposit a portion of the cash amount of the Purchase Price payable at the Closing with the Escrow Agent  as detailed below (the "Escrow Amount" ), to be governed by the terms set forth in the Escrow Agreement.  The Escrow Amount shall be deposited into an interest bearing account and interest earned thereon will be held and distributed in accordance with the Escrow Agreement.  The Escrow Amount to be deposited shall equal the result of the following calculation: (i) $3,500,000 minus (ii) any amount of the Purchase Price that is subject to the Earn-Out Mechanism as at the Closing, such that if at least US$ 3,500,000 of the Purchase Price is subject to the Earn-Out Mechanism as at the Closing, then no amount shall be deposited with the Escrow Agent.  Subject to the terms of the Escrow Agreement, the Escrow Amount shall be held by the Escrow Agent for a period of 12 months, immediately following which the full amount of the Escrow Amount held at such time by the Escrow Agent shall be released and transferred by the Escrow Agent to the Seller.
 
10.5.    Indemnification Process .
 
10.5.1.              Any Buyer Indemnified Person or Seller Indemnified Person seeking indemnification under this Section   10 (an “ Indemnified Person ”) shall give each party from whom indemnification is being sought (each, an “ Indemnifying Person ”) prompt notice of any matter (a “ Notice of Claim ”) which such Indemnified Person has determined has given rise to or could give rise to a right of indemnification under this Agreement, stating the amount of the Losses, if known, and method of computation thereof, and containing a reference to the provisions of this Agreement in respect of which such right of indemnification is claimed or arises as promptly as practicable after becoming aware of such matter; provided , however , that the failure to so provide such Notice of Claim will not relieve the Indemnifying Person(s) from any Liability which they may have under this Agreement or otherwise (unless and only to the extent that such failure results in the loss or compromise in any material respect of any material rights or defenses of the Indemnifying Person(s) and the Indemnifying Person(s) was not otherwise aware of such action or claim).
 
10.5.2.              The Liabilities of an Indemnifying Person under this Section 10 with respect to Losses arising from Claims of any third party which are subject to the indemnification provided for in this Section 10 (“ Third Party Claims ”) shall be governed by the following additional terms and conditions:
 
(a)               Upon delivery of a Notice of Claim that relates to a Third Party Claim, the Indemnified Person shall also deliver to the Indemnifying Person copies of all relevant documentation with respect to such Third Party Claim, including, without limitation, any summons, complaint or other pleading that may have been served, any written demand or any other document or instrument.
 
(b)               The Indemnifying Person shall have the right to defend against the Third Party Claim on its own, with counsel reasonably satisfactory to the Indemnified Persons, subject to (i) the right of the Indemnified Persons to participate (at its own expense and with counsel of its own choice) in the defense of such Third Party Claim, and subject to (ii) the Indemnifying Person's written acknowledgement that it is obligated to provide indemnification to the Indemnified Persons with respect to such Third Party Claim.  The Indemnifying Person, on the one hand, and the Indemnified Persons, on the other hand, shall make available to each other and their counsel and accountants all books and records and information relating to any Third Party Claims, keep each other apprised as to the details and progress of all proceedings relating thereto, and render to each other such assistance as may be reasonably required to ensure the proper and adequate defense of any and all Third Party Claims.
 
 
45

 
 
(c)               No Third Party Claim shall be settled or compromised by the Indemnified Persons, and no Indemnified Person shall admit any Liability under any Third Party Claim, without the written consent of the Indemnifying Person. Any settlement or compromise made in violation of the foregoing sentence shall relieve the Indemnifying Person from its indemnification obligations in respect of such Third Party Claim.
 
10.6.    The provisions of this Section 10 constitute the Parties' exclusive rights and remedies arising from or related to any breach or violation of this Agreement.
 
11.
TERMINATION.
 
11.1.     Termination . This Agreement may be terminated and the transactions contemplated hereby may be abandoned at any time prior to Closing Date:
 
11.1.1.              By either Buyer or Seller, by means of written notice to the other, if:
 
(a)               the Closing Date shall not have occurred within 120 days of the Signing Date (the “ Drop Dead Date ”); provided , however , that the right to terminate this Agreement under this Section 11.1.1 shall not be available to any party whose failure to fulfill any material obligation under this Agreement was  the cause of, or resulted in, the failure of the Closing to occur on or before such date;
 
(b)               a competent Court or Governmental Authority shall have issued an Order or taken any other action, in each case, which has become final and non-appealable and which restrains, enjoins or otherwise prohibits the Closing; or
 
(c)               such party (the “ Non-Breaching Party ”) is not in breach of any of its obligations, agreements or covenants under this Agreement, and if the other party (the “ Breaching Party ”) shall have or failed to perform in any material respect any of its covenants or other agreements contained in this Agreement, and (A) is incapable of being cured; or (B) if capable of being cured, is not cured prior to the earlier of: (x) the Business Day prior to the Drop Dead Date, or (y) the date that is thirty (30) days from the date that the Breaching Party is notified of such breach.
 
11.1.2.              By Buyer if it reveals a Major Issue that cannot be remedied by the Seller prior to the Drop Dead Date, provided that Buyer notified Seller in writing of the existence of Major Issue promptly upon becoming aware of it.
 
11.2.     No Other Termination. The parties agree that, except as otherwise set forth in Section 11.1, this Agreement may not be otherwise terminated.
 
 
46

 
 
11.3.    Effect of Termination .  In the event of the termination of this Agreement in accordance with this Section 11, this Agreement and any of the applicable Transaction Documents (other than this Section 11.3, and Sections 9.5, 9.6, 12 and 14, which shall survive such termination) will forthwith become void, and there will be no Liability on the part of Buyer or Seller or any of their respective officers or directors to the other and all rights and obligations of any party hereto will cease.  Notwithstanding the immediately preceding sentence, in the event this Agreement is so terminated in circumstances where the Party receiving a notice of termination has failed to fulfill any material obligation under this Agreement or has otherwise been the cause of the failure of the Closing to occur on or before Closing Date, then such termination will be without prejudice to any rights or remedies available to the terminating Party under this Agreement or at Law.
 
12.
NON COMPETE
 
12.1.    Subject to the consummation of the Closing, Seller agrees that for a period commencing at the Closing Date and ending on the fifth (5th) anniversary thereof it shall not engage, either directly or indirectly, whether in Israel or outside of Israel, as principal or for another's account, solely or jointly with others, or through any form of ownership in another entity or otherwise (other than by holding less than 5% of the equity or voting power of any publicly traded company), in any business that operates in the field of the Business or otherwise competes with the Business.
 
12.2.    As of the Signing Date, in any event where Seller is approached by any Person including customers, suppliers and distributors in connection with the Business, Seller shall promptly advise Buyer of such approach in writing and shall refer such Person to Buyer.
 
13.
CONFIDENTIALITY
 
Subject to any obligation to comply with: (i) any Law; (ii) any rule or regulation of any Governmental Authority or securities exchange; or (iii) any subpoena or other legal process to make information available to the Persons entitled thereto, whether or not the transactions contemplated herein shall be concluded, this Agreement, its Exhibits, Schedules, the Transaction Documents shall be kept in confidence by each party, and each party shall cause its directors, officers, employees, representatives, agents and attorneys to hold such information confidential. Such confidentiality shall be maintained to the same degree as such party maintains its own confidential information (but in no event less than reasonable care) and shall be maintained until such time, if any, as any such data or information either is, or becomes, published or a matter of public knowledge (other than as a result of a breach of this Agreement).  This provision shall survive any termination of this Agreement.
 
14.
MISCELLANEOUS.
 
14.1.     Actions Regarding Non-Compete . In the event that any of the non-compete or non-solicitation undertakings in this Agreement (each, a " Non-Compete Undertaking ") is deemed a restrictive arrangement by the Restrictive Practices Authority or otherwise under applicable Israeli Law, the Parties agree to cooperate in seeking the approval or exemption from the Restrictive Practices Authority or any other relevant Court or Regulatory Authority in respect of such Non-Compete Undertaking, provided, however that in the event that such approval or exemption is not received, then the period of the Non-Compete Undertaking shall be deemed to be reduced to a period of four (4) years following the Closing Date.
 
 
47

 
 
14.2.     Expenses . All fees, costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby including, without limitation, legal and accounting fees and any, fees, costs and expenses borne in connection with any due diligence investigations carried out with respect to the transactions contemplated hereby, including the Due Diligence Review (“ Transaction Expenses ”), shall be borne and paid by the Party incurring such Transaction Expenses, whether or not the Closing occurs.
 
14.3.     Amendment .  This Agreement may be amended only by an instrument in writing signed by duly authorized representatives of Buyer and Seller.
 
14.4.     Entire Agreement .  This Agreement, together with its Schedules, Exhibits, the Transaction Documents, and all other ancillary agreements, documents and instruments to be delivered in connection herewith, contain the entire understanding of the parties with respect to the subject matter hereof and supersede all prior agreements, either oral or written, including, without limitation, that certain Letter of Intent entered into by the Parties on July 18, 2013, which is hereby terminated and of no further force or effect. Without limiting the generality of foregoing and notwithstanding anything in this Agreement to the contrary, no Party is making any representation or warranty whatsoever, oral or written, express or implied, in connection with the transactions contemplated by this Agreement and the Transaction Documents other than those set forth in this Agreement or in the Transaction Documents and no Party is relying on any statement, representation or warranty, oral or written, express or implied, made by any other Party except for the representations and warranties set forth in this Agreement or in the Transaction Documents.
 
14.5.     Third Party Beneficiaries .  Nothing express or implied in this Agreement is intended to confer, nor shall anything herein confer, upon any Person other than the Parties and the respective successors or assigns of the parties, any rights, remedies, or Liabilities whatsoever, except to the extent that such third person is an Indemnified Person in respect of the indemnification provided in accordance with Section 10 of this Agreement.
 
14.6.     Seller Disclosure Schedule .   Nothing in Seller Disclosure Schedule constitutes an admission of any liability or obligation of Seller or the Seller Group to any third party, nor an admission against Seller’s or the Seller Group's interest to any third party. Seller Disclosure Schedule contains information, descriptions and disclosures regarding Seller only, all of which constitutes confidential information of Seller.
 
14.7.     Assignment .  No Party hereto shall assign or otherwise transfer this Agreement or any of its rights hereunder, or delegate any of its obligations hereunder, without the prior written consent of the other Party hereto.
 
14.8.     Governing Law; Jurisdiction .  This Agreement shall be governed by the laws of the State Israel without giving effect to any choice of law or conflict of law provision or rule that would cause application of the laws of any jurisdiction other than the State of Israel.  The parties hereby stipulate that any action or other legal proceeding arising under or in connection with this Agreement shall be commenced and prosecuted in its entirety exclusively in the competent courts located in Tel-Aviv or the Merkaz Districts, Israel, each party hereby submitting to the exclusive jurisdiction thereof.
 
 
48

 
 
14.9.     Severability .  If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of law, or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner adverse to any party.  Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner to the end that transactions contemplated hereby are fulfilled to the extent possible.
 
14.10.   Notices .  All notices or other communications which are required or permitted hereunder shall be in writing and sufficient if delivered personally or sent by registered mail, return receipt requested, or by facsimile, with confirmation as provided above addressed as follows:
 
If to Buyer:                                           SuperCom Ltd.
The Nolton House_
14 Shenkar Street, Herzeliya
Attention:  Chief Executive Officer
Facsimile: 09-889 0820
Email:arie@supercom.com
 
With a copy to:                                   S. Friedman & Co., Advocates
5 th Floor
Amot Investment Tower
2 Weitzman Street
Tel Aviv, Israel
Attention:  Sarit Molcho and Arnon Mainfeld
Facsimile: 03-6931830
Email: saritm@friedman.co.il; arnonm@friedman.co.il

 
If to Seller:                                          On Track Innovations Ltd.
Z.H.R Industrial Zone
Rosh Pina, Israel
Attention:  Chief Executive Officer
Facsimile: 04-693 8887
Email: ofer@otiglobal.com
 
 
49

 
 
With a copy to:                                    Sharon Raviv & Co., Law Offices
Floor 13
11 Menachem Begin Street
Ramat Gan, Israel
Attention:  Sharon Raviv, Adv.
Facsimile: 03-6161500
Email: sharon@ravivlaw.com
 
or to such other address as the party to whom notice is to be given may have furnished to the other party in writing in accordance herewith.  All such notices or communications shall be deemed to be received (a) in the case of personal delivery, on the date of such delivery, (b) in the case of facsimile transmission, upon confirmed receipt, and (c) in the case of registered mailing, on the fifth working day following the date on which the piece of mail containing such communication was posted.
 
14.11.   Representation by Counsel .  Each Party hereto acknowledges that it has been advised by legal and any other counsel retained by such party in its sole discretion.  Each Party acknowledges that such Party has had a full opportunity to review this Agreement and the Transaction Documents and all related exhibits, schedules and ancillary agreements and to negotiate any and all such documents in its sole discretion, without any undue influence by any other party hereto or any third party.
 
14.12.    Construction .  The Parties have participated jointly in the negotiations and drafting of this Agreement and in the event of any ambiguity or question of intent or interpretation, no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any of the provisions of this Agreement.
 
14.13.  Waivers.  No waiver by any Party, whether express or implied, of its rights under any provision of this Agreement shall constitute a waiver of the other Party’s rights under such provisions at any other time or a waiver of the other Party’s rights under any other provision of this Agreement.  No failure by any party to take any action against any breach of this Agreement or default by another party shall constitute a waiver of the former party’s right to enforce any provision of this Agreement or to take action against such breach or default or any subsequent breach or default by the other party.  To be effective any waiver must be in writing and signed by the waiving party.
 
14.14.   Counterparts .  This Agreement may be executed in two or more counterparts, any one of which need not contain the signatures of all parties, but all of which counterparts when taken together will constitute one and the same agreement.
 
[ Remainder of Page Intentionally Left Blank ]
 
 
50

 
 
[Signature Page to an Asset Purchase Agreement dated August 14, 2013]
 
NOW THEREFORE, the parties hereto have executed, or caused this Asset Purchase Agreement to be executed by their duly authorized representatives, as of the date first written above.
 
 
ON TRACK INNOVATIONS LTD:
 
By: /s/ Ofer Tziperman,  Shay Tomer
 
Title: CEO / CFO
 
SUPERCOM LTD:
 
By: /s/ Arie Trabelsi, Doron Ilan
 
Title: CEO / CFO
 
51


 


Exhibit 10.10
 
Personal and Special Employment Agreement
 
made and signed in Rosh Pina on August 6, 2013
 
Between:
On Track Innovations Ltd. (Reg. No. 52-004286-2)
   
 
A Public Company registered in Israel
   
 
of Z.H.R. I.Z., Rosh Pina 12000
   
 
(hereinafter: " the Company ")
   
       
And between :
Shay Tomer   (ID No.   034961284)
   
 
61 Haerez St., Ramat Yishai
   
 
(hereinafter: " the Employee ")
   
 
Whereas
Since April 24 th 2007, the Employee has been employed by the Company as a Comptroller in the Company’s Finance Department and as of June 1 st , 2013  (the “ Effective Date ”) the Employee has been promoted and appointed as Chief Financial Officer (“ CFO ”) of the Company (hereinafter “ the Position ”); and
 
Whereas
The Company wishes to continue to employ the Employee in the Position, under the terms and conditions set forth below in this agreement (“ this Agreement ”), which were  approved by  the Company’s Board of Directors (“ the Board ”) on July 20 th , 2013, as required by law; and
 
Whereas
it was agreed that the Employee shall be employed by the Company in the Position while maintaining full continuity of his rights, including his rights to severance pay; and
 
Whereas
the Employee gave his consent to hold the Position and to perform the duties required in the Position, and he has declared that he has the ability, experience, qualifications and skills required for performing this position, and there is no legal or contractual hindrance or other hindrance preventing him from serving in this Position and from performing his duties as set forth in the provisions of this Agreement; and
 
Whereas
the parties wish to stipulate their mutual rights and obligations and the terms of the employment of the Employee in the Position in this Agreement, all as set forth and stipulated therein;
 
 
 

 
 
Therefore it was agreed, declared and stipulated between the parties as follows:
 
A.            Introduction
 
1.
The preamble of this Agreement and its appendices constitute an inseparable part thereof.
 
B.            The Position, Subordination and Powers
 
2.
Following the  approval of the terms of this Agreement by the Board as mentioned above, the Employee shall continue to perform his roles as CFO of the Company and its subsidiaries or affiliates from the Effective Date and thereafter.
 
3.
In the framework of his Position, the Employee shall be responsible, among others, for the Company’s Financial Department activities and any other duties imposed to him from time to time by the Company’s Chief Executive Officer (“ CEO ”) and/or the Board and related activities such role involved.
 
4.
In performing the Position the Employee shall be subject to the Company’s CEO, and he shall act in accordance with the instructions and policies as shall be determined from time to time by the CEO and/or the Board.
 
5.
Without derogating from the provisions in this Agreement, for the avoidance of any doubt, it is clarified and agreed that in the event that any task shall be imposed on the Employee which could create a contact with another Company's subsidiary, or a company connected to the Company (hereinafter jointly referred to as: " the Affiliated Companies "), then this task will not create any employer-employee relationship between him and any of the Affiliated Companies.
 
6.
In the framework of the Employee's duties, he shall have all the powers required for performing the Position.
 
7.
The Employee shall work five days a week, from Sunday to Thursday. Notwithstanding the aforesaid it is clarified and agreed that the Employee could be required by virtue of his Position and if necessary for his work, to work also on weekends including on Saturdays and on holidays, and he gives his consent to the aforesaid.
 
8.
In light of his senior position which requires an increased extent of personal trust,   it is agreed between the parties that the provisions of the Work and Rest Hours Law - 1951 shall not apply to his employment, and the Employee shall not be entitled to receive any additional payment or consideration for working beyond a regular working day and working hours.
 
 
2

 
 
9.
It is agreed that in determining the sum of the Employee's salary the parties have assumed that the Employee shall be required to work far beyond the routine working week in the Company.
 
C.            The Employee's Obligations
 
10.
The Employee undertakes to perform the duties and tasks that shall be imposed on him with appropriate faith and diligence and to the Company's benefit, avoiding any conflict of interests between personal and irrelevant interests, and the Company's interests.
 
11.
The Employee undertakes to lawfully work and act in accordance with the Company's rules and instructions and to dedicate his best efforts, time and abilities to fulfill the Position efficiently, skillfully and responsibly, all in accordance with the requirements of this agreement. He also undertakes not to engage in any other work or business, whether directly or indirectly, except for his work in the Company, either for salary or without, unless this is according to a written permit from the Company's CEO.
 
This permit is not required for culture, sport and lecturing activities, or for holding shares in other companies that are not in competition with the Company and/or the Subsidiaries, and in a case of potential competing companies the Employee holds no more than 1%.
 
12.
The Employee must act in accordance with the Company's instructions regarding security and business ethics, including not receiving any benefit from any party, as a result and/or with respect to his work and duties in the Company, to protect the information of the Company and to keep confidential any matter that is not within the public domain.
 
13.
The Employee undertakes to notify the Company’s CEO immediately and without any delay of any matter or issue and/or any of his activities in respect to which he has a personal interest in and/or that could create a conflict of interests with his duties in the Company.
 
D.            The Uniqueness of the Agreement
 
14.
The terms of employment of the Employee, in their entirety, are as defined in this Agreement and in it only, and the terms of any other agreement whatsoever shall not apply to the Employee, including any collective agreement or collective arrangement or any custom that applies, if applicable or that shall apply to any of the other employees of the Company.
 
15.
Any change in this agreement is contingent on it being in writing and signed by the parties.
 
16.
In order to avoid doubt, this Agreement comes instead and replaces any previous arrangement and/or agreement between the parties including prior agreements.
 
 
3

 
 
17.
However, and for the avoidance of any further doubt, it is agreed that the seniority of the Employee for the purpose of calculating his rights shall be as of the beginning of his employment on April 24 th , 2007.
 
E.             The Consideration
 
18.
In consideration for performing his duties as set forth in this agreement, the Employee shall receive a salary, annual Bonus, options for shares and other benefits (severance pay, Employees' insurance, advanced education fund and refund of expenses etc.) as set forth hereafter.
 
19.
Except for the granting of options to the Employee, the terms of the Employee's employment by the Company are subject only to this agreement, and the Employee shall not be entitled to any payment or to any right with respect to his employment in the Company or the termination of his employment, unless it is expressly mentioned in this Agreement.
 
E.1           The Salary
 
20.
The Company shall pay the Employee as of the Effective Date and thereafter a gross monthly salary in the sum set forth in appendix A attached hereto (hereinafter" " the Salary "). The salary shall be paid to the Employee no later than the 9 th day of each month in respect of the previous month. Payment shall be linked to the cost of living allowance in the economy in accordance with an expansion order that shall be announced and applicable to all employers and employees in Israel.
 
21.
The above salary shall constitute the basis for all allocations made on behalf of the Employee and in respect of his employment, to Employee's Insurance for redemption of accumulated vacation and any other social benefit in accordance with the law.
 
Notwithstanding the above, the Bonus defined hereafter and/or any other payment are not and shall not constitute a part of the salary of the Employee for all intents and purposes, and no allocations shall be made in respect thereof.
 
22.
Not later than the 31 st of January each year, the CEO and/or the Board shall consider and set the Employee's salary for the following year.
 
E.2           Annual Bonus
 
23.
The Company shall have absolute discretion to pay the Employee an annual bonus (hereinafter: " the Bonus "). The Bonus shall be decided on an annually basis by the Company’s CEO, subject to the approval of the Board considering the Company’s Compensation Policy for Executive Officers and in accordance with the achievement of the Employee’s targets as determined on an annual basis from time to time by the Company’s CEO. The targets of the Employee will be determined by the Company’s CEO not later than the 31 st January of each year with respect to the following year (however in the first year of this Agreement, the targets for the Bonus shall be set forth by September 30 th , 2013).
 
 
4

 
 
In determining the Bonus as mentioned, Company’s CEO shall consider the Compensation Plan for Executive Officers of the Company, the Company's income and/or profitability insofar as far as this concerns the Employee.
 
The Bonus plan for the first year is set forth in appendix A of the agreement and is subject to changes from time to time.
 
24.
The gross Bonus for each year shall be paid to the Employee the following month after the publishing of the annual Financial Statements for the corresponding year. All taxes and levies on the Bonus shall be borne by the Employee.
 
25.
Notwithstanding the foregoing, according to the full discretion of the Company’s CEO, and subject to the cash flow of the Company and the financial results as shall be reflected in the quarterly statements of the Company, the Company may extend to the Employee an advance payment on account of a Bonus. Such an advance shall be offset from the then current and future annual Bonuses.
 
E.3          Option Package
 
26.
In order to encourage the long-term success of the Company, without derogating from the aforesaid in chapter E.2 above and subject to the approval of Company’s Compensation Committee and the Board, and the provisions of the law, the Company shall issue to the Employee an options package (hereinafter" " the Options Package ") in accordance with the terms and mechanism set forth in appendix A of the agreement.
 
Without derogating the general provisions aforesaid or the set forth in Annex A, it is agreed that in the case of a merger and/or sale of the Company or its material assets, in whole or in part, with or to a third party (hereinafter: " the Sale Event ") the vesting and exercise period set forth in Annex A shall be accelerated and the Employee shall be entitled to immediately exercise all his remaining non-vested options at its exercise price before or after the occurrence of the Sale Event, at the Employees Choice.
 
E.4           Vacation, Sick Days and Convalescence Pay
 
27.
The Employee shall be entitled to 24 work days of annual vacation for each year of his employment. The Employee shall be required to exploit at least 7 vacation days each year. The balance of vacation days may be accumulated, provided they do not exceed 100 days in total.
 
 
5

 
 
Any days in excess of the above cannot be accumulated and without derogating from the above, vacation days cannot be redeemed before the termination of the employment. Consequently days that have not been exploited and cannot be redeemed shall be lost.
 
28.
The Employee is entitled to sick days, and to payment in respect thereof in accordance with the provisions of the Sick Pay Law. The Employee is entitled to accrue up to 90 sick days at the most. Sick days that shall not be actually used are not redeemable.
 
Sick days for which disability insurance has been paid, shall be deducted from the sick days entitlement. However, the Company has paid in respect of such days the difference between the disability insurance and the payment entitlement in respect of such days, if any.
 
29.
The Employee shall be entitled to an annual 10 days payment of convalescence pay (“Dmei Havraa”) in accordance with the provisions of the expansion order in respect of convalescence pay as published by the Labor Authorities.
 
E.5           Employees' Insurance
 
30.
The Company shall continue to insure the Employee with his current Employees insurance policy in the Employee's name.  Each month the Company shall pay and/or deduct in respect of the above policy the following sums:
 
 
30.1.
An amount equal to 8 1/3 % of the salary shall be transferred by the Company on account of severance pay.
 
 
30.2.
An amount equal to 5% of the salary for pension shall be transferred by the Company in respect of pension (Provident Fund). An equal amount of 5% shall be deducted from the Employee's salary and transferred as the Employee's contribution to such fund.
 
31.
In addition, the Company shall insure the Employee with Employee's Insurance Policy's insurers for disability at a cost that shall not exceed 2.5% of his salary.
 
32.
The tax levied on the above Company's allocations to the Employee's insurance, if any, shall be borne by the Employee.
 
33.
Further to Section 30 - 32 above, the Company hereby forfeits any right it may have in the reimbursement of sums paid by Company into the above mentioned executive insurance policy, except in the event: (i) that employee withdraws such sums from the executive insurance policy, other than in the event of death, disability or retirement at the age of 60 or more; and/or (ii) of the occurrence of any of the events provided for in Sections 16 and 17 of the Severance Pay Law, 1963.
 
 
6

 
 
34.
It is further agreed that such payment contribution made by the Company towards the executive insurance policy as mentioned above, and any interest and/or profit accumulated thereto, shall be on account of severance payment due to Employee under any circumstances in which Employee shall be entitled to severance payment subject to the applicable law, including but not limited to the Severance Pay Law, 1963.
 
E.6           Provident Fund
 
35.
The Company shall continue to allocate payments to the Employee's current provident fund. 7.5% of the salary shall be allocated by the Company and 2.5% of the salary shall be deducted from the Employee's salary as his share in the payments. The tax owed with respect to the above payment to the Provident Fund shall be borne by the Employee.
 
36.
The Company shall release the Provident Fund upon termination of the employment hereunder, for any reason except for in the circumstances provided in section 46.2 hereafter.
 
E.7           Refund of Costs, Vehicle, Company, Meals, Mobile Telephone
 
37.
The Company shall reimburse the Employee all of the reasonable costs spent by him in the execution of his duties in accordance and subject to the reimbursement policy of costs adopted by the Company.
 
In the event that no such policy has yet been adopted, costs shall be refunded to the Employee within 10 days after the last day of the month for which they are refunded against receipts or other supporting documentation.
 
The reimbursement of costs (or the right thereto) cannot be converted or offset against a Bonus or other payment.
 
38.
Company Car. During the Term of the Employment, the Company shall place at the Employee's exclusive disposal a car for his use at the level detailed in Annex A hereto. All the expenses in connection with the maintenance and use of the said car shall be borne and paid by the Company, excluding fines. The Employee hereby undertakes to use the car that shall be placed at his disposal as aforesaid reasonably and properly qua an owner who cares for his property, and in the absence of another arrangement in writing between him and the Company he undertakes to return the said car to the Company immediately upon the termination of the Prior Notice Period. The Company shall gross up the value of the benefit to the Employee in placing the car at his disposal as aforesaid in the amount of the tax applicable to him is respect of the said benefit.
 
39.
The Employee shall be entitled to eat lunches at the Company's dinner-room or at restaurants with arrangement for Company’s employees. The tax in respect of that benefit shall be grossed up and paid by the Company.
 
 
7

 
 
40.
The Company shall provide the Employee with a mobile telephone (an extension of which shall be installed, if required, in the vehicle). The Company shall cover all the operating costs thereof and all taxes shall be grossed up and paid by the Company.
 
41.
For the sake of caution it is agreed and declared that all the grossed up payments for tax purposes include the entire sum of severance pay in respect to these payments. The parties to this agreement shall request the approval of the Minister of Labor for their agreement as mentioned according to section 28 of the Severance Pay Law – 1963.
 
F.            The Term of the Agreement and the Manner of its termination
 
42.
The continuance of the employment of the Employee is for an unspecified period (the: “ Employment Period” ).
 
43.
The Employment Period shall terminate within six (6) months of a Termination Notice (“ Prior Notice Period ”). Each party is entitled to give a termination notice at any time and for any reason or without any reason to the other party of its wish to terminate the employment and the employment hereunder shall terminate at the expiration of the Prior Notice Period.
 
44.
During the Prior Notice Period the Employee must continue to fulfill his Position and perform all of his duties according to this agreement and according to the Company's request to make a maximum effort to perform the full and organized transfer of his Position to his replacement.
 
45.
Notwithstanding the aforesaid, it is clarified and agreed that the Company shall be entitled at all times, according to its discretion to request the Employee to immediately terminate his Position (or within a shorter period than the Prior Notice Period) and in such case the employer-employee relationship shall end at the time stipulated in the Company's request and this is without derogating from the Employee's rights in accordance with this agreement and the law, to receive payment in lieu of the Prior Notice Period, severance pay and any other payments that are due to him, if at all, for the period of his employment in the Company and its termination.
 
46.
In the event of the termination of this agreement the following provisions shall apply:
 
 
46.1.
If the termination of employment was as a result of the Employee's dismissal (except for dismissal on the background of circumstances set forth in section 46.2 hereafter) or as a result of the Employee's resignation, or God forbid as a result of circumstances that prevent the continuation of the Employee's employment in the Company (including his death), the Employee shall be entitled (or his heirs respectively):
 
 
8

 
 
 
46.1.1.
To receive from the Company: a monthly salary in respect of the Prior Notice Period or the end of his employment period, whichever is later. However, if at the request of the Company, the employment terminated earlier, then the Employee shall receive for the months for which the employment during the Prior Notice Period was shortened, and this is when the Employee was requested to continue his work during the Prior Notice Period. Should the Employee, at the request of the Company, refrain from working during the part of the Prior Notice Period, the Company shall pay in respect of those months the payment in lieu of Prior Notice Period as per paragraph 45 hereinabove, and
 
 
46.1.2.
Subject to the provisions in chapter E.2 above, the Company shall pay the pro rata Bonus in respect of the proportional part of the year. The sum of the Bonus to which he is entitled (if any). Should the employment terminate (including the Prior Notice Period) before the end of the year, a pro rata Bonus in respect thereof; and
 
 
46.1.3.
To receive from the Company severance payments according to the applicable law, including but not limited to the Severance Pay Law, 1963, calculated based on the Employee’s last month salary prior the termination of employment, of which it will transferred to the Employee and into his name, the Employee's Insurance and the Provident Fund and to allow the Employee the use of Company's car including the payment of the expenses thereof until the end of the Prior Notice Period and/or the end of the Employment Period, whichever is the later;
 
 
46.1.4.
Compensation for non-compete – a one-time compensation sum against the Employee’s undertaking in chapter G hereafter "Secrecy and Non – Competition". Such compensation shall be in the sum equal to six (6) salaries as the salary is defined in chapter E.1 above. 50% of the above compensation shall be paid at the end of the employment and the remaining balance shall be deposited in trust with the Company's attorney with instructions to release it to the Employee 12 months after the end of his employment, provided that the Employee has fulfilled all of his undertakings, as set forth in the confidentiality and non–competition chapter hereafter. This payment shall be refunded to the Company if and when the non-compete and confidentiality undertaking has been breached in any way and the Company shall have the right to offset such a refund from any obligation and/or payment to which the Employee is entitled.
 
 
9

 
 
 
46.2.
It is agreed and declared that in the event of the Employee's dismissal as a result of a breach of trust or material breach of the Employee's confidentiality and non–competition undertakings as set forth in the confidentiality and non- competition chapter hereafter and in appendix B hereafter, or in the event of dismissal in circumstances that deny the Employee's right to severance pay in accordance with the law – the Employee shall not be entitled to receive a Prior Notice Period to his dismissal or payment in place of a Prior Notice Period, and he shall not be entitled to the payment of severance pay or any other payment that the Company is not required to pay, including any payment that is due to the Employee as a Bonus payment. In accordance with the law, the Company shall be entitled to offset the sum of the advance payments from any payment that is due to the Employee from the Company.
 
G.            Confidentiality and Non Competition
 
47.
The Employee shall sign the undertakings to maintain confidentiality set forth in appendix B which constitutes an integral part of this agreement.
 
48.
The Employee undertakes that during the employment period and for a period of 12 months after the termination of the employment agreement he shall refrain from being in direct or indirect contact with a customer of the Company or of the subsidiaries of the Company in any matter that relates to the Company's business or the businesses of its subsidiaries or affiliates unless it is with the specific approval of the Company; and or
 
 
48.1.
Being in direct or indirect contact with a customer of the Company or of the Subsidiaries or of the Affiliated companies (whether as an employee, consultant or any other way), in any matter that refers to the Company's business, the business of the Subsidiaries or of the Affiliated companies, unless it is within the framework of his employment in the Company.
 
 
48.2.
Engage, directly or indirectly, for any reason, in Israel or anywhere in the world, in any business, work or any other engagement in the field of contactless smart cards that compete with the Company's business, the business of the Subsidiaries or Affiliated companies, and/or
 
 
48.3.
Solicit the Company's employees or suppliers, the Subsidiaries' or Affiliated companies' employees or suppliers to any business association with him.
 
H.            Deductions and Taxes
 
49.
The payments and benefits of whatsoever description granted to the Employee pursuant to this agreement are subject to the deduction of income tax and other compulsory deductions which the Company has to deduct according to any law, and nothing stated in this Agreement shall be interpreted as imposing upon the Company the burden of paying tax or any other compulsory payment for which the Employee is liable, other than the value of the benefit of placing the car and mobile phone at the Employee's disposal and providing the Employee with meals, which shall be grossed up by the Company as provided in Section E.7 above.
 
 
10

 
 
I.              Waiver or Precedent
 
50.
No Waiver made by the Company (if any) shall constitute a precedent with respect to any other case, similar or otherwise, and no inference shall be made in respect thereof.  The Company shall be entitled to exercise any of its rights hereunder that have not been specifically waived in writing.
 
J.             Notices
 
51.
The parties' addresses set in  the preamble thereof would be the relevant address of this agreement and any notice sent to that address shall be considered as if received, within five days of its posting.
 
K.            The Law and Jurisdiction
 
52.
This agreement is governed by the Laws of the State of Israel, and the Labor Court shall have jurisdiction with respect to all matters concerning and/or arising thereof.
 
And in witness whereof the parties have signed
 
  /s/ Shay Tomer  
/s/ Ofer Tziperman / Arie G. Rubinstein
CEO / General Counsel & Corporate Secretary
 
   Employee  
The Company
 
 
 
11

 
 
ANNEX B
 
Confidentiality and Non Competition Undertaking
 
I, the undersigned, Shay Tomer (Id No. 034961284), hereby declare and undertake towards On Track Innovations Ltd. and any of its parent/controlling corporation, subsidiaries and/or affiliated entities (hereinafter collectively, the “ Company ”) as follows:
 
1.
In this Undertaking:
 
 
1.1.
the term “ Confidential Information ” means any and all information relating to the Company’s proprietary technology or business including, without limitation, information, data, know-how, formulas, concepts, tests, drawings, specifications, applications, designs and trade secrets, patents, know-how, technology data and all other information, design methodology, engineering and manufacturing processes and data and information related to Company’s products or their development, equipment, suppliers, sales, customers, potential customers, business operations and plans, financial situation, members, employees and investors.
 
 
1.2.
the term “ Confidential Documents ” means any documents containing Confidential Information, including without limitation: (i) any documents, notes, memoranda, summaries, analyses, paper works, sketches, designs, charts, specifications, prints, compilations, or any other writings relating to the Confidential Information, and any other materials embodied in drawings, floppy discs, tapes, CD ROM, software or in any other possible way containing or relating to the Confidential Information or any part thereof, whether or not prepared by the Company or on it’s behalf, (ii) all documents received, used, or that shall be received or used, by me in relation with my employment in the Company, and/or (iii) the contents of such Confidential Documents as stored in my memory.
 
 
1.3
the term " Competing Goods " means any goods sold in competition with the prescribed goods;
 
 
1.4
the term " Competing Services " means any services rendered in competition with the prescribed services;
 
 
1.5
the term " Prescribed Areas " means Israel or in any other part of the world in which the Company conducts its business;
 
 
1.6
the term " Prescribed Customers " means any person who is or was a customer of the Company at the termination date; or who is or was a customer of the Company at the termination date or who was a potential customer with which I had been engaged in negotiations with a view to doing business on behalf of the Company within the period of 6 (six) months preceding the termination date;
 
 
1.7
the term " Prescribed Goods " means any products sold by the Company in the ordinary course of business as at the termination date or which is then included in any strategic plan of the Company;
 
 
1.8
the term " Prescribed Services " means any services rendered by the Company in the ordinary course of business as at the termination date or which is then included in any strategic plan of the Company;
 
 
 

 
 
 
1.9
the term " Prescribed Suppliers " means any person who is or was a supplier of prescribed goods and/or prescribed services to the company at the termination date;  or is or was a supplier of prescribed goods and/or prescribed services to the company at the termination date with which I had been engaged in negotiations with a view to doing business on behalf of  the company within the period of 6 (six) months preceding the termination date;
 
 
1.10
the term R estraint Period ” means a period of 12 (twelve) months calculated from the termination date;
 
 
1.11
the term “ Termination Date ” means the date upon which my employment by the company ceases or is terminated for any reason whatsoever;
 
2.
I am fully aware that the Confidential Information and Confidential Documents are the  exclusive property of the Company, and that they were made or shall be made available to me and for my use solely for the purpose of my work as an employee of the Company.
 
3.
I undertake towards the Company as follows:
 
 
3.1.
to maintain as fully confidential all Confidential Information and Confidential Documents;
 
 
3.2.
not to disclose or divulge to any third party, or allow any third party access to any of the Confidential Information or Confidential Documents, or use any of thereof, whether directly or indirectly, save exclusively for the purposes of my work as an employee of the Company.
 
 
3.3.
not to misuse any of the Confidential Information or Confidential Documents, or any part  thereof, in a manner other than the usual use of the Confidential Information and Confidential Documents and for a purpose other than the purpose for which the Confidential Information and Confidential Documents were divulged to me.
 
 
3.4.
not to make public or divulge in any way the Confidential Information and Confidential Documents or any part  thereof.
 
 
3.5.
not to duplicate, copy, scan, or create in any other way copies of the Confidential Documents or any part thereof, except for the purpose for which the Confidential Information and Confidential Documents were divulged to me.
 
 
3.6.
Not not challenge the Company's intellectual property rights in any way, including without limitation, by filing to any court, patent or other authority, a claim, opposition or request for cancellation against such rights. The provisions of this Section 3.6 shall survive termination.
 
 
3.7.
upon demand from the Company, at any time whatsoever, to return to the Company the Confidential Information and Confidential Documents or any part thereof or copies thereof in any form whatsoever, and to, if so required, confirm in writing to the Company that all the Confidential Information and Confidential Documents or any copies thereof in any form whatsoever which had been in my possession have been returned to the Company, and that I did not retain any copies of it, including copies made by electronic forms.
 
 
B - 2

 
 
 
3.8.
not to remove from the Company’s premises or take for my use any of the Confidential Information and Confidential Documents without the Company’s prior written approval, unless if such removal is made strictly for the purposes of performing my undertakings towards the Company.
 
4.
I agree and accept that:
 
 
4.1.
The Company reserves all rights in any inventions, patents, copyrights, designs, and any other intellectual property invented or devised by it in relation to the Confidential Information and Confidential Documents.
 
 
4.2.
Any invention including any patent or patent application and any copyrights or any other intellectual property (the “ IP ”) invented or created by me during my employment with the Company or as a result of my employment with the Company, shall be the exclusive property of the Company, and I do not have and shall not have any demand or claim against the Company relating to the IP. I undertake to sign any document and to do any other act required in order to register the said rights in the name of the Company, or to prove the Company’s rights, if and to the extent that this is required in the opinion of the Company and/or the Company’s legal advisors.
 
 
4.3.
I shall not challenge the Company's IP in any way, including without limitation, by filing to any court, patent or other authority, a claim, opposition or request for cancellation against such  rights
 
5.
The restrictions of use and disclosure set forth in this undertaking shall not apply to any Confidential Information and Confidential Documents which after they were disclosed became, available to the general public, through no breach of a confidentiality undertaking towards the Company.
 
6.
It is recorded that in the course of his my duties I (i) have acquired and/or will acquire considerable know-how in and will learn of the Company's techniques relating to the business; (ii) will have access to names of customers with whom the Company does business whether embodied in written form or otherwise; (iii)will have the opportunity of forging personal links with customers of the company; and (iv) generally will have the opportunity of learning and acquiring the trade secrets, business connections and other confidential information appertaining to the Company's business.
 
I acknowledged that the only effective and reasonable manner in which the Company's rights in respect of its business secrets and customer connections can be protected is the restraint I am imposing upon myself as set forth hereunder. Therefor, in consideration of the Non Competition Payment, as set in my Employment Agreement, I hereby undertake that during the term of my employment with the Company and for the duration of the Restraint Period, whether as proprietor, partner, director, shareholder, member, employee, consultant, contractor, financier, agent, representative, assistant, trustee or beneficiary of a trust or otherwise and whether for reward or not, directly or indirectly, I shall not -
 
 
6.1
carry on or be interested or engaged in or concerned with or employed by any company, close corporation, firm, undertaking or concern which carries on, in the Prescribed Areas any business which sells Prescribed Goods and/or Competing Goods or renders Prescribed Services or Competing Services or in the course of which Prescribed Goods or Competing Goods are sold and/ or Prescribed Services or Competing Services are rendered;  provided that I shall not be deemed to have breached my undertaking by reason of my – (i) holding shares in the Company;  or (ii) holding shares in any company the shares of which do not in aggregate constitute more than 5% (five per cent) of any class of the issued share capital of such company and which are listed on a recognised stock exchange if the shares owned by me or by my relatives (as defined in the Israeli Companies Act 1999) which do not in the aggregate constitute more than 5% (five per cent) of any class of the issued share capital of such company.
 
 
B - 3

 
 
6.2
 
 
6.2.1
not to solicit, on my own account or for any other person, the services of, or endeavor to entice away from the Company any director, employee, consultant or a subcontractor of, or any other person related to the Company, who during the period of 12 months prior to such termination occupied a   senior or managerial   position in relation to the Company, and/or who was likely (in the opinion of the Company) to be: (i) in possession of Confidential Information; or (ii) able to influence the customers’ connections of the Company (whether or not such person would commit any breach of his contract of employment or engagement with the Company).
 
 
6.2.2
furnish any information or advice (whether oral or written) to any prescribed customer that I intend to or will, directly or indirectly, be interested or engaged in or concerned with or employed by any company, close corporation, firm, undertaking or concern carried on in any of the Prescribed Areas which sells Prescribed Goods and/or Competing Goods or renders Prescribed Services and/or Competing Services or in the course of which Prescribed Goods and/or Competing Goods are sold and/or Prescribed Services or Competing Services are rendered during the Restraint Period;  or
 
 
6.2.3
furnish any information or advice (whether oral or written) to any Prescribed Customer or use any other means or take any other action which is directly or indirectly designed, or in the ordinary course of events calculated, to result in any such Prescribed Customer terminating his association with the company and/or transferring his business to or purchasing any Prescribed Goods or Competing Goods or accepting the rendering of any Prescribed Services or Competing Services from any person other than the company, or attempt to do so.
 
 
6.3
solicit orders from Prescribed Customers for the Prescribed Goods and/or any Competing Goods and/or the Prescribed Services and/or any Competing Services; or canvass business in respect of the Prescribed Goods and/or any Competing Goods and/or the Prescribed Services and/or Competing Services from Prescribed Customers; or sell or otherwise supply any Prescribed Goods and/or Competing Goods to any Prescribed Customer; or render any Prescribed Services and/or Competing Services to any Prescribed Customer; or purchase any Prescribed Goods and/or Competing Goods from any Prescribed Supplier or accept the rendering of any Prescribed Services and/or Competing Services from it; or solicit appointment as a distributor, licensee, agent or representative of any Prescribed Supplier in respect of Prescribed Goods and/or Prescribed Services, including on behalf of or for the benefit of a Prescribed Supplier.
 
 
B - 4

 
 
 
6.4
Each of the undertakings set out in this Section 6 (including those appearing in a single sub-section) is severable inter alia as to (i) the nature of interest, act or activity; (ii) the categories of persons falling within the definition of prescribed customers; (iii) the categories of goods falling within the definition of the Prescribed Goods and Competing Goods; (iv) the categories of services falling within the definition of the Prescribed Services and Competing Services; and (v) the categories of persons falling within the definition of Prescribed Supplier;
 
7.
It is agreed and recorded that, without prejudice to any right or remedy which is available to the Company under any law or agreement, the unauthorized disclosure or use of any Confidential Information and Confidential Documents or a breach of my undertakings pursuant to Section 6 above, will cause immediate or irreparable injury to the Company and that the Company can not be adequately compensated for such injury in monetary damages, then, in order to safeguard the Company from any possible breach of confidentiality, I consent in advance that the Company will be permitted to obtain, from any Court or Tribunal, any temporary or permanent injunctive relief necessary to prevent such unauthorized disclosure or use, or threat of unauthorized disclosure or use.
 
8.
This Undertaking shall form an integral part of my employment agreement with the Company and a breach of any of my obligations hereunder, shall also constitute a material breach of such employment agreement.
 
9.
This Undertaking shall be governed by the laws of the State of Israel and the competent courts in Tel-Aviv shall have exclusive jurisdiction in all matters pertaining or relating thereto.
 
10.
If any condition, term or covenant of this Agreement shall at any time be held to be void, invalid or unenforceable, such condition, covenant or term shall be construed as severable and such holding shall attach only to such condition, covenant or term and shall not in any way affect or render void, invalid or unenforceable any other condition, covenant or term of this Agreement, and this Agreement shall be carried out as if such void, invalid or unenforceable term were not embodied herein.
 
11. 
Unless specifically limited herein, my undertakings hereunder shall be valid: (i) during the term of my employment in the Company, and unless the Company waived such right in writing, following termination of my employment with the Company without time limitation; (ii) in Israel or outside Israel, and - (iii) whether such undertakings may or may not be registered under any register prescribed by law.
 
Date:  6/8/2013
 
/s/ Shay Tomer                                  
 
   
(signature)
 
       
 
Name: Shay Tomer
 
 
B - 5


 
 


Exhibit 10.11
 
English translation from original document in Hebrew
 
Personal Employment Agreement
 
That was signed in Rosh Pina on the 2nd day of the month of June 2013
 
By and between
 
On Track Innovations Ltd.
A public Company registered in Israel from the Industrial Zone Z.H.R, Rosh Pin (hereinafter the " Company ")
 
-of the first part-
 
And
 
Shlomi Eytan Identity certificate no. 032171621
26 Avnei Chen Street, Tel Mond
(hereinafter the " Employee "),
 
-of the second part-
 
Whereas:
the Employee wishes to be employed by the Company at the Position of Chief Sales and Marketing Officer (hereinafter the " Position ") and the Company wishes to employ him in this Position, all subject to the terms and provisions set forth hereafter in this agreement;
 
And whereas:
the Employee declares that there is nothing preventing him from entering into this agreement and that he has the abilities, experience and skills required for fulfilling the Position and he has expressed his wish to be employed by the Company at the Position,
 
And whereas:
the parties wish to put the terms of the Employee's employment in writing, in this agreement all as set forth hereafter in this agreement and subject to the terms and provisions included in it.
 
Therefore it was stipulated, declared and agreed between the parties as follows:
 
A.            General
 
1.
The preamble of this agreement constitutes an integral part of this agreement.
 
2.
The appendixes of this agreement are an integral part of this agreement.
 
3.
The titles of the sections are for the purpose of convenience only and they shall not be used to interpret any of the terms of this agreement.
 
B.             The Employment
 
4.
This agreement fully contains the terms and provisions that apply to the employment of the Employee by the Company. No agreements and/or general and/or special collective agreements or others shall apply to the employment relationship between the parties and the employment relationship shall be determined in this agreement only.
 
 
 

 
 
5.
The Employee's Undertakings:
 
The Employee hereby undertakes:
 
 
5.1.
To perform the job diligently honestly and faithfully, in any place, in Israel and abroad, in accordance with instructions that he shall receive from time to time from his supervisors, and for this purpose he shall dedicate his time, efforts, abilities and experience insofar as necessary and required. The Employee shall not engage in any work or engagement that is not within the framework of his employment in the Company without the Company's prior written approval.
 
 
5.2.
There is nothing preventing him, whether according to agreement or otherwise from entering into this agreement and performing his undertakings according to it.
 
 
5.3.
According to the management's demand, the Employee shall go through medical examinations and/or other tests and/or he shall furnish medical certificates and/or medical statements regarding the condition of his health, insofar as he shall be required for checking his suitability to the Position.
 
 
5.4.
The Employee undertakes to notify the Company regarding any change in the condition of his health and to cooperate with the Company, if it shall demand according to its discretion, medical documents or it shall refer him to a medical examination.
 
 
5.5.
The Company undertakes that it shall carefully keep all of the medical details, and only use them for the purpose of insurance and/or with respect to his ability to fulfill his Position.
 
 
5.6.
All the details that he gave the Company at the time of presenting his candidacy to the Position are full, correct and accurate, and he undertakes to notify the Company regarding any change that shall occur in them.
 
 
5.7.
The Employee undertakes to notify the Employer, immediately without any delay, of any matter or issue in respect to which he has a personal interest and that could create a conflict of interests with his Position at the Company.
 
D.             Work Hours
 
6.
It is agreed by the parties that the Employee's Position is a managerial position that requires a special amount of personal trust, therefore the provisions of the Work Hours and Rest Law, 5711- 1951 shall not apply to his employment (hereinafter the " Work Hours and Rest Law ") and the Employee shall not be entitled to receive any special or additional consideration from the Company for working overtime.
 
E.             Consideration
 
7.
The Company shall pay the Employee, in consideration for his employment in the Company, a monthly salary as set forth in the notice regarding employment terms which is attached to this agreement as appendix A (hereinafter the " Effective Salary ").
 
8.
The Effective Salary shall be updated in accordance with the cost of living as shall apply to the entire economic market, and subject to the periodic decision of the management.
 
9.
The components of the salary shall be updated, if at all, according to the Company's sole discretion, once per year in the month of January.
 
10.
The Effective Salary alone shall constitute the basis for making allocations for social benefits as mentioned in this agreement and for severance pay.
 
 
 

 
 
11.
It is hereby clarified that any grant and/or participation in costs and/or refund of costs and/or any other benefit which the Employee shall receive (if at all), do not constitute a part of the Effective Salary for receiving social benefits, including severance pay and/or allocations made to the different funds.
 
F.            Annual Vacation, Sickness Pay and Convalescence Pay
 
12.
The Employee shall be entitled to annual vacation as set forth in appendix A .
 
13.
The Employee shall coordinate his vacation with the Company and with the approval of his direct manager at least 14 days in advance.
 
14.
It is hereby clarified that vacation days may not be accumulated beyond two annual accumulated quotas, and that the unused vacations days beyond the permitted accumulation as mentioned above shall be erased unless it was otherwise agreed between the parties in writing.
 
15.
The Employee shall be entitled to sickness pay in accordance with the Sickness Pay Law, and against presenting medical certificates.
 
16.
After the Employee shall complete one full year of employment he shall be paid convalescence pay in accordance with the amounts and rules, as shall be determined from time to time in agreements between the Coordination Office of the Economic Organizations and the Histadrut.
 
G.            The Term of the Agreement
 
17.
This agreement shall come into effect on the date of its signature for an unlimited period.
 
18.
Notwithstanding the aforesaid, each of the parties may terminate this agreement for any reason and without any reason, and this is by giving a prior written notice as mentioned in appendix A .
 
19.
During the early notice period the Employee shall continue his Position, and he shall transfer the Position in an efficient and organized manner to his replacement, in accordance with the Company's decision. Notwithstanding the aforesaid, the Company may forgo the Employee's work during the early notice period, all or in part.
 
20.
During the early notice period, whether the Employee worked in full or in part, or not, the Employee shall be entitled to his full salary in addition to all the various benefits that accompany it. Notwithstanding the aforesaid, the Company shall be entitled to notify the Employee of the immediate severance of the employment relationship and pay him consideration for the early notice (in the amount of the monthly salary that the Employee would have earned had he continued to work during the early notice period), and in this case the Employee shall be entitled to early notice pay only.
 
21.
Notwithstanding the aforesaid, the Company shall be entitled to immediately dismiss the Employee without early notice in cases of breach of trust; he maliciously caused damage to the Company or its property; he was convicted of a criminal offense with respect and/or as a result of the Position; he was convicted of a shameful criminal offense.
 
H.            Provident Funds, Supplementary Study Fund and Managers Insurance
 
22.
If and insofar it was determined in appendix A , the Company shall make allocations to a pension fund and/or managers insurance or provident fund and/or supplementary study fund in the name of the Employee.
 
 
 

 
 
23.
The Company shall transfer the payments required each month and it shall deduct from the Employee's salary a parallel sum for the Employee's share as mentioned in appendix A .
 
24.
For the sake of avoiding doubt, payments to the pension fund and/or managers insurance, if and insofar as he is entitled to them in accordance with appendix A , shall be calculated according to the Effective Salary as defined above.
 
25.
It is hereby clarified that the payments of the Employer to the pension fund and/or managers' insurance shall be in lieu of the Employee's entitlement to severance pay, as this term is defined in section 14 of the Severance Pay Law, 5723- 1963.
 
I.             Termination of Employment
 
26.
If the Employee's employment in the Company has been terminated for any reason, except in the case of dismissal in circumstances that deny the Employee the right to receive severance pay, the Employee shall be entitled to receive all of the sums that have accumulated in his favor, including the relative share of the commissions set forth in appendix A, and all the sums that were allocated for pension (insofar as allocated), whether from his allocations or from the Company's allocations, including all the linkage differences, interest and profits that have accumulated in that fund for such allocations.
 
27.
The Company and the Employee have adopted for the purpose of this agreement the General Approval regarding Employers' Payments to a Pension Fund and Insurance Fund in lieu of Severance Pay according to the Severance Pay Law, 5723- 1963 (section 14 of the law), as published with the signature of the Labor Minister on the 30 th of June 1998 and which was published in the official gazette 4659 (hereinafter the "Order of the Minister of Labor"). The version of the order of the Minister of Labor is attached to this agreement as appendix C.
 
28.
The Company's payments, as mentioned above shall be in place of 100% severance pay that shall be due to the Employee or to his survivors for the salary for which the payments were paid and for the period that they were paid (hereinafter the " Absolved Salary ")
 
29.
The order of the Ministry of Labor shall apply to the Company's allocations however this cannot derogate from the Employee's right to severance pay according to law, collective agreement, expansion order, or labor agreement, for wages beyond the absolved salary.
 
30.
If the Employee's employment was terminate due to his resignation or due (God forbid) to reasons that prevent the continuation of his work in the Company (including his death) the Employee shall be entitled (or his survivors shall be entitled, respectively):
 
 
30.1
To receive from the Company the monthly salary for only the part of the period of the year that he actually worked, furthermore the relative share of the commissions set forth in appendix A.
 
 
30.2
To receive from the compensation fund all the sums that have accumulated in his favor in this fund for the allocations made to the provident fund, whether from his allocations or from the Company's allocations, including all the linkage differences, interest and profits that have accumulated in this fund and to receive the allocations that have accumulated in his favor in the supplementary study fund, whether from his allocations or whether from the Company's allocations.
 
31.
It is hereby agreed and declared that in the event that the dismissal of the Employee is due to a breach of trust or other fundamental breach by him of his undertakings towards the Company according to this agreement, including inter alia, with respect to confidentiality and non – competition including dismissal in circumstances that deny according to any law, the Employee his right to severance pay, then notwithstanding the provisions in this agreement, the Employee shall not be entitled to receive an early notice of his dismissal or early notice pay for this dismissal and he shall not be entitled to severance pay and the Company shall be entitled to demand that he return all the sums that it transferred to the severance pay fund on account of severance pay as mentioned, including any linkage differences, interest and profits that have accumulated in this fund for these sums.
 
 
 

 
 
32.
At the end of the Employee's employment in the Company the Employee shall deliver to the Company all of the documents, information and any material or other property that he received or that was prepared by him with respect to his employment in the Company.
 
33.
For the sake of avoiding doubt the Employee shall not have a right of offset and/or the right of lien against the Company with respect to any property or money of the Company that the Employee holds or with respect to any debt of the Employee to the Company.
 
J.              Professional Trips Abroad
 
34.
The Employee is aware, that in the framework of his Position he shall be sent from time to time, by the Company abroad for various periods.
 
35.
The Employee undertakes to fulfill all of the instructions and guidelines of the Company in the framework of such mission.
 
36.
It is hereby agreed that with respect to trips above 14 days, a departure day shall not be determined until after consulting with the Employee.
 
37.
The Employee's refusal to travel abroad in the framework of his Position, after he was requested to do so by the Company without any relative reason constitutes a breach of his duties as an Employee.
 
38.
The Company will pay the travel costs, accommodations and per diem abroad in accordance with the Company's policy, as shall be determined from time to time.
 
K.            Confidentiality and Non - Competition
 
39.
The Employee hereby declares that he is aware that in light of the Company's business the maintaining of confidentiality of all information and/or document that he shall receive during his employment is very important, and he undertakes to maintain confidentiality in accordance with the confidentiality agreement attached hereto as appendix C of the agreement.
 
40.
The Employee hereby undertakes:
 
 
40.1
Not to enter into a contractual engagement, directly or indirectly, with a customer of the Company and/or companies associated with it, whether as self employed or whether employed under salary, including by a partnership or holding by himself or by others, of management shares or rights in any corporations, during the term of this agreement and for an additional term of 12 months after the end of the term of this agreement, in any matter connected to the Company's business, except in the framework of his employment for the Company. It is clarified that a list of customers and/or suppliers and/or a marketing layout and/or any other list that was used in the Employee's regular activities in the framework of his employment in the Company are a commercial secret of the Company. The Employee undertakes not to exploit and/or use these lists, unless the Company has given its express written consent.
 
 
40.2
Not to engage during the term of this agreement and for an additional term of 12 months after the end of the term of this agreement, for any reason, in Israel or anywhere else in the world, whether directly or indirectly, in a business, Position, work or any other engagement in the field of contact/ contactless smart cards or any other field competing with the Company's business and/or the Company's associated with it.
 
 
 

 
 
 
40.3
Not to harm in any manner the Company's reputation or the reputation of any of the Company's shareholders or the Company's reserve of customers.
 
41.
The Employee and the Company hereby declare that the Effective Salary as defined in this agreement was agreed by them taking into consideration, inter alia, the non- competition restrictions that apply to the Employee according to section 43 above.
 
L.            Intellectual Property and Service Inventions
 
42.
Any invention, patent, copyright, trademark, commercial secret, knowhow and information that were developed by the Employee as a result of his employment in the Company and/or during his employment in the Company shall belong to the Company, and the Employee undertakes to sign any document that shall be required for realizing the Company's rights as mentioned.
 
M.            Miscellaneous
 
43.
The payments and benefits of any type and kind that are granted to him according to this agreement are subject to income tax deductions and other obligatory deductions which the Company must deduct according to any law and nothing stated in this agreement shall be construed as imposing on the Company the duty to pay tax or any other obligatory payment that applies to the Employee except for the benefit value of meals which shall be grossed up by the Company or if otherwise agreed.
 
44.
The terms of his employment in the Company are regulated only according to this personal employment agreement between him and the Company and except for the express provisions in this agreement the Employee shall not be entitled to any other payments or benefits for his employment and the termination of his employment in the Company.
 
45.
This Company shall take the place of all prior written or verbal agreements between the Company and the Employee.
 
46.
Any change and/or cancellation of any of the sections of this agreement shall be made only in a written document which shall be signed by both parties.
 
47.
The parties' addresses for the purpose of this agreement shall be as mentioned in the title of this agreement and any notice, document or court document that shall be sent by one party to the other according to the addresses above shall be considered as having reached their destination, if personally delivered – at the time of their delivery, and if delivered by registered mail – at the end of 72 hours after they were sent as mentioned.
 
In witness whereof the parties have signed:
 
/s/ Dalit Bizan
VP of Human Resources
  /s/ Shlomi Eytan
On Track Innovations Ltd.
 
The Employee
 
Date: 2 nd of June 2013
 
 
 

 
 
Appendix B
 
General Approval regarding the Payments of Employers to a Pension Fund and Insurance Fund
instead of the payment of Severance Pay according to the Severance Pay Law, 5723- 1963
 
By virtue of my authority according to section 14 of the Severance Pay Law 5723 – 1963, (hereinafter the "Law") I confirm that payments that the Employer paid starting from the date this approval was published, for his Employee for comprehensive pension in a pension provident fund which is not an insurance fund as defined in the Income Tax Regulations (Rules for Approving and Managing a Provident Fund) 5724 – 1964 (hereinafter: "Pension Fund"), or managers insurance including the possibility of a pension or a combination of payment to a pension plan and to plan which is not a pension plan in an insurance fund as mentioned above (hereinafter: "Insurance Fund"), including payment that he paid while combining payments to a pension fund and to an insurance fund whether there is a pension plan in the insurance fund or not (hereinafter: the "Employer's Payments") shall be in lieu of severance pay due to the Employee for the salary from which these payments were paid to the fund and for the period which they paid (hereinafter: the "Absolved Salary") provided the all of the following have existed:
 
The Employer's Payments-

(a)
To the pension fund are not less than 14 1/3% of the Absolved Salary or 12% of the Absolved Salary if the Employer pays for his Employee in addition to this also payments to supplement severance pay to a pension provident fund or to an insurance fund in the name of the Employee in the amount of 2 1/3% of the Absolved Salary. If the Employer did not pay in addition to the 12% also 2 1/3% as mentioned, his payments shall come instead of 72% of the severance pay of the Employee, only.

(b) 
To an insurance fund, not less than one of the following:
 
(1)
13 1/3 % of the Absolved Salary, if the Employer also paid in addition to this payments to ensure monthly income in the event of loss of ability to work, in a plan that was approved by the Supervisor of the Capital Market and Savings in the Finance Ministry at the rate required in order to ensure 75% of the Absolved Salary at least or at a rate of 2 1/2 % of the Absolved Salary, whichever is the lower of the two (hereinafter: "Payment to Disability Insurance");
 
(2)
11% of the Absolved Salary, if the Employer also paid in addition Payment to Disability Insurance, and in this event the Employer's payment shall come instead of only 72% of the Employee's severance pay. If the Employer paid in addition to this also payments to supplement severance pay to the severance pay provident fund or insurance fund in the name of the Employee at the rate of 2 1/3% of the Absolved Salary the Employer's payments shall come instead of 100% of the Employee's severance pay.
 
2.
A written Agreement was executed between the Employer and the Employee not later than three months after the Employer's payments have begun to be paid in which –
 
(a)
The Employee has agreed to the arrangement according to which this approval in the version specifying the Employer's payments to the pension fund and insurance fund respectively. The version of this approval will be included in the mentioned Agreement;
 
(b)
An advance waiver of the Employer of any right that he might have to a refund of funds from his payments, unless the Employee's right to severance pay has been denied in a judgment by virtue of section 16 or 17 of the Law or the Employee withdrew funds from the pension fund or the insurance fund not as a result of an Entitling Event. "Entitling Event" shall mean - death, disability or retirement at the age of sixty or more.
 
3.
This approval does not derogate from the Employee's right to severance pay according to the law, collective Agreement, expansion order or employment Agreement, for salary beyond the Absolved Salary.
 
 
Eliyahu Ishai
 
Minister of Labor and Welfare
 
 
 

 
 
Appendix C
 
On Track Innovations Ltd.
 
Written Undertaking regarding Confidentiality, Intellectual Property and Non- Competition
 
I the undersigned, Shlomi Eytan, bearer of identity certificate number 032171621 hereby declare and undertake towards On Track Innovations Ltd., and any other subsidiary of it or Company associated with it (jointly and separately hereafter the "Company"), as follows:
 
1.
In this document the terms set forth hereafter shall have the meaning stipulated at their side:
 
 
1.1.
"Secret Information" means any secret information or commercial secret of any type and kind of the Company or with respect to the Company or its business or concerning any of the Company's shareholders or its customers or the business of any of the Company's shareholders or that concerns future plans of the Company regarding the manner of managing its business, including an information connected to products produced by the Company or their development, their manufacture or marketing to the Company's customers, to the Company's calculations, the Company's relationship with its customers and its suppliers, to financial information and other information concerning the Company's business and the products manufactured or developed by the Company including any information concerning the intellectual property rights including patents, models, copyrights and the technology that the Company uses or develops with respect to the Company's products.
 
 
1.2.
"Secret Document" the drawings, accounts, specifications, printouts, disks, magnetic film, computer programs, compact discs, work papers and any document or database that includes the secret information all or in part, whether it was prepared by the Company or for it; any document of any type and kind that were used by me or shall be used by me with respect to my work in the Company.
 
 
1.3.
The "Agreement" means the employment agreement of the 2 nd of June 2013 which was sold between me and the Company.
 
2.
I am aware of the fact all the secret documents all of them without any exception, that include the secret information or any part of it, or that are connected to it, shall be considered for all intents and purposes and at any time the Company's sole property, and I do not have and I shall not have any rights in the secret information or in the secret documents including in any development or future improvement that shall be made in the framework of my work for the Company or with respect to it.
 
3.
I hereby confirm and undertakes towards the Company as follows:
 
 
3.1.
To keep complete secret and not to disclose to another or to others the secret information or the secret documents or any part of them, whether directly or indirectly or whether in any other manner, and not to harm in any way the Company's reputation or any of the Company's shareholders or the Company's reserve of customers.
 
 
3.2.
Not to make any use, exploitation or implementation of the secret information or the secret documents or any part of them except for the use required for implementing the purpose for which the secret information or the secret documents have been given to me by the Company.
 
 
3.3.
Not to publish the secret information or the secret documents or any part of them in any manner.
 
 
 

 
 
 
3.4.
Not to copy, not to photograph, not to photocopy and not to create in any other manner copies of the secret documents or any part of them, including by copying them by computer, except only that is required for implementing the purpose for which the secret information or the secret document have been given to me by the Company or for performing the work for the Company.
 
 
3.5.
To return to the Company the secret information and the secret documents including any copy that was made of them, no later than at the end of completing the use of them for the purpose for which the Company gave me the secret information or the secret documents or no later than within 24 (twenty four) hours after I was required to do so by the Company, or at the time my employment is terminated by the Company – whichever is the earlier of these times, without any copies of the secret information and the secret document being left with me, including copies that were made by computer.
 
 
3.6.
Not to remove from the Company's office or take for my private use any secret information or secret documents without the prior written permission of the Company, provided that it is required only for performing the work for the Company in the framework of the Position.
 
4.
I agree that:
 
 
4.1.
Any secret information and secret documents and any other information that was made and/or developed by me during the period of my employment shall be and shall remain under the Company's sole ownership.
 
 
4.2.
The Company reserves all the rights in any patent, copyrights or any other copyright that was invented or planned by the Company with respect to the secret information and the secret documents.
 
 
4.3.
Any information including any patent or patent request, trademarks, service marks, drawings, moral rights (droit moral), and any copyrights or other intellectual property rights (jointly hereinafter referred to as the "Intellectual Property Rights") that were invented or created or that shall be invented or created during the period of my employment for the Company, as a result of my work or with respect to my work for the Company, shall be, from the date of their creation, intellectual property exclusively owned by the Company, and I do not have and I shall not have any claim or lawsuit against the Company with respect to the intellectual property rights. I undertake to sign any document and to take any action that shall be required for registering the rights as mentioned in the name of the Company or to prove the Company's rights, if this is required according to the Company and/or its legal advisors.
 
 
4.4.
If the Company shall not be able as a result of my emotional or physical condition or as a result of my refusal to cooperate with the Company to guarantee my signature on an application according to any law to register a patent or copyrights in the name of the Company (as mentioned in section 4.3 above) then I hereby grant an absolute and irrevocable general power of attorney to the Company and/or any of its Employees that are authorized to sign on its behalf and/or to act on its behalf in order to submit a registration application and to act in order to obtain registration of a patent or copyright in the name of the Company. This section 4.4 is the same as a power of attorney as mentioned.
 
 
4.5.
Without derogating from the generality of the aforesaid I undertake not to submit an objection and/or to object in any way the Company's intellectual property rights including, inter alia, regarding patents or patent applications of the Company and/or on its behalf.
 
 
 

 
 
5.
Taking into consideration the fact that the Company shall invest much resources in my training for performing my work in the Company that are expressed, inter alia, by, becoming familiar with the field which the Company engages in and in consideration for the non- competition remuneration paid to me according to the agreement, I hereby undertake towards the Company:
 
 
5.1.
Not to enter into any contractual engagement, directly or indirectly with a customer of the Company or any of the associated companies (whether as an Employee, consultant, self employed or otherwise) for the period of 12 months after the end of the term of the agreement, in any matter that is connected to the Company's business, except in the framework of my employment for the Company.
 
 
5.2.
Not to engage, during the term of this agreement and for an additional period of 12 months after the term of this agreement for any reason, in Israel or any other place in the world, whether directly or indirectly, in any business, Position, work or other engagement in the field of contact/ contactless smart cards or in the field of parking, parking lots and toll roads, that competes with the Company's business and/or the business of its associated companies.
 
 
5.3.
Not to persuade, in my favor or in the favor of any third party, any directly, Employee or consultant of the Company to leave the Company or to grant services to another, for a period of 12 months before the end of my employment for the Company who filled a central Position or managerial Position with respect to the Company and/or it is probable (according to eh Company) that he had in his possession secret information or that he could affect the Company's relationship with its customers (whether if this person shall breach the employment agreement or contractual engagement with the Company or not).
 
6.
I hereby agree without derogating from any right or remedy available to the Company according to law or agreement, prohibited use or disclosure of the secret information or the secret documents or a breach of my other undertakings as mentioned in this written undertakings shall cause immediate and irreparable damage to the Company and that financial compensation shall not suffice to compensate the Company due to this, and therefore in order to protect it against a possible breach of my obligation of secrecy towards it, I agree in advance that the Company shall be entitled to receive, in any court or any other legal instance, any temporary or permanent remedy that is required in order to prevent such prohibited disclosure or use, or threat to disclose or use the secret information as mentioned.
 
7.
I confirm that a breach of any of my undertakings according to this written undertaking by any other person on my behalf that has been exposed to the secret information and/or the secret documents shall be considered as a breach of this written undertaking by me.
 
8.
Except of otherwise limited in this document, my undertakings according to this written undertaking shall be in force: (a) for the entire period of my employment for the Company, except if the Company waived this in writing, after my work for the Company ended without any limit in time; (b) whether in Israel or outside of Israel; and (c) whether these undertakings may be registered according to law or not.
 
9.
This written undertaking constitutes an integral part of my employment agreement by the Company and a breach of my undertakings according to this undertaking shall also constitute a breach of my employment agreement.
 
10.
If a term or provision of this written undertaking shall be considered at any time as invalid or unenforceable, such term or provision shall be considered as being excluded and such determination shall refer to these terms or provisions only and they shall not affect in any way the other provisions of this written undertaking and this written undertaking shall be performed as if the term or provision which are null and void or unenforceable are not included in it.
 
11.
I confirm by my signature below that I have carefully read the provisions of this written undertaking above, and the undertakings set forth above which I have taken upon myself are clear to me.
 
In witness whereof I have signed on the 2 nd of the month of June 2013
 
 
/s/ Shlomi Eytan
Shlomi Eytan
 
 
signature
 
 
 




Exhibit 10.12
 
PERSONAL EMPLOYMENT AGREEMENT

Signed and executed in Rosh Pina, as of the 22 day of December 2013
 
Between:
On Track Innovations Ltd. (Reg. No. 52-004286-2)
 
 
a public company registered in Israel
 
 
of Z.H.R. I.Z., Rosh Pina 12000 (the " Company ")
 
   
of the one part
     
And:
Ofer Tziperman (ID No.057438244)
 
 
of 2 Leshem St., PO Box 204, Shimsheet 17906, Israel
 
 
(the " Employee ")
 
   
                                                                              on the other part
 
Whereas
the Employee has been employed by the Company’s subsidiary PARX Ltd., since January 16 th , 2011 as President of PARX and EasyPark Ltd. (hereunder referred to as the “ Subsidiaries ”), and the Company wishes to employ the Employee, in addition to his foregoing roles in the Subsidiaries, as its Chief Executive Officer (the " Position ") from the date of the approval of his appointment to the Position by the Company’s board of directors on March 7, 2013 (the " Effective Date ") and thereafter, subject to the terms and conditions set forth below in this Agreement, and provided the terms of employment according this Agreement shall be approved by the Company’s General Meeting as required by the law; and

Whereas
the Employee warrants that he has the qualifications and skills required for the purposes of performing the Position and that there is no hindrance - legal, contractual or otherwise - for the execution by him of this Agreement.

NOW THEREFORE, THE PARTIES HAVE AGREED AS FOLLOWS:
 
1.
Nature of the Agreement - General and Applicability

 
1.1.
Subject to the approval of the Company’s General Meeting as aforesaid this Agreement exhaustively prescribes the terms and conditions applicable to the Employee's terms of employment with the Company and its Subsidiaries from the Effective Date and thereafter, and accordingly this Agreement shall replace any prior arrangements or terms of employment of the Employee and no collective or other special agreements, including his existing employment agreement in regards the Employee’s employment at the Subsidiaries, shall apply to the employment relations between the Employee and the Company and its Subsidiaries. It is herein clarified the employment terms set forth herein shall apply to the employment of the Employee in the Position, even if his employment at any of the Company’s subsidiaries is expired or terminated.
 
 
 

 

 
 
1.2.
It is hereby warranted and agreed that the Employee, whose employment started on January 16 th 2011 as President of the Subsidiaries, unless otherwise agreed in writing by the Parties, will continue to perform his roles and duties in the Subsidiaries as prescribed hereunder; however, the provisions of this Agreement shall replace the existing terms of employment of the Employee in the Subsidiaries and only this Agreement shall apply to the Employee from the Effective date and thereafter relating to the employment of the Employee in the Position and his employment at the Subsidiaries. For the avoidance of doubt it is herein agreed that  for the purposes of this Agreement and the calculation of the Employee’s seniority and employment rights according to it, all and any of the Employee’s rights will be calculated from the commencement of the Employee’s work on January 16, 2011.

 
1.3.
Notwithstanding the foregoing, the Parties agree that section 15 of the Employee’s employment agreement with Parx Ltd shall remain in full force and effect for purposes of this Agreement, under which the Employee was granted stock options of the Company equivalent to the four percent (4%) of the then total outstanding shares of Parx Ltd., vested in equal annual installments during a four year vesting term, each installment to be vested at the end of a vesting period of 12 months of employment, excluding in the event Parx Ltd. perform a public offering (IPO), or is merged, acquired or sold to a third party (“Sell Event”), where in such event the aforesaid vesting period shall be accelerated and the Employee shall be entitled to exercise forthwith his then remaining outstanding stock options. The Parties acknowledge it was also agreed that if Parx Ltd., before such Sell Event, shall allocate additional outstanding shares of Parx Ltd. to third parties, within such transaction it will allocate to the Employee any additional number of stock options necessary to preserve that the Employee is entitled to hold up to four percent (4%) of the outstanding shares of Parx Ltd after such Sell Event.

2.
The Employee's Duties

 
2.1.
The Employee shall be employed in the position of Chief Executive Officer (“ CEO ”) of the Company and CEO of the Subsidiaries. By virtue of the Position the employee shall be responsible for the day to day and routine management of the Company and the operations involved therein, and supervise the activities of the Subsidiaries. In the performance of the Position, the Employee shall be subject to the directions and policies prescribed from time to time by the Company's board of directors.
 
 
2

 
 
 
2.2.
For avoidance of doubt, it is warranted and agreed that, without derogating from the provisions of this Agreement, in the event that any position whatsoever is imposed upon the Employee which involves engagement with another subsidiary of the Company and/or other companies forming or which shall form part of the Company's group (collectively the "Related Companies"), such position shall not create employer-employee relations between him and any of the Related Companies and that notwithstanding any such position, the Employee shall be considered solely as the Company's and the Subsidiaries employee.
 
3.
The Employee's Undertakings

The Employee hereby undertakes:

 
3.1.
To perform the duties and assignments imposed upon him in the scope of his employment with the Company with devotion, honesty and fidelity, subject to the Company's policy in existence from time to time, and to dedicate to the performance of the said duties all his know-how, qualifications and experience and all the time, diligence and attention required for the performance thereof efficiently, with fidelity and in accordance with the requirements of this Agreement, and to use his best endeavors in order to advance the affairs and business of the Company and the realization of its objectives.

 
3.2.
Not to engage, during the Term of Employment (as defined in Section 10.1 below), in any engagement not within the scope of his employment with the Company pursuant to this Agreement other than with the Company's prior written consent, provided however, that such consent shall not be required for voluntary, cultural, sportive or lecturing activities or for holding of securities of any company other than companies which are in competition with the Company and in which the Employee shall not hold more than 1%.

 
3.3
The Employee hereby declares and commits that his current involvement in other businesses as stated in Annex C hereto, shall not adversely affect or come on the account of the time and efforts he shall need to devote to fulfill his obligations under this Agreement.

4.
Monthly Salary

 
4.1.
In consideration for the Employee's employment and the performance his other undertakings to the Company and the Subsidiaries pursuant to this Agreement, the Company shall pay the Employee, by no later than the 9th of each month in respect of the preceding month, a monthly salary (gross) of NIS in the amount stated in Annex A hereto (the " Monthly Salary ").

 
4.2
By no later than December 31st of each year, the Company's board of directors shall determine the Employee's salary for the following year.

 
3

 


 
4.3
The Monthly Salary does not include convalescence pay (“Dmei-Havraa”), which will be paid in addition to the Salary in amounts prescribed by applicable law.

 
4.4
The Monthly Salary alone shall be considered for the purpose of calculating the amounts to be deposited in the Employee’s executive insurance policy and vocational fund, as set forth in Section 8 below, as well as other social rights available at law, and no Bonus (defined below) or additional entitlement will be considered to be part of the Monthly Salary for such intents and purposes.

5.
Bonus

 
5.1.
The Company, pursuant to a resolution of its compensation committee and the resolution of the Board, in its sole discretion, subject to the provisions of the applicable law, is entitled to give the Employee, in accordance with targets to be determined by such compensation committee by no later than December 31 of each calendar year (" Year ") in respect of the next Year (but in its first meeting following April 1, 2013 in respect of 2013), a monetary annual bonus (the " Bonus "). In determining such Bonus, the compensation committee shall relate to the Company's Executive Officers Compensation Plan, the Company’s revenues, and/or the Company's profits, as applicable to the Employee. Such Bonus plan shall be detailed in Annex A hereto as may by changed from time with mutual consent.

 
5.2.
To tie the Employee’s performance with the long term success of the Company and without derogating from the provisions of Section 5.1 above, the Company, subject to the approval of the Compensation Committee and the Board, and the applicable provisions of the law, shall allocate stock options (the “ Stock Options ”) to the Employee according to the amount and mechanism as shall be detailed in Annex A hereto.
 
 
5.3.
The Bonus for each Year shall be paid to the Employee within 30 days from the publication of the audited annual financial statements of the Company of such Year.

 
5.4.
When, in the sole discretion of the Board, feasible in light of the Company's cash flow situation and financial results as reflected in the quarterly financial statements of the Company, the Company may make allowances to the Employee, pursuant to a resolution of the Board, on account of earned Bonuses which allowances shall be deducted from the Yearly computed amount of Bonus payable to the Employee in respect of the Year in which such allowances were made (the " Allowances ").

 
4

 
 
 
6.
Car and Additional Expenses

 
6.1
Car and Meals. During the Term of the Employment, the Company shall place at the Employee's exclusive disposal a car for his use at the level detailed in Annex A hereto and shall provide him with lunch meals at the Company's premises. All the expenses in connection with the maintenance and use of the said car shall be borne and paid by the Company, excluding fines. The Employee hereby undertakes to use the car that shall be placed at his disposal as aforesaid reasonably and properly qua an owner who cares for his property, and in the absence of another arrangement in writing between him and the Company he undertakes to return the said car to the Company immediately upon the termination of the Prior Notice Period (as defined in Section 10.1 below). For avoidance of doubt, the Company shall gross up the value of the benefit to the Employee in placing the car at his disposal and providing him with meals as aforesaid in the amount of the tax applicable to him is respect of the said benefits.

 
6.2
Expense Reimbursement. The company shall reimburse the Employee for all out-of-pocket business expenses, reasonably and necessarily incurred in connection with, or related to, the performance of his duties under this Agreement, subject to and in accordance with the Company’s then current expense reimbursement policy, if any. To the extent the Company has not adopted an expense reimbursement policy, reimbursement of expenses in accordance with the provisions of this Section 6.2 shall be made within ten (10) days from the beginning of each month, for the preceding month, against submission by the employee of receipts or other appropriate supporting documentation, but expenses exceeding NIS 10,000 per item or in total shall be subject to prior approval by the Board. The Board may reasonably request additional documentation or a further explanation to substantiate any business expense submitted for reimbursement, and retains the discretion to approve or deny a request for reimbursement or part of it. Employee must submit any request for reimbursement no later than ninety (90) days following the date that such business expense was incurred. Except as stated in this Section 6.2 or unless otherwise agreed to between the Company and the Employee in writing, with respect to the performance of specific duties, the Company shall have no liability to reimburse Employee for any expenses incurred by Employee in connection with his employment by the Company. A reimbursement (or right thereto) may not be exchanged or liquidated for any other benefit or payment.

7.
Annual Leave, Sick Leave

 
7.1.
The Employee shall be entitled to payment of 24 (twenty four) annual leave days in respect of each year of employment pursuant to this Agreement.

 
5

 
 
 
7.2.
The annual leave days to which the Employee is entitled are accruable, provided always that the Employee shall not be entitled to accrue in any working year seven of the annual leave days to which he is entitled and in total the Employee shall not be entitled to accrue more than 100 days for the purposes of redemption and 30 days for the purposes of taking actual leave. Employee shall not be entitled to redeem any outstanding leave days remaining at his disposal during the term of his employment, and such, if any, shall be redeemable only upon the Employee‘s termination of employment.

 
7.3.
The Employee is entitled to sick leave and sick pay at the rates and times prescribed by law. Sick leave shall not be redeemable. The Employee shall be entitled to accrue up to 90 (ninety) days for the purpose of taking actual sick leave. The Employee shall be entitled to convalescence pay at the rates and times prescribed by law.

8.
Executives' Insurance and Vocational Studies Fund

 
8.1.
The Company shall continue the Employee's existing executive insurance policy in the Employee's name. Each month during the Term of Employment the Company shall transfer and pay to the executive insurance policy the following amounts:

 
8.1.1.
An amount equal to 8-1/3% (eight and one third percent) of the Monthly Salary on account of the severance pay fund.
 
8.1.2.
An amount equal to 5% (five percent) of the Monthly Salary on account of provident fund.
 
8.1.3.
An amount of up 2.5% (two and a half percent) of The Monthly Salary on account of loss of working capacity insurance.

Furthermore the Company shall deduct from the Monthly Salary an amount equal to 5% (five percent) which shall be remitted to the said executive insurance fund such being on account of the provident fund and in respect of the Employee's part of the provision to the said fund.

 
8.2
Further to Section 8.1 above, Company hereby forfeits any right it may have in the reimbursement of sums paid by Company into the above mentioned executive insurance policy, except in the event: (i) that employee withdraws such sums from the executive insurance policy, other than in the event of death, disability or retirement at the age of 60 or more; and/or (ii) of the occurrence of any of the events provided for in Sections 16 and 17 of the Severance Pay Law, 1963.

 
8.3
Should the employment be terminated by resignation of the Employee (excluding under such circumstances that employee’s resignation is deemed by applicable law as dismissal by the employer) the Employee shall be entitled to said executives' insurance fund and the vocational studies fund (including all the amounts, which have accrued to his benefit in such funds, whether from his own provisions or from provisions of the Company and/or the Related Companies, including all linkage differentials, interest and profits that have accrued in the said fund in respect of the said provisions.
 
 
6

 

 
 
8.4
Should the employment be terminated by the Company’s dismissal of the Employee (excluding under such circumstances depriving for severance payment as prescribed in article 10.2.2 below) the Company shall assign the Employee upon termination of his employment any and all rights accrued in the executives' insurance fund and the vocational studies fund (including all the amounts, which have accrued to his benefit in such funds, whether from his own provisions or from provisions of the Company and/or the Related Companies, including all linkage differentials, interest and profits that have accrued in the said fund in respect of the said provisions on account of his severance payments) and shall pay the Employee the difference between said funds to the severance payments to which the Employee is entitled under the Severance Pay Law, 1963.

9.
The Company shall attend to making a vocational studies fund in the Employee's name and shall make a provision each month to the said vocational studies fund of an amount equal to 7.5% (seven and a half percent) of the Monthly Salary. Furthermore, an amount equal to 2.5% (two and a half percent) of the Monthly Salary shall be deducted from the Monthly Salary, such being in respect of the Employee's part of the provision to the vocational studies fund.

10.
Term and Termination
 
 
10.1.
This Agreement is for a specified term of three (3) years commencing on the Effective Date and terminating on March 6 th 2016 (the “ Initial Term ”). This Initial Term shall be automatically extended for successive two periods of three (3) years each (the “ Extended Term ”) (the Initial Term and the Extended Term hereinafter individually or collectively shall be referred to as: the “ Term of Employment ”.) Notwithstanding the aforesaid, it is herein clarified that the Term of Employment may be at any time terminated by the Company, whether for cause or without cause, or by the Employee, by a party serving the other with at least six (6) months' prior written notice (the " Prior Notice Period ") and upon such termination of employment the provisions of article 10.2 hereunder shall apply. Following such notice, the Employee shall continue in his Position and perform his undertakings pursuant to this Agreement during the Prior Notice Period, and, at the Company's request he shall use his best endeavors to transfer his Position in an efficient and orderly manner to his successor within the Prior Notice Period. Notwithstanding the above, it is hereby warranted and agreed that the Company shall be entitled at any time, in its discretion to demand that the Employee terminate his Position forthwith (or within a period shorter than the Prior Notice Period) and in such event the employer-employee relations between the Company and the Employee shall terminate on the date designated in the said demand, all without derogating from the Employee's rights pursuant to this Agreement and at law to payment in lieu of prior notice in respect of the Prior Notice Period, to severance pay and to all other amounts due to him (if any) in connection with his employment and the termination of his employment with the Company (and the period in respect of which employer-employee relations actually existed between the Company and the Employee pursuant to the above provisions is hereinafter referred to as "The Term of Employment").
 
 
7

 
 
 
10.2.
In the event of termination of this Agreement, the following provisions shall apply:

 
10.2.1.
Should the termination of the employment be as a result of dismissal (other than dismissal in circumstances depriving the Employee of the right to severance pay as provided in Section 10.2.2 below), the Employee's resignation or, heaven forbid, as a result of circumstances preventing the continuation of his employment with the Company (including his death), the Employee shall be entitled (or, as the case may be, his heirs shall be entitled):

 
10.2.1.1
to receive the Monthly Salary from the Company only for and in respect to the Prior Notice Period (not until the end of the Term of Employment), such being whether the Employee was requested to continue working during the Prior Notice Period or otherwise; and

 
10.2.1.2
to receive, following publication of the financial statements relating to the year during which such termination has occurred, pursuant to Section 5.3 above, the amounts of the Bonus and Stock Options payable to him (if at all) pursuant to Section 5 above calculated on a linear basis in respect of such part of the year in which the Employee has been actually employed with the Company, including the entire Prior Notice Period, as shall be pro rata calculated from the yearly Bonus and Stock Options, computed pursuant to Section 5.1 and 5.2 above.

 
10.2.1.3
to assign to the Employee the rights accrued in the executives' insurance fund and the vocational studies fund all the amounts, which have accrued to his benefit in such funds, whether from his own provisions or from provisions of the Company and/or the Related Companies, including all linkage differentials, interest and profits that have accrued in the said fund in respect of the said provisions.

 
10.2.1.4
to continue to use the Company car with all its related costs per Section 6 above, until the end of the Prior Notice Period.
 
 
8

 

 
 
10.2.1.5
to receive a onetime compensation against the Employee’s commitment in Section 11 below. Such onetime compensation shall be equal to Twelve (12) Monthly Salaries as defined in Section 4 above. The Company will pay the Employee upon the termination of Employment 50% of this amount and the remainder 50% will be deposited upon the termination of employment with the Company’s External Counsel under escrow, to be released after 12 months from the termination of Employment, subject to the fulfillment of the Employees commitment in Section 11 below.

 
10.2.2.
It is hereby agreed and warranted that in the event that the Employee's dismissal is as a result of a breach of fidelity or material breach of his confidentiality or non competition undertakings to the Company pursuant to Section 11 below and Annex B hereto or dismissal in other circumstances depriving, according to any law, the Employee of the right to severance pay, then, notwithstanding anything to the contrary provided in this Agreement, the Employee shall not be entitled to receive prior notice of his dismissal or payment in lieu of prior notice and he shall not be entitled to severance pay or any other payment which the Company is not legally bound to pay, including any payment due to the Employee as a Bonus payment. In such event, the Employee shall be obligated to reimburse Allowances, which were granted, to Employee pursuant to Section 5.4 above in the last Year of the Employee's employment with the Company, and subject to applicable law, the Company shall be entitled to set off the amounts of such allowances from any payments due to the Employee from the Company.
 
11.
Confidentiality and Non-Competition

 
11.1.
The Employee shall sign a confidentiality undertaking towards the Company, which is attached as Annex B hereto, and forms an integral part of this Agreement.

 
11.2.
The Employee undertakes that during the term of his employment with the Company and for a period of twelve (12) months following the termination of the Employee's employment with the Company, he shall not:

 
11.2.1.
engage, directly or indirectly, with any customer of the Company or the Related Companies (whether as employee, consultant, self-employed or otherwise) in any matter relating to the Company's or the Related Companies' business unless in the framework of his employment with the Company.

 
11.2.2.
engage, directly or indirectly, for whatsoever reason, in Israel or anywhere else, in any business, position employment or other engagement whatsoever in the sphere of contactless smart cards which competes with the Company's business.
 
 
9

 
 
 
11.2.3.
solicit any of the Company’s employees or contractors.
 
12.
Further Provisions

The Employee hereby warrants that he is aware and agrees that:

 
12.1.
In the scope of his Position with the Company pursuant to this Agreement, he is not an employee to whom the Hours of Work and Rest Law, 5711-1951 applies, and he shall not be entitled to claim or receive any payments or increments whatsoever for working overtime or on Sabbaths and festivals, and the monthly salary payable to him as aforesaid also includes full compensation for working overtime and on Sabbaths and festivals.

 
12.2.
The amount of the Monthly Salary payable to him as specified in Section 4 above, and it alone, shall be the basis for the provisions and deductions in respect of the social benefits specified in this agreement; and all the bonuses, contributions to expenses and other benefits granted to him or which shall be given to him (if at all) pursuant to this Agreement or in connection with his employment by the Company do not constitute a component of his Monthly Salary and shall not be taken into account in respect of the provisions or other benefits whatsoever granted to the Employee pursuant to this Agreement which are computed on the basis of his Monthly Salary; and the expression the "Monthly Salary" wherever it appears in this agreement refers to the Monthly Salary as defined in Section 4 above, without any increments whatsoever.

 
12.3.
The payments and benefits of whatsoever description granted to the Employee pursuant to this Agreement are subject to the deduction of income tax and other compulsory deductions which the Company has to deduct according to any law, and nothing stated in this Agreement shall be interpreted as imposing upon the Company the burden of paying tax or any other compulsory payment for which the Employee is liable, other than the value of the benefit of placing the car at the Employee's disposal and providing the Employee with meals, which shall be grossed up by the Company as provided in Section 6 above.

 
12.4.
Except in relation to the grant of options to the Employee by the Company, the terms and conditions of the Employee's employment by the Company are regulated solely pursuant to this personal employment agreement between him and the Company and save as expressly provided in this Agreement the Employee shall not be entitled to any payments or other benefits in respect of his employment and the termination of his employment with the Company.
 
 
10

 
 
13.
Amendments to the Agreement

Amendment to this agreement shall not be valid unless made in a duly signed document by the parties.
 
14.
Addresses

The parties' addresses for the purposes of this agreement shall be as specified in the heading hereto and any notice, document or court process sent by one party to the other according to the above addresses shall be deemed to have reached its destination: if delivered by hand - at the time of delivery, and if dispatched by registered post - after 72 hours have elapsed from the time of dispatch as aforesaid.
 
15.
Law and Jurisdiction
 
This Agreement shall be governed by the laws of the State of Israel, and the competent Labor Courts in Tel- Aviv District shall have exclusive jurisdiction in all matters pertaining or relating thereto.
 
IN WITNESS WHEREOF THE PARTIES HAVE SET THEIR HANDS:
 
 
/s/ Shay Tomer  / Arie G. Rubinstein
CFO / General Counsel & Corporate Secretary
 
 
/s/ Ofer Tziperman
 
 
ON TRACK INNOVATIONS LTD
 
 OFER TZIPERMAN
 
 
 
11

 
 
ANNEX B
 
Confidentiality and Non Competition Undertaking
 
I, the undersigned, Ofer Tziperman (ID No.057438244) , hereby declare and undertake towards On Track Innovations Ltd. and any of its parent/controlling corporation, subsidiaries and/or affiliated entities (hereinafter collectively, the “Company”) as follows:

1.
In this Undertaking:
 
 
1.1.
the term “ Confidential Information ” means any and all information relating to the Company’s proprietary technology or business including, without limitation, information, data, know-how, formulas, concepts, tests, drawings, specifications, applications, designs and trade secrets, patents, know-how, technology data and all other information, design methodology, engineering and manufacturing processes and data and information related to Company’s products or their development, equipment, suppliers, sales, customers, potential customers, business operations and plans, financial situation, members, employees and investors.
 
 
1.2.
the term “ Confidential Documents ” means any documents containing Confidential Information, including without limitation: (i) any documents, notes, memoranda, summaries, analyses, paper works, sketches, designs, charts, specifications, prints, compilations, or any other writings relating to the Confidential Information, and any other materials embodied in drawings, floppy discs, tapes, CD ROM, software or in any other possible way containing or relating to the Confidential Information or any part thereof, whether or not prepared by the Company or on it’s behalf, (ii) all documents received, used, or that shall be received or used, by me in relation with my employment in the Company, and/or (iii) the contents of such Confidential Documents as stored in my memory.
 
 
1.3
the term " Competing Goods " means any goods sold in competition with the prescribed goods;
 
 
1.4
the term " Competing Services " means any services rendered in competition with the prescribed services;
 
 
1.5
the term " Prescribed Areas " means Israel or in any other part of the world in which the Company conducts its business;
 
 
1.6
the term " Prescribed Customers " means any person who is or was a customer of the Company at the termination date; or who is or was a customer of the Company at the termination date or who was a potential customer with which I had been engaged in negotiations with a view to doing business on behalf of the Company within the period of 6 (six) months preceding the termination date;
 
 
 

 
 
 
1.7
the term " Prescribed Goods " means any products sold by the Company in the ordinary course of business as at the termination date or which is then included in any strategic plan of the Company;
 
 
1.8
the term " Prescribed Services " means any services rendered by the Company in the ordinary course of business as at the termination date or which is then included in any strategic plan of the Company;
 
 
1.9
the term " Prescribed Suppliers " means any person who is or was a supplier of prescribed goods and/or prescribed services to the company at the termination date; or is or was a supplier of prescribed goods and/or prescribed services to the company at the termination date with which I had been engaged in negotiations with a view to doing business on behalf of the company within the period of 6 (six) months preceding the termination date;
 
 
1.10
the term R estraint Period ” means a period of 12 (twelve) months calculated from the termination date;
 
 
1.11
the term “ Termination Date ” means the date upon which my employment by the company ceases or is terminated for any reason whatsoever;
 
2.
I am fully aware that the Confidential Information and Confidential Documents are the exclusive property of the Company, and that they were made or shall be made available to me and for my use solely for the purpose of my work as an employee of the Company.
 
3.
I undertake towards the Company as follows:
 
 
3.1.
to maintain as fully confidential all Confidential Information and Confidential Documents;
 
 
3.2.
not to disclose or divulge to any third party, or allow any third party access to any of the Confidential Information or Confidential Documents, or use any of thereof, whether directly or indirectly, save exclusively for the purposes of my work as an employee of the Company.
 
 
3.3.
not to misuse any of the Confidential Information or Confidential Documents, or any part thereof, in a manner other than the usual use of the Confidential Information and Confidential Documents and for a purpose other than the purpose for which the Confidential Information and Confidential Documents were divulged to me.
 
 
3.4.
not to make public or divulge in any way the Confidential Information and Confidential Documents or any part thereof.
 
 
3.5.
not to duplicate, copy, scan, or create in any other way copies of the Confidential Documents or any part thereof, except for the purpose for which the Confidential Information and Confidential Documents were divulged to me.
 
 
B - 2

 
 
 
3.6.
Not not challenge the Company's intellectual property rights in any way, including without limitation, by filing to any court, patent or other authority, a claim, opposition or request for cancellation against such rights. The provisions of this Section 3.6 shall survive termination.
 
 
3.7.
upon demand from the Company, at any time whatsoever, to return to the Company the Confidential Information and Confidential Documents or any part thereof or copies thereof in any form whatsoever, and to, if so required, confirm in writing to the Company that all the Confidential Information and Confidential Documents or any copies thereof in any form whatsoever which had been in my possession have been returned to the Company, and that I did not retain any copies of it, including copies made by electronic forms.
 
 
3.8.
not to remove from the Company’s premises or take for my use any of the Confidential Information and Confidential Documents without the Company’s prior written approval, unless if such removal is made strictly for the purposes of performing my undertakings towards the Company.
 
4.
I agree and accept that:
 
 
4.1.
The Company reserves all rights in any inventions, patents, copyrights, designs, and any other intellectual property invented or devised by it in relation to the Confidential Information and Confidential Documents.
 
 
4.2.
Any invention including any patent or patent application and any copyrights or any other intellectual property (the “ IP ”) invented or created by me during my employment with the Company or as a result of my employment with the Company, shall be the exclusive property of the Company, and I do not have and shall not have any demand or claim against the Company relating to the IP. I undertake to sign any document and to do any other act required in order to register the said rights in the name of the Company, or to prove the Company’s rights, if and to the extent that this is required in the opinion of the Company and/or the Company’s legal advisors.
 
 
4.3.
I shall not challenge the Company's IP in any way, including without limitation, by filing to any court, patent or other authority, a claim, opposition or request for cancellation against such rights
 
5.
The restrictions of use and disclosure set forth in this undertaking shall not apply to any Confidential Information and Confidential Documents which after they were disclosed became, available to the general public, through no breach of a confidentiality undertaking towards the Company.
 
 
B - 3

 
 
6.
It is recorded that in the course of his my duties I (i) have acquired and/or will acquire considerable know-how in and will learn of the Company's techniques relating to the business; (ii) will have access to names of customers with whom the Company does business whether embodied in written form or otherwise; (iii)will have the opportunity of forging personal links with customers of the company; and (iv) generally will have the opportunity of learning and acquiring the trade secrets, business connections and other confidential information appertaining to the Company's business.
 
I acknowledged that the only effective and reasonable manner in which the Company's rights in respect of its business secrets and customer connections can be protected is the restraint I am imposing upon myself as set forth hereunder. Therefor, in consideration of the Non Competition Payment, as set in my Employment Agreement, I hereby undertake that during the term of my employment with the Company and for the duration of the Restraint Period, whether as proprietor, partner, director, shareholder, member, employee, consultant, contractor, financier, agent, representative, assistant, trustee or beneficiary of a trust or otherwise and whether for reward or not, directly or indirectly, I shall not -
 
 
6.1
carry on or be interested or engaged in or concerned with or employed by any company, close corporation, firm, undertaking or concern which carries on, in the Prescribed Areas any business which sells Prescribed Goods and/or Competing Goods or renders Prescribed Services or Competing Services or in the course of which Prescribed Goods or Competing Goods are sold and/ or Prescribed Services or Competing Services are rendered; provided that I shall not be deemed to have breached my undertaking by reason of my – (i) holding shares in the Company; or (ii) holding shares in any company the shares of which do not in aggregate constitute more than 5% (five per cent) of any class of the issued share capital of such company and which are listed on a recognised stock exchange if the shares owned by me or by my relatives (as defined in the Israeli Companies Act 1999) which do not in the aggregate constitute more than 5% (five per cent) of any class of the issued share capital of such company.
 
6.2
 
 
6.2.1
not to solicit, on my own account or for any other person, the services of, or endeavor to entice away from the Company any director, employee, consultant or a subcontractor of, or any other person related to the Company, who during the period of 12 months prior to such termination occupied a   senior or managerial   position in relation to the Company, and/or who was likely (in the opinion of the Company) to be: (i) in possession of Confidential Information; or (ii) able to influence the customers’ connections of the Company (whether or not such person would commit any breach of his contract of employment or engagement with the Company).
 
 
B - 4

 
 
 
6.2.2
furnish any information or advice (whether oral or written) to any prescribed customer that I intend to or will, directly or indirectly, be interested or engaged in or concerned with or employed by any company, close corporation, firm, undertaking or concern carried on in any of the Prescribed Areas which sells Prescribed Goods and/or Competing Goods or renders Prescribed Services and/or Competing Services or in the course of which Prescribed Goods and/or Competing Goods are sold and/or Prescribed Services or Competing Services are rendered during the Restraint Period; or
 
 
6.2.3
furnish any information or advice (whether oral or written) to any Prescribed Customer or use any other means or take any other action which is directly or indirectly designed, or in the ordinary course of events calculated, to result in any such Prescribed Customer terminating his association with the company and/or transferring his business to or purchasing any Prescribed Goods or Competing Goods or accepting the rendering of any Prescribed Services or Competing Services from any person other than the company, or attempt to do so.
 
 
6.3
solicit orders from Prescribed Customers for the Prescribed Goods and/or any Competing Goods and/or the Prescribed Services and/or any Competing Services; or canvass business in respect of the Prescribed Goods and/or any Competing Goods and/or the Prescribed Services and/or Competing Services from Prescribed Customers; or sell or otherwise supply any Prescribed Goods and/or Competing Goods to any Prescribed Customer; or render any Prescribed Services and/or Competing Services to any Prescribed Customer; or purchase any Prescribed Goods and/or Competing Goods from any Prescribed Supplier or accept the rendering of any Prescribed Services and/or Competing Services from it; or solicit appointment as a distributor, licensee, agent or representative of any Prescribed Supplier in respect of Prescribed Goods and/or Prescribed Services, including on behalf of or for the benefit of a Prescribed Supplier.
 
 
6.4
Each of the undertakings set out in this Section 6 (including those appearing in a single sub-section) is severable inter alia as to (i) the nature of interest, act or activity; (ii) the categories of persons falling within the definition of prescribed customers; (iii) the categories of goods falling within the definition of the Prescribed Goods and Competing Goods; (iv) the categories of services falling within the definition of the Prescribed Services and Competing Services; and (v) the categories of persons falling within the definition of Prescribed Supplier;
 
7.
It is agreed and recorded that, without prejudice to any right or remedy which is available to the Company under any law or agreement, the unauthorized disclosure or use of any Confidential Information and Confidential Documents or a breach of my undertakings pursuant to Section 6 above, will cause immediate or irreparable injury to the Company and that the Company can not be adequately compensated for such injury in monetary damages, then, in order to safeguard the Company from any possible breach of confidentiality, I consent in advance that the Company will be permitted to obtain, from any Court or Tribunal, any temporary or permanent injunctive relief necessary to prevent such unauthorized disclosure or use, or threat of unauthorized disclosure or use.
 
 
B - 5

 
 
8.
This Undertaking shall form an integral part of my employment agreement with the Company and a breach of any of my obligations hereunder, shall also constitute a material breach of such employment agreement.
 
9.
This Undertaking shall be governed by the laws of the State of Israel and the competent courts in Tel-Aviv shall have exclusive jurisdiction in all matters pertaining or relating thereto.
 
10.
If any condition, term or covenant of this Agreement shall at any time be held to be void, invalid or unenforceable, such condition, covenant or term shall be construed as severable and such holding shall attach only to such condition, covenant or term and shall not in any way affect or render void, invalid or unenforceable any other condition, covenant or term of this Agreement, and this Agreement shall be carried out as if such void, invalid or unenforceable term were not embodied herein.
 
11.
Unless specifically limited herein, my undertakings hereunder shall be valid: (i) during the term of my employment in the Company, and unless the Company waived such right in writing, following termination of my employment with the Company without time limitation; (ii) in Israel or outside Israel, and - (iii) whether such undertakings may or may not be registered under any register prescribed by law.
 
Date: 12/22/2013
  /s/ Ofer Tziperman  
   
(signature)
 
       
   
Name: Ofer Tziperman
 
 
 
B - 6

 
 
ANNEX C – LIST OF OTHER ACTIVITIES
 
 
1.
Employee is a founder and shareholder of LocatioNet Systems Ltd., and is currently consulting the company on a monetization and assertion process of its patents.

 
2.
Employee is the sole owner of Radius Projects Tomas Ltd., through which he is conducting various business opportunities and consulting services.

 




Exhibit 10.13

EMPLOYMENT AGREEMENT

THIS EMPLOYMENT AGREEMENT (“ Agreement ”) is by and among On Track Innovations Ltd., an Israeli corporation (“ OTI Israel ”) and OTI America, Inc., a Delaware corporation (collectively the “ Company ” or “ OTI ”), and Dimitrios Angelis (“ Executive ”).

RECITALS

A.           The Company is involved in the business of designing, developing and marketing solutions based on its secure contactless microprocessor-based smart card technology.

B.            The Company wishes to employ Executive and Executive wishes to be employed by the Company in accordance with the terms and conditions set forth in this Agreement.

AGREEMENT

In consideration of the mutual covenants herein contained, and other good and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, Executive and the Company agree as follows:

1.              Employment .  Effective on the date that this Agreement is approved by the requisite majorities of the shareholders of the Company in a duly convened shareholders meeting (the “ Effective Date ”), the Company will employ Executive, and Executive agrees to be employed as Chief Executive Officer of OTI America, which responsibilities shall include the management of the Company’s intellectual property and its related litigation and licensing and all other management authorities, unless otherwise determined by the board of directors of OTI Israel.  Executive will comply in all material respects with all rules, policies, and procedures of the Company as established by the Company’s articles of incorporation and bylaws and policies as adopted by its board of directors from time to time.  During Executive’s employment, Executive will not engage in any other business activity that interferes with or prevents Executive from carrying out Executive’s obligations under this Agreement, whether or not such activity is pursued for gain, profit, or other pecuniary advantage.  Executive will report only to the board of directors of OTI Israel.  Only OTI Israel's board of directors may change Executive’s title, job responsibilities and to whom he reports without Executive’s consent, provided that in all cases Executive retains the title of and responsibilities of an executive officer of OTI America or the Company and the Compensation and Equity Incentives (Section 3 hereof) and Other Benefits (Section 4 hereof) remain unchanged.  Executive currently serves on the Company’s board of directors, and is currently the chairman of the board of directors, and such work may continue and not be in violation of this Agreement. Company acknowledges and accepts that Executive may be associated with and contribute to the organizations listed in Exhibit A, which activities and list will be reviewed and approved not less than annually by the Company’s compensation committee.   Executive is obligated to devote his full time, attention and energies to perform the duties assigned hereunder as Chief Executive Officer, and Executive agrees to perform such duties diligently, faithfully and to the best of his abilities.  
 
 
 

 
 
2.              Term of Employment .  Employment under this Agreement shall be for a term (the “ Term ”) of three (3) years from the date of this Agreement (the " Original Employment Term "); however, either Executive or the Company may terminate Executive’s employment at any time with or without Cause or Good Reason, as defined in this Agreement, and without notice, subject to the terms of this Agreement including Section 5.2.2; provided that the Employment Term shall be automatically extended, subject to earlier termination as expressly provided in this Agreement, for successive additional one (1) year periods (the “ Additional Terms ”), unless either Executive or the Company submits written notice to the other at least one-hundred eighty (180) days prior to the end of the Original Employment Term or the then Additional Term.  Any termination of Executive’s employment by Executive or the Company (other than death) shall be communicated by written notice of termination to the other party. [

3.              Compensation and Equity Incentives .   During the Term of Executive’s employment under this Agreement, Executive shall be entitled to compensation computed and paid as follows, reduced by applicable federal, state, and local withholdings, or payroll or other taxes or fees and authorized deductions:

3.1            Salary .  Executive shall be paid an annual gross salary at the rate of $300,000 (the “ Annual Base Salary ”), with actual amounts paid to be prorated for the actual period of employment, payable in equal installments in accordance with the Company’s normal payroll practices.  The Board of Directors of OTI Israel shall review Executive’s Annual Base Salary at least annually for adjustments based on Executive’s performance and other relevant factors and may determine in its sole discretion whether any increase in Annual Base Salary shall be made, provided that in any event an increase of up to 15% per annum shall not require the approval of the shareholders in accordance and subject to the Company’s Executives Compensation Policy.  The Annual Base Salary shall not be decreased without Executive’s express written consent.

3.2            Annual Bonus .   During employment with the Company, the board of directors of OTI Israel will adopt a bonus plan based on the criteria established in section 6.2.3 and 6.2.4 of the Company’s Executive Officers Compensation Policy under which Executive starting on the year 2014, shall participate, as and to the extent provided by the plan as adopted by the board of directors.

3.3            Special Bonus .  The Company will pay Executive a cash bonus (less applicable withholdings) upon commencement of full time employment of $50,000.
 
3.4            Stock Option Grant .  The Company will grant to Executive an option (the “ Option ”) to purchase 150,000 shares of OTI Israel's ordinary shares (the “ Shares ”), the exercise price of which shall be the market price of the Shares as determined by the closing price of the Shares on Nasdaq on the date this Agreement is approved by the Company’s shareholders.  The Option shall vest as follows:  1/3 after twelve (12) months of full time employment, additional 1/3 after twenty four (24) months of full time employment and the last 1/3 after thirty six (36) months of full time employment.

 
- 2 -

 

4.              Other Benefits .
 
4.1            Certain Benefits .  Executive shall participate in employee benefit programs, established by the Company for personnel on a basis commensurate with Executive’s position and in accordance with the Company’s benefit plans and arrangements from time to time, including eligibility requirements. During the Term, the Company shall provide Executive full medical coverage (e.g. health and dental), as provided to employees from time to time by the Company.

4.2            Expenses .  The Company shall reimburse Executive in accordance with the Company’s policies and procedures for reasonable expenses necessarily incurred in Executive’s performance of Executive’s duties against appropriate receipts and vouchers indicating the specific business purpose for each such expenditure; provided, in any event, that such expenses may not exceed the provision for such expenses in the then applicable Company annual operating budget.

4.3            Indemnification .  In accordance with the terms and provisions of the Company’s articles of association and applicable law, Company will defend, indemnify and hold harmless Executive from and against any and all demands, claims, actions, causes of action, assessments, liabilities, losses, damages, costs and expenses, including reasonable attorneys fees arising from the Executive’s service under this Agreement, to the maximum extent permitted under applicable law. Notwithstanding anything herein to the contrary, this Section will survive the termination of this Agreement.

4.4            Change of Control . In the event there is a change in control of the Company and Executive is no longer employed by the Company, then Executive shall receive the following:
 
a. Executive’s Options shall all immediately vest; and
b. Executive shall receive one years’ then Annual Base Salary; and
 
c. Executive’s Options shall be treated as ordinary shares under the Poison Pill plan.

For the purposes of this section “change of control” shall mean with respect to OTI Israel: (a) a merger or consolidation wherein a majority of the shareholders of the Company immediately prior to the merger or consolidation do not own a majority of the voting shares of the surviving corporation immediately following the merger or consolidation, (b) the consummation of a tender offer or takeover bid for the Shares (other than a tender offer by the Company or an affiliate), the result of which is that a majority of the shareholders of OTI Israel immediately prior to the tender offer do not own a majority of the voting shares of the surviving corporation immediately following the tender offer, (c) a sale of all or substantially all the assets of OTI Israel, and (d) the dissolution of OTI Israel.
 
 
- 3 -

 

 
5.              Termination .   The following provisions shall apply upon termination of Executive’s employment under applicable circumstances as set forth below.  Any amount payable to Executive under this Section 5 shall be subject to all applicable federal, state, and local withholdings, or payroll or other taxes.  Except as set forth in this Section 5 , upon termination of employment, Executive shall not be entitled to further payments, severance, or other benefits arising under this Agreement or from Executive’s employment with the Company.

5.1            By the Company with Cause or by Executive without Good Reason .  If the Company terminates Executive’s employment for Cause or if Executive terminates Executive’s employment without Good Reason, Executive shall be paid for unpaid wages and unused accrued vacation earned through the termination date.

5.1.1           “ Cause ,” as used herein, means any of the following: (i) willful misconduct, moral turpitude, failure to perform duties described in paragraph 1 hereinabove after thirty (30) days’ written notice of the need to cure the failure and cure has not been effected within that time period, or which failure, if previously cured, recurs;  (ii) dishonesty, fraud, or gross negligence; (iii) personal conduct that is materially detrimental to the business and for which Executive did not have a good faith belief that such conduct was in the Company’s best interests; or (iv) the commission of conduct that would constitute a felony or gross misdemeanor.

5.1.2           “ Good Reason ,” as used herein, means any material breach of this Agreement by the Company which, if curable, has not been cured within thirty (30) days after the Company has been given written notice of the need to cure the breach, or which breach, if previously cured, recurs.

5.2            By the Company other than for Cause or Total Disability or by Executive for Good Reason .  If the Company terminates Executive’s employment other than for Cause or Total Disability or if Executive terminates Executive’s employment for Good Reason, the Company shall provide to Executive the amounts set forth in this Section 5.2.

5.2.1           Unpaid salary earned through the termination date; and

5.2.2           Separation payments in an amount equal to twelve (12) months Annual Base Salary in effect at the time of termination.

 
- 4 -

 

5.3            Total Disability; Death .  If the Company or Executive terminates Executive’s employment due to Executive’s Total Disability or death, the Company shall pay to Executive unpaid wages earned through the termination date, and, if termination is due to disability, the benefits of disability insurance shall continue as provided in the Company’s disability policy.  “ Total Disability ” as used herein shall have the same meaning as the term “Total Disability” as used in the Company’s long-term disability policy in effect at the time of termination, if one exists.  If the Company does not have a long-term disability policy in effect at such time, the term “Total Disability” shall mean Executive’s inability (with or without such accommodation as may be required by law protecting persons with disabilities) to perform the essential functions of Executive’s duties hereunder for a period aggregating ninety (90) calendar days in a twelve (12) month period.

6.              Confidential Information .

6.1            Definition .  Executive has obtained or may obtain from OTI or any of its Affiliates or agents or representatives (collectively, for purposes of this Section 6, “ OTI Entities ”), information, including information concerning OTI Entities’ (i) business, development, and marketing plans, (ii) prices and pricing strategies, (iii) trade secrets, and (iv) other ideas, concepts, strategies, designs, suggestions, and recommendations (collectively, the “ Confidential Information ”).  “Confidential Information” includes, but is not limited to, information of the foregoing type or nature of any of the OTI Entities’ shareholders and affiliates, but does not include information in the public domain through no fault of Executive.

6.2            Non-Disclosure and Return of Confidential Information .  Executive shall not disclose any of the Confidential Information to any other person or entity, or use any Confidential Information for any purpose unless authorized in writing by the Company.  Executive shall return all Confidential Information to the Company, along with any and all copies, immediately upon termination of Executive’s employment with the Company.

6.3            Third Party’s Information . Executive agrees to maintain the confidentiality of, and not to use for any purpose except in furtherance of his duties under this Agreement, confidential information he or the OTI Entities receives from one or more third parties to which any of the OTI Entities is subject to a duty of non-disclosure and to restrictions on the use thereof.

6.4            General .  Executive’s obligation under this Agreement is in addition to any obligations Executive has under state or federal law.  Executive’s obligations under this Section 6 are indefinite in term and shall survive the termination of this Agreement.

 
- 5 -

 

7.              Remedies .   Notwithstanding any other provisions of this Agreement regarding dispute resolution, Executive agrees that Executive’s violation of any of Section 6 , of this Agreement, if proven would cause the Company or its affiliates irreparable harm which would not be adequately compensated by monetary damages and that an injunction may, subject to the provisions of Section 12.6 , be granted by any court or courts or arbitral panel having jurisdiction, restraining Executive from violation of the terms of this Agreement, upon any breach or threatened breach of Executive of the obligations set forth in any of Section 6 .  The preceding sentence shall not be construed to limit the Company or its affiliates from any other relief or damages to which it may be entitled as a result of Executive’s breach of any provision of this Agreement, including Sections 6 .

8.              Disclosure .  Executive   agrees fully and completely to reveal the terms of the terms of Section 6 of this Agreement to any future employer or business contacts of Executive   and authorizes the Company and its Affiliates, at their election, to make such disclosure.

9.              Representation and Warranties of Executive .  Executive is a member in good standing of the bar association for the state of New Jersey, and will continue to maintain such membership, and has not been the subject of any disciplinary action by such bar association.  Subject to the Executive resigning from his current work position, Executive represents and warrants to the Company that Executive is free to enter into this Agreement and has no commitment, arrangement, or understanding to or with any party that restrains or is in conflict with Executive’s performance of the covenants, services, and duties provided for in this Agreement.  Executive shall not in the course of Executive’s employment violate any obligation that Executive owes any former employers.

10.            Assignability .  During Executive’s employment, this Agreement may not be assigned by either party without the written consent of the other; provided, however, that the Company may assign its rights and obligations under this Agreement without Executive’s consent to any of its Affiliates or to a successor by sale, merger, or liquidation, if such successor carries on the business substantially in the form in which it is being conducted at the time of the sale, merger, or liquidation and notwithstanding anything in this Agreement, such assignment and Executive’s transfer of employment thereunder shall not be deemed a termination of employment under Section 5.2 of this Agreement. This Agreement is binding upon Executive, Executive’s heirs, personal representatives, and permitted assigns and on the Company, its successors, and assigns.

11.            Survival .  Notwithstanding anything to the contrary in this Agreement, the obligations of this Agreement shall survive a termination of this Agreement or the termination of Executive’s employment with the Company, except for obligations under Sections 1 , 2 , 3, 4.1 and 4.2 .

 
- 6 -

 


12.            Miscellaneous Provisions .

12.1            Entire Agreement; Amendment .  This Agreement constitutes the entire agreement among the parties thereto with respect to the subject matter hereof and thereof and supersede any prior agreement or understandings among the parties as to such matters, oral or written, all of which are hereby canceled.  This Agreement may only be modified or amended by written agreement of the parties hereto.

12.2            Governing Law .  This Agreement shall be construed and enforced in accordance with the internal laws of the State of New Jersey, without giving effect to any principles of conflicts of laws.

12.3            Headings .  The headings in this Agreement are inserted for convenience only and shall not affect the interpretations of this Agreement.

12.4            Severability .  If any provision of this Agreement or the application thereof to any Person or circumstance shall be invalid, illegal, or unenforceable to any extent, the remainder of this Agreement and the application thereof shall not be affected and shall be enforceable to the fullest extent permitted by law.

12.5            Heirs, Successors, and Assigns .  Each of the covenants, terms, provisions, and agreements herein contained shall be binding upon and inure to the benefit of the parties hereto and, to the extent permitted by this Agreement, their respective heirs, legal representatives, successors, and assigns.

12.6            Mediation and Arbitration .  Should any dispute arise out of or relate to this Agreement, or its breach, and if the dispute or breach cannot be settled through direct discussions without attorneys present, the dispute will first be submitted for confidential and nonbinding mediation where each party is represented by a person authorized to compromise its claims and negotiate and execute a settlement agreement to such dispute.  Each party agrees to participate in such mediation in a good faith effort to resolve such dispute.  The mediator shall be as mutually agreed by the parties, except that if the parties are unable to agree on a mediator, each party shall designate a mediator who shall together designate an independent third person to mediate the dispute.  If the mediation shall be unsuccessful in resolving the dispute, the dispute will then be submitted for confidential and binding arbitration with parties represented by attorneys if so chosen.  The parties shall be entitled to invoke the rules of discovery applicable to state court proceedings.  The arbitration proceedings shall be conclusive and any party to any award rendered in any such arbitration proceeding shall be entitled to have judgment entered thereon.  The arbitrator shall determine the “prevailing party” and such party shall be entitled to its actual attorneys’ fees and costs which shall be part of the award.  The foregoing shall not prevent any party from seeking temporary injunctive relief from a court of competent jurisdiction for any impending, actual, or threatened breach of the provisions of this Agreement in the Superior Court of the State of New Jersey, County of Morris
 
 
- 7 -

 
 
12.7            Attorneys’ Fees, etc.   If a suit, action, arbitration, or other proceeding of any nature whatsoever (including, without limitation, any bankruptcy proceeding) is instituted in connection with any controversy arising out of this Agreement or to interpret or enforce any rights under this Agreement, the prevailing party shall be entitled to recover his attorneys’ fees and all other fees, costs and expenses actually incurred and reasonably necessary in connection therewith, as determined by the arbitrator or by the court at trial or on appeal or review, in addition to an other amounts provided by law.

12.8            Counterparts .  This Agreement may be executed in counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument.  Facsimile signatures of the parties to this Agreement or any amendment of this Agreement shall be deemed original signatures, and each member or other party shall forward to the Company the original signed version of such document promptly following facsimile transmission.

12.9            Executive’s Recognition of Agreement .   Executive acknowledges that Executive has read and understood this Agreement and agrees that its terms are necessary for the reasonable and proper protection of the business of the Company and its Affiliates.  Executive acknowledges that Executive had this Agreement reviewed by an attorney of his selection.

12.10.         Notices .  Any notice required or permitted to be given hereunder is sufficient if in writing and delivered by hand, by facsimile, or by registered or certified mail, to the parties at the respective addresses set forth below their signatures herein, or such other address as may be provided to each party by the other.

12.11.         Waivers .  No failure on the part of either party to exercise, and no delay in exercising, any right or remedy hereunder will operate as a waiver thereof; nor will any single or partial waiver of a breach of any provision of this Agreement operate or be construed as a waiver of any subsequent breach; nor will any single or partial exercise of any right or remedy hereunder preclude any other or further exercise thereof or the exercise of any other right or remedy granted hereby or by law.
 
[ remainder of page intentionally blank ]
 
 
- 8 -

 
 
SIGNATURE PAGE – EMPLOYMENT AGREEMENT

IN WITNESS WHEREOF, the parties have duly signed and delivered this Agreement as of December 22, 2013, to be effective on the Effective Date.
 
ON TRACK INNOVATIONS, LTD.
 
By /s/ Ofer Tziperman / Shay Tomer
Title: CEO / CFO
 
OTI AMERICA, INC.
 
By /s/ Ofer Tziperman
Title: Chairman
 
EXECUTIVE
 
/s/ Dimitrios Angelis
Dimitrios Angelis

 
- 9 -

 

Exhibit A
 
1. Habitat for Humanity, Board Member

2. 310 West 18 th Street Owners Cooperative, Board Member

3. Distinguished Homes LLC, Principal

4. Mirror Me Designs LLC, Principal
 
- 10 -




Exhibit 21.1

LIST OF SUBSIDIARIES
 
 
1.
Easy Park Ltd. – incorporated under the laws of the State of Israel.
 
 
2.
PARX Ltd. – incorporated under the laws of the State of Israel.
 
 
3.
OTI America Inc. – incorporated under the laws of Delaware, U.S.A.
 
 
4.
OTI PetroSmart (Pty) Ltd. – incorporated under the laws of the Republic of South Africa.
 
 
5.
ASEC S.A. (Spolka Akcyjna) – incorporated under the laws of the Republic of Poland.
 
 
6.
Easy Park Israel Ltd. – incorporated under the laws of the State of Israel.
 
 
7.
Softchip Israel Ltd. – incorporated under the laws of the State of Israel.
 
 
8.
Softchip Technologies (3000) Ltd. – incorporated under the laws of the State of Israel.
 
 
9.
CPI Communication Israel Ltd. – incorporated under the laws of the State of Israel.
 
 
10.
SmartCard Engineering S.A.S. – incorporated under the laws of the French Republic.
 
 
11.
Inseal S.A.S. – incorporated under the laws of the French Republic.
 
 




Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
The Board of Directors
 
On Track Innovations Ltd.
 
We consent to the incorporation by reference in the registration statements (No. 333-101491, No. 333-116429, No. 333-128106, No. 333-140786, No. 333-149034, No. 333-149575, No. 333-173075 and No. 333-179306 and No. 333-192443) on Form S-8 of On Track Innovations Ltd. of our report dated March 31, 2014, with respect to the consolidated balance sheets of On Track Innovations Ltd. and its subsidiaries as of December 31, 2013 and 2012 and the related consolidated statements of operations,  comprehensive loss, changes in equity and cash flows for each of the years in the three-year period ended December 31, 2013, which report appears in the December 31, 2013 annual report on Form 10-K of On Track Innovations Ltd.
 
/s/ Somekh Chaikin
Certified Public Accountants (Isr.)
A Member Firm of KPMG International
 
Tel Aviv, Israel
March 31, 2014
 


 


Exhibit 31.1
 
CERTIFICATION
 
I, Ofer Tziperman, certify that:
 
1. I have reviewed this annual report on Form 10-K of   On Track Innovations Ltd.;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13(a)-15(f) and 15d-15(f)) of the registrant and have:
 
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
Date: March 31, 2014
   
/s/ Ofer Tziperman
——————————————
Ofer Tziperman
Chief Executive Officer
(Principal Executive Officer)
 


 


Exhibit 31.2
 
CERTIFICATION
 
I, Shay Tomer, certify that:
 
1. I have reviewed this annual report on Form 10-K of   On Track Innovations Ltd.;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13(a)-15(f) and 15d-15(f)) of the registrant and have:
 
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
Date: March 31, 2014
   
 
/s/ Shay Tomer
——————————————
Shay Tomer
Chief Financial Officer
(Principal Financial Officer)
 


 


Exhibit 32.1
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
 
In connection with the Annual Report (the “Report”) of On Track Innovations Ltd. (the “Company”) on Form 10-K for the period ended December 31, 2013, as filed with the Securities and Exchange Commission on the date hereof, I, Ofer Tziperman, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
 
1.
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date: March 31, 2014
 
 
By: /s/ Ofer Tziperman
——————————————
Ofer Tziperman
Chief Executive Officer



 
 


Exhibit 32.2
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
 
In connection with the Annual Report (the “Report”) of On Track Innovations Ltd. (the “Company”) on Form 10-K for the period ended December 31, 2013, as filed with the Securities and Exchange Commission on the date hereof, I, Shay Tomer, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
 
1.
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date: March 31, 2014
 
 
By: /s/ Shay Tomer
——————————————
Shay Tomer
Chief Financial Officer